More annual reports from Koninklijke Philips N.V. :
2023 ReportPeers and competitors of Koninklijke Philips N.V. :
Nortech SystemsAnnual Report
2014
Innovating for a
healthier, more
sustainable world
Contents
Significant developments
In September 2014 Philips announced its plan to sharpen its strategic focus
by establishing two stand-alone companies focused on the HealthTech and
Lighting Solutions opportunities.
1 Performance highlights
2 Message from the CEO
3 Philips in 2014 at a glance
4 Our strategic focus
4.1 Addressing global challenges
4.2 How we create value
4.3 Accelerate! journey continues
4.4 Lives improved
4.5 Global presence
4.6 Our strategy in action
5 Group performance
5.1 Financial performance
5.2 Social performance
5.3 Environmental performance
5.4 Proposed distribution to shareholders
5.5 Outlook
6 Sector performance
6.1 Healthcare
6.2 Consumer Lifestyle
6.3 Lighting
6.4 Innovation, Group & Services
7 Risk management
7.1 Our approach to risk management and business
control
7.2 Risk categories and factors
7.3 Strategic risks
7.4 Operational risks
7.5 Compliance risks
7.6 Financial risks
7.7 Separation risk
8 Management
9 Supervisory Board
10 Supervisory Board report
10.1 Report of the Corporate Governance and
Nomination & Selection Committee
10.2 Report of the Remuneration Committee
10.3 Report of the Audit Committee
11 Corporate governance
11.1 Board of Management
11.2 Supervisory Board
11.3 General Meeting of Shareholders
11.4 Meeting logistics and other information
11.5 Investor Relations
To achieve this transformation, from January 1, 2015, Philips started to
integrate the sectors Consumer Lifestyle and Healthcare into one operating
company focused on our HealthTech businesses. At the same time Philips is
taking the next step in the implementation of its new operating model
which will give the company a dedicated, focused and lean management
structure, as a result of the planned integration of the relevant sector and
group layers.
The establishment of the two stand-alone companies will also involve the
split and allocation of the current Innovation, Group & Services sector to
each company in 2015. This means that in the course of 2015 the IG&S
sector as currently described in this Annual Report will disappear and no
longer be presented as a separate segment for reporting purposes.
Philips also started the process to carve out its Lighting business into a
separate legal structure and will consider various options for ownership
structures for this company with direct access to capital markets. The
proposed separation of the Lighting business impacts all businesses and
markets as well as all supporting functions and all assets and liabilities of
the Group and may require complex and time consuming disentanglement
efforts. Philips expects the separation will take approximately 12-18 months
and currently estimates separation costs to be in the range of EUR 300-400
million in 2015. However, the separation could take more time than
originally planned or anticipated, which may expose Philips to risks of
additional cost and other adverse consequences. It should be noted that
there is no certainty as to the method or timing of the separation of the
Lighting business. For further information on specific risks involved in the
separation please refer to chapter 7, Risk management, of this Annual
Report.
Finally, Philips is in discussion with external investors for the combined
Lumileds and Automotive Lighting businesses and expects to complete a
transaction in the first half of 2015. Therefore, the combined businesses of
Lumileds and Automotive are reported as discontinued operations in the
Consolidated statements of income and cash flows. As a result, Lumileds
and Automotive sales and EBITA are no longer included in the Lighting and
Group results of continuing operations. Prior-period financial information
presented and discussed in this Annual Report have been restated for the
treatment of the combined businesses of Lumileds and Automotive as
discontinued operations (see note 3, Discontinued operations and other
assets classified as held for sale). The applicable assets and liabilities of
these combined businesses are reported under Assets and Liabilities
classified as held for sale in the consolidated balance sheets as of
December 31, 2014.
These developments will have a significant impact on Philips and its
organization in many respects. From an external financial reporting
perspective, it should be noted that the planned organizational changes will
require Philips to transition to a new reporting structure in the course of
2015. At that stage, and in view of applicable IFRS requirements, Philips will
report and discuss its financial performance on the basis of different
reportable segments than the sectors currently presented and discussed in
this Annual Report.
Further updates will be provided in the course of 2015.
IFRS basis of presentation
The financial information included in this document is based on IFRS, as
explained in the note 1, Significant accounting policies, unless otherwise
indicated.
Forward-looking statements and other information
Please refer to chapter 19, Forward-looking statements and other
information, of this Annual Report for more information about forward-
looking statements, third-party market share data, fair value information,
IFRS basis of preparation, use of non-GAAP information, statutory financial
statements and management report, and reclassifications.
Dutch Financial Markets Supervision Act
This document comprises regulated information within the meaning of the
Dutch Financial Markets Supervision Act (Wet op het Financieel Toezicht).
Statutory financial statements and management report
The chapters Group financial statements and Company financial statements
contain the statutory financial statements of the Company. The introduction
to the chapter Group financial statements sets out which parts of this
Annual Report form the Management report within the meaning of Section
2:391 of the Dutch Civil Code (and related Decrees).
2
Annual Report 2014
4
6
9
10
10
12
14
15
15
16
21
21
32
38
43
43
44
45
51
56
62
67
67
69
69
71
73
74
75
76
78
80
83
83
88
90
90
94
97
99
101
12 Group financial statements
12.1 Management’s report on internal control
12.2 Report of the independent auditor
12.3 Independent auditors’ report on internal control
over financial reporting
12.4 Consolidated statements of income
12.5 Consolidated statements of comprehensive
income
12.6 Consolidated balance sheets
12.7 Consolidated statements of cash flows
12.8 Consolidated statements of changes in equity
12.9 Notes
105
106
106
107
108
109
110
112
114
115
General, sector and main countries information
1 Significant accounting policies
2
Information by sector and main country
3 Discontinued operations and other assets
classified as held for sale
4 Acquisitions and divestments
5
Interests in entities
Notes related to the income statement
Income from operations
6
7 Financial income and expenses
8
Income taxes
9 Earnings per share
Notes related to the balance sheet
10 Property, plant and equipment
11 Goodwill
12
Intangible assets excluding goodwill
15
13 Other financial assets
14 Other assets
Inventories
16 Receivables
17 Equity
18 Debt
19 Provisions
20 Post-employment benefits
21 Accrued liabilities
22 Other liabilities
Notes related to the cash flow statement
23 Cash used for derivatives and current financial
assets
24 Purchase and proceeds from non-current
financial assets
Other notes
25 Contractual obligations
26 Contingent assets and liabilities
27 Related-party transactions
28 Share-based compensation
29 Information on remuneration
30 Fair value of financial assets and liabilities
31 Details of treasury / other financial risks
32 Subsequent events
115
126
129
130
131
132
134
135
139
140
141
143
144
145
145
145
146
149
149
152
157
158
158
158
158
159
162
162
165
168
171
175
13 Company financial statements
13.1 Balance sheets before appropriation of results
13.2 Statements of income
13.3 Statement of changes in equity
13.4 Notes
A Net income
B Audit fees
C
Intangible assets
D Financial fixed assets
E Other financial assets
F Receivables
G Shareholders’ equity
H Debt
I Other current liabilities
J Employees
K Contractual obligations and contingent
liabilities not appearing in the balance sheet
L Subsequent events
13.5 Independent auditor’s report
14 Sustainability statements
14.1 Economic indicators
14.2 Social statements
14.3 Environmental statements
14.4 Independent Auditor’s Assurance Report
14.5 Global Reporting Initiative (GRI) table 4.0
15 Reconciliation of non-GAAP information
16 Five-year overview
17 Investor Relations
17.1 Key financials and dividend policy
17.2 Share information
17.3 Philips’ rating
17.4 Performance in relation to market indices
17.5 Financial calendar
17.6 Investor contact
18 Definitions and abbreviations
19 Forward-looking statements and other
information
176
177
178
178
179
179
179
179
179
180
180
180
182
182
182
182
182
183
187
192
192
207
213
214
225
229
232
232
234
236
236
239
239
241
243
Annual Report 2014
3
Performance highlights 1
1 Performance highlights
Prior-period financial information has been restated for the treatment of the combined businesses of Lumileds and Automotive as discontinued operations
(see note 3, Discontinued operations and other assets classified as held for sale) and for two voluntary accounting policy changes (see note 1, Significant
accounting policies). For a reconciliation to the most directly comparable GAAP measures, see chapter 15, Reconciliation of non-GAAP information, of this
Annual Report.
Philips Group
Key data in millions of EUR unless otherwise stated
2013 - 2014
Philips Group
Free cash flow in millions of EUR
2010 - 2014
Sales
Comparable sales growth
EBITA
as a % of sales
EBIT
as a % of sales
Net income (loss)
Net income attributable to shareholders
per common share in EUR:
basic
diluted
Net operating capital
Free cash flow
Shareholders’ equity
Employees at December 31
2013
21,990
3%
2,276
10.4%
1,855
8.4%
1,172
1.28
1.27
10,238
82
2014
21,391
(1)%
821
3.8%
486
2.3%
411
0.45
0.45
8,838
497
11,214
10,867
116,082
113,678
of which discontinued operations
10,445
8,313
1,148
1,691
(53)
610
1,645
1,886
(241)
497
Free cash flow
Operating cash flows
1,303
82
912
(543)
(663)
(830)
(806)
Net capital expenditures
‘10
‘11
‘12
‘13
‘14
Performance in millions of EUR unless otherwise stated
2013 - 2014
Group
Healthcare
Consumer Lifestyle
Lighting
Sales
2013
2014
21,990
21,391
Green Product sales
10,997
11,065
2013
9,575
2014
9,186
3,690
3,508
4%
4%
2013
4,605
2014
4,731
2,270
2,605
3%
15%
2013
7,145
2014
6,869
5,037
4,952
4%
2%
3%
1%
Sales in mature
geographies1)
Sales in growth
geographies1)
EBITA
Net operating
capital
14,322
14,004
2%
7,154
6,890
4%
2,418
2,508
4%
4,254
4,182
2%
7,668
2,276
7,387
4%
2,421
2,296
5%
2,187
2,223
2%
2,891
2,687
7%
821
64%
1,512
616
59%
483
573
19%
580
293
49%
10,238
8,838
14%
7,437
7,565
2%
1,261
1,353
7%
4,462
3,638
18%
1) For a definition of mature and growth geographies see chapter 18, Definitions and abbreviations, of this Annual Report
Philips Group
Gross margin in millions of EUR
2010 - 2014
42.3%
8,173
40.4%
8,051
42.5%
9,337
39.3%
8,729
38.4%
8,206
In value
As a % of sales
Philips Group
Net debt (cash) to group equity in billions of EUR
2010 - 2014
15.1
12.4
11.2
11.2
11.0
Group equity
0.7
0.7
1.4
2.2
Net debt (cash)
‘10
‘11
‘12
‘13
‘14
(1.2)
‘10
‘11
‘12
‘13
‘14
4
Annual Report 2014
Performance highlights 1
Philips Group
General and administrative expenses in millions of EUR
2010 - 2014
Philips Group
Research and development expenses in millions of EUR
2010 - 2014
3.8%
847
3.8%
825
4.0%
795
3.4%
657
3.5%
747
General and administrative
expenses
7.8%
1,724
453
7.5%
1,659
405
7.6%
1,635
Research and development
expenses
463
Green Innovation
7.7%
1,543
363
7.4%
1,436
313
As a % of sales
As a % of sales
1,123
1,180
1,271
1,254
1,172
Other Innovation
‘10
‘11
‘12
‘13
‘14
‘10
‘11
‘12
‘13
‘14
Philips Group
Green Product sales per sector in millions of EUR
2010 - 2014
Philips Group
Operational carbon footprint in kilotonnes CO2-equivalent
2010 - 2014
50.0%
10,997
51.7%
11,065
5,037
4,952
Lighting
As a % of sales
2,270
2,605
Consumer Lifestyle
46.3%
10,285
5,056
1,619
3,610
3,690
3,508
Healthcare
38.8%
7,719
3,955
1,101
2,663
35.8%
6,899
3,696
1,067
2,136
1,877
121
698
163
246
1,753
118
628
119
256
649
632
1,601
160
582
118
216
525
1,664
213
558
117
226
1,543
168
Discontinued operations
479
Manufacturing
124
227
Non-industrial operations
Business travel
550
545
Logistics
‘10
‘11
‘12
‘13
‘14
‘10
‘11
‘12
‘13
‘14
Philips Group
Brand value1) in billions of USD
2010 - 2014
10.3
9.8
8.7
8.7
9.0
Philips Group
New patents filed in number of patents
2010 - 2014
1,680
1,450
1,500
1,550
1,300
‘10
‘11
‘12
‘13
‘14
‘10
‘11
‘12
‘13
‘14
1) As measured by Interbrand
Annual Report 2014
5
Message from the CEO 2
2 Message from the CEO
“ We believe that our active reshaping of the portfolio is the
best way to create value for our shareholders and to ensure
a successful future for the customers and employees of
both companies.” Frans van Houten, CEO Royal Philips
mobile and cloud-based technologies that allow data
sharing will help health care systems to improve patient
outcomes, quality of care delivery and cost
productivity.
We see considerable scope to grow in this space, both
organically and through bolt-on acquisitions. Our
acquisition of Volcano is the next step in building out
our HealthTech portfolio and will strengthen our
leadership in the growing image-guided therapy
market.
Similarly, in the Lighting Solutions space, our LED-
based connected value propositions are going beyond
illumination and transforming the way we use our
personal and public spaces. By giving people satisfying
and inspiring experiences, solutions such as Power over
Ethernet office lighting, city-wide lighting management
and our Philips Hue smart home lighting are set to
transform the very fabric of modern life.
Dear stakeholder,
In 2014 we further sharpened our strategic focus and
took the next step on our Accelerate! transformation
journey by announcing our plan to establish two pure-
play, customer-focused companies in the areas of
HealthTech and Lighting Solutions – both leveraging
the trusted Philips brand.
In light of the mega-trends that are shaping our world
– growing and aging populations, the increase in
chronic diseases, urbanization, energy resource
constraints, etc. – both companies will be well placed
to capture growth opportunities as innovative
technology solutions & services partners.
Royal Philips will help address the challenges facing the
health care ecosystem through new, more integrated
forms of care delivery across the health continuum –
aided by Big Data, clinical decision support, and the
Internet of Things.
The convergence of our consumer technologies that
facilitate healthy living, our medical technologies that
help clinicians to deliver better treatment, and our
6
Annual Report 2014
The separation of our Lighting business into a lean,
agile, stand-alone company will ensure it is better
positioned to capture growth as the world leader in
energy-efficient, digital lighting solutions.
We believe that this active reshaping of the portfolio,
including the projected sale of the combined Lumileds
and Automotive Lighting components businesses, is the
best way to create value for our shareholders and to
ensure a successful future for the customers and
employees of both companies.
Performance in 2014 - a challenging year
As we had expected, 2014 was a difficult year. We
continued to improve operational performance in most
businesses, yet saw significant headwinds (e.g. market
slowdown, exchange rate fluctuations) and other items
(e.g. legal matters, restructuring, internal quality and
supply chain issues) denting our results, with EBITA
declining by 6.6 percentage points of sales.
Sales were 1% lower on a comparable basis, reflecting
sustained softness in a number of markets, including
China and Russia, and the voluntary temporary
suspension of production at our Cleveland facility.
These factors – compounded by currency effects and
the delayed ramp-up of production and shipment from
our Cleveland facility – also impacted profitability,
resulting in reported EBITA of 3.8% of sales.
Having said that, the overall figures mask some
encouraging performance and strategic shifts. At
Healthcare, a major effort was made to remediate the
situation in Cleveland and secure external certification
of the updated quality management system – setting
the stage for a better 2015 as the resumption of
shipments gathers momentum. Expanding its offering
to help consumers make healthier choices, Consumer
Lifestyle continued to perform very well, posting strong
growth and earnings. And, pursuing its four-pillar
strategy, Lighting recorded a 32% increase in LED-
based sales.
We also took decisive action to address
underperformance. At Healthcare in the US we rolled
out a new go-to-market model for enterprise-level
integrated account management. Also in North
America, we strengthened Professional Lighting
Solutions’ management team and refined a multi-
channel go-to-market model to unlock the potential we
see in that market. And in Europe, we acted to
strengthen Consumer Luminaires’ fundamentals and
cost structure, including an optimized portfolio and
supply chain.
By the end of 2014 we had completed 41% of our EUR
1.5 billion share buy-back program, and we continue
working to further improve the efficiency of our balance
sheet.
Message from the CEO 2
Supported by Accelerate!
Our Accelerate! transformation program helped us
manage through this challenging year, driving
improvements across the organization, not least in
serving our customers better. Strong customer focus
was key to securing long-term partnerships with
Karolinska University Hospital and Stockholm County
Council in Sweden, Mayo Clinic in the US, and Reinier
de Graaf hospital in the Netherlands.
We are seeing quarter-to-quarter growth in the number
of such deals, which are all about clinical knowledge,
in-depth relationships, and integrated solutions rather
than discrete products. Customers are not asking for
specific items of equipment, but rather our advice and
help in devising, for example, a care pathway to ensure
a patient is accurately diagnosed as quickly as possible
and in the operating room within 90 minutes of having
a stroke. Faced with challenges like these, our
combination of customer focus, innovative strength
and solutions thinking is key to delivering a successful
outcome.
In this context, I am very pleased that the KLAS
organization presented Philips with the Best in KLAS
award for 2014 during a ceremony at the annual RSNA
event in Chicago. The Best in KLAS rankings are based
on feedback from customers.
In 2014 we continued to apply Lean methodology to
transform our customer value chains. This again
enabled us to speed up time-to-market for our
innovations – locally relevant value propositions, such
as our affordable VISIQ ultra-mobile ultrasound
system, our smart Air Purifier in China, and our flat
SlimStyle LED light bulb. Innovations like these make a
real difference to people’s lives.
Accelerate! also helped us to deliver gross overhead
cost savings of EUR 284 million in the year, keeping us
on track to hit our 2016 cumulative target of EUR 1.8
billion.
Other key developments in 2014
In Interbrand’s annual ranking of the world’s top 100
brands, our brand value rose by 5%, passing the USD 10
billion mark for the first time.
In Philips Research’s centenary year, we underscored
our commitment to meaningful innovation by investing
EUR 1,635 million in Research & Development in line
with prior years and achieving our target of EUR 2 billion
spend on Green Innovation a year ahead of schedule.
Turning investment into intellectual property, we filed
1,680 patent applications. And with a view to capturing
opportunities to create a healthier, more sustainable
Africa, we set up an Innovation Hub for the continent in
Kenya.
We continued to deliver on our EcoVision commitments
in 2014, and our sustainability drive again received
widespread recognition – a #14 ranking in Interbrand’s
Annual Report 2014
7
Message from the CEO 2
top 50 Best Global Green Brands, acknowledgement as
a leader in both carbon disclosure and performance by
the Carbon Disclosure Project, and top scores in the
Dow Jones Sustainability Index. We also continued to
upscale our efforts in the area of circular economy,
which we believe presents a significant value-creation
opportunity. For instance, we opened a new
refurbishment center for medical imaging systems in
Best (Netherlands), signed an agreement with the
island of Aruba to revamp its entire public lighting
system, and expanded our partnership with the Ellen
MacArthur Foundation, a circular economy advocate.
I am also delighted that we were able to set up the
Philips Foundation, a registered charity organization
dedicated to helping enable lasting social change in
disadvantaged communities through the application of
innovation, talent and resources provided by Philips.
An exciting future
With our decision to create two companies in the areas
of HealthTech and Lighting Solutions, we have clearly
set our strategic direction.
The road ahead is clear, and our determination to
succeed absolute. By continuing to execute our
Accelerate! program, we will serve our customers better
and compete more effectively in the coming years. We
will listen closely to our customers, so we continue to
understand and anticipate their needs and market
requirements.
We will improve operational excellence in everything
we do, enhance our capabilities, and implement a
standard operating model. Building upon the Philips
Business System, this operating model will make us a
simpler, more agile company, while also reducing
overhead cost.
In order to drive growth, we have encouraged locally
relevant innovation, invested in developing business
with governments, boosted our advertising and
promotion investments, and started new business
creation in areas such as Healthcare Informatics,
Solutions & Services, Healthcare Transformation
Services and Personal Health Solutions.
Over the coming year we will also maintain our focus on
improving gross margins, e.g. through our Design for
Excellence (DfX) program. And we will realize
productivity gains from the overhaul of our business
model architecture, with all businesses adopting one of
four standardized business models.
In conclusion
We are proposing to the upcoming Annual General
Meeting of Shareholders to maintain this year’s
distribution at EUR 0.80 per share, in cash or stock.
8
Annual Report 2014
Philips Group
Dividend per common share in EUR
2009-2015
0.75
0.75
0.75
0.80
0.80
0.70
0.70
‘09
‘10
‘11
‘12
‘13
‘14
‘151)
1) Subject to approval by the 2015 Annual General Meeting of
Shareholders
Looking ahead, we remain cautious about the macro-
economic outlook and expect ongoing volatility in
some of our end-markets. We also anticipate further
restructuring and separation costs in 2015 and 2016.
As of year-end 2014 we are tracking one percentage
point behind on the path to achieving each of our 2016
Group financial targets. We are convinced that this does
not change our longer-term performance potential,
considering the attractiveness of the Lighting Solutions
and HealthTech markets and our competitive position.
Later this year, as we progress with the separation of
Philips and reallocation of IG&S, we will update the
market about the integral performance targets for each
of the two operating companies.
On behalf of my colleagues on the Executive
Committee, I would like to thank all our employees for
their hard work over the past year, as well as their
willingness to embrace change. And I wish to thank our
customers, shareholders and other stakeholders for the
trust and support they continue to give us.
Frans van Houten
Chief Executive Officer
3 Philips in 2014 at a glance
Philips in 2014 at a glance 3
January 9
February 4
March 3
March 17
Centenary of Philips Research
improving people’s lives
through innovation
Available in over 100
countries, the Airfryer is now
a truly global proposition
Grand total of 47 prestigious
awards at 2014 iF design
awards
Joint venture to create
leading lighting player in
Saudi Arabia
March 20
April 14
May 27
June 24
Establishment of Innovation
Hub in Kenya underlines
commitment to Africa
Red Dot Awards jury
acknowledges Philips’ design
leadership
Health care partnership with
Stockholm County Council
and Karolinska University
Hospital
Philips a top riser in
Interbrand sustainability
ranking
June 26
June 30
July 1
September 23
Strategic alliance with
Salesforce to deliver cloud-
based health care information
technology
Lumileds and Automotive
Lighting to be combined in
stand-alone company
Philips becomes official
lighting partner of FC Bayern
Munich
Plan to establish two
separate companies in
HealthTech and Lighting
Solutions
October 9
October 15
October 30
November 13
Brand value reaches a record
high in Interbrand ranking
15-year partnership with
Reinier de Graaf hospital to
enhance future patient care
Philips jumps 20 places in
Boston Consulting Group’s
innovation ranking
Philips opens new imaging
systems refurbishment facility
in the Netherlands
November 17
November 29
December 17
December 19
Philips Lighting named
European Frost & Sullivan
Lighting Company of the year
Philips presented with Best in
KLAS award for 2014, based
on customer feedback, at
RSNA
Announcement of planned
acquisition of Volcano to
expand leadership in image-
guided therapy
Philips to upgrade Madrid’s
entire street lighting system
with 225,000 connected,
energy-efficient lights
Annual Report 2014
9
Our strategic focus 4
4 Our strategic focus
4.1 Addressing global challenges
For 124 years, Philips has been a leader in building and shaping markets with our
meaningful innovations. We have always been guided by our passion to improve
people’s lives – true to our vision of making the world healthier and more sustainable
through innovation.
In 2014 we announced the next phase of our Accelerate! transformation, moving from a
holding company structured around multiple divisions to two stand-alone operating
companies – in HealthTech and Lighting Solutions – with the ambition of capturing
growth and creating value, both leveraging the trusted Philips brand.
Market opportunities
With our understanding of many of the longer-term challenges our world faces, we see major opportunities to apply
our innovative competencies and create value for our stakeholders by delivering technology solutions that improve
people’s lives more effectively.
We see a growing need for integrated health care delivery
As the population gets older, with more chronic and lifestyle-related diseases, health care systems are struggling to
increase access and quality of care while managing spiraling costs. At the same time, people are increasingly looking
for new ways to proactively monitor and manage their health. This is driving the convergence of professional health care
and consumer end-markets across the health continuum.
With customers expressing a need for integrated solutions, Royal Philips’ businesses in HealthTech – with their combined
clinical and consumer capabilities and cloud-based digital health platform – are well positioned to capture growth in
an increasingly connected world, where people are wanting to live healthier lives and societies are looking for more
effective and lower-cost solutions along the health continuum. Their total addressable market is estimated at over EUR
100 billion.
Health continuum model
Healthy living
Prevention
Diagnosis
Treatment
Recovery
Home care
Consumers
increasingly
engaged in their
health journey
Increased
emphasis on
population health
Ongoing focus on
total quality and
cost of care
Care shifting to
lower-cost settings
and homes
10
Annual Report 2014
Our strategic focus 4.1
We see increasing demand for energy-efficient and digital lighting
The lighting industry is undergoing a radical transformation, driven by the market’s transition to LED and digital
technology. Three mega-trends are providing a huge opportunity.
The rapid rise in the world’s population and in new lighting applications is increasing global demand for light. At the
same time, with lighting accounting for 19% of global electricity consumption, the world really needs that light to be
energy-efficient. And with the integration of LED technology, lighting controls and software opening up new functionality
and services, the world will also benefit from the compelling new applications that digital light can offer.
As a stand-alone company, the Lighting Solutions business will be better positioned to capture the value which is shifting
from individual products to connected LED lighting systems and services, more than offsetting the decline of
conventional lighting. Its total addressable market is estimated at over EUR 60 billion.
Lighting mega-trends
More light
More energy-efficient light
Digital light
Annual Report 2014
11
Our strategic focus 4.1
4.2 How we create value
Understanding and meeting people’s needs
At Philips, our starting point is always to understand the specific challenges local people face – whether they be a
hospital director, a city planner, a doctor, a real estate developer, a consumer, etc.
Having gained these deep insights, we then apply our outstanding innovation capabilities, strong brand, global footprint
and talented and engaged people – often in value-adding partnerships – to deliver solutions that meet these needs
and make the world healthier and more sustainable.
We measure the impact our solutions are having around the world with our independently verified Lives Improved model.
We take a two-dimensional approach – social and ecological – to improving people’s lives. Products and solutions that
directly support the curative (care) or preventive (well-being) side of people’s health, determine the contribution to the
social dimension. The contribution to the ecological dimension is determined by means of our Green Product portfolio,
such as our energy-efficient lighting.
Our business system
To ensure that success is repeatable, i.e. that we create value for our stakeholders time and time again and deliver on
our mission and vision, we have adopted the Philips Business System.
Having a single business system reduces complexity, increases speed and, crucially, allows us to spend more time with
customers and driving improvement across the company.
Our mission
To improve people’s lives through meaningful innovation
Our vision
At Philips, we strive to make the world healthier and more sustainable through innovation. Our goal is to improve the
lives of 3 billion people a year by 2025. We will be the best place to work for people who share our passion. Together
we will deliver superior value for our customers and shareholders.
Philips CAPs
Our unique strengths
Philips
Group
Strategy
Where we
invest
Mission
Vision
Guiding Statement
Philips
Excellence
How we operate
Philips Path to Value
What we deliver
Group strategy
We manage our portfolio with clearly defined strategies
and allocate resources to maximize value creation.
CAPs
We strengthen and leverage our core Capabilities,
Assets and Positions as they create differential value:
deep customer insight, technology innovation, our
brand, global footprint, and our people.
Excellence
We are a learning organization that applies common
operating principles and practices to deliver to our
customers with excellence.
Path to Value
We define and execute business plans that deliver
sustainable results along a credible Path to Value.
The ‘Creating value for our stakeholders’ diagram,
based on the International Integrated Reporting
Council framework, shows how – with the Philips
Business System at the heart of our endeavors – we use
six different forms of capital to drive value in the short,
medium and long term.
12
Annual Report 2014
Creating value
for our
stakeholders
Philips
Business
System
Capital
inputs
Value
outcomes
Human
• Employees 105,365
• Training spend EUR 45 million
on 280,000+ courses
Intellectual
• Invested in R&D EUR 1.6 billion
(Green Innovation EUR 463
million)
• Employees in R&D 11,704 in 60
R&D centers
Financial
• Debt EUR 4.1 billion
• Equity EUR 11.0 billion
• Market capitalization EUR 22.1
billion
Manufacturing
• Manufacturing sites 93, Cost
of materials used EUR 7,296
million
• Total assets EUR 28.4 billion,
Capital expenditure EUR 437
million
Natural
• Energy used in manufacturing
11,257 terajoules
• Water used 3.1 million m3
• Recycled content in our
products 13 kilotonnes
Social
• Stakeholder engagements
Capitals
Our strategic focus 4.2
Human
• Employee benefit expenses
EUR 6,080 million
• EES 72% positive
• Sales per employee EUR
204,000
Intellectual
• New patent applications 1,680
and IP royalties EBITA EUR
299 million
• New product sales EUR 440
million and 52% Green Product
sales
Financial
• Comparable sales growth %
(0.9)%
• EBITA as % of sales 3.8%
• Return on invested capital
4.5%
• Dividend paid EUR 729 million
• Taxes paid EUR 344 million
Manufacturing
• EUR 21 billion products and
solutions sold corresponding
to 1.9 billion lives improved
Natural
• CO2 emissions 1,375 kilotonnes
• 14,500 kilotonnes (estimated)
products put on market
• 75.0 kilotonnes waste, of
which 80% recycled
Social
• Brand value USD 10.3 billion
and 14th Best Global Green Brand
• Philips Foundation
Human
Intellectual
Financial
Manufacturing
Natural
Social
We employ diverse
and talented people
and give them the
skills and training
they need to ensure
their effectiveness
and their personal
development and
employability.
We apply our
innovation and
design expertise to
create new products
and solutions that
meet local customer
needs.
We raise the funds
we need for our
businesses from
capital providers.
We then prioritize
our investment
opportunities,
focusing on those
areas offering the
best prospects for
growth and returns.
We apply Lean
techniques also to
our manufacturing
processes to
produce high-
quality products. We
manage our supply
chain in a
responsible way.
We are a responsible
company and aim to
minimize the
environmental
impact of our supply
chain, our
operations, and our
products and
solutions.
We engage with
stakeholders and
contribute to
customers and
society through our
products and
solutions, but also
through our tax
payments, the
products and
services we buy, and
our investments in
local communities.
Annual Report 2014
13
Our strategic focus 4.2
4.3 Accelerate! journey continues
Path to Value
In 2011 we embarked upon our multi-year Accelerate! journey of change and performance improvement. This program
is made up of five streams intended to:
• make us more customer-focused
• resource our business/market combinations to win
• create lean end-to-end customer value chains
• implement a simpler, standardized operating model
• drive a growth and performance culture
Designed to transform Philips into a truly agile and entrepreneurial company, Accelerate! is all about delivering
meaningful innovation to our customers in local markets – and doing so in a fast and efficient way.
We are now in the fourth year of this transformation process, and our Path to Value is clearly mapped out:
Philips Group
Path to Value
Initiate new growth engines
• Invest in adjacencies
• Seed emerging business areas
Expand global leadership positions
• Invest to strengthen our core businesses
• Resource allocation to right businesses and geographies
Accelerate!
Transform to address underperformance
• Turnaround or exit underperforming businesses
• Productivity and margin improvements
• Rebuild culture, processes, systems and capabilities
• Implement the Philips Business System
2011
2016
To achieve our value creation goal, we have set ourselves targets to be realized by the end of 2016. These indicate the
value we create, as measured by sales growth, profitability and our use of capital.
Group financial targets for 2016
• Comparable sales growth 4-6%
• Reported EBITA margin 11-12%
• Return on invested capital >14%
As of year-end 2014 we are tracking 1 percentage point behind on the path to achieving each of these targets. We are
convinced that this does not change our longer-term performance potential, considering the attractiveness of the
Lighting Solutions and HealthTech markets and our competitive position. Later in 2015, as we progress with the
separation of the Lighting business from the Philips Group and the re-allocation of IG&S, we will update the market
about the integral performance targets for each of the two operating companies.
14
Annual Report 2014
4.4 Lives improved
Our strategic focus 4.4
Markets
1. Africa
2. ASEAN
3. Benelux
4. Central & East Europe
5. DACH
6. France
7. Greater China
8.
9.
Iberia
Indian Subcontinent
10.
Italy, Israel and Greece
11. Japan
12. Latin America
13. Middle East & Turkey
14. Nordics
15. North America
16. Russia and Central Asia
17. UK & Ireland
Lives improved (millions)1)
Population (millions)2)
GDP (USD billions)3)
48
208
28
88
91
59
334
44
174
51
26
127
95
26
349
81
49
1.137
938
28
130
98
66
1.401
58
1.476
79
126
500
335
26
478
263
69
2.504
5.789
1.472
1.585
4.939
2.909
11.626
1.633
2.330
2.693
4.770
4.697
3.445
1.722
20.511
2.623
3.105
1) Source: Philips
2) Source: The World Bank, CIA Factbook & Wikipedia
3) Source: IMF, CIA Factbook & Wikipedia
4.5 Global presence
Markets
Asia & Pacific
EMEA
Latin America
Sales
6,226
7,261
1,226
North America
6,678
Number of
employees
Employees
female
Employees male
R&D centers
Manufacturing
sites
Tangible and
intangible assets
40,049
34,417
7,910
22,989
36%
32%
46%
35%
64%
68%
54%
65%
10
28
2
20
21
34
6
32
1,796
2,916
110
7,799
Annual Report 2014
15
1139271611121514810654317
Our strategic focus 4.6
4.6 Our strategy in action
Family-centered care for newborns
In a child’s first precious weeks of life, every parent knows their family is
the center of the universe. And when that child is sick, medics need every
tool to ensure that family gets the best care.
philosophy of the Family Center Care, the collaboration
ensures the well-being of all the people involved – the
child, the family and the healthcare staff.
“Family-centered care is our philosophy, we want to
combine technology with humanization and place the
mother and newborn at the center of this,” says
Professor Fabio Mosca, Director of the Intensive
Neonatal Unit at Italy’s Mangiagalli Hospital.
Instead of his intensive care unit being a place defined
by life and death, it has, thanks to Philips, become a unit
remarkably attuned to the specific rhythms of mother
and baby. The entire unit’s environment has been
adapted specifically for two main reasons. First, to
boost the baby’s immune system and, second, to
improve a mother’s chance of breast-feeding
successfully.
This is a great example of the kind of partnership Philips
has perfected – improving people’s lives through using
innovative technologies, skills and know-how
throughout the continuum of care. By sharing the
.
16
Annual Report 2014
Our strategic focus 4.6
Getting to the heart of health
Recent research suggests that the ongoing health of our teeth and gums
has a connection with the health of our heart.
Which is why some innovative thinking from Philips
specifically focused on how to improve dental care has
had such a profound effect on the way we manage our
lifestyles, no matter how old we are or where we live.
Everyone knows that brushing teeth regularly is
essential for good oral hygiene, but sometimes to truly
improve people’s lives, we need a helping hand from
technology. As Michael Noack, Professor of Dental Care
& Periodontology at the University of Cologne states,
the applied technology of the revolutionary Philips
Sonicare electric toothbrush protects gums and
removes plaque far better than regular toothbrushes.
The difference between the two is obvious, he says.
A consumer medical breakthrough that was first
developed in the 1980s and which has been
continuously perfected since, the Sonicare electric
toothbrush is designed to empower people to take
control of their personal dental care. It’s the very
embodiment of the sort of meaningful, impactful
innovations that Philips has become synonymous with.
“My personal experience is that patients who use
Philips Sonicare have an easier time removing biofilm
plaque.” Michael Noack, Professor of Dental Care &
Periodontology, University of Cologne
Annual Report 2014
17
Our strategic focus 4.6
Illumination and beyond
Connected lighting systems combine intelligent illumination with data
and connectivity to deliver the best possible lighting experience and
extraordinary value beyond illumination.
In indoor spaces, light points can also be outfitted with
wireless communications. Because lighting is installed
virtually everywhere that people go, the lighting system
becomes a pervasive platform for information and
services.
Businesses can create mobile apps to deliver in-
context information and a range of location-based
services to the users of indoor spaces, including indoor
wayfinding, in-context information, personalization,
and targeted discounts.
Connected lighting can also integrate with third-party
technologies, creating flexible, scalable systems that
can be configured to respond to the specific
requirements of professional and public environments.
In a connected lighting system, every light point is
networked together and digitally controlled, creating a
more intelligent, flexible, efficient, and dynamic lighting
system.
When merged with the IT network in a building or city
and connected to lighting management software, a
connected lighting system allows the managers of
spaces to simplify and streamline the commissioning,
monitoring, and management of lighting in a city or
facility, exercise greater control over the ambience and
atmosphere of illuminated spaces, and improve energy
efficiency.
By outfitting light points with motion, occupancy, and
other kinds of sensors, a connected lighting system can
provide deeper insight into the usage and activities of
indoor and outdoor spaces.
With real-time and historical occupancy data,
managers can specifically target the distribution of
lighting and other resources, such as heating, cooling,
and cleaning, to achieve unprecedented levels of
energy efficiency and sustainability.
18
Annual Report 2014
Our strategic focus 4.6
Small in size, big in recycled plastics
With high recycled plastic content and other sustainability credentials,
the new SENSEO® Up coffee machine is part of a major initiative to
incorporate recycled plastics into product design.
In designing SENSEO® Up – our first one-cup coffee
machine aimed at single or double households – we
challenged our designers to specify recycled plastics
right from the start of the design process.
The designers had to contend with two challenges. The
first was a question of aesthetics. Recycled plastics are
only available in dark colors, but not a real deep black.
We overcame this problem by using a different
architecture built around an internal frame that is not
visible to the end-user.
The second challenge was to use recycled plastics in
the baseplate. First, we textured the part to give the
recycled plastic a high-quality look and feel. Then we
used one matt black color for the complete range
instead of many color variations. And thirdly, we made
the baseplate less visible by focusing attention on the
colored housing above it. This approach allowed us to
make the baseplate from 90% ABS plastic from post-
consumer electronic waste.
By designing-in the use of recycled plastics from the
outset, we succeeded in launching the new SENSEO®
Up with 13% recycled plastics content. SENSEO® Up
offers other environmental benefits too. Its compact
size means that it needs less packaging and causes
fewer emissions in transport. And it goes to off mode
immediately after the coffee is brewed, saving 10%
energy compared to other SENSEO® machines shutting
off automatically.
Annual Report 2014
19
Our strategic focus 4.6
Slim LED bulb, slimmer utility bills
Breaking with traditional design, the Philips SlimStyle LED bulb shows
that a value-priced offering can deliver the innovation, energy efficiency
and light quality that consumers want.
Having defined the required design, there were still
significant technical hurdles to be overcome. As Peter
Bukkems, Senior Mechanical Engineer, Philips Lighting
explains: “For me as mechanical engineer the biggest
challenge was to combine the thermal and optical
disciplines into one product. We solved the thermal
performance by removing the expensive aluminum
heat sink and making direct contact from the LED board
towards the covers. We integrated the optics into the
clean plastic materials. We made the assembly
complete by using ultrasonic welding – we didn’t use
any screws or glue in the design, but simply melted the
two covers together.”
Innovative design, affordable price, lasting energy
savings, and no compromise on light quality – it’s a
winning combination.
“The main drive to start the SlimStyle project was to
maintain our leadership position in LED lighting
worldwide,” says Agnieszka Kudyba, Integral Project
Leader at Philips Lighting. “We’re in the midst of the LED
revolution. Now we need to make sure we get mass
adoption. The challenge was to get a replacement for
the 60 W bulb, lasting for 25,000 hours, below 10
dollars. And we had to get it on the shelf within six
months in order to strengthen our position as a leader
in LED lighting. And we did it!”
The main architectural challenges in this project were
to achieve the lowest cost possible and to fulfill US
ENERGY STAR requirements. “From past experience we
learned that we needed to reduce the number of
components of the lamp,” explains Gon Weijers,
Architect, Philips Lighting. “So we moved from more
than 10 parts to only five parts in this lamp, which makes
disassembly and recycling of the lamp much easier. And
also, its compactness and low weight reduces shipping
costs and CO2 emissions. The combination of all these
insights led us to the design of this lamp, which is flat,
functional and innovative.”
20
Annual Report 2014
5 Group performance
Group performance 5
“ Overall, 2014 was a setback in our performance trajectory.
We have taken clear action to drive stronger operational
performance across our business, and expect sales growth
and EBITA margin improvements in 2015 and beyond.”
Ron Wirahadiraksa, CFO Royal Philips
5.1 Financial performance
Prior-period financial information has been restated for
the treatment of the combined businesses of Lumileds
and Automotive as discontinued operations (see note 3,
Discontinued operations and other assets classified as
held for sale) and for two voluntary accounting policy
changes (see note 1, Significant accounting policies).
Management summary
The year 2014
• In 2014, we continued to improve operational performance
in most businesses, yet saw significant headwinds -
ranging from geo-political crises and exchange rate
fluctuations, to legal matters and the voluntary suspension
of production at the Cleveland facility. In 2014, the
voluntary suspension of production at our Cleveland
facility and the jury verdict in the Masimo litigation strongly
impacted our 2014 performance.
At our Healthcare facility in Cleveland, Ohio, certain issues
in the general area of manufacturing process controls were
identified during an ongoing US Food and Drug
Administration (FDA) inspection. To address these issues,
on January 10, 2014 we started a voluntary, temporary
suspension of new production at the facility, primarily to
strengthen manufacturing process controls. The
suspension negatively impacted Healthcare’s sales and
EBITA in 2014.
On October 3, 2014 Philips announced that it would
appeal the jury verdict in the patent infringement lawsuit
by Masimo Corporation (Masimo), in which Masimo was
awarded compensation of USD 467 million (EUR 366
million). The jury verdict is part of extensive litigation,
which started in 2009, between Masimo and Philips
involving several claims and counterclaims related to a
large number of patents.
• Net income for the year amounted to EUR 411 million, as
lower operational earnings were partly offset by lower
income tax expense and higher results from investments
in associates and discontinued operations.
• Sales amounted to EUR 21,391 million, a 3% nominal
decline for the year. Excluding unfavorable currency
effects, comparable sales were 1% below the level of 2013,
Annual Report 2014
21
Group performance 5.1
due to Healthcare and Lighting. Healthcare comparable
sales declined by 2%, mainly due to Imaging Systems.
Lighting comparable sales were 3% below the level of
2013, as declines at Light Sources & Electronics and
Consumer Luminaires were tempered by growth at
Professional Lighting Solutions. Comparable sales at
Consumer Lifestyle were 6% above the level of 2013,
mainly driven by double-digit growth at Health & Wellness.
• Comparable sales in growth geographies were in line with
2013, while mature geographies declined by 1% as a result
of the overall macroeconomic developments. In 2014,
growth geographies accounted for 35% of total sales.
• EBIT amounted to EUR 486 million, or 2.3% of sales,
compared to EUR 1,855 million, or 8.4% of sales, in 2013.
EBIT declines at Healthcare, Lighting and IG&S were partly
offset by an improvement at Consumer Lifestyle.
• Operating activities generated cash flows of EUR 1,303
million, which was EUR 391 million higher than in 2013. The
increase was mainly due to higher cash inflows and
working capital reductions in 2014, as well as the payment
of the European Commission fine in 2013. Cash flows
before financing activities were EUR 269 million higher
than in 2013, as an increase in cash flows from operating
activities was partly offset by higher outflows related to
acquisitions of new businesses.
• By the end of 2014, Philips had completed 41% of the EUR
1.5 billion share buy-back program.
Philips Group
Key data in millions of EUR unless otherwise stated
2012 - 2014
2012
2013
2014
22,234
21,990
21,391
1,003
2,276
4.5%
10.4%
592
2.7%
(329)
(218)
1,855
8.4%
(330)
(466)
821
3.8%
486
2.3%
(301)
(26)
(211)
(25)
62
(166)
1,034
221
136
(30)
138
1,172
190
411
Condensed statement of income
Sales
EBITA 1)
as a % of sales
EBIT
as a % of sales
Financial income and expenses
Income tax expense
Results of investments in
associates
Income (loss) from continuing
operations
Income from discontinued
operations - net of income tax
Net income (loss)
Other indicators
Net income (loss) attributable to
shareholders per common share
in EUR:
basic
diluted
(0.04)
(0.04)
1.28
1.27
0.45
0.45
Net operating capital (NOC)1)
9,316
10,238
8,838
Cash flows before financing
activities1)
1,174
50
319
Employees (FTEs)
118,087
116,082
113,678
of which discontinued
operations
10,631
10,445
8,313
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
5.1.1 Sales
The composition of sales growth in percentage terms in
2014, compared to 2013, is presented in the table below.
Philips Group
Sales growth composition in %
2014 versus 2013
com-
parable
growth
currency
effects
consoli-
dation
changes
nominal
growth
(2.0)
(1.6)
(0.5)
(4.1)
5.8
(2.6)
(11.8)
(0.9)
(3.1)
(2.3)
(0.1)
(2.0)
0.0
1.0
2.9
0.2
2.7
(3.9)
(9.0)
(2.7)
Healthcare
Consumer
Lifestyle
Lighting
Innovation, Group
& Services
Philips Group
Group sales amounted to EUR 21,391 million in 2014,
which represents a 3% nominal decline compared to
2013.
Adjusted for a 2% negative currency effect, comparable
sales were 1% below the level of 2013. Comparable sales
were up 6% at Consumer Lifestyle. Healthcare and
Lighting saw comparable sales decline by 2% and 3%
respectively.
Healthcare sales amounted to EUR 9,186 million, which
was EUR 389 million lower than in 2013. Mid-single-
digit growth at Customer Services and low-single-digit
growth at Patient Care & Monitoring Solutions were
offset by a double-digit decline at Imaging Systems.
Healthcare Informatics, Solutions & Services sales were
in line with 2013. Mature geographies recorded a low-
single-digit decline, mainly due to North America and
Western Europe. Growth geographies also recorded a
low-single-digit decline, with solid growth in Latin
America and Middle East & Turkey offset by a double-
digit decline in China.
Consumer Lifestyle reported sales of EUR 4,731 million,
which was EUR 126 million higher than in 2013, or 6%
higher on a comparable basis. Health & Wellness
achieved double-digit growth and Domestic
Appliances high-single-digit growth, while Personal
Care recorded low-single-digit growth. Growth
geographies achieved high-single-digit growth, driven
by strong growth in China, India and Middle East &
Turkey. Mature geographies recorded low-single-digit
growth, with mid-single-digit growth in Western Europe
and other mature geographies and low-single-digit
growth in North America.
Lighting sales amounted to EUR 6,869 million, which
was EUR 276 million lower than in 2013, or 3% lower on
a comparable basis. A high-single-digit decline at
Consumer Luminaires and mid-single-digit decline at
Light Sources & Electronics were tempered by low-
single-digit growth at Professional Lighting Solutions. A
low-single-digit decline was seen in mature
22
Annual Report 2014
Group performance 5.1.2
geographies, largely due to Western Europe and North
America. Growth geographies recorded a mid-single-
digit decline, mainly driven by China.
Philips Group
Sales, EBIT and EBITA
in millions of EUR unless otherwise stated
2013 - 2014
IG&S reported sales of EUR 605 million, which was EUR
60 million lower than in 2013, mainly due to lower
royalty income.
5.1.2 Earnings
In 2014, Philips’ gross margin was EUR 8,206 million, or
38.4% of sales, compared to EUR 9,337 million, or 42.5%
of sales, in 2013. Gross margin in 2014 included EUR 249
million of restructuring and acquisition-related charges,
whereas 2013 included EUR 48 million of restructuring
and acquisition-related charges. 2014 also included
charges of EUR 366 million related to the jury verdict in
the Masimo litigation, EUR 68 million of impairment and
other charges, and EUR 49 million of mainly inventory
write-downs related to the voluntary suspension of
production at the Cleveland facility. Excluding these
items, the year-on-year decline was mainly driven by
operational decline at Healthcare and Lighting as well
as negative currency impacts.
Selling expenses increased from EUR 5,057 million in
2013 to EUR 5,124 million in 2014. 2014 included EUR 128
million of restructuring and acquisition-related charges,
compared to EUR 45 million of restructuring charges in
2013. The year-on-year increase was mainly
attributable to higher restructuring activities. Selling
expenses increased from 23.0% of sales to 24.0%.
General and administrative expenses amounted to EUR
747 million in 2014, compared to EUR 825 million in
2013. As a percentage of sales, costs decreased from
3.8% in 2013 to 3.5% in 2014. 2014 included EUR 23
million of restructuring and acquisition related-charges,
compared to EUR 5 million in 2013. 2014 also included
a EUR 67 million past-service pension gain in the
Netherlands, while 2013 included a pension settlement
loss of EUR 31 million.
Research and development costs decreased from EUR
1,659 million in 2013 to EUR 1,635 million in 2014.
Research and development costs in 2014 included EUR
34 million of restructuring and acquisition-related
charges, compared to EUR 2 million in 2013. The year-
on-year decrease was mainly due to lower spend at
IG&S, partly offset by higher restructuring costs in all
sectors. As a percentage of sales, research and
development costs increased from 7.5% in 2013 to 7.6%
in 2014.
The overview below shows sales, EBIT and EBITA
according to the 2014 sector classifications.
Sales
EBIT
%
EBITA1)
%
2014
Healthcare
9,186
456
5.0%
616
6.7%
Consumer
Lifestyle
Lighting
Innovation,
Group & Services
4,731
6,869
605
Philips Group
21,391
520
185
(675)
486
11.0%
2.7%
−
2.3%
573
293
(661)
821
12.1%
4.3%
−
3.8%
2013
Healthcare
9,575
1,315
13.7%
1,512
15.8%
Consumer
Lifestyle
Lighting
Innovation,
Group & Services
4,605
7,145
429
413
9.3%
5.8%
483
580
10.5%
8.1%
665
(302)
−
(299)
−
Philips Group
21,990
1,855
8.4%
2,276
10.4%
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
In 2014, EBIT decreased by EUR 1,369 million year-on-
year to EUR 486 million, or 2.3% of sales. 2014 included
EUR 434 million of restructuring and acquisition-
related charges, compared to EUR 100 million in 2013.
2014 included EUR 366 million related to the jury verdict
in the Masimo litigation, EUR 49 million mainly related
to inventory write-downs in the Cleveland facility,
charges of EUR 244 million related to legal matters, EUR
68 million of impairment and other charges related to
industrial assets at Lighting, and a EUR 67 million past-
service pension cost gain in the Netherlands. 2013 EBIT
was also impacted by a net gain of EUR 47 million from
a past-service pension cost gain and related settlement
loss in the US, as well as a EUR 21 million gain on the
sale of a business in Healthcare.
Amortization and impairment of intangibles, excluding
software and capitalized product development costs,
amounted to EUR 332 million in 2014, compared to EUR
393 million in 2013. In 2014, goodwill impairment
charges amount to EUR 3 million consisting of
impairments on divested businesses in Healthcare and
Lighting. In 2013, goodwill impairment charges
amounted to EUR 28 million, including EUR 26 million
as a result of reduced growth expectations in Consumer
Luminaires, see note 11, Goodwill.
EBITA declined from EUR 2,276 million, or 10.4% of
sales, in 2013 to EUR 821 million, or 3.8% of sales, in
2014. EBITA showed a year-on-year decrease at all
sectors except Consumer Lifestyle.
Healthcare
EBITA decreased from EUR 1,512 million, or 15.8% of
sales, in 2013 to EUR 616 million, or 6.7% of sales, in
2014. Restructuring and acquisition-related charges in
2013 were close to zero, compared to EUR 70 million in
2014. 2014 included EUR 366 million related to the jury
Annual Report 2014
23
Group performance 5.1.3
verdict in the Masimo litigation, EUR 49 million mainly
related to inventory write-downs in the Cleveland
facility, and a EUR 16 million past-service pension cost
gain in the Netherlands. 2013 included a past-service
pension cost gain of EUR 61 million and a gain on the
sale of a business of EUR 21 million. The decline in EBITA
was largely due to operational losses related to the
voluntary suspension of production at the Cleveland
facility and negative currency impacts.
Consumer Lifestyle
EBITA improved from EUR 483 million, or 10.5% of sales,
in 2013 to EUR 573 million, or 12.1% of sales, in 2014. 2014
included restructuring and acquisition-related charges
of EUR 9 million and a EUR 11 million past-service
pension cost gain in the Netherlands. 2013 included
restructuring and acquisition-related charges of EUR 14
million and a past-service pension cost gain of EUR 1
million in the US. The increase was largely driven by
higher sales and operational improvements.
Lighting
EBITA declined from EUR 580 million, or 8.1% of sales,
in 2013 to EUR 293 million, or 4.3% of sales, in 2014.
Restructuring and acquisition-related charges
amounted to EUR 245 million in 2014, compared to EUR
83 million in 2013. 2014 EBITA included EUR 68 million
of impairment and other charges related to industrial
assets and a EUR 13 million past-service pension cost
gain in the Netherlands, while 2013 EBITA included a
past-service pension cost gain of EUR 10 million in the
US. The decrease in EBITA was largely driven by higher
restructuring charges and lower sales volume.
Innovation, Group & Services
EBITA declined from a loss of EUR 299 million in 2013
to a loss of EUR 661 million in 2014. 2014 EBITA included
restructuring and acquisition-related charges of EUR
110 million, provisions of EUR 244 million related to
legal matters and a EUR 27 million gain from a past-
service pension cost gain in the Netherlands. 2013
included restructuring and acquisition-related charges
of EUR 3 million and a pension settlement loss of EUR
25 million. Excluding these items, the year-on-year
EBITA decline was mainly driven by higher investments
in emerging business areas and lower IP income.
Philips increased its brand value by 5% to over USD 10.3
billion in the 2014 ranking of the world’s 100 most
valuable brands, as measured by Interbrand. In the 2014
listing, Philips is now ranked the 42nd most valuable
brand in the world.
Philips Group
Advertising and promotion expenses in millions of EUR
2010 - 2014
4.3%
852
3.7%
829
3.9%
760
4.3%
913
4.0%
869
Advertising and promotion
expenses
As a % of sales
‘10
‘11
‘12
‘13
‘14
5.1.4 Research and development
Research and development costs decreased from EUR
1,659 million in 2013 to EUR 1,635 million in 2014. 2014
included EUR 34 million of restructuring and
acquisition-related charges, compared to EUR 2 million
in 2013. The year-on-year decrease was driven by IG&S,
partly offset by increases at Healthcare and Lighting. As
a percentage of sales, research and development costs
increased from 7.5% in 2013 to 7.6%.
Philips Group
Research and development expenses in millions of EUR
2010 - 2014
7.8%
1,724
7.5%
1,659
7.6%
1,635
Research and development
expenses
7.7%
1,543
7.4%
1,436
As a % of sales
5.1.3 Advertising and promotion
Philips’ total advertising and promotion expenses were
EUR 913 million in 2014, an increase of 5% compared to
2013. The increase was mainly due to investments in
mature markets, such as the Netherlands, Germany and
United States. The advertising and promotion spend in
key growth geographies decreased by 5% compared to
2013, largely due to lower spend in China. The total
advertising and promotion investment as a percentage
of sales was 4.3% in 2014, compared to 4.0% in 2013.
‘10
‘11
‘12
‘13
‘14
Philips Group
Research and development expenses in millions of EUR
2012 - 2014
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
2012
2013
2014
858
256
341
269
810
268
313
268
822
263
330
220
Philips Group
1,724
1,659
1,635
24
Annual Report 2014
5.1.5 Pensions
In 2014, the total costs of post-employment benefits
amounted to EUR 241 million for defined-benefit plans
and EUR 144 million for defined-contribution plans,
compared to EUR 291 million and EUR 134 million
respectively in 2013.
The above costs are reported in Operating expenses
except for the net interest cost component which is
reported in Financial income and expense. The net
interest cost for defined-benefit plans was EUR 59
million in 2014 (2013: EUR 71 million).
2014 included past-service cost gains in the
Netherlands of EUR 67 million, which were mainly
related to the mandatory plan change in the
Netherlands, where a salary cap of EUR 100,000 must
be applied to the pension salary with effect from
January 1, 2015. This change lowers the Company’s
Defined Benefit Obligation which is recognized as a
past-service cost gain. Compensatory measures are
given in wages for employees impacted.
2013 included past-service cost gains of EUR 81 million,
which included EUR 78 million related to the
announced freeze of accrual after December 31, 2015
for salaried workers in the Company’s US defined-
benefit pension plan. In the same US plan a settlement
loss of EUR 31 million was recognized in 2013 following
a lump-sum offering to terminated vested employees.
This offering resulted in settling the pension obligations
towards these employees. The past-service cost gain is
allocated to the respective sectors of the US employees
involved, whereas the settlement loss is allocated fully
to Pensions in IG&S as it related to inactive employees.
The overall funded status of our defined-benefit
pension plans in 2014 decreased compared to 2013 due
to a decrease in discount rates used to measure the
defined benefit obligation. The deficits recognized on
our balance sheet increased by approximately EUR 393
million due to lower discount rates in the US and
Germany and a new adopted mortality table in the US.
In 2014, further progress was made in managing the
financial exposure to defined-benefit plans by two
further buy-ins in the UK plan.
Healthcare
Consumer Lifestyle
Lighting
For further information, refer to Post-employment
benefits.
5.1.6 Restructuring and impairment charges
In 2014, EBIT included net charges totaling EUR 414
million for restructuring. In addition to the annual
goodwill-impairment tests for Philips, trigger-based
impairment tests were performed during the year,
resulting in a goodwill impairment of EUR 1 million at
Healthcare and EUR 2 million at Lighting.
Innovation, Group & Services
Continuing operations
Discontinued operations
Cost breakdown of restructuring and
related charges:
Personnel lay-off costs
Release of provision
Restructuring-related asset
impairment
Other restructuring-related costs
Continuing operations
Discontinued operations
Group performance 5.1.5
2013 included EUR 84 million of restructuring charges
and a goodwill impairment of EUR 26 million at
Consumer Luminaires, mainly as a consequence of
reduced growth rates resulting from a slower-than-
anticipated recovery of certain markets, as well as
delays in the introduction of new product ranges.
For further information on sensitivity analysis, please
refer to note 11, Goodwill.
In 2014, the most significant restructuring projects
related to Lighting and IG&S and were driven by
industrial footprint rationalization and the Accelerate!
transformation program. Restructuring projects at
Lighting centered on Light Sources & Electronics and
Professional Lighting Solutions, the largest of which
took place in the Belgium, Netherlands and France.
Innovation, Group & Services restructuring projects
mainly were related to IT and group and country
overheads and centered primarily on the Netherlands,
US and Belgium. Restructuring projects at Healthcare
mainly took place in the US and the Netherlands.
Consumer Lifestyle restructuring projects were mainly
in the Netherlands.
In 2013, the more significant restructuring projects were
related to industrial footprint rationalization at Lighting.
The largest projects were centered at Consumer
Luminaires and Light Sources & Electronics, mainly in
the Unites States, France and Belgium. Innovation
Group & Services restructuring projects were largely
focused on the Financial Operations Service Units,
primarily in Italy, France and the United States.
Restructuring projects at Consumer Lifestyle were
mainly seen at Personal Care in the Netherlands and
Austria and Coffee in Italy.
For further information on restructuring, refer to note 19,
Provisions.
Philips Group
Restructuring and related charges in millions of EUR
2012 - 2014
Restructuring and related charges per
sector:
2012
2013
2014
116
38
294
56
504
36
414
(33)
66
57
504
36
(6)
10
77
3
84
33
95
(62)
25
26
84
33
68
8
225
113
414
18
354
(36)
57
39
414
18
Annual Report 2014
25
Group performance 5.1.7
5.1.7 Financial income and expenses
A breakdown of Financial income and expenses is
presented in the table below.
Philips Group
Financial income and expenses in millions of EUR
2012 - 2014
Interest expense (net)
Sale of securities
Impairments
Other
2012
(326)
1
(8)
4
2013
(269)
–
(10)
(51)
2014
(251)
60
(17)
(93)
Financial income and expenses
(329)
(330)
(301)
Net interest expense in 2014 was EUR 18 million lower
than in 2013, mainly as a result of lower average
outstanding debt and interest related to pensions in
2014.
The results related to investments in associates
improved from a loss of EUR 25 million in 2013 to a gain
of EUR 62 million in 2014. 2014 included a EUR 32
million dilution gain related to Philips’ stake in Corindus
Vascular Robotics, while 2013 included a provision for
the net impact of expected payments related to the
agreed transfer of the remaining 30% stake in the TP
Vision joint venture.
The Company’s participation in income increased from
EUR 5 million in 2013 to a gain of EUR 30 million in 2014.
The gain in 2013 was mainly attributable to the results
of Philips Medical Capital.
For further information, refer to note 5, Interests in
entities.
5.1.10 Non-controlling interests
The gain from the sale of stakes in 2014 amounted to
EUR 60 million, mainly from Neusoft, Chimei Innolux,
Gilde III and Sapiens.
Net income attributable to non-controlling interests
amounted to a loss of EUR 4 million in 2014, compared
to a gain of EUR 3 million in 2013.
Other financial expense amounted to EUR 93 million in
2014, primarily consisting of interest expense related to
the jury verdict in the Masimo litigation, and accretion
expense associated with other discounted provisions
and uncertain tax positions.
For further information, refer to note 7, Financial income
and expenses.
5.1.8 Income taxes
Income taxes amounted to EUR 26 million, compared
to EUR 466 million in 2013. The effective income tax rate
was 14.1%. The decrease in 2014 was mainly due to
lower income before tax and application of favorable
tax regulations relating to R&D investments. The
comparable effective income tax rate for 2013 was
30.6%.
For 2015, the effective tax rate is expected to be in the
range of 28% and 30%. However, the actual rate will
depend on the geographical mix of actual profits.
For further information, refer to note 8, Income taxes.
5.1.9 Results of investments in associates
Philips Group
Results of investments in associates in millions of EUR
2012 - 2014
2012
2013
2014
Company’s participation in income
(5)
5
Investment impairment and other
charges
Dilution gain
Results of Investments in
associates
(206)
–
(30)
–
(211)
(25)
30
–
32
62
5.1.11 Discontinued operations
Discontinued operations consist primarily of the
combined businesses of Lumileds and Automotive, the
Audio, Video, Multimedia and Accessories (AVM&A)
business, and the Television business. The results
related to these businesses are reported under
Discontinued operations in the Consolidated
statements of income and Consolidated statements of
cash flows.
On June 30, 2014, Philips announced the start of the
process to combine the Lumileds and Automotive
Lighting businesses into a stand-alone company and
explore strategic options to attract capital from third-
party investors for this combined business. Philips is
actively discussing the sale of the business with
potential buyers and expects a transaction to be
completed in the first half of 2015.
The AVM&A business, also known as WooX Innovations,
was divested to Gibson Brands Inc. in June 2014.
The Television business was divested as part of a
strategic partnership agreement with TPV Technology
Ltd (TPV) that was signed on April 1, 2012. Philips
retained a 30% interest in TP Vision Holdings BV (TP
Vision venture) and on May 29, 2014 transferred the
remaining 30% stake in TP Vision to TPV. After
completion, TPV fully owns TP Vision, which will enable
further integration with TPV’s TV business.
Income from discontinued operations increased by
EUR 52 million to EUR 190 million in 2014. The year-on-
year increase was mainly due to a net gain related to
the divestment of our Television business. Income from
discontinued operations mainly consisted of net
income of EUR 141 million related to the combined
businesses of Lumileds and Automotive, EUR 18 million
26
Annual Report 2014
Group performance 5.1.12
related to AVM&A, and EUR 31 million mainly related to
other dicontinued operations mainly net income on the
Television business, partly offset by the European
Commission’s Smartcard fine.
For further information, refer to note 3, Discontinued
operations and other assets classified as held for sale.
Also in 2012, Philips agreed to extend its partnership with
Sara Lee Corp (Sara Lee) to drive growth in the global coffee
market. Under a new exclusive partnership framework, which
will run through to 2020, Philips will be the exclusive
SENSEO® consumer appliance manufacturer and distributor
for the duration of the agreement. As part of the agreement,
Philips divested its 50% ownership right in the SENSEO®
trademark to Sara Lee.
5.1.12 Net income
Net income decreased from EUR 1,172 million in 2013 to
EUR 411 million in 2014. The decrease was largely due
to lower EBIT of EUR 1,369 million, partly offset by lower
income tax charges of EUR 440 million and higher
results from investment in associates of EUR 87 million.
Basic earnings per common share from net income
attributable to shareholders decreased from EUR 1.28
per common share in 2013 to EUR 0.45 per common
share in 2014.
5.1.13 Acquisitions and divestments
Acquisitions
In 2014, Philips acquired Unisensor, a Danish healthcare
company, and a 51% interest in General Lighting
Company (GLC) based in The Kingdom of Saudi Arabia
(KSA). Philips also purchased some minor magnetic
resonance imaging (MRI) activities from Hologic, a US
healthcare company. Acquisitions in 2014 and previous
years led to post-merger integration charges of EUR 1
million in Healthcare, EUR 1 million in Consumer
Lifestyle and EUR 19 million in Lighting.
In 2013, there were four minor acquisitions. Acquisitions
in 2013 and previous years led to post-merger
integration charges totaling EUR 16 million in 2013:
Healthcare EUR 6 million, Consumer Lifestyle EUR 4
million, and Lighting EUR 6 million.
In 2012, Philips completed the acquisition of Indal
within Lighting. Acquisitions in 2012 and previous years
led to post-merger integration charges totaling EUR 50
million in 2012: Healthcare EUR 18 million, Consumer
Lifestyle EUR 18 million, and Lighting EUR 14 million.
Divestments
In 2014, Philips completed the divestment of its
Lifestyle Entertainment activities to Gibson Brands Inc.
Philips also completed two other divestments of
business activities which related to Healthcare and
Lighting activities.
In 2013, Philips completed several divestments of business
activities, mainly related to certain Healthcare activities.
In 2012, Philips completed several divestments of business
activities, namely the Television business, certain Lighting
manufacturing activities, Speech Processing activities and
certain Healthcare service activities.
For details, please refer to note 4, Acquisitions and
divestments.
5.1.14 Performance by geographic cluster
In 2014, sales declined 1% on a comparable basis (-3%
nominally largely attributable due to unfavorable foreign
exchange impacts) mainly due to Healthcare and Lighting.
Sales in mature geographies were EUR 318 million lower than
in 2013, or 1% lower on a comparable basis. Sales in Western
Europe were 1% lower than in 2013, with declines at
Healthcare and Lighting partly offset by growth at Consumer
Lifestyle. Sales in North America declined by EUR 205
million, or 2% on a comparable basis. Comparable sales in
other mature geographies showed a 1% decline, with growth
at Healthcare and Consumer Lifestyle offset by a decline at
Lighting and IG&S.
In growth geographies, sales declined by EUR 281 million
mainly due to unfavorable foreign exchange impacts and
were flat on a comparable basis, with high-single-digit
growth at Consumer Lifestyle offset by a decline at
Healthcare and Lighting. Strong growth was achieved in India
and Middle East & Turkey, while decline was seen in China
and Russia & Central Asia.
Philips Group
Comparable sales growth by geographic cluster1) in %
2012 - 2014
13.6
8.9
1.9
(0.3)
(1.3)
5.5
2.7
0
(0.9)
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
Mature geographies
Growth geographies
Philips Group
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
Annual Report 2014
27
Group performance 5.1.15
Philips Group
Sales by geographic cluster in millions of EUR
2012 - 2014
22,234
21,990
21,391
7,387
1,821
7,340
7,668
1,759
6,883
7,387
Growth
1,661
Other mature
6,678
North America
5,686
5,680
5,665
Western Europe
‘12
‘13
‘14
5.1.15 Cash flows provided by continuing
operations
Cash flows from operating activities
Net cash flows from operating activities amounted to
EUR 1,303 million in 2014, which was EUR 391 million
higher than in 2013, mainly due to higher inflows from
working capital reductions.
Philips Group
Cash flows from operating activities and net capital
expenditures in millions of EUR
2010 - 2014
1,691
1,886
912
610
1,303
Cash flows from operating
activities
(241)
(543)
(663)
(830)
(806) Net capital expenditures
‘10
‘11
‘12
‘13
‘14
28
Annual Report 2014
Condensed consolidated statements of cash flows for
the years ended December 31, 2012, 2013 and 2014 are
presented below:
Philips Group
Condensed consolidated cash flow statements1)
in millions of EUR
2012 - 2014
Net income (loss)
Adjustments to reconcile net income
to net cash provided by operating
activities
Net cash provided by operating
activities
2012
(30)
2013
1,172
2014
411
1,916
(260)
892
1,886
912
1,303
Net cash used for investing activities
(712)
(862)
(984)
Cash flows before financing
activities2)
Net cash used for financing activities
Cash (used for) provided by
continuing operations
Net cash (used for) provided by
discontinued operations
Effect of changes in exchange rates
on cash and cash equivalents
Total change in cash and cash
equivalents
Cash and cash equivalents at the
beginning of year
Cash and cash equivalents at the
end of year
1,174
(293)
50
319
(1,241)
(1,189)
881
(1,191)
(870)
(143)
(115)
193
(51)
(63)
85
687
(1,369)
(592)
3,147
3,834
2,465
3,834
2,465
1,873
1) Please refer to section 12.7, Consolidated statements of cash flows, of
this Annual Report
2) Please refer to chapter 15, Reconciliation of non-GAAP information, of
this Annual Report
Cash flows from investing activities
In 2014, cash flows from investing activities resulted in
a net outflow of EUR 984 million. This was attributable
to EUR 806 million cash used for net capital
expenditures, EUR 258 million used for acquisitions of
businesses and non-current financial assets, and EUR
7 million used for derivatives and current financial
assets, partly offset by EUR 87 million of net proceeds
from non-current financial assets and divestments.
In 2013, cash flows from investing activities resulted in
a net outflow of EUR 862 million. This was attributable
to EUR 830 million cash used for net capital
expenditures, EUR 101 million cash used for derivatives
and current financial assets, as well as EUR 24 million
used for acquisitions of businesses and non-current
financial assets, partly offset by EUR 93 million of net
proceeds mainly from divestment.
Net capital expenditures
Net capital expenditures amounted to a cash outflow
of EUR 806 million, compared to an outflow of EUR 830
million in 2013. The year-on-year decrease was mainly
due to lower investments at Healthcare and Lighting.
Group performance 5.1.16
Philips Group
Cash flows from acquisitions and financial assets,
divestments and derivatives in millions of EUR
2010 - 2014
EUR 407 million, including the redemption of a USD 143
million bond. Additionally, net cash outflows for share
buy-back and share delivery totaled EUR 562 million.
119
360
(241)
(418)
132
(32)
(8)
(178)
80
(471)
Divestments and derivatives
(43)
(24)
(258)
Acquisitions and financial assets
(550)
(428)
‘10
‘11
‘12
‘13
‘14
Acquisitions and financial assets
The net cash impact of acquisitions of businesses and
financial assets in 2014 was a total of EUR 258 million.
There was a EUR 177 million outflow for acquisitions of
businesses, mainly related to the acquisition of a 51%
interest in the General Lighting Company (GLC) in The
Kingdom of Saudi Arabia (KSA), and a EUR 81 million
outflow for financial assets, mainly in the form of a EUR
60 million loan to TPV Technology Limited.
The net cash impact of acquisitions of businesses and
financial assets in 2013, was a total of EUR 24 million.
There was a EUR 11 million outflow for acquisitions of
businesses and a EUR 13 million outflow for financial
assets.
Divestments and derivatives
Cash proceeds of EUR 87 million were received mainly
from divestment of the Shakespeare business and the
sale of shares in Neusoft. Cash flows from derivatives
and current financial assets led to a net cash outflow of
EUR 7 million.
In 2013, cash proceeds of EUR 93 million were received
from divestments, mainly of non-strategic businesses
within Healthcare. Cash flows from derivatives and
current financial assets led to a net cash outflow of EUR
101 million.
Cash flows from financing activities
Net cash used for financing activities in 2014 was EUR
1,189 million. Philips’ shareholders were given EUR 729
million in the form of a dividend, of which the cash
portion of the dividend amounted to EUR 292 million.
The net impact of changes in debt was a decrease of
EUR 301 million. Additionally, net cash outflows for
share buy-back and share delivery totaled EUR 596
million.
Net cash used for financing activities in 2013 was EUR
1,241 million. Philips’ shareholders were given EUR 678
million in the form of a dividend, of which the cash
portion of the dividend amounted to EUR 272 million.
The net impact of changes in debt was a decrease of
5.1.16 Cash flows from discontinued operations
In 2014, cash from discontinued operations amounted
to an inflow of EUR 193 million. The combined
Automotive and Lumileds businesses had a cash inflow
of EUR 240 million attributable to operating activities.
The Television business used net cash of EUR 8 million,
attributable to operating activities. The Audio, Video,
Multimedia and Accessories business used net cash of
EUR 19 million, with cash outflows from operating
activities of EUR 107 million, partly offset by EUR 88
million of cash inflows from investing activities.
In 2013, EUR 115 million cash was used by discontinued
operations. The combined Automotive and Lumileds
businesses had a cash inflow of EUR 94 million
attributable to operating activities. The Television
business used net cash of EUR 138 million, attributable
to cash outflows of EUR 91 million for operating
activities and EUR 47 million for investing activities. The
Audio, Video, Multimedia and Accessories business
used net cash of EUR 72 million attributable to
operating activities.
5.1.17 Financing
Condensed consolidated balance sheets for the years
2012, 2013 and 2014 are presented below:
Philips Group
Condensed consolidated balance sheet1) in millions of EUR
2012 - 2014
Intangible assets
10,679
9,766
10,526
Property, plant and equipment
2,959
2,780
2,095
2012
2013
2014
Inventories
Receivables
Assets held for sale
Other assets
Payables
Provisions
3,495
4,858
3,240
3,314
4,892
5,040
43
507
3,213
2,909
1,613
3,891
(6,210)
(5,435)
(5,293)
(2,956)
(2,554)
(3,445)
Liabilities directly associated with
assets held for sale
Other liabilities
(27)
(348)
(349)
(4,169)
(3,094)
(4,193)
Net asset employed
11,885
12,663
13,199
Cash and cash equivalents
3,834
2,465
1,873
Debt
Net debt
(4,534)
(3,901)
(4,104)
(700)
(1,436)
(2,231)
Non-controlling interests
(34)
(13)
(101)
Shareholders’ equity
(11,151)
(11,214)
(10,867)
Financing
(11,885)
(12,663)
(13,199)
1) Please refer to section 12.6, Consolidated balance sheets, of this Annual
Report
The financing structure in 2015 will be broadly in line
with 2014.
Annual Report 2014
29
Group performance 5.1.18
5.1.18 Cash and cash equivalents
In 2014, cash and cash equivalents decreased by EUR
592 million to EUR 1,873 million at year-end. The
decrease was mainly attributable to an outflow on cash
outflows for treasury share transactions of EUR 596
million, cash dividend payout of EUR 292 million, EUR
301 million from decreases in debt and a EUR 258
million outflow related to acquisitions. This was partly
offset by a EUR 497 million free cash flow.
Philips Group
Cash balance movements in millions of EUR
2014
2013
Divestments
Free cash flow
Other
Debt
Acquisitions
Treasury share transaction
Dividend
Discontinued operations
2014
2,465
+87
+4971)
+782)
-301
-258
-596
-292
+193
1,873
-592
1) Please refer to chapter 15, Reconciliation of non-GAAP information, of
this Annual Report
Includes cash flow for derivatives and currency effect
2)
5.1.19 Debt position
Total debt outstanding at the end of 2014 was EUR 4,104
million, compared with EUR 3,901 million at the end of
2013.
Philips Group
Changes in debt in millions of EUR
2012 - 2014
New borrowings
Repayments
Currency effects and consolidation
changes
Changes in debt
2012
(1,361)
631
56
(674)
2013
2014
(64)
471
226
633
(69)
370
(504)
(203)
In 2014, total debt increased by EUR 203 million. New
borrowings of EUR 69 million consisted mainly of
replacements to lease contracts. Repayment of EUR
370 million included a EUR 250 million repayment of a
five year loan. Other changes resulting from
consolidation and currency effects led to an increase of
EUR 504 million.
In 2013, total debt decreased by EUR 633 million. New
borrowings of EUR 64 million consisted mainly of
replacements to lease contracts. Repayment of EUR 471
million included a USD 143 million redemption on USD
bonds as well as payments on short-term debt. Other
changes resulting from consolidation and
currency effects led to a decrease of EUR 226 million.
30
Annual Report 2014
Long-term debt as a proportion of the total debt stood
at 90% at the end of 2014 with an average remaining
term of 11.6 years, compared to 85% and 12.8 years at
the end of 2013.
For further information, please refer to note 18, Debt.
5.1.20 Shareholders’ equity
Shareholders’ equity decreased by EUR 347 million in
2014 to EUR 10,867 million at December 31, 2014. The
decrease was mainly a result of EUR 714 million related
to purchase shares for the share buy-back program and
coverage for the LTI program, partially offset by EUR 415
million net income and EUR 50 million of other
comprehensive income. The dividend payment to
shareholders in 2014 reduced equity by EUR 293 million
including tax and service charges, while the delivery of
treasury shares increased equity by EUR 116 million and
share-based compensation plans increased equity by
EUR 88 million.
The number of outstanding common shares of Royal
Philips at December 31, 2014 was 914 million (2013: 913
million). At the end of 2014, the Company held 17.1
million shares in treasury to cover the future delivery of
shares (2013: 20.7 million shares). This was in
connection with the 40.8 million rights outstanding at
the end of 2014 (2013: 44.3 million rights) under the
Company’s long-term incentive plans. At the end of
2014, the Company held 3.3 million shares for
cancellation (2013: 3.9 million shares).
5.1.21 Net debt to group equity
Philips ended 2014 in a net debt position (total debt less
cash and cash equivalents) of EUR 2,231 million,
compared to a net debt position of EUR 1,436 million at
the end of 2013.
Philips Group
Net debt (cash) to group equity1) in billions of EUR
2010 - 2014
15.1
12.4
11.2
11.2
11.0 Group equity2)
0.7
0.7
1.4
2.2
Net debt (cash)
(1.2)
‘10
‘11
‘12
‘13
‘14
(8) : 108
5 : 95
6 : 94
11 : 89
17 : 83
ratio
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
2) Shareholders’ equity and non-controlling interests
5.1.22 Liquidity position
Including the Company’s cash position (cash and cash
equivalents), as well as its EUR 1.8 billion committed
revolving credit facility the Company had access to
available liquidity of EUR 3.673 million vs. Gross Debt
(including short and long term) of EUR 4.104 million as
of December 31, 2014.
As of December 31, 2013 the Company had access to
net available liquid resources of EUR 429 million
including the Company’s net debt (cash) position (cash
and cash equivalents, net of debt), listed available-for-
sale financial assets, as well as its EUR 1.8 billion
committed revolving credit facility.
Philips Group
Liquidity position in millions of EUR
2012 - 2014
Cash and cash equivalents
3,834
2,465
2012
2013
2014
1,873
Committed revolving credit
facility/CP program/Bilateral loan
Liquidity
Available-for-sale financial assets
at fair value
Short-term debt
Long-term debt
1,800
1,800
1,800
5,634
4,265
3,673
120
65
75
(809)
(592)
(392)
(3,725)
(3,309)
(3,712)
Net available liquidity resources
1,220
429
(356)
Philips has a EUR 1.8 billion committed revolving credit
facility that can be used for general group purposes and
as a backstop of its commercial paper program. In
January 2013, the EUR 1.8 billion facility was extended
by 2 years until February 2018. The commercial paper
program amounts to USD 2.5 billion, under which
Philips can issue commercial paper up to 364 days in
tenor, both in the US and in Europe, in any major freely
convertible currency. There is a panel of banks, in
Europe and in the US, which service the program. The
interest is at market rates prevailing at the time of
issuance of the commercial paper. There is no collateral
requirement in the commercial paper program. Also,
there are no limitations on Philips’ use of funds from the
program. As at December 31, 2014, Philips did not have
any loans outstanding under these facilities.
Philips’ existing long-term debt is rated A3 (with stable
outlook) by Moody’s and A- (with negative outlook) by
Standard & Poor’s. As part of the capital allocation
policy, it is Philips’ ambition to manage its financial
ratios to be in line with an A3/A- rating. There is no
assurance that Philips will be able to achieve this goal.
Ratings are subject to change at any time. The
Company’s outstanding long-term debt and credit
facilities do not contain financial covenants or cross
acceleration provisions that are based on adverse
changes in ratings or on material adverse change.
As at December 31, 2014, Philips had total cash and cash
equivalents of EUR 1,873 million. Philips pools cash
from subsidiaries to the extent legally and
economically feasible. Cash not pooled remains
Group performance 5.1.22
available for local operational or investment needs.
Philips had a total gross debt position of EUR 4,104
million at year-end 2014.
Philips believes its current liquidity is sufficient to meet
its present working capital requirements. Philips
intends to finance the acquisition of Volcano through a
combination of cash on hand and the issuance of short-
term debt.
5.1.23 Cash obligations
Contractual cash obligations
Presented below is a summary of the Group’s
contractual cash obligations and commitments at
December 31, 2014.
Philips Group
Contractual cash obligations1) in millions of EUR
2014
Payments due by period
less
than 1
year
94
61
total
3,665
232
244
244
1-3
years
3-5
years
after 5
years
6
1,030
2,535
80
–
37
–
54
–
986
236
293
159
298
860
353
166
253
88
2,617
198
387
299
1,733
131
70
2,499
2,499
51
–
10
–
–
–
11,234
3,755
983
1,788
4,708
Long-term
debt2)
Finance lease
obligations
Short-term
debt
Operating
leases
Derivative
liabilities
Interest on
debt3)
Purchase
obligations4)
Trade and other
payables
Contractual
cash
obligations
1) Obligations in this table are undiscounted
2) Long-term debt includes short-term portion of long-term debt and
excludes finance lease obligations
3) Approximately 15% of the debt bears interest at a floating rate. The
majority of the interest payments on variable interest rate loans in the
table above reflect market forward interest rates at the period end and
these amounts may change as the market interest rate changes
4) Philips has commitments related to the ordinary course of business
which in general relate to contracts and purchase order commitments
for less than 12 months. In the table, only the commitments for multiple
years are presented, including their short-term portion
Philips has no material commitments for capital
expenditures.
Additionally, Philips has a number of commercial
agreements, such as supply agreements, which provide
that certain penalties may be charged to the Company
if it does not fulfill its commitments.
Certain Philips suppliers factor their trade receivables
from Philips with third parties through supplier finance
arrangements. At December 31, 2014 approximately
EUR 357 million of the Philips accounts payables were
known to have been sold onward under such
arrangements whereby Philips confirms invoices.
Annual Report 2014
31
Group performance 5.1.23
Philips continues to recognize these liabilities as trade
payables and will settle the liabilities in line with the
original payment terms of the related invoices.
5.2.1
Other cash commitments
The Company and its subsidiaries sponsor post-
employment benefit plans in many countries in
accordance with legal requirements, customs and the
local situation in the countries involved. For a
discussion of the plans and expected cash outflows,
please refer to note 20, Post-employment benefits.
The Company had EUR 380 million restructuring-
related provisions by the end of 2014, of which EUR 230
million is expected to result in cash outflows in 2015.
Refer to note 19, Provisions for details of restructuring
provisions and potential cash flow impact for 2014 and
further.
A proposal will be submitted to the upcoming Annual
General Meeting of Shareholders to declare a
distribution of EUR 0.80 per common share (up to EUR
735 million), in cash or shares at the option of the
shareholder, against the net income and retained
earnings for 2014. Further details will be given in the
agenda for the Annual General Meeting of
Shareholders, to be held on May 7, 2015.
Guarantees
Philips’ policy is to provide guarantees and other letters
of support only in writing. Philips does not provide other
forms of support. At the end of 2014, the total fair value
of guarantees recognized on the balance sheet
amounted to less than EUR 1 million (December 31,
2013: less than EUR 1 million). Remaining off-balance-
sheet business and credit-related guarantees provided
on behalf of third parties and associates decreased by
EUR 13 million during 2014 to EUR 21 million. Off-
balance-sheet guarantees for year end 2013 were
restated from EUR 333 million to EUR 34 million to
reflect guarantees related to associates and third-party
only.
5.1.24 Analysis of 2013 compared to 2012
The analysis of the 2013 financial results compared to
2012, and the discussion of the critical accounting
policies, have not been included in this Annual Report.
These sections are included in Philips’ Form 20-F for
the financial year 2014, which will be filed electronically
with the US Securities and Exchange Commission.
5.2 Social performance
Our businesses provide innovative solutions that
address major trends affecting the world – the demand
for affordable healthcare, the need for greater energy
efficiency, and the desire for personal well-being.
Philips further strengthened its focus on sustainability
in 2014 through a number of initiatives described in the
Social and Environmental performance sections.
32
Annual Report 2014
Improving people’s lives
At Philips, we strive to make the world healthier and
more sustainable through innovation. Our goal is to
improve the lives of 3 billion people a year by 2025. To
guide our efforts and measure our progress, we take a
two-dimensional approach – social and ecological – to
improving people’s lives. Products and solutions from
our portfolio that directly support the curative (care) or
preventive (well-being) side of people’s health,
determine the contribution to the social dimension. As
healthy ecosystems are also needed for people to live
a healthy life, the contribution to the ecological
dimension is determined by means of our steadily
growing Green Product portfolio, such as our energy-
efficient lighting.
Through Philips products and solutions that directly
support the curative or preventive side of people’s
health, we improved the lives of 670 million people in
2014, driven by our Healthcare sector. Additionally, our
well-being products that help people live a healthy life,
and our Green Products that contribute to a healthy
ecosystem, improved the lives of 290 million and 1.5
billion people respectively. After the elimination of
double counts – people touched multiple times – we
arrived at 1.9 billion lives. This is an increase of 200
million compared to 2013, mainly driven by Consumer
Lifestyle in Greater China, Lighting in North America,
Central & Eastern Europe, and Middle East & Turkey,
and Healthcare in Greater China and the ASEAN
countries. Our baseline of 1.7 billion people a year,
established in 2012, has been adjusted to 1.6 billion to
reflect the impact of the exclusion of the Automotive
and Lumileds businesses. More information on this
metric can be found in chapter 14, Sustainability
statements, of this Annual Report.
Philips Group
Lives improved (in billions)
0.29
by Philips
well-being
products
0.67
by Philips
care products
1.5
by Philips
Green Products
Total: 1.9 (double counts eliminated)
Double counts
Conceptual drawing, areas do not reflect actual proportions
Group performance 5.2.2
5.2.2 Employee engagement
Employee engagement is key to our competitive
performance. Engaged employees help us meet our
business goals and help make Philips a great place to
work. We have used employee engagement surveys for
over a decade to gather feedback and focus areas and
have seen tangible results along our journey.
Philips Group
Gender diversity in %
2012 - 2014
29
29
29
43
42
42
18
19
20
14
15
18 Female
As announced in 2012, we survey Employee
Engagement on a bi-annual basis, starting in 2013. In
2014 we implemented a brief, complementary, team-
focused survey called My Accelerate! Survey (MAS).
We have observed and shown via research the
correlation between the Employee Engagement Index
and the Net Promoter Score question “How likely is it
you would recommend Philips as a great place to work?
“ (the measurement that cumulatively covers emotional
commitment, pride and active recommendation). We
used the Net Promoter Score as a proxy for the EES
results in 2014 which was based on survey results of
some 17,000 employees. In 2015 we will perform a full
Employee Engagement Survey again.
Philips Group
Employee Engagement Index in %
2010 - 2014
11
12
10
14
6
15
9
16
17
11
Unfavorable
Neutral
77
76
79
75
72
Favorable
‘10
‘11
‘121)
‘13
‘142)
1) Based on 60 pulse surveys conducted in 2012
2) Based on My Accelerate! Surveys
For more information on MAS, please refer to sub-
section 14.2.1, Engaging our employees, of this Annual
Report.
5.2.3 Diversity and inclusion
Based on the deployment of our comprehensive strategy, in
2014 Philips continued making progress on its diversity and
inclusion (D&I) agenda. We believe a diverse workforce and
an inclusive work environment are essential to a thriving
innovative business and we strive to attract employees from
a wide range of backgrounds.
57
58
58
71
71
71
82
81
80
86
85
82 Male
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
Staff
Professionals
Management
Executives
Regarding gender diversity, we recorded an increase in
the share of female executives to 18% at year-end 2014
– up from 15% in 2013. We are well on track to achieve
the aspiration of 20% female executives by year-end
2016 – having embedded D&I objectives in HR
processes and culture-building activities, combined
with the active engagement of senior female leaders
globally.
One of the key drivers of progress is the redesigned
talent management approach, which includes a
comprehensive approach to succession planning for all
executives and other key positions in order to also drive
development and career planning for individuals. In
2014, 28% of new executives internally promoted were
women, and women represented 31% of all external
executive hires. Demonstrating the Group’s
commitment to D&I, development of gender diversity
has been made a key performance indicator for Philips.
Philips Group
New hire diversity in %
2012 - 2014
33
34
36
24
29
29
45
42
47
27
31 Female
12
88
55
58
53
67
66
64
76
71
71
73
69 Male
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
Staff
Professionals
Management
Executives
Philips has one woman on its Executive Committee and
three female members of its Supervisory Board. Our
executives originate from more than 30 countries.
In 2014, Philips employed 35% females, the same
percentage as in 2013.
Annual Report 2014
33
Group performance 5.2.3
Philips Group
Employees per age category in %
2012 - 2014
33
32
31
31
32
32
21
21
20
28
27
26
31
31
31
24
25
25
9
9
9 Female
13
13
14 Male
7
4
‘12
6
4
‘13
7
4
‘14
5.2.4 Employment
The total number of Philips Group employees (continuing
operations) was 105,365 at the end of 2014, compared to
105,637 at the end of 2013. Approximately 36% were
employed in the Lighting sector, 35% in the Healthcare sector
and approximately 16% in the Consumer Lifestyle sector.
Philips Group
Employees per sector in FTEs at year-end
2012 - 2014
Healthcare
37,460
37,008
37,065
Consumer Lifestyle
16,542
17,255
16,639
2012
2013
2014
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
‘12
‘13
‘14
Lighting
under 25
25-35
35-45
45-55
over 55
Innovation, Group & Services
41,757
11,697
38,671
37,808
12,703
13,853
Continuing operations
107,456
105,637
105,365
Discontinued operations
10,631
10,445
8,313
Philips Group
118,087
116,082
113,678
Compared to 2013, the number of employees in
continuing operations decreased by 272. The decrease
reflects industrial footprint rationalization at Lighting,
divestments at Healthcare, and a reduction in third-
party workers at Consumer Lifestyle, partly offset by the
consolidation of the General Lighting Company (GLC)
acquisition at Lighting and an increase in temporary
workers in the IT Service Units at IG&S.
Approximately 52% of the Philips workforce was
located in mature geographies, and about 48% in
growth geographies. In 2014, the number of employees
in mature geographies decreased by 1,733, mainly due
to the company’s overhead reduction program and the
industrial footprint reduction at Lighting. Growth
geographies headcount increased by 1,461, largely
driven by the GLC acquisition in The Kingdom of Saudi
Arabia (KSA).
Philips Group
Employees per geographic cluster in FTEs at year-end
2012 - 2014
Western Europe
North America
2012
2013
2014
29,803
28,944
29,105
25,375
24,401
22,283
Other mature geographies
3,304
3,419
3,643
Mature geographies
58,482
56,764
55,031
Growth geographies
48,974
48,873
50,334
Continuing operations
107,456
105,637
105,365
Discontinued operations
10,631
10,445
8,313
Philips Group
118,087
116,082
113,678
In 2014, employee turnover amounted to 15.7% (of
which 8.7% was voluntary), slightly below 2013 and
mainly caused by the changing industrial footprint, the
company’s overhead reduction program and the high
turnover of manufacturing staff in our factories, mainly
in the growth markets.
Philips Group
Employee turnover in %
2014
Female
Male
Staff
22.4
19.1
Philips Group
20.5
Profes-
sionals
Manage-
ment
Execu-
tives
12.0
10.2
10.7
9.8
8.8
9.0
9.9
14.0
13.3
Total
18.2
14.1
15.7
Philips Group
Voluntary turnover in %
2014
Female
Male
Philips Group
Staff
13.5
10.3
11.6
Profes-
sionals
Manage-
ment
Execu-
tives
7.0
5.5
5.9
5.2
3.9
4.2
5.9
7.4
7.2
Total
10.8
7.5
8.7
Compared to the percentage of women employed by
Philips in 2014, we see a relatively higher outflow of
women in the Staff and Professionals categories and a
lower outflow of female Executives.
Philips Group
Exit diversity in %
2013 - 2014
30
33
18
22
9
13
Female
70
67
82
78
91
87 Male
43
46
57
54
‘13
‘14
‘13
‘14
‘13
‘14
‘13
‘14
Staff
Professionals
Management
Executives
34
Annual Report 2014
Philips Group
Employment in FTEs at year-end
2012 - 2014
Balance as of January 1
125,240
118,087
116,082
2012
2013
2014
Consolidation changes:
Acquisitions
Divestments
Changes in discontinued
operations
Other changes
909
(1,024)
(3,545)
(3,493)
–
(705)
(186)
(1,114)
1,506
(247)
(2,132)
(1,531)
Balance as of December 31
118,087
116,082
113,678
In 2015, the number of employees is expected to remain
broadly in line with 2014, with increases from our
acquisition of Volcano Corporation to be offset by
reductions from footprint-related initiatives.
5.2.5 Developing our people
Our drive to build a learning organization which is
leader led has progressed significantly, and the Philips
University was launched formally in Q4. Philips
University is embracing 70:20:10 as part of the long-
term journey to build a learning culture that allows us
to become a learning organization: 70% of learning is
carried out on the job, 20% through coaching and
mentoring (through others), and the remaining 10%
through formal learning methods (classroom and e-
learning).
Training spend
Our external training spend in 2014 amounted to EUR
44.7 million, a decrease compared to EUR 47.3 million
in 2013, which is the result of the rationalization of
content made in 2013.
For more information on developing our people, please
refer to sub-section 14.2.2, People development, of this
Annual Report.
5.2.6 Health and Safety
Philips strives for an injury-free and illness-free work
environment, with a sharp focus on reducing the
number of injuries and improving processes. The Lost
Workday Injury Cases (LWIC) rate is defined as a KPI, on
which we set yearly targets for the company and our
individual sectors.
We regret to report that one of our Healthcare Field
Service employees passed away after a traffic accident
in France whilst traveling home.
In 2014 we recorded 227 LWIC, i.e. occupational injury
cases where the injured person is unable to work one
or more days after the injury. This represents a
significant decrease compared with 280 in 2013, and
continues the consecutive reduction trend from 2010.
The LWIC rate decreased to 0.23 per 100 FTEs,
compared with 0.27 in 2013. The number of Lost
Workdays caused by injuries increased by 403 days to
9,068 days in 2014.
Group performance 5.2.5
For more information on Health and Safety, please refer
to sub-section 14.2.4, Health and Safety performance,
of this Annual Report.
5.2.7 Philips’ General Business Principles renewed
Our General Business Principles (GBP) set the standard
for how to conduct business, both for individual
employees and for the company itself. In our drive for
continuous improvement, the GBP were revised in 2014
to help ensure that everyone acts with integrity, and
also to better reflect the changing business landscape
in which we operate.
For a description of GBP processes and policies, please
refer to section 7.1, Our approach to risk management
and business control, of this Annual Report.
The General Business Principles have been rewritten,
but without deviating from the fundamental principles
for doing business which are firmly rooted in Philips’
heritage. Without making substantial changes to these
standards, the GBP have been turned into a document
that is easy to read and understand for everyone. They
have been translated into 32 languages, allowing
almost every employee to read them in their native
language. The GBP form an integral part of labor
contracts in virtually every country in which Philips
operates.
Training and awareness
Following the updating of the General Business
Principles, a new e-learning was launched in October.
In this mandatory online training course employees are
informed about the contents of the GBP and the way in
which Philips applies them. This course, in which every
employee with an e-mail account has been invited to
participate, is available in 21 languages and is taken by
every new hire joining the company. During the last
quarter of 2014, out of the 73,000 employees with an
e-mail account, well over 57,000 (77%) took this e-
learning. At the end of the training course employees
are asked to confirm that they will always act with
integrity. In addition, GBP Compliance Officers around
the world also attended a series of face-to-face training
courses aimed at helping them perform their supporting
role more effectively.
The launch of the e-learning was just one of the events
that formed part of the global communication
campaign on the GBP. These communication efforts
culminated in a ‘GBP dialog week’, for the second year
in a row, in which managers were invited to host dialog
sessions with their teams about the Philips GBP. Tens of
thousands of Philips employees participated in these
sessions and managers reported very high levels of
engagement.
The results of the monitoring measures in place are
given in sub-section 14.2.5, General Business
Principles, of this Annual Report.
Annual Report 2014
35
Group performance 5.2.8
5.2.8 Working with stakeholders
5.2.10 Supplier sustainability
Many of our products are being created and
manufactured in close cooperation with a wide range
of business partners, both in the electronics industry
and other industries. Philips needs suppliers to share
our commitment to sustainability, and not just in the
development and manufacturing of products but also
in the way they conduct their business. We require
suppliers to provide a safe working environment for
their workers, to treat workers with respect, and to work
in an environmentally sound way. Our programs are
designed to engage and support our suppliers on a
shared journey towards continuous improvement in
supply chain sustainability.
As a leading company in sustainability, Philips acts as a
catalyst and supports our suppliers in their pursuit of
continuous improvement in social and environmental
performance. We recognize that this is a huge challenge
requiring an industry-wide effort in collaboration with
other societal stakeholders. Therefore, we take a
leading role, together with peers in the industry, in the
Electronic Industry Citizenship Coalition (EICC) and
encourage our strategic suppliers to join the EICC too.
In 2014, Philips initiated a new EICC taskforce on
process chemicals in the supply chain. We will also
continue to seek active cooperation and dialogue with
other societal stakeholders including governments and
civil society organizations, either directly or through
institutions like the EICC, the multi-stakeholder
programs of the Sustainable Trade Initiative IDH, and
the OECD.
Supplier Sustainability Involvement Program
The Philips Supplier Sustainability Involvement
Program is our overarching program to help improve
the sustainability performance of our suppliers. We
create commitment from our suppliers by requiring
them to comply with our Regulated Substances List and
the Philips Supplier Sustainability Declaration, which
we include in all purchasing contracts. The Declaration
is based on the EICC code of conduct and we have
added requirements on Freedom of Association and
Collective Bargaining. The topics covered in the
Declaration are listed below. We monitor supplier
compliance with the Declaration through a system of
regular audits.
In organizing ourselves around customers and markets,
we create dialogues with our stakeholders in order to
explore common ground for addressing societal
challenges, building partnerships and jointly
developing supporting ecosystems for our innovations.
Working with partners is crucial in delivering on our
vision to make the world healthier and more sustainable
through innovation. An overview of stakeholders and
topics discussed is provided in chapter 14,
Sustainability statements, of this Annual Report.
For more information on our stakeholder engagement
activities, please refer to sub-section 14.2.7,
Stakeholder Engagement, of this Annual Report.
5.2.9 Social Investment Programs
2014 was a transition year for Philips’ social investment
program. With the creation of the Philips Foundation, a
new global strategy was rolled out, focusing on disaster
relief, local community investment and social
entrepreneurship. The Philips Foundation is
responsible for the overall strategy and global non-
profit partnerships. Philips’ country organizations, while
aligning with the global strategy, have the ability to
drive regional programs that fit the specific needs of
local communities.
For example, in 2014, Philips Brazil rolled out the
program “Light Up Your Game” across 10 countries in
Latin America. Working together with non-profit
organizations such as the KNVB and IDEAAS, they were
able to install over 27 solar and semi-solar Community
Light Centers, which provide safe and functional space
for sports and other community activities after dark.
In North America, the Philips Cares program provides
ways for employees to work together to improve
people’s lives by creating healthy, sustainable
communities that contribute to the success and well-
being of future generations. This can take many forms:
from helping a child to excel in math, or providing safety
and energy-efficient home improvements for the
disadvantaged, to raising awareness about the
importance of cardiac health. In 2014 alone, more than
5,000 employee volunteers participated in community
outreach projects that suited their needs, schedules,
and passions through partnerships with organizations
such as the American Heart Association, Rebuilding
Together, and the National 4-H Council.
In 2015 and beyond, all programs run by Philips country
organizations on social investments will come under
the umbrella of the Philips Foundation.
More information about the Philips Foundation and its
purpose and scope can be found at sub-section 14.2.6,
The Philips Foundation, of this Annual Report.
36
Annual Report 2014
Labor
Health and Safety
• Freely chosen employment
• Child labor prohibition
• Working hours
• Wages and benefits
• Humane treatment
• Non-discrimination
• Freedom of association
• Occupational safety
• Emergency preparedness
• Occupational injury and illness
• Industrial hygiene
• Physically demanding work
• Machine safeguarding
• Sanitation, food and housing
Environmental
Ethics
• Environmental permits and
reporting
• Pollution prevention and
resource reduction
• Hazardous substances
• Waste water and solid waste
• Air emissions
• Product content restrictions
• Business integrity
• No improper advantage
• Disclosure of information
• Intellectual property
• Fair business, advertising and
competition
• Protection of identity
• Responsible sourcing of
minerals
• Privacy
• Non-retaliation
Management system
• Company commitment
• Risk assessment and risk
management
• Management accountability
• Training
• Communication
• Corrective action process
• Worker feedback and
and responsibility
participation
• Improvement objectives
• Legal and customer
requirements
• Documentation and records
• Audits and assessments
• Supplier responsibility
2014 supplier audits in risk countries
In 2014, Philips conducted 203 full-scope audits.
Additionally, 35 audits of potential suppliers were
performed. Potential suppliers are audited as part of
the supplier approval process, and they need to close
any zero-tolerance issues before they can start
delivering to Philips. In our new audit approach, we
place more focus on capacity-building programs to
realize structural improvements leading to better audit
results.
Philips Group
Accumulative number of initial and continual conformance
audits
2005 - 2014
+203
2,365
+200
+159
+212
+273
+360
+277
+166
+365
150
‘05
‘06
‘07
‘08
‘09
‘10
‘11
‘12
‘13
‘14
total
Group performance 5.2.10
As in previous years, the majority of the audits in 2014
were done in China. The total number of full-scope
audits carried out since we started the program in 2005
is 2,365. This number includes repeated audits (129 in
2014), since we execute a full-scope audit at our risk
suppliers every three years. The audit program covers
90% of our spend with risk suppliers.
Philips Group
Distribution of supplier audits by country
2014
China
India
Mexico
Brazil
Other
24
6
9
8
156
Audit findings
We believe it is important to be transparent about the
issues we observe during the audits. Therefore we have
published a detailed list of identified major non-
compliances in our Annual Report since 2010.
To track improvements, Philips measures the
‘compliance rate’ for the identified risk suppliers, i.e. the
percentage of risk suppliers that were audited within
the last three years and do not have any – or have
resolved all – major non-compliances. During 2014 we
achieved a compliance rate of 86% (2013: 77%).
Please refer to sub-section 14.2.8, Supplier indicators,
of this Annual Report for the detailed findings of 2014.
Supplier development and capacity building
Based on many years of experience with the audit
program, we know that a combination of audits,
capacity building, consequence management and
structural attention from management is crucial to
realize structural and lasting changes at supplier
production sites. In 2014 we continued our focus on
capacity-building initiatives which are offered to help
suppliers improve their practices. Our supplier
sustainability experts in China organized training,
visited suppliers for on-site consultancy, conducted
pre-audit checks and helped suppliers to train their
own employees on topics like occupational health and
safety, emergency preparedness, chemicals
management, dust explosion and prevention, and fire
safety.
We also teamed up with peers in the industry and civil
society organizations to work on capacity building at
Chinese factories via the IDH Electronics Program, an
innovative multi-stakeholder initiative sponsored by
the Sustainable Trade Initiative (Initiatief Duurzame
Handel). The goal is to improve working conditions for
more than 500,000 employees in the electronics
sector. Three years ago the program was kicked-off in
China’s Pearl River Delta, and has now expanded to
Annual Report 2014
37
Group performance 5.2.10
also cover supplier factories in the Yangtze River Delta
area. A total of 21 Philips suppliers are now participating
in the program.
respects, the sustainability performance in accordance
with the reporting criteria. We refer to section 14.4,
Independent Auditor’s Assurance Report, of this Annual
Report.
5.2.11 Conflict minerals: issues further down the
chain
In line with Philips’ commitment to supply-chain
sustainability, we are concerned about the situation in
eastern DRC (the Democratic Republic of the Congo),
where proceeds from the mining sector are used to
finance rebel conflicts in the region. Philips does not
directly source minerals from the DRC and the mines
are typically seven or more tiers away from our direct
suppliers. Philips nevertheless feels obliged to address
this issue through the means and influencing
mechanisms available to us.
We were one of the first companies to survey our
suppliers to identify smelters used in the supply chain
that produce the metals of concern, and one of the four
companies to have our SEC Conflict Minerals report
audited in 2014. We are cooperating with industry to
drive the identified smelters to become compliant with
the Conflict-Free Smelter Program or an equivalent
third-party audit program. We also realize how
important it is not to boycott the minerals from the DRC
and neighboring countries entirely. That is why we are
supporting verified conflict-free supply chains that
contribute to economic development in the DRC region.
For more details and results of our supplier
sustainability program, please refer to sub-section
14.2.8, Supplier indicators, of this Annual Report.
5.3 Environmental performance
EcoVision
Philips has a long sustainability history stretching all the
way back to our founding fathers. In 1994 we launched
our first program and set sustainability targets for our
own operations. Next we launched our first EcoVision
program in 1998 which focused on the environmental
dimension of our operations and products. We also
started to focus on sustainability in our supply chain in
2003. We extended our scope further in 2010 by
including the social dimension of products and
solutions, which is now reflected in our company vision:
We strive to make the world healthier and more
sustainable through innovation. Our goal is to improve
the lives of 3 billion people a year by 2025.
Philips publishes every year a full Integrated Annual
Report with the highest (reasonable) assurance level on
the financial, social and environmental performance.
With that overall reasonable assurance level Philips is
a frontrunner in this field. KPMG has provided
reasonable assurance on whether the information in
chapter 14, Sustainability statements, of this Annual
Report, section 5.2, Social performance, of this Annual
Report and section 5.3, Environmental performance, of
this Annual Report presents fairly, in all material
38
Annual Report 2014
The main elements of the EcoVision program are:
▪ Improving people’s lives
▪ Green Product sales
▪ Green Innovation, including Circular Economy
▪ Green Operations
▪ Health and Safety
▪ Supplier Sustainability
In this Environmental performance section an overview
is given of the most important environmental
parameters of the program. Improving people’s lives,
Health and Safety, and Supplier Sustainability are
addressed in the Social performance section. Details of
the EcoVision parameters can be found in the chapter
14, Sustainability statements, of this Annual Report.
5.3.1 Green Innovation
Green Innovation is the Research & Development
spend related to the development of new generations
of Green Products and Green Technologies. We
announced in 2010 our plan to invest a cumulative EUR
2 billion in Green Innovation during the coming 5 years.
In 2014, Philips already achieved this EUR 2 billion
target a year ahead of schedule as we invested some
EUR 463 million in Green Innovation, excluding
Lumileds and Automotive. Lighting continued to be the
largest contributor, mainly as a result of investments in
LED. The impact of Lumileds and Automotive on Green
Innovation is significant at EUR 105 million in 2014 and
EUR 104 million in 2013.
Philips Group
Green Innovation per sector in millions of EUR
2010 - 2014
453
38
209
70
136
‘12
405
27
223
75
80
‘13
463
21
Group Innovation
255
Lighting
97
Consumer Lifestyle
Healthcare
90
‘14
363
36
175
67
85
‘11
313
46
151
56
60
‘10
Healthcare
Healthcare develops innovative solutions across the
continuum of care in collaboration with clinicians and
customers, to improve patient outcomes, provide better
value, and expand access to care. Healthcare
investments in Green Innovation in 2014 amounted to
EUR 90 million, an increase of EUR 10 million compared
to 2013. In hardware innovation, we take into account
all Green Focal Areas and aim to reduce environmental
impact over the total lifecycle, with a focus on energy
efficiency and substance management. Other areas
covered include increased levels of recycled content in
our products, remote servicing and closing the
materials loop contributing to a circular economy, e.g.
through upgrading strategies, parts harvesting and
refurbishing. Healthcare actively supports a voluntary
industry initiative (COCIR) for improving the energy
efficiency of imaging equipment. Moreover, we are
actively partnering with care providers to look together
for innovative ways to reduce the environmental impact
of healthcare, for example by optimizing energy
efficient use of medical equipment.
Consumer Lifestyle
Increased R&D investments at Consumer Lifestyle are
also reflected in increased Green Innovation which
amounted to EUR 97 million in 2014 compared to EUR
75 million in 2013. This increase resulted in higher Green
Product sales in all Business Groups. The sector
continued its work on improving the energy efficiency
of its products, closing the materials loop (e.g. by using
recycled materials in products and packaging) and the
voluntary phase-out of polyvinyl chloride (PVC),
brominated flame retardants (BFR) and Bisphenol A
(BPA) from food contact products. In particular, more
than 80% of the shaving, grooming and oral healthcare
products are completely PVC/BFR-free.
Lighting
At Lighting, we strive to make the world healthier and
more sustainable through energy-efficient lighting
systems. With a 2014 investment of EUR 255 million in
Green Innovation (excluding Lumileds and Automotive
at EUR 105 million), Lighting invested EUR 32 million
more than in 2013. Increasing investments in digital
lighting solutions have led to further improvements in
the area of energy efficiency. In 2014, Lighting piloted a
breakthrough connected lighting system for offices,
featuring Power-over-Ethernet (PoE-enabled)
luminaires. By offering employees personal control of
the lighting above their desks, the system delivers
appropriate task lighting levels while keeping general
lighting levels lower, enhancing both worker efficiency
and energy efficiency. The connected lighting system
integrates with other building systems such as heating,
ventilation, and IT services to realize significant energy
savings — not only on lighting, but also on HVAC and
other services, which together account for up to 70% of
a building’s energy usage.
Beyond significant energy efficiency benefits, the
connected lighting system supports the transition to a
more circular economy. PoE-enabled luminaires
eliminate the need for power cabling, simplifying
installation and lowering initial costs. A flexible and
open system architecture streamlines servicing and
maintenance, affords an easy upgrade path, and
extends system lifetime.
Group performance 5.3.1
Philips Group Innovation
Philips Group Innovation invested EUR 21 million in
Green Innovations, spread over projects focused on
global challenges related to water, air, waste, energy,
food and access to affordable healthcare. Group
Innovation used the Sustainable Innovations
Assessment tool, in which innovation projects are
mapped, categorized and scored along the
environmental and social dimension in order to identify
those innovation projects that drive sustainable
innovation.
Philips Green Patent portfolio
At the end of 2014, Philips’ IP portfolio comprised 8%
green patent families, which means that all these
patent families were labeled with at least one Green
Focal Area. In 2014, 10% of our total patent filings were
flagged as green patent family. Energy efficiency is the
most frequently occurring Green Focal Area throughout
the portfolio. Multiplying the portfolio percentage with
our annual patent portfolio cost in 2014 determines the
amount that we invest in Green IP, which constitutes
part of Philips investment in Green Innovation.
While a product can become green by incorporating an
environmentally friendly technology, such technology
cannot necessarily be protected in a patent because of
lack of patentability over the state-of-the-art
technology. Therefore not all Green Technologies
implemented in our Green Products can be captured in
patents.
Energy efficiency of products
Energy efficiency is a key Green Focal Area for our
Green Products. According to our analysis, about 97%
of the energy consumed during the use phase of our
products is attributable to Lighting products. The
remaining 3% is split over Consumer Lifestyle and
Healthcare. Therefore, we focus on the energy
efficiency of our Lighting products in the calculation.
The annual energy consumption per product category
is calculated by multiplying the power consumption of
a product by the average annual operating hours and
the annual pieces sold and then dividing the light
output (lumens) by the energy consumed (watts). The
average energy efficiency of our total product portfolio
increased slightly in 2014 to 40.5 lumen per watt (but
improved 21% compared to 2009, the baseline year).
The exclusion of Lumileds and Automotive has a limited
upward effect on the energy efficiency of the portfolio.
In 2014 LED sales advanced well, but demand for
conventional lighting remained fairly stable due to the
challenging economic environment. Since the number
of traditional lamps sold is significantly higher than
LEDs, the energy efficiency improvement of the total
Lighting portfolio in 2014 was limited. We expect the
energy efficiency to improve in the coming years as the
traditional incandescent lamp is banned in more
countries. Our target for 2015 is a 50% improvement
compared to the 2009 baseline. In this target setting,
assumptions were made about the speed of the
Annual Report 2014
39
Group performance 5.3.1
regulatory developments in this area, which fell short of
expectations. Therefore, in 2015 the target of 50%
improvement will not yet be achieved. Further details
on this parameter and the methodology can be found
in the document ‘Energy efficiency of Philips products’
at www.philips.com/sustainability.
Circular Economy
The transition from a linear to a circular economy is
essential to create a sustainable world. A circular
economy aims to decouple economic growth from the
use of natural resources and ecosystems by using these
resources more effectively. It is a driver of innovation in
the areas of material, component and product re-use,
as well as new business models such as system
solutions and services. In a circular economy, more
effective (re)use of materials enables the creation of
more value, both by means of cost savings and by
developing new markets or growing existing ones.
For more information on our Circular Economy
activities, please refer to sub-section 14.3.1, EcoVision,
of this Annual Report.
Closing the materials loop
The amount of collection and recycling for 2013
(reported in 2014) was calculated at 31,500 tonnes, a 3%
increase compared to 31,000 tonnes reported in 2013,
mainly driven by lower weight of products and
components in Healthcare, offset by higher volumes in
Lighting. The 2009 baseline for global collection and
recycling amounts was around 22,500 tonnes, based
on the data retrieved from the WEEE collection
schemes and from our own recycling and refurbishment
services (mainly Healthcare).
Recycled materials
We calculated the amount of recycled materials used in
our products in 2014 at some 13,000 tonnes (2013:
14,000 tonnes), by focusing on the material streams
plastics (Consumer Lifestyle), aluminum (Lighting),
refurbished products, and spare parts harvesting
(Healthcare) depending on the relevance in each
sector.
Our target is to double global collection and recycling
and the amount of recycled materials in our products
by 2015 compared to 2009, when the baseline was set
at 7,500 tonnes. Further details on this parameter and
the methodology can be found in the document
‘Closing the materials loop’ at
www.philips.com/sustainability.
5.3.2 Green Product sales
Green Products offer a significant environmental
improvement in one or more Green Focal Areas: Energy
efficiency, Packaging, Hazardous substances, Weight,
Recycling and disposal and Lifetime reliability. Sales
from Green Products, excluding the Lumileds and
Automotive business, increased to EUR 11.1 billion in
2014, or 52% of sales (50% in 2013), thereby reaching a
record level for Philips.
40
Annual Report 2014
The exclusion of Lumileds and Automotive had a 1%
negative impact on the total Green Product sales
percentage.
Philips Group
Green Product sales per sector in millions of EUR
2010 - 2014
50.0%
10,997
51.7%
11,065
5,037
4,952
Lighting
As a % of sales
2,270
2,605
Consumer Lifestyle
46.3%
10,285
5,056
1,619
3,610
3,690
3,508
Healthcare
38.8%
7,719
3,955
1,101
2,663
35.8%
6,899
3,696
1,067
2,136
‘10
‘11
‘12
‘13
‘14
Through our EcoDesign process, we aim to create
products that have significantly less impact on the
environment during their whole lifecycle. Overall, the
most significant improvements have been realized in
our energy efficiency Green Focal Area, an important
objective of our EcoVision program, although there was
also growing attention for hazardous substances and
recyclability in all sectors in 2014, the latter driven by
our Circular Economy initiatives.
New Green Products from each sector include the
following examples.
Healthcare
During 2014, Healthcare expanded the Green Product
portfolio with seven new products, although Green
Product sales decreased slightly due to the Cleveland
production suspension. The newly introduced products
improve patient outcomes, provide better value, and
expand access to care, while reducing environmental
impact. Philips’ new Affinity platform, for example,
delivers superb image quality and performance, and
features a modern and elegant cart design with a
simple-to-use touchscreen-based control panel, and
ease-of-use imaging workflow. At the same time it
reduces energy use by almost 40% compared to its
predecessor model. Other examples are new X-ray
systems such as DuraDiagnost compact and
MobileDiagnost Opta systems, which feature
significantly lower product and packaging weight
(ranging between 20% and 38%), and, in the case of the
MobileDiagnost Opta, a 67% reduction in energy usage
compared to its predecessor model. Green Products
from Patient Care & Monitoring Systems include the
MX550 patient monitor, Avalon CL fetal monitor and
PageWriter TC10 cardiograph, for which product weight,
energy consumption and packaging weight have been
significantly reduced (by between 24% and 62%).
Consumer Lifestyle
Consumer Lifestyle focuses on Green Products which
meet or exceed our minimum requirements in the areas
of energy consumption, packaging, and substances of
concern. The sales of Green Products in 2014 surpassed
55% of total sales. All our Green Products with
rechargeable batteries (like toothbrushes, shavers, and
grooming products) exceed the stringent California
energy efficiency norm by at least 10%. We are making
steady progress in developing PVC/BFR-free products.
More than 60% of sales consist of PVC/BFR-free
products, with the exception of the power cords, for
which there are not yet economical viable alternatives
available.
In 2014, more vacuum cleaners, coffee machines and
irons were launched with parts made of recycled
plastics. In total we have applied some 625 tons of
recycled plastics in our products. An example is the new
SENSEO® Up, the plastic parts of which consist of 13%
recycled material.
Lighting
Green Product sales within Lighting increased from 70%
in 2013 to 72% in 2014. Connected lighting systems
contributed to Green Product sales with solutions like
CityTouch, a system for outdoor lighting management.
CityTouch offers simple web applications to remotely
control street lights and analyze related data. This gives
cities the flexibility to dim lights to low levels wherever
possible to save energy, or to boost light levels at the
touch of a button when more light is needed (for
example, in the case of an accident). The system helps
cities save energy and operate more efficiently, while
increasing citizens’ feeling of safety.
CityTouch technology is spreading around the world,
with installations in Buenos Aires, Rotterdam, and
Markham, Ontario, Canada. In the Spanish town of
Salobre, CityTouch software combines with LED
luminaires to reduce the municipality’s energy
consumption by more than 70% and cut CO2 emissions
by 29 tons per year. In a number of London boroughs,
over 70,000 light points will be managed by CityTouch.
5.3.3 Green Operations
The Green Operations program focuses on the main
contributors to climate change, recycling of waste,
reduction of water consumption and reduction of
emissions of restricted and hazardous substances. Full
details can be found in chapter 14, Sustainability
statements, of this Annual Report.
Carbon footprint and energy efficiency
After achieving our EcoVision4 carbon emissions
reduction target in 2012, we continued our energy
efficiency improvement programs across different
disciplines. In 2014 our carbon footprint decreased by
5% compared to 2013, resulting in a total of 1,375
Group performance 5.3.2
kilotonnes CO2. This was mainly achieved by emissions
reductions in our manufacturing facilities, resulting from
operational changes and decreased energy usage due
to lower load with an increased share coming from
renewable sources (some 55% in 2014), and less
transport activities. These reductions were, however,
partly offset by increased emissions from our non-
industrial activities, the floor space of our global non-
industrial property portfolio increased by 2%. Business
travel emissions remained stable compared to 2013,
however we have noted a decrease in emissions from
lease cars due to our successful Green Lease car
program, whilst air travel increased over the course of
2014. We continue to promote video conferencing as an
alternative to travel.
Our operational energy efficiency increased 2% from
1.17 terajoules per million euro sales in 2013 to 1.14
terajoules per million euro sales in 2014 as a result of
energy efficiency programs in our industrial sites.
The impact of the exclusion of Lumileds and
Automotive is displayed as discontinued operations in
the graph below; the size of which varies over the years,
but averages around 10% over the past 5 years.
Emissions from discontinued operations in our
industrial activities have been identified exactly.
Emissions from our non-industrial facilities and
business travel have been estimated based on FTE
data. For our logistics emissions the part of
discontinued operations has been estimated using
revenue share as a proxy where applicable.
Philips Group
Operational carbon footprint in kilotonnes CO2-equivalent
2010 - 2014
1,877
121
698
163
246
1,753
118
628
119
256
649
632
1,601
160
582
118
216
525
1,664
213
558
117
226
1,543
168
Discontinued operations
479
Manufacturing
124
227
Non-industrial operations
Business travel
550
545
Logistics
‘10
‘11
‘12
‘13
‘14
Philips Group
Operational carbon footprint by Greenhouse Gas Protocol
scopes in kilotonnes CO2-equivalent
2010 - 2014
Scope 1
Scope 2
Scope 3
2010
2011
2012
2013
2014
403
458
895
378
368
889
355
345
741
360
315
776
320
283
772
Philips Group
1,756
1,635
1,441
1,451
1,375
Annual Report 2014
41
Group performance 5.3.3
Philips Group
Ratios relating to carbon emissions and energy use
2010 - 2014
Operational CO2 emissions in kilotonnes CO2-equivalent
Operational CO2 efficiency in tonnes CO2-equivalent per million EUR sales
2010
1,756
91
2011
1,635
82
2012
1,441
65
2013
1,451
66
2014
1,375
64
Operational energy use in terajoules
28,030
26,570
25,052
25,646
24,464
Operational energy efficiency in terajoules per million euro sales
1.45
1.33
1.13
1.17
1.14
351
338
303
586
537
2,282
2,249
2,413
2,249
2,052
Philips Group
Industrial waste delivered for recycling in %
2014
Water
Total water intake in 2014 was 3.1 million m3, about 6%
lower than in 2013. This decrease was mainly due to
lower production volumes at multiple Lighting sites as
well as a significant reduction at a Consumer Lifestyle
site in China which implemented various water savings
actions. This was partly offset by one Healthcare site
that cooled magnets with water instead of helium.
Many Philips sites have water savings programs.
Lighting represents around 66% of total water usage. In
this sector, water is used in manufacturing as well as for
domestic purpose. The other sectors use water mainly
for domestic purposes. The exclusion of Lumileds and
Automotive has a significant downward impact on the
water consumption of Philips. In 2014, Lumileds and
Automotive accounted for 1.7 million m3 of water.
Philips Group
Water intake in thousands of m3
2010 - 2014
2010
256
2011
308
2012
2013
2014
421
454
514
Healthcare
Consumer
Lifestyle
Lighting
Innovation,
Group & Services
Continuing
operations
Discontinued
operations
7
–
–
–
–
2,896
2,895
3,137
3,289
3,103
1,322
1,433
1,720
1,755
1,700
Philips Group
4,218
4,328
4,857
5,044
4,803
In 2014, 72% of water was purchased and 28% was
extracted from groundwater wells.
Waste
In 2014, total waste was comparable to 2013 at 75
kilotonnes. Lighting contributed to 72% of total waste,
Consumer Lifestyle to 15% and Healthcare to 13%.
Waste generated by 8 new reporting sites was offset by
5 discontinued sites. The exclusion of Lumileds and
Automotive had a 7% downward impact on total waste.
In 2013, an Automotive site in the Netherlands reported
10 kilotonnes of demolition scrap.
42
Annual Report 2014
Philips Group
Total waste in kilotonnes
2010 - 2014
Healthcare
Consumer
Lifestyle
Lighting
Innovation,
Group & Services
Continuing
operations
Discontinued
operations
2010
2011
2012
2013
2014
11.2
9.3
10.4
9.6
9.8
23.2
61.7
19.6
58.1
12.7
57.5
11.4
54.9
11.3
53.9
0.1
–
–
–
–
96.2
87.0
80.6
75.9
75.0
8.4
7.0
7.0
16.1
5.4
Philips Group
104.6
94.0
87.6
92.0
80.4
Total waste consists of waste that is delivered for
landfill, incineration or recycling. Materials delivered for
recycling via an external contractor comprised 60
kilotonnes, which equals 80% of total waste, an
improvement compared to 79% in 2013, as our
manufacturing sites implemented recycling programs.
Of the 20% remaining waste, 75% comprised non-
hazardous waste and 25% hazardous waste.
24
28
19
Paper
Glass
Metal
Wood
Plastic
Demolition scrap
1
Waste chemicals
Other
9
6
6
7
Emissions
Emissions of restricted substances totaled 9 kilos in
2014, on par with 2013, as our mercury emissions at
Lighting were for the second year in a row as low as
reasonably achievable, according to our assessment.
The level of emissions of hazardous substances
decreased from 35,118 kilos to 28,310 kilos (-19%),
driven by a reduction of Xylene emissions at various
Consumer Lifestyle sites, due to a decrease in use of
specific lacquers and thinners. All sectors have
reduction programs for the restricted and hazardous
substances.
Philips Group
Restricted and hazardous substances in kilos
2010 - 2014
Restricted
substances
Hazardous
substances
2010
2011
2012
2013
2014
188
111
55
9
9
60,272 63,604 67,530
35,118
28,310
For more details on restricted and hazardous
substances, please refer to sub-section 14.3.3, Green
Operations, of this Annual Report
5.4 Proposed distribution to shareholders
Pursuant to article 34 of the articles of association of
Royal Philips, a dividend will first be declared on
preference shares out of net income. The remainder of
the net income, after reservations made with the
approval of the Supervisory Board, shall be available
for distribution to holders of common shares subject to
shareholder approval after year-end. As of December
31, 2014, the issued share capital consists only of
common shares; no preference shares have been
issued. Article 33 of the articles of association of Royal
Philips gives the Board of Management the power to
determine what portion of the net income shall be
retained by way of reserve, subject to the approval of
the Supervisory Board.
A proposal will be submitted to the 2015 Annual
General Meeting of Shareholders to declare a dividend
of EUR 0.80 per common share (up to EUR 735 million),
in cash or in shares at the option of the shareholder,
against the net income for 2014 and retained earnings.
Shareholders will be given the opportunity to make
their choice between cash and shares between May 13,
2015 and June 5, 2015. If no choice is made during this
election period the dividend will be paid in shares. On
June 5, 2015 after close of trading, the number of share
dividend rights entitled to one new common share will
be determined based on the volume weighted average
price of all traded common shares Koninklijke Philips
N.V. at Euronext Amsterdam on June 3,4 and 5, 2015.
The Company will calculate the number of share
dividend rights entitled to one new common share (the
‘ratio’), such that the gross dividend in shares will be
approximately equal to the gross dividend in cash. On
June 9, 2015 the ratio and the number of shares to be
issued will be announced. Payment of the dividend and
delivery of new common shares, with settlement of
fractions in cash, if required, will take place from June
10, 2015. The distribution of dividend in cash to holders
of New York Registry shares will be made in USD at the
USD/EUR rate fixed by the European Central Bank on
June 8, 2015.
Dividend in cash is in principle subject to 15% Dutch
dividend withholding tax, which will be deducted from
the dividend in cash paid to the shareholders. Dividend
in shares paid out of net income and retained earnings
Group performance 5.3.3
is subject to 15% dividend withholding tax, but only in
respect of the par value of the shares (EUR 0.20 per
share).
In 2014, a dividend of EUR 0.80 per common share was
paid in cash or shares, at the option of the shareholder.
For 60% of the shares, the shareholders elected for a
share dividend resulting in the issue of 18,811,534 new
common shares, leading to a 2.1% percent dilution. EUR
292 million was paid in cash. For additional information,
see chapter 17, Investor Relations, of this Annual Report.
The balance sheet presented in this report, as part of
the Company financial statements for the period ended
December 31, 2014, is before appropriation of the result
for the financial year 2014.
5.5 Outlook
Overall, 2014 was a setback in our performance
trajectory. We have been taking clear actions to drive
stronger operational performance across our
businesses and expect sales growth and EBITA margin
improvements in 2015 and beyond. However, looking
ahead, we remain cautious regarding the
macroeconomic outlook and expect ongoing volatility
of some of our end-markets. We also anticipate further
restructuring and separation costs in 2015 and 2016.
Due to these factors, we are tracking 1 percentage point
behind on the path to achieving each of our 2016
comparable sales growth, EBITA and ROIC Group
targets. We are convinced that this does not change our
longer-term performance potential, considering the
attractiveness of the Lighting Solutions and HealthTech
markets and our competitive position. Later this year, as
we progress with the separation of Philips and
reallocation of IG&S, we will update the market about
the integral performance targets for each of the two
operating companies.
Annual Report 2014
43
Sector performance 6
6 Sector performance
Philips Group
Our structure
2014
Koninklijke Philips N.V.
Healthcare
Consumer
Lifestyle
Imaging Systems
Personal Care
Lighting
Light Sources &
Electronics
Customer Services
Domestic Appliances
Consumer Luminaires
Innovation,
Group & Services
Group Innovation
Intellectual Property &
Royalties
Healthcare Informatics,
Solutions & Services
Patient Care &
Monitoring Solutions
Health & Wellness
Professional Lighting
Solutions
Group and regional
costs
Automotive Lighting1)
Lumileds1)
1) On June 30, 2014, Philips announced the start of the process to combine the Lumileds and Automotive Lighting businesses into a stand-alone company and
explore strategic options to attract capital from third-party investors for this combined business. The results of the combined Lumileds/Automotive Lighting
components business are reported as discontinued operations.
Our structure in 2014
Koninklijke Philips N.V. (the ‘Company’) is the parent
company of the Philips Group (‘Philips’ or the ‘Group’).
The Company is managed by the members of the Board
of Management and Executive Committee under the
supervision of the Supervisory Board. The Executive
Committee operates under the chairmanship of the
Chief Executive Officer and shares responsibility for the
deployment of Philips’ strategy and policies, and the
achievement of its objectives and results.
In 2014, Philips’ activities in the field of health and well-
being were organized on a sector basis, with each
operating sector – Healthcare, Consumer Lifestyle and
Lighting – being responsible for the management of its
businesses worldwide.
The Innovation, Group & Services sector includes the
activities of Group Innovation and Group and regional
management organizations. Additionally, the global
shared business services for procurement, finance,
human resources, IT and real estate are reported in this
sector, as well as certain pension costs.
At the end of 2014, Philips had 93 production sites in 25
countries, sales and service outlets in approximately
100 countries, and 113,678 employees.
2015 and beyond
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities.
To achieve this transformation, from January 1, 2015,
Philips started to integrate the sectors Consumer
Lifestyle and Healthcare into one operating company
focused on our HealthTech businesses. At the same
time Philips is taking the next step in the
implementation of its new operating model which will
give the company a dedicated, focused and lean
management structure, as a result of the planned
integration of the relevant sector and group layers.
Philips also started the process to carve out its Lighting
business into a separate legal structure and will
consider various options for ownership structures with
direct access to capital markets.
The establishment of the two stand-alone companies
will also involve the split and allocation of the current
Innovation, Group & Services sector to each company
in 2015. This means that in the course of 2015 the IG&S
sector as currently described in this Annual Report will
disappear and no longer be presented as a separate
segment for reporting purposes.
44
Annual Report 2014
6.1 Healthcare
Sector performance 6.1
“ We remain steadfast in our commitment to enable the best
possible care provision at the lowest cost wherever care is
provided, from the hospital to the home.”
Frans van Houten, CEO Royal Philips
• By leveraging world-class innovation, deep clinical
expertise and extensive relationships, global access
to healthcare providers, and an integrated solutions
portfolio, we provide greater value while helping
lower the cost of care across the health continuum.
• Our multi-year Accelerate! program continues to
improve our operational performance, helping offset
market headwinds.
• We are focused on delivering on our financial
commitments and driving growth, despite ongoing
softness in a number of markets, including the US,
Europe and China.
• Capitalizing on the convergence of professional
healthcare and consumer end-markets, we will
leverage our consumer and healthcare businesses to
capture the vast opportunities along the health
continuum – from healthy living to preventative care,
definitive diagnostics, minimally invasive therapy,
and hospital and home care for recovering and
chronically ill patients.
6.1.1 Health care landscape
Health care systems around the world are under
increasing economic pressure. More people are living
longer, and more are living with chronic conditions –
driving healthcare spending to unsustainable levels.
Shortages of healthcare professionals are also adding
to the relentless challenge of delivering better care at
lower cost to growing patient populations.
Fundamental transformative changes are already
taking place in the health care industry to enable the
provision of affordable, quality care to everyone who
needs it. There is a shift in emphasis from volume to
value, and from a singular focus on clinical outcomes to
a more holistic approach to population health. Greater
attention is also being paid to the benefits of healthy
living and home care as a way to lessen the burden on
health systems.
Increasingly, providers and patients see the need for
patients to take a more active role in managing their
health – giving rise to the health consumer. Mobile and
digital technologies will be significant enablers of this
trend, leading to new care delivery models that give
patients more control and responsibility for their
healthcare, and offer providers more solutions for
improving access and outcomes while managing costs.
6.1.2 About Philips Healthcare
At Philips, we deliver innovative, integral technology
solutions designed to create value by improving the
quality and delivery of care while lowering cost. Our
Annual Report 2014
45
Sector performance 6.1.2
broad and deep clinical expertise and technology
leadership across the health continuum and
commitment to customer collaboration are core to our
business and truly differentiate us.
Philips is one of the world’s leading health care
companies (based on sales) along with General Electric
and Siemens. The competitive landscape in the health
care industry is evolving with the emergence of a
considerable number of new market players. The
United States, our largest market, represented 40% of
Healthcare’s global sales in 2014, followed by China,
Japan and Germany. Growth geographies accounted
for 25% of Healthcare sales. Philips Healthcare has
approximately 37,000 employees worldwide.
In 2014, our Healthcare business was organized around
four strategic business groups, including the newly
formed Healthcare Informatics, Solutions & Services
group, which brings together key assets across
Healthcare to address opportunities arising from rapid
changes in the industry and the increasing importance
of technologies, such as mobile devices, the Cloud,
social media, Big Data and the Internet of Things. In
2014, these business groups were:
• Imaging Systems: Integrated clinical solutions that
include radiation oncology and portfolio
management; advanced diagnostic imaging,
including computed tomography (CT), magnetic
resonance imaging (MRI) and molecular imaging (MI);
diagnostic X-ray, including digital X-ray and
mammography; interventional X-ray, encompassing
cardiology, radiology, surgery and other areas; and
ultrasound, a modality with diverse customers and
broad clinical presence
• Patient Care & Monitoring Solutions: Enterprise-
wide patient monitoring solutions, from value
solutions to sophisticated connected solutions, for
real-time clinical information at the patient’s
bedside; patient analytics, patient monitoring and
clinical decision support systems; mother and child
care, including products and solutions for pregnancy,
labor and delivery, newborn and neonatal intensive
care and the transition home; and therapeutic care,
including cardiac resuscitation, emergency care
solutions, therapeutic temperature management,
anesthesia care, hospital respiratory systems and
ventilation, sleep management, respiratory care and
non-invasive ventilation
• Customer Services: Product and solution services
and support, including clinical support and
performance services; education and value-added
services; installation; remote proactive monitoring;
and customer service agreement
• Healthcare Informatics, Solutions & Services:
Advanced Healthcare IT consisting of integrated
software solutions, imaging informatics for radiology
and cardiology departments, Picture Archiving and
Communication systems (PACS) and fully integrated
Electronic Medical Record (EMR) systems; a
professional services business (Healthcare
46
Annual Report 2014
Transformation Services) spanning consulting,
education, clinical and business performance
improvement, program management, system
integration services; specialized solutions including
care coordination, home monitoring to make the
aging experience better, and primary and secondary
care solutions to expand access to care in emerging
markets. All solutions and software businesses will be
supported by the Philips HealthSuite Digital Platform
to enable interoperability, Big Data analytics,
optimized workflows and care pathways, rapid
application development, enhanced patient
centricity and engagement.
Philips Healthcare
Total sales by business as a %
2014
Imaging Systems
Patient Care & Monitoring Solutions
35
32
Healthcare Informatics,
Solutions & Services
6
Customer Services
27
Sales at Healthcare are generally higher in the second
half of the year largely due to the timing of new product
availability and customer spending patterns.
Regulatory requirements
Philips Healthcare is subject to extensive regulation. We
are committed to compliance with regulatory product
approval and quality system requirements in every
market we serve, by addressing specific terms and
conditions of local and national regulatory authorities,
including the US FDA, the SFDA in China, and other
comparable foreign agencies. Obtaining regulatory
approval is costly and time-consuming, but a
prerequisite for market introduction.
Progress was made in 2014 in the remediation of the
quality management system at our Healthcare facility
in Cleveland, Ohio. Following external certification of
the updated quality management system we resumed
production, which had been voluntarily suspended
earlier in the year, with production ramp-up expected
to continue through 2015.
With regard to sourcing, please refer to sub-section
14.2.8, Supplier indicators, of this Annual Report.
6.1.3 2014 highlights
The health continuum of healthy living, prevention,
diagnosis, treatment, recovery and home care
remained a growing and exciting market for Philips
Healthcare. Leveraging our portfolio, insights and
capabilities, we focused on creating value across our
businesses and markets through collaborative
innovation, including:
• Large-scale partnerships – We entered into a
number of strategic, multi-year agreements that
address government and health system goals of
improving population health and delivering quality
care more effectively. These included a 15-year
contract with Reinier de Graaf Hospital in the
Netherlands, a 14-year contract with Karolinska
University Hospital and the Stockholm County
Council in Sweden, and a 10-year contract related to
the 700-bed Philippine Orthopedic Centre in the
Philippines.
• Co-created solutions – We collaborated on smart
solutions co-created in the clinical environment, such
as working with the University of Washington on
advancements in diagnostics and informatics to
improve outcomes, drive operational efficiency and
reduce costs per patient.
• Strategic alliances – We formed key partnerships to
help drive healthcare transformation, including an
alliance with Salesforce.com to deliver an open,
cloud-based healthcare platform that will enable
collaborative care management between patients
and healthcare professionals.
We also introduced locally relevant solutions for
making quality care accessible to wider patient
populations in markets such as India and Africa. These
innovations included VISIQ, an ultra-mobile, tablet-
based system for ultrasound imaging, and Efficia
DFM100, an integrated defibrillator and monitor
solution.
We are proud that customers named Philips Healthcare
as the overall Best in KLAS Imaging Equipment
Company in 2014 for the second year in a row.
In 2014, we entered the fourth year of our Accelerate!
journey, which continued to drive improvements in
operational performance, as we focused on
strengthening our innovation pipeline while making
progress on cost savings.
In December 2014 Philips entered into an agreement to
acquire Volcano Corporation, a global leader in
catheter-based imaging and measurement solutions
for cardiovascular applications. Volcano’s
complementary portfolio and expertise will create
opportunities to accelerate revenue growth for our
image-guided therapy business.
Sector performance 6.1.3
6.1.4 2014 financial performance
Philips Healthcare
Key data in millions of EUR unless otherwise stated
2012 - 2014
Sales
Sales growth
2012
2013
9,983
9,575
2014
9,186
% increase (decrease), nominal
13%
(4)%
(4)%
% increase (decrease),
comparable1)
EBITA 1)
as a % of sales
EBIT
as a % of sales
Net operating capital (NOC)1)
Cash flows before financing
activities1)
6%
1,226
12.3%
1,026
10.3%
7,976
1%
1,512
15.8%
1,315
13.7%
7,437
(2)%
616
6.7%
456
5.0%
7,565
1,298
1,292
910
Employees (in FTEs)
37,460
37,008
37,065
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
In 2014, sales amounted to EUR 9,186 million, 4% lower
than in 2013 on a nominal basis. Excluding a 2%
negative currency effect, comparable sales decreased
by 2%. Customer Services achieved mid-single-digit
growth and Patient Care & Monitoring Solutions posted
low-single-digit growth, while HealthCare Informatics,
Services & Solutions sales were in line with 2013.
Imaging Systems recorded a double-digit decline.
Green Product sales amounted to EUR 3,508 million, or
38% of sector sales.
Geographically, comparable sales in growth
geographies showed a low-single-digit decline, with
strong growth in Latin America and Middle East &
Turkey offset by a double-digit decline in China. In
mature geographies, comparable sales also showed a
low-single-digit decline. The year-on-year sales
decrease was largely attributable to North America and
Western Europe, as sales in other mature geographies
showed a low-single-digit increase, led mainly by
Japan.
EBITA decreased from EUR 1,512 million, or 15.8% of
sales, in 2013 to EUR 616 million, or 6.7% of sales, in
2014. Restructuring and acquisition-related charges
amounted to EUR 70 million in 2014, while in 2013 they
were close to zero. 2014 EBITA included charges of EUR
366 million related to the jury verdict in the Masimo
litigation, EUR 49 million of mainly inventory write-
downs related to the Cleveland facility, and a EUR 16
million past-service pension cost gain in the
Netherlands.
In 2014, the voluntary suspension of production at our
Cleveland facility and the jury verdict in the Masimo
litigation strongly impacted our 2014 performance. At
our Healthcare facility in Cleveland, Ohio, certain issues
in the general area of manufacturing process controls
were identified during an ongoing US Food and Drug
Administration (FDA) inspection. To address these
Annual Report 2014
47
Sector performance 6.1.4
issues, on January 10, 2014 we started a voluntary,
temporary suspension of new production at the facility,
primarily to strengthen manufacturing process controls.
The suspension negatively impacted Healthcare’s sales
and EBITA in 2014.
On October 3, 2014 Philips announced that it would
appeal the jury verdict in the patent infringement
lawsuit by Masimo Corporation (Masimo), in which
Masimo was awarded compensation of USD 467 million
(EUR 366 million). The jury verdict is part of extensive
litigation, which started in 2009, between Masimo and
Philips involving several claims and counterclaims
related to a large number of patents.
EBITA in 2013 also included EUR 61 million from a past-
service pension gain and a EUR 21 million gain on the
sale of a business excluding these items. The decrease
in EBITA was mainly driven by operational losses
related to the voluntary suspension of production at the
Cleveland facility and negative currency impacts.
EBIT amounted to EUR 456 million, or 5.0% of sales, and
included EUR 159 million of charges related to
intangible assets.
Net operating capital increased by EUR 128 million to
EUR 7,565 million. Higher provisions and lower fixed
assets were offset by currency impacts.
Cash flows before financing activities decreased from
EUR 1,292 million in 2013 to EUR 910 million in 2014,
largely due to lower earnings.
Philips Healthcare
Sales per geographic cluster in millions of EUR
2010 - 2014
8,601
1,701
8,852
1,905
968
1,046
9,983
2,368
1,252
9,575
2,421
1,133
9,186
2,296
Growth
1,080
Other mature
3,901
3,953
4,393
4,089
3,896
North America
2,031
1,948
1,970
1,932
1,914
Western Europe
‘10
‘11
‘12
‘13
‘14
Philips Healthcare
Sales and net operating capital1) in billions of EUR
2010 - 2014
8.0
10.0
7.4
9.6
7.6
9.2
Sales
8.9
8.6
8.4
8.9
Net operating capital
‘10
‘11
‘12
‘13
‘14
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
Philips Healthcare
EBIT and EBITA 1) in millions of EUR
2010 - 2014
15.8%
1,512
12.3%
1,226
1,315
1,026
13.1%
1,129
866
12.2%
1,080
27
1,053
263
‘10
200
‘12
197
‘13
‘11
6.7%
616
456
160
‘14
EBITA in value
EBIT in value
EBITA as a % of sales
Amortization and impairment
in value
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
6.1.5 Delivering on EcoVision sustainability
commitments
The increasing population and rising levels of human
development worldwide pose a number of challenges,
such as scarcity of natural resources, pollution, and
stressed health care systems. Philips Healthcare
continues to help increase the number of lives
improved annually around the globe by developing
solutions that improve access to care, while at the same
time respecting the boundaries of natural resources.
In 2014, Green Product sales in Healthcare amounted
to EUR 3.5 billion and we introduced seven new Green
Products to support energy efficiency, materials
reduction and other sustainability goals. We are also
actively collaborating with care providers to look for
innovative ways to reduce the environmental impact of
health care, for example by improving the energy
efficiency of medical equipment. Another example is
the launch of a new imaging systems refurbishment
facility in Best, the Netherlands, in support of the
transition to a circular economy in Healthcare.
48
Annual Report 2014
Philips was presented with the 2014 “Champion for
Change” Award by Practice Greenhealth. The award
honors businesses who have not only taken steps to
improve their organization’s green practices, but have
also gone the extra mile to help their clients and
associates expand their sustainable practices as well.
6.1.6 2015 and beyond
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities. To achieve this
transformation, from January 1, 2015, Philips started to
integrate the sectors Healthcare and Consumer
Lifestyle into one operating company focused on our
HealthTech businesses.
In the HealthTech space, Royal Philips will focus on the
vast market opportunities created by the convergence
of professional healthcare and consumer end-markets
across the health continuum, from healthy living and
prevention to diagnosis, treatment, recovery and home
care.
Building on combined clinical and consumer
capabilities, we will focus on solutions aimed at
empowering consumers and patients to take greater
control of their own health, enabling payers and
providers to improve outcomes while managing overall
cost, and helping governments increase access to high-
quality, affordable care.
From an external financial reporting perspective, it
should be noted that the planned organizational
changes will require Philips to transition to a new
reporting structure in the course of 2015. At that stage,
and in view of applicable IFRS requirements, Philips will
report and discuss its financial performance on the
basis of different reportable segments than the sectors
currently presented and discussed in this Annual
Report.
Further updates will be provided in the course of 2015.
Sector performance 6.1.5
Annual Report 2014
49
Sector performance 6.1.6
Innovating on the ward
A unique partnership with a hospital in China has yielded astonishing
results in the field of diagnostics, in a country with rising health problems,
where many specialists are unable to cope with increased workloads.
The huge West China Hospital in the country’s fourth
largest city, Chengdu, plays host to a ground-breaking
collaboration between doctors and engineers from
Philips. China accounts for half of all new cases of liver
cancer in Asia, but old cancer diagnostic technologies
involved complex and time-consuming invasive
procedures that presented risk to the patient and meant
their recovery times were lengthened.
The Philips ElastPQ is a non-invasive machine using
state-of-the-art ultrasound technology. It provides
medics with valuable data that can be used to
accurately diagnose liver cancer – both at a fraction of
the cost and at greater speed. However, it’s not simply
the innovation – the presence of Philips engineers on
site facilitates ongoing research and development in a
hospital setting. This continuous innovation is an
inspiring medical partnership where doctors and
engineers join forces to match technology with actual
clinical need. It’s leading to faster and more accurate
cancer diagnosis – with all the obvious benefits that
entails for patients.
50
Annual Report 2014
“Having joined forces (with Philips), we’re bridging the
gap to match technology with actual clinical need.
Today the focus is on liver cancer, but I hope to expand
the collaboration to other areas.” Dr. Yan Luo, Director
of the Ultrasound Department, West China Hospital
6.2 Consumer Lifestyle
Sector performance 6.2
“ Across the world people are looking for new ways to take
greater control of their personal health. Ways to cook
healthily, to breathe clean air, to ensure good oral health.
Ways to care for themselves and their families at home. At
Consumer Lifestyle we are playing a key role in this
consumerization of healthcare, expanding our offering to
help consumers make healthier choices every day. We
empower them to be healthy and live well, avoiding illness
through conscious healthy behavior.”
Pieter Nota, CEO Philips Consumer Lifestyle
• We are rigorously executing our strategy, with locally
relevant innovation delivering strong growth and
driving profitability.
• Future growth drivers are clearly set: grow the core
businesses through local and global innovation
platforms, and geographical expansion of proven
propositions; further expand in the domain of
personal health by exploring new business
adjacencies and new business areas.
• The sector has made strong progress to reposition
towards a healthy living and disease prevention
portfolio, in more attractive markets, with better
margins.
• Our multi-year Accelerate! program has transformed
the sector into a market-driven organization, by
changing our operating model and instilling a strong
performance culture and end-to-end approach.
6.2.1 Lifestyle retail landscape
Across the world, consumers are looking for solutions
that help them to be healthy, live well and enjoy life.
They want to be in control of their personal health and
to care for their family and friends. They want to look
and feel good.
Annual Report 2014
51
Sector performance 6.2.1
In a connected, digital world, consumers are looking for
smart, personalized solutions. Purchase decisions are
increasingly made or influenced online; this is as true of
consumers in growth geographies such as China, as it is
in developed markets such as Western Europe.
The rise of the middle class in growth geographies is
another trend impacting the retail landscape. This
rapidly expanding group has increasing spending
power.
In 2014, economic headwinds caused continued
pressure on consumer spending in some markets.
However, living a healthy life remained a high priority
for consumers.
6.2.2 About Philips Consumer Lifestyle
At Consumer Lifestyle we aim to make a difference to
people’s lives by enabling them to make healthy
choices every day, and through conscious healthy
behavior avoid illness. In recent years, Consumer
Lifestyle has been responding to the need and desire
of consumers to take greater control of their own health.
We have largely reshaped our portfolio toward the
healthy living and disease prevention areas of the
health continuum, targeting more attractive markets
with better margins.
The sector is focused on value creation through
category leadership and operational excellence. We are
increasing the quality and local relevance of product
innovation, the speed with which we innovate, and
expanding our distribution to capture increasing
spending power in growth geographies.
Consumer Lifestyle is built around businesses and
markets, enabling us to direct investments to where the
growth is, addressing locally relevant consumer needs.
We take locally developed platforms and adapt them
for other markets or on a global scale.
Our end-to-end approach is accelerating specialist
capability development in mature markets, to enable
effective partnerships with customers and consumers,
and in growth geographies, to enable development of
go-to-market strategies
In 2014 the Consumer Lifestyle sector consisted of the
following areas of business:
• Health & Wellness: mother and child care, oral
healthcare, pain management
• Personal Care: male grooming, beauty
• Domestic Appliances: kitchen appliances, coffee,
garment care, floor care, air purification
52
Annual Report 2014
Philips Consumer Lifestyle
Total sales by business as a %
2014
Health & Wellness
Personal Care
Domestic Appliances
21
32
47
We offer a broad range of products from high to low
price/value quartiles, necessitating a diverse
distribution model. We continue to expand our portfolio
and increase its accessibility, particularly in lower-tier
cities in growth geographies. We are well positioned to
increasingly capture growth in online sales. Over the
course of 2014 we implemented innovative approaches
in online and social media to build our brand and drive
sales in local markets and globally. On the Philips
Global Facebook page for instance, an educational
personal health and well-being campaign helped
increase the number of fans from 4 million to 6 million.
More locally, a UK-focused Domestic Appliances
campaign, which was activated on several social
channels, generated interest from almost 2 million
consumers in just 3 months.
Under normal economic conditions, the Consumer
Lifestyle sector experiences seasonality, with higher
sales in the fourth quarter.
Consumer Lifestyle employs approximately 16,600
people worldwide. Our global sales and service
organization covers more than 50 developed and
growth geographies. In addition, we operate
manufacturing and business creation organizations in
Argentina, Austria, Brazil, China, India, Indonesia, Italy,
the Netherlands, Romania, the UK and the US.
Regulatory requirements
Consumer Lifestyle is subject to regulatory
requirements in the markets where it operates. This
includes the European Union’s Waste from Electrical
and Electronic Equipment (WEEE), Restriction of
Hazardous Substances (RoHS), Registration,
Evaluation, Authorization and Restriction of Chemicals
(REACH), Energy-use of Products (EuP) requirements
and Product Safety Regulations. Consumer Lifestyle
has a growing portfolio of medically regulated products
in its Health & Wellness and Personal Care businesses.
For these products we are subject to the applicable
requirements of the US FDA, the European Medical
Device Directive, the SFDA in China and comparable
regulations in other countries. Through our growing
beauty, oral healthcare and mother and child care
product portfolio the range of applicable regulations
has been extended to include requirements relating to
cosmetics and, on a very small scale, pharmaceuticals.
With regard to sourcing, please refer to sub-section
14.2.8, Supplier indicators, of this Annual Report.
6.2.3 2014 highlights
• Empowering consumers to take control of their own
health with digital solutions for healthy living and
disease prevention, Philips launched its latest
connected devices and apps at IFA in Berlin.
Highlights included a smart air purifier, an app to
manage treatment of chronic pain and an oral
healthcare app to help kids brush their teeth more
effectively.
• Continuing the geographical expansion of Philips
product innovations, the Philips Airfryer is now
available in more than 100 countries. Philips is a
leader in the world’s low-fat fryer market.
• The success of established propositions like the
Philips Sonicare DiamondClean and the Philips
Sonicare AirFloss, along with new introductions like
Philips Sonicare for Kids, drove continued growth
across the world, in particular in China, Japan,
Germany and North America.
• Delivering on its male grooming growth strategy to
drive loyalty and create more value among existing
users, Philips launched the Philips Shaver Series
9000, our most advanced shaver yet, in 47 countries
around the world.
• Award-winning designs and advanced technology
further strengthened Philips’ leadership position in
the Chinese air purification market, with consumers
responding to innovations such as the Vitashield
Intelligent Purification System, which removes indoor
contaminants that can impact health and well-being.
• Professional endorsement and channel expansion
are core to the growth momentum of Philips’ Mother
and Childcare business (Avent). In Germany,
distribution was further extended in the drugstore
channel, with professional endorsement a key trigger
for consumers. In China, distribution was expanded
to more cities, with a continued focus to make Philips
Avent the brand that is most recommended by
mothers.
6.2.4 2014 financial performance
Philips Consumer Lifestyle
Key data in millions of EUR unless otherwise stated
2012 - 2014
Sales
Sales growth
2012
2013
4,319
4,605
2014
4,731
% increase (decrease), nominal
15%
7%
3%
% increase (decrease),
comparable1)
EBITA 1)
as a % of sales
EBIT
as a % of sales
Net operating capital (NOC)1)
Cash flows before financing
activities1)
9%
456
10%
483
6%
573
10.6%
10.5%
12.1%
400
9.3%
1,205
429
9.3%
1,261
520
11.0%
1,353
413
480
553
Employees (in FTEs)
16,542
17,255
16,639
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
Sector performance 6.2.3
Sales amounted to EUR 4,731 million, a nominal
increase of 3% compared to 2013. Excluding a 3%
negative currency impact, comparable sales were 6%
higher year-on-year. Health & Wellness achieved
double-digit-growth and Domestic Appliances
recorded high-single-digit growth, while Personal Care
recorded low-single-digit growth. Green Product sales
amounted to EUR 2,605 million, or 55% of total sector
sales.
From a geographical perspective, comparable sales
showed an 8% increase in growth geographies and 3%
growth in mature geographies. In growth geographies,
increase was mainly driven by China and Middle East &
Turkey, primarily in the Health & Wellness and Domestic
Appliances businesses. Growth geographies’ share of
sector sales was in line with 2013 at 47%.
EBITA increased from EUR 483 million, or 10.5% of sales,
in 2013 to EUR 573 million, or 12.1% of sales, in 2014.
Restructuring and acquisition-related charges
amounted to EUR 9 million in 2014, compared to EUR
14 million in 2013. EBITA in 2013 also included a EUR 1
million past-service pension cost gain in the US. The
year-on-year EBITA increase was driven by improved
earnings in all businesses and more than offset currency
headwinds.
EBIT amounted to EUR 520 million, or 11.0% of sales,
which included EUR 53 million of amortization charges,
mainly related to intangible assets at Health & Wellness
and Domestic Appliances.
Net operating capital increased from EUR 1,261 million
in 2013 to EUR 1,353 million in 2014, due to higher
working capital and a reduction in provisions.
Cash flows before financing activities increased from
EUR 480 million in 2013 to EUR 553 million in 2014,
mainly attributable to higher earnings.
Philips Consumer Lifestyle
Sales per geographic cluster in millions of EUR
2010 - 2014
4,605
4,731
4,319
1,954
2,187
2,223
Growth
272
768
299
769
324
781
Other mature
North America
3,771
1,532
228
688
3,316
1,290
193
560
1,273
1,323
1,325
1,350
1,403
Western Europe
‘10
‘11
‘12
‘13
‘14
Annual Report 2014
53
Sector performance 6.2.4
Philips Consumer Lifestyle
Sales and net operating capital1) in billions of EUR
2010 - 2014
CO2-neutral production sites. In 2014, 68% of the
electricity used in factories came from renewable
sources and 80% of the industrial waste was recycled.
1.3
4.6
1.4
4.7
Sales
1.2
4.3
6.2.6 2015 and beyond
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities. To achieve this
transformation, from January 1, 2015, Philips started to
integrate the sectors Consumer Lifestyle and
Healthcare into one operating company focused on our
HealthTech businesses.
In the HealthTech space, Royal Philips will focus on the
vast market opportunities created by the convergence
of professional healthcare and consumer end-markets
across the health continuum, from healthy living and
prevention to diagnosis, treatment, recovery and home
care.
Building on combined clinical and consumer
capabilities, we will focus on solutions aimed at
empowering consumers and patients to take greater
control of their own health, enabling payers and
providers to improve outcomes while managing overall
cost, and helping governments increase access to high-
quality, affordable care.
From an external financial reporting perspective, it
should be noted that the planned organizational
changes will require Philips to transition to a new
reporting structure in the course of 2015. At that stage,
and in view of applicable IFRS requirements, Philips will
report and discuss its financial performance on the
basis of different reportable segments than the sectors
currently presented and discussed in this Annual
Report.
Further updates will be provided in the course of 2015.
0.9
3.8
0.9
3.3
Net operating capital
‘10
‘11
‘12
‘13
‘14
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
Philips Consumer Lifestyle
EBIT and EBITA 1) in millions of EUR
2010 - 2014
12.1%
573
EBITA in value
10.5%
483
10.6%
456
6.4%
211
188
23
‘10
4.1%
153
109
44
‘11
520
EBIT in value
400
429
EBITA as a % of sales
56
‘12
54
‘13
53
‘14
Amortization and
impairment in value
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
6.2.5 Delivering on EcoVision sustainability
commitments
Sustainability plays an important role at Consumer
Lifestyle, with the main focus on optimizing the
sustainability performance of our products and
operations. Green Products, which meet or exceed our
minimum requirements in the area of energy
consumption, packaging and/or substances of concern,
accounted for 55% of total sales in 2014. All Green
Products with rechargeable batteries exceed the
stringent California energy efficiency standard. And
over 60% of total sales are PVC- and/or BFR-free
products (excluding power cords).
In 2014 we continued to increase the use of recycled
materials in our products. Over 625 tons of recycled
plastics were used in vacuum cleaners, irons and coffee
machines. We also launched the new SENSEO® Up, of
which the plastic parts consist of 13% recycled material.
In our operations we continue to use more energy from
renewable sources, with the ultimate aim of having
54
Annual Report 2014
Sector performance 6.2.6
New ways to fry
Fried food is somewhat of a tradition in Saudi Arabia, as it is in many
countries. It has become so popular that almost a quarter of students
eschew a healthy diet and are now classified as obese.
In addition, almost three quarters of over-40s in the
country are overweight, which puts enormous strain on
the medical system.
of a unique experiment, Saudi medical professionals
gave her a Philips Airfryer, along with other patients
suffering from high blood pressure or diabetes, to see if
using the Philips Airfryer could help her lose weight.
The Airfryer uses innovative Rapid Air Technology so
that up to 80% less fat is used to cook dishes like French
fries* – but with remarkably similar results. Nutritious
recipes, inspired by a clever and meaningful kitchen
tool such as the Airfryer, can transform the health of
both kitchen novices and those who think of
themselves as culinary experts.
* Compared to frying fresh fries in a conventional Philips
deep-fat fryer
Dental assistant Mai Matbouli had to change her
lifestyle because she was overweight and this was
impacting on her health and ability to walk. So, as part
Annual Report 2014
55
Sector performance 6.3
6.3 Lighting
“ We are leading the industry transformation, capturing
market opportunities and creating value for our customers.
Going forward, Philips Lighting will become a stand-alone
Lighting Solutions company. This will enable us to further
capitalize on the fundamental changes taking place in the
lighting industry and deliver innovations that create value
and boost growth.” Eric Rondolat, CEO Philips Lighting
• The lighting industry is undergoing a radical
transformation.
• The lighting market is being driven by the transition
to LED and digital applications.
• With our four-pillar strategy our goal is to create
further value as a world-class lighting solutions
provider.
• We continue on our Accelerate! journey to achieve
operational excellence across our businesses.
• The separation process is fully under way and is
expected to take approximately 12-18 months.
6.3.1 Lighting business landscape
We are witnessing a number of trends and transitions
that are affecting the lighting industry and changing the
way people use and experience light.
We serve a large and attractive market that is driven by
the need for more light, the need for energy-efficient
lighting, and the need for digital lighting. The world’s
population is forecast to grow from 7 billion today to
over 9 billion people by 2050. At the same time, we are
witnessing unprecedented urbanization, with over 70%
of the world’s population expected to live in urban
areas by 2050. These trends will increase demand for
light. In addition, in the face of resource constraints and
climate change, the world needs that light to be energy-
efficient. At the same time, the lighting industry is
moving from conventional to LED lighting, which is
changing the way people use, experience and interact
with light. LED technology, when combined with
sensors, controls and software and linked into a
network, is allowing light points to achieve a degree of
intelligence. This is further opening up the possibility of
new functionalities and services based on the
transmission and analysis of data.
The lighting market is expected to grow by 3-5% per
annum between 2013 and 2018. The majority of this
growth will be driven by LED-based solutions and
applications – heading towards a 60-65% share by
2018 – and growth geographies.
56
Annual Report 2014
Sector performance 6.3.2
6.3.2 About Philips Lighting
Philips Lighting is a global market leader with
recognized expertise in the development, manufacture
and application of innovative, energy-efficient lighting
products, systems and services that improve people’s
lives. We have pioneered many of the key
breakthroughs in lighting over the past 124 years, laying
the basis for our current strength and leading position
in the digital transformation.
In 2014, Philips Lighting spanned the entire lighting
value chain – from light sources, luminaires, electronics
and controls to application-specific systems and
services – through the following businesses:
• Light Sources & Electronics: LED, eco-halogen,
(compact) fluorescent, high-intensity discharge and
incandescent light sources, plus electronic and
electromagnetic gear, modules and drivers
• Consumer Luminaires: functional, decorative,
We have a firm strategy which is based upon four pillars:
lifestyle, scene-setting luminaires
• Lead the technological revolution – strengthening
our leadership position through continued
innovation in high-quality, energy-efficient and
connected LED systems.
• Win in the consumer market – meeting consumers’
needs by building on our strength in lighting to deliver
high-quality LED lamps and luminaires. We are
pioneering and shaping the market with innovative
products, such as the Hue connected home lighting
system that can be controlled by a smartphone or
tablet. In addition, we are expanding new channels
to market including online, retailers in food and
consumer electronics, and children’s retail.
• Drive innovation in professional lighting systems and
services – providing integrated offerings for this
market, which has been an early adopter of energy-
efficient LED and now connected lighting
technologies.
• Accelerate! – We have entered the next phase and
will transition into a separate legal structure to further
our position as a world-class provider of lighting
solutions. We aim to fuel growth by strengthening our
capabilities and simplifying our organizational
structure to become faster and more agile.
We aim to further invest in LED leadership while at the
same time capitalizing on our broad portfolio,
distribution and brand in conventional lighting by
flexibly anticipating and managing the phase-out of
conventional products.
We address people’s lighting needs across a full range
of market segments. Indoors, we offer lighting solutions
for homes, shops, offices, schools, hotels, factories and
hospitals. Outdoors, we offer solutions for roads,
streets, public spaces, residential areas and sports
arenas, as well as solar-powered LED off-grid lighting.
In addition, we address the desire for light-inspired
experiences through architectural projects. Finally, we
offer specific applications of lighting in specialized
areas, such as horticulture and water purification.
• Professional Lighting Solutions: controls and
luminaires for city beautification, road lighting, sports
lighting, office lighting, shop/hospitality lighting,
industry lighting
• Automotive Lighting: car headlights and signaling*
• Lumileds: packaged LEDs*
* On June 30, 2014, Philips announced the start of the
process to combine the Lumileds and Automotive
Lighting businesses into a stand-alone company and
explore strategic options to attract capital from third-
party investors for this combined business. The results
of the combined Lumileds/Automotive Lighting
components business are reported as discontinued
operations.
Philips Lighting
Total sales by business as a %
2014
Light Sources & Electronics
Consumer Luminaires
6
59
Professional Lighting Solutions
35
The Light Sources & Electronics business conducts its
sales and marketing activities through the professional,
OEM and consumer channels, the latter also being used
by our Consumer Luminaires business. Professional
Lighting Solutions is organized in a trade business
(commodity products) and a project solutions business
(project luminaires, systems and services).
The conventional lamps industry is highly consolidated,
with GE and Osram as established key competitors. The
LED lighting market, on the other hand, is very dynamic.
We face new competition from Asia and new players
from the semiconductor and building management
sectors. The luminaires industry is fragmented, with our
competition varying per region and per market
segment.
Under normal economic conditions, Lighting’s sales are
generally not materially affected by seasonality.
Philips Lighting has manufacturing facilities in some 25
countries in all major regions of the world, and sales
organizations in more than 60 countries. Commercial
activities in other countries are handled via distributors
Annual Report 2014
57
Sector performance 6.3.2
working with our International Sales organization.
Lighting has approximately 37,800 employees
worldwide.
Regulatory requirements
Lighting is subject to significant regulatory
requirements in the markets where it operates. These
include the European Union’s Waste from Electrical and
Electronic Equipment (WEEE), Restriction of
Hazardous Substances (RoHS), Registration,
Evaluation, Authorization and Restriction of Chemicals
(REACH), Energy-using Products (EuP) and Energy
Performance of Buildings (EPBD) directives.
6.3.3 2014 highlights
In 2014, our lighting innovations underlined our four-
pillar strategy aimed at delivering even greater value for
our customers and other stakeholders.
• Philips is to provide the city of Madrid, Spain with
225,000 energy-efficient street lights. The renewal of
the city’s entire street lighting system makes it the
world’s largest street lighting upgrade to date.
• Groundbreaking innovations in LED bulbs include:
elimination of the heat sink to make our SlimStyle
range flat, so reducing costs; including an innovative
lens for a sparkling light effect to mimic the light of an
incandescent light bulb; creating CrispWhite, a
technological innovation that makes white appear
whiter and colors richer, an ideal lighting solution to
display products at their best.
• In addition to these innovations for retrofit lamps, we
created new concepts by integrating LEDs into
carpets and ceiling panels.
• We continued to pioneer innovations in connected
lighting, broadening applications in segments such as
home, retail, office, sports and city lighting. For
offices, we installed the first commercially available
Power-over-Ethernet (PoE) connected lighting
system, which connects office lighting fixtures to a
building’s IT network. The lighting system gathers
data about how space is being used, helping to
reduce energy, heating and cleaning costs, for
example, while allowing office workers to set their
own personal lighting using their smartphone.
• In cities we continue to install our connected
CityTouch lighting system. This intelligent lighting
system enables cities to remotely control light points
from a single, online user interface to deliver light
where and when it is needed, ensuring people feel
safe in well-lit streets even while reducing energy
consumption. It can dim light points outside of peak
hours, detect failures and provide smart lighting
workflow support, reducing energy and maintenance
costs.
• At the major sports events in Russia (Sochi) and
Brazil, we lit up the majority of the stadiums. For
Chelsea FC we installed a LED pitch lighting solution
designed to provide players, fans and Television
broadcasters with an outstanding visual experience.
This was the world’s first LED pitch lighting to be used
by a ‘top flight’ soccer club that meet the stringent
58
Annual Report 2014
requirements of broadcasters and sports federations.
As the official lighting partner of FC Bayern München,
Philips will transform the façade of the Allianz
Stadium, into a dynamic and colorful LED display.
• With Philips Hue, our innovative connected lighting
system for the home, we continue to transform the
way we use light to personalize our homes and bring
extraordinary experiences into the living room. We
offer the most comprehensive portfolio of lighting
products that can be connected to the smart home
ecosystem: controls, connected luminaires,
connected strips, connected lamps. We also team up
with partners like Apple, Logitech, Deutsche Telekom,
Syfy Universal and more to deliver a seamless
experience, and the ever-growing number of apps
developed by third parties will ensure further new
experiences over time.
• Philips acquired 51% of General Lighting Company
(GLC) in the Kingdom of Saudi Arabia. This company
combines Philips’ expertise in LED technology and
global supply base with GLC’s deep local market
knowledge and strong commercial capabilities,
making it the leading lighting player in the largest
economy in the Middle East.
6.3.4 2014 financial performance
Philips Lighting
Key data in millions of EUR unless otherwise stated
2012 - 2014
Sales
Sales growth
% increase (decrease),
nominal
% increase (decrease),
comparable1)
EBITA 1)
as a % of sales
EBIT
as a % of sales
Net operating capital (NOC)1)
Cash flows before financing
activities1)
2012
7,303
2013
7,145
2014
6,869
11%
(2)%
(4)%
4%
69
0.9%
(78)
(1.1)%
4,635
1%
580
8.1%
413
5.8%
4,462
(3)%
293
4.3%
185
2.7%
3,638
314
418
442
Employees (in FTEs)
41,757
38,671
37,808
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
In 2014, sales amounted to EUR 6,869 million, 4% lower
on a nominal basis. Excluding a 1% negative currency
effect, comparable sales decreased by 3%. Light
Sources & Electronics recorded mid-single-digit growth
and Consumer Luminaires posted a high-single-digit
decline, while Professional Lighting Solutions recorded
low-single-digit growth.
From a geographical perspective, comparable sales in
growth geographies showed a mid-single-digit decline,
largely driven by decline across all businesses in China.
As a result, sales in growth geographies decreased from
40% of total sales in 2013 to 39% in 2014. Comparable
sales in mature geographies showed a low-single-digit
decline, with Western Europe and North America
recording a low-single-digit decline and other mature
geographies registering a mid-single-digit decline.
Sales of LED-based products grew to 34% of total sales,
up from 25% in 2013, driven by Light Sources &
Electronics and Professional Lighting Solutions. Sales
of energy-efficient Green Products exceeded EUR
4,952 million, or 72% of sector sales.
EBITA declined from EUR 580 million, or 8.1% of sales,
in 2013 to EUR 293 million, or 4.3% of sales in 2014.
Restructuring and acquisition-related charges
amounted to EUR 245 million in 2014, compared to EUR
83 million in 2013. 2014 also included a EUR 13 million
past-service pension cost gain in the Netherlands and
EUR 68 million of impairment and other charges related
to industrial assets, while 2013 included a EUR 10 million
past-service pension cost gain. The decrease in EBITA
was mainly attributable to higher restructuring and
acquisition-related charges and lower sales volume.
EBIT amounted to EUR 185 million, or 2.7% of sales,
which included EUR 106 million of amortization
charges, mainly related to intangible assets at
Professional Lighting Solutions.
Net operating capital decreased by EUR 824 million to
EUR 3.6 billion. The decrease was mainly due to the
reclassification of Lumileds and Automotive as assets
held for sale in 2014, partly offset by positive currency
impacts.
Cash flows before financing activities increased from
EUR 418 million in 2013 to EUR 442 million, as lower
earnings were partly offset by a reduction in working
capital.
Philips Lighting
Sales per geographic cluster in millions of EUR
2010 - 2014
6,464
6,608
2,281
226
2,492
224
7,303
7,145
6,869
2,853
234
2,891
2,687
Growth
213
198
Other mature
1,848
1,832
1,991
1,827
1,779
North America
2,109
2,060
2,225
2,214
2,205 Western Europe
‘10
‘11
‘12
‘13
‘14
Sector performance 6.3.4
Philips Lighting
Sales and net operating capital1) in billions of EUR
2010 - 2014
4.6
7.3
4.5
7.1
3.6
6.9
Sales
5.5
6.5
5.0
6.6
Net operating capital
‘10
‘11
‘12
‘13
‘14
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
Philips Lighting
EBIT and EBITA1) in millions of EUR
2010 - 2014
5.0%
330
9.9%
643
528
769
115
(439)
8.1%
580
413
167
0.9%
69
147
(78)
4.3%
293
185
108
EBITA in value
EBIT in value
EBITA as a % of sales
Amortization and
impairment in value
‘10
‘11
‘12
‘13
‘14
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
6.3.5 Delivering on EcoVision sustainability
commitments
In 2014, Philips Lighting invested EUR 255 million in
Green Innovation, compared to EUR 223 million in 2013
(excluding Lumileds and Automotive at EUR 105 million
and EUR 104 million respectively). Investments
continue to be made in energy-saving technologies
such as LED and connected lighting systems and
services. In January, Philips announced the
introduction of the new InstantFit LED T8, which
reduces costs for facility managers replacing
fluorescent tube lighting with energy-efficient LED
technology, known as LED tube lamps (TLEDs). TLEDs
use up to 40% less energy compared to linear
fluorescent tube lighting and require less maintenance
due to their long lifetime. If current fluorescent lighting
was replaced by TLED lamps globally the energy saving
potential would be equivalent to the output of 210
medium-sized power plants.
The energy efficiency of the total product portfolio
increased slightly from 40.1 lumens per watt in 2013 to
40.5 lumens per watt in 2014 due to a volume shift in
Annual Report 2014
59
Sector performance 6.3.5
the portfolio. Within the framework of the Green
Operations 2015 program, Philips Lighting has reduced
its carbon footprint in manufacturing (scope 1 and 2
emissions) by approximately 40% since the baseline
year of 2007. In 2014, 81% of our total industrial waste
was re-used as a result of recycling.
6.3.6 2015 and beyond
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities. To achieve this
transformation, Philips started the process to carve out
its Lighting business into a separate legal structure and
will consider various options for ownership structures
with direct access to capital markets.
As a stand-alone company, the Lighting Solutions
business will be better positioned to capture the value
which is shifting from individual products to connected
LED lighting systems and services.
Philips is also in discussion with external investors for
the combined Lumileds and Automotive Lighting
businesses and expects to complete a transaction in
the first half of 2015. Therefore, the combined
businesses of Lumileds and Automotive are reported as
discontinued operations in the Consolidated
statements of income and cash flows.
From an external financial reporting perspective, it
should be noted that the planned organizational
changes will require Philips to transition to a new
reporting structure during the course of 2015. At that
stage, and in view of applicable IFRS requirements,
Philips will report and discuss its financial performance
on the basis of different reportable segments than the
sectors currently presented and discussed in this
Annual Report.
Further updates will be provided in the course of 2015.
60
Annual Report 2014
Sector performance 6.3.6
Putting a bridge back on the map
The port city of Corpus Christi, Texas, has always been dominated by its
magnificent bridge across the bay. But as times got tougher, the lights on
the bridge went out and a nocturnal landmark disappeared.
Because the locals love the Corpus Christi Harbor
Bridge so much, it has even boosted the fortunes of one
local photographer, who now uses the bridge as a
dramatic outdoor studio.
Happily it’s now back – and, with the help of thousands
of energy-saving and environmentally-friendly LEDs,
it’s infinitely more striking than ever before. An exciting
new project to re-illuminate the structure, in which the
city authorities worked in partnership with Philips, gave
the Corpus Christi Harbor Bridge a makeover by treating
it as a living work of art.
They didn’t just demonstrate how LED lighting in cities
can transform a space – they created a vibrant
attraction that allowed this industrial design jewel to
show itself in a new, 21st century guise. Multi-colored
strip lights now pick out the contours of the bridge in a
beautiful, ever-changing, ultra-modern display that has
become a tourist attraction in its own right and
revitalized the area.
“Philips had a very innovative design department.
They’ve been here every day to help us through the
process,” says Terry Orf, Senior Architect at Naismith
Engineers.
Annual Report 2014
61
Sector performance 6.4
6.4 Innovation, Group & Services
“ In 2014, we continued to strengthen our innovation process,
becoming much more efficient, effective and faster. We are
improving our ability to innovate end-to-end and increasing
our focus on digital innovation. By using technology, data
and algorithms we are making our innovations even more
relevant and meaningful for people on an individual level.”
Jim Andrew, Chief Innovation & Strategy Officer
• Philips Research celebrated its 100th anniversary in
2014 – a century-long track record of innovations
that improved the world.
• Philips established its Africa Innovation Hub in
Nairobi, Kenya, enabling the co-creation of locally
relevant solutions, business models and partnerships
to address key challenges in the continent.
• Philips rose to number 3 global position of patent
applicants at the European Patent Office.
• For Philips Design, 2014 was a record-breaking year
with 137 design awards.
Introduction
Innovation, Group & Services comprises the activities of
Philips Group Innovation, Group headquarters,
including country and regional management, and
certain costs of pension and other post-retirement
benefit plans. Additionally, the global shared business
services for procurement, finance, human resources, IT
and real estate are reported in this sector.
6.4.1 About Innovation, Group & Services
Philips Group Innovation
At Philips, our innovation efforts are closely aligned
with our business strategy. Philips Group Innovation
(PGI) feeds the innovation pipeline, enabling its
business partners – the Philips operating businesses –
to create new business options through new
technologies, new business creation, and intellectual
property development. Focused research and
development improvement activities drive time-to-
market efficiency and increased innovation
effectiveness.
PGI boosts innovation from idea to product as co-
creator and strategic partner for the Philips businesses
and complementary Open Innovation ecosystem
partners. It does so through cooperation between
research, design, marketing, strategy and businesses in
interdisciplinary teams along the innovation chain, from
front-end to first-of-a-kind product development. In
62
Annual Report 2014
addition, PGI opens up new value spaces beyond the
direct scope of current businesses (Emerging Business
Areas), manages the Company-funded R&D portfolio,
and creates synergy for cross-sector initiatives.
PGI encompasses Philips Research, Philips Innovation
Services, the Philips Innovation Campus in Bangalore,
the Philips Innovation Center Shanghai, Philips Design,
the Philips Healthcare Incubator, and the Emerging
Business Areas. In total, PGI employs some 5,000
professionals around the globe.
PGI actively participates in Open Innovation through
relationships with academic and industrial partners, as
well as via European and regional projects, in order to
improve innovation effectiveness and efficiency,
capture and generate new ideas, enhance technology
partnering capabilities, and share the related financial
exposure. The High Tech Campus in Eindhoven
(Netherlands), the Philips Innovation Campus in
Bangalore (India), and the Philips Innovation Center in
Shanghai (China) are prime examples of environments
enabling Open Innovation.
Through Open Innovation, Philips also seeks to ensure
proximity of innovation activities to growth
geographies. Underlining its commitment to locally
relevant innovations, Philips established an Innovation
Hub for Africa in Nairobi (Kenya), which is enabling the
co-creation of new solutions, business models and
partnerships to address key challenges in the continent
and provide meaningful innovations. This innovation
hub cooperates closely with local universities, NGOs
and start-ups. As a result, the first Philips Community
Life Center was opened in Kenya, which provides
access to healthcare, enables social, educational and
commercial activities after dark, and enhances
neighborhood safety and security.
A joint initiative between PGI, IT and multiple Philips
businesses aims at speeding up digital innovation to
create personalized solutions. One of the results in 2014
was that Philips, together with Radboud University in
Nijmegen, the Netherlands, created the first wearable
diagnostic prototype for patients with a chronic
obstructive pulmonary disease (COPD) that feeds data
collected from patients at home to clinicians through
the Philips HealthSuite Digital Platform.
Philips Research
Philips Research, which celebrated its 100th
anniversary in 2014, is the main partner of Philips’
operating businesses for technology-enabled
innovation. It creates new technologies and the related
intellectual property (IP), which enables Philips to grow
in businesses and markets. Together with the
businesses and the markets, Philips Research co-
creates innovations to strengthen the core businesses
as well as to open up new opportunities in adjacent
business areas. Research’s innovation pipeline is
Sector performance 6.4.1
aligned with Philips’ vision and strategy and inspired by
unmet customer needs as well as major societal
challenges.
At Light & Building, the world’s leading trade fair for
lighting and building services technology, Philips
launched Power-over-Ethernet connected lighting.
This ground-breaking lighting system enables the
connection of office lighting fixtures to a building’s IT
network, via standard network cables. The lighting
system acts as an information pathway, enabling
workers to control and access other building services
via their smartphones and reduces the cost of
ownership for building owners.
In the area of Healthcare, Philips Research co-created
with John Hopkins University and Hospital a new 3D
MRI-based technology to assess liver tumor response
after chemo-embolization. This 3D technology can
precisely measure living and dying tumor tissue to
quickly show whether highly toxic chemotherapy –
delivered directly through a tumor’s blood supply – is
working.
Together with Consumer Lifestyle, several digital
propositions for connected products have been co-
created, such as the Smart Air Purifier, which provides
insights into the cleanness of the air via an app. Another
example is the iGrooming app, which provides
consumers with a style preview and advice for shaving.
Philips and Eindhoven University of Technology (TU/e)
announced a strategic cooperation aimed at
accelerating the exploration and development of digital
innovations in healthcare, lighting and data science.
Philips Innovation Services
Philips Innovation Services offers a wide range of
technical and industry consulting services in
development, industrialization and supply chain.
Innovation Services’ skills are leveraged by Philips
Businesses, Markets and Philips Group Innovation in all
regions and in a wide range of projects across the end-
to-end value chain.
Examples of recent contributions by Innovation
Services are: the Vereos PET/CT scanner; the Smart Air
Purifier; the SlimStyle LED lamp and Luminous Carpets.
Innovation Services also supports Philips’ drive to
deliver innovations that are locally relevant, such as a
low-cost LED lamp for Africa.
Philips Innovation Campus Bangalore
Philips Innovation Campus Bangalore (PIC) hosts
activities from most of our operating businesses, Philips
Research, Design, IP&S, and IT. Healthcare is the largest
R&D organization at PIC, with activities in Imaging
Systems, Patient Care & Monitoring Solutions, and
Healthcare Informatics, Solutions & Services. While PIC
originally started as a software center, it has since
developed into a broad product development center
(including mechanical, electronics, and supply chain
Annual Report 2014
63
Sector performance 6.4.1
capabilities). Several Healthcare businesses have also
located business organizations focusing on growth
geographies at PIC.
digital pathology solution that is designed to optimize
productivity and workflow, and ultimately to improve
the quality of diagnosis.
Philips Innovation Center Shanghai
Philips Research China is Philips’ second-largest
research lab globally. The organization has staff
working in the Healthcare, Consumer Lifestyle and
Lighting programs and cooperates extensively with
Philips labs across the world. Research China anchors
our broader commitment to our Shanghai R&D campus
as an innovation hub.
Another proposition called Minicare provides direct
diagnostic information at the patients’ bedside,
enabling physicians to make medical decisions on the
spot. Based on innovative technologies, we have
designed easy-to-use, patient-centric IVD (in-vitro
diagnostics)-enabled solutions and connected services
that have the potential to revolutionize health
management and improve existing workflows.
Philips Design
Philips Design partners with the Philips businesses,
Group Innovation, and functions to ensure that our
innovations are people-focused, meaningful and
locally relevant, and that the Philips brand experience
is differentiating, consistent and drives customer
preference across all its touch-points.
Philips Design is a global function within the company,
comprised of a Group Design team that leads the
function and develops new competencies, and fully
integrated sector Design teams ensuring close
alignment with the Philips businesses. The organization
is made up of designers across various disciplines, as
well as psychologists, ergonomists, sociologists and
anthropologists – all working together to understand
people’s needs and desires and to translate these into
relevant solutions and experiences that create value for
people and business. Design’s forward-looking
exploration projects deliver vital insights for new
business development.
Together with the Healthcare Transformation Services
business, Philips Design is developing in-depth
consulting relationships with our Healthcare partners.
The Experience Design team recently supported the
complete renovation of the Infusion Center for cancer
patients at the Broward Health Medical Center in
Florida, USA, in order to improve the experience for
patients and optimize workflow for staff. The successful
design outcome was recognized with an Avatar Patient
Experience award and the Healthcare Design award in
2014.
Philips Design is widely recognized as a world leader in
design, and 2014 was a record-breaking year with 137
design awards. Especially worth mentioning is the
impressive haul of 47 iF awards and 39 Red Dot Awards,
the latter including a ‘best of the best’ award for the
Ambient Experience IBA Proton Therapy Suite installed
at the Willis-Knighton Cancer Center in Shreveport,
Louisiana (US).
Philips Healthcare Incubator
The Philips Healthcare Incubator is a business group
dedicated to identifying, developing and bringing to
market breakthrough products and services that drive
the future of healthcare. One example is by
empowering pathologists with a complete connected
64
Annual Report 2014
In the third quarter of 2014, Philips completed the
acquisition of Unisensor, a start-up company offering
technology which we plan to leverage for miniaturized,
mobile diagnostics solutions.
Philips Emerging Business Areas
Philips Emerging Business Areas identify, create and
grow new activities that are outside the scope of the
current operating businesses. The portfolio is managed
on a venturing basis. The opportunities and business
models identified by the individual new business
activities determine the approach to commercial
partnerships, sourcing of technology, and platforms to
reach customers. Current examples of successful new
solution businesses or enablers for these include
Horticulture, Light for Health, Photonics, and Wearable
Sensing Technologies.
Philips is ushering in a new era of indoor farming with
LED ‘light recipes’ that help optimize crop yield and
quality. Indoor farms grow vegetables sustainably and
locally in areas where traditional field farming is not
feasible. Philips Horticulture LED solutions are being
applied on a large scale at forward-thinking growers
worldwide like Green Sense Farms near Chicago, the
city farm of Osaka Prefecture University, and the
tomato nurseries Wim Peters in the Netherlands and
R&L Holt in the UK.
Leveraging its advanced understanding of the
biological effects of light, a team of Philips Light for
Health researchers, collaborating with leading research
institutions and hospitals, has developed a number of
products that feature LED light and offer proven
medical benefits.
Philips Photonics is a global leader in VCSEL
technology and designs, manufactures, markets and
sells VCSEL-based solutions for data communications,
consumer and industrial applications. VCSELs are LED-
like lasers enabling applications like gesture control,
environmental sensing, precise scene illumination for
surveillance cameras, and ultra-fast data
communication. Philips Photonics has enabled the
introduction of laser-based PC mice and high-bit-rate
active optical cables, as well as introducing VCSEL-
based solutions for industrial processing of plastic
materials.
Philips Wearable Sensing Technologies (WeST) delivers
accurate and reliable continuous personal health
measurements through modules specifically designed
for integration in wearable devices. The first-generation
module fueled a new product category of heart rate-
monitoring sport watches that work without a chest-
strap.
Philips Intellectual Property & Standards
Philips IP&S proactively pursues the creation of new
intellectual property in close co-operation with Philips’
operating businesses and Philips Group Innovation.
IP&S is a leading industrial IP organization providing
world-class IP solutions to Philips’ businesses to
support their growth, competitiveness and profitability.
Philips’ IP portfolio currently consists of approximately
14,200 patent families (68,400 patent rights), 2,780
trademark families (46,600 trademark rights), 3,650
design families (91,400 design rights) and 2,130 domain
name families (4,850 domain names). Philips filed 1,680
patent applications in 2014, with a strong focus on the
growth areas in health and well-being.
IP&S participates in the setting of standards to create
new business opportunities for the Philips operating
businesses. A substantial portion of revenue and costs
is allocated to the operating businesses. Philips
believes its business as a whole is not materially
dependent on any particular patent or license, or any
particular group of patents and licenses.
Group and Regional Costs
Group and Regional organizations support the creation
of value, connecting Philips with key stakeholders,
especially our employees, customers, government and
society. These organizations include the Executive
Committee, Brand Management, Sustainability, New
Venture Integration, the Group functions related to
strategy, human resources, legal and finance, as well as
country and regional management.
Accelerate! investments
Innovation, Group & Services plays an important role in
the Accelerate! program, notably by helping to improve
the end-to-end value chain. The End-to-End approach
consists of three core processes: Idea-to-Market,
Market-to-Order, and Order-to-Cash. Innovation,
Group & Services supports a more efficient and effective
Idea-to-Market process in five focal areas: speeding up
time-to-market, portfolio optimization, driving
breakthrough innovation, improving innovation
competencies, and strengthening the position of
Philips as an innovation leader.
Sector performance 6.4.1
6.4.2 2014 financial performance
Philips Innovation, Group & Services
Key data in millions of EUR unless otherwise stated
2012 - 2014
Sales
Sales growth
2012
2013
2014
629
665
605
% increase (decrease), nominal
(8)%
6%
(9)%
% increase (decrease),
comparable1)
EBITA of:
Group Innovation
IP Royalties
Group and regional costs
Accelerate! investment
Pensions
Service units and other
EBITA 1)
EBIT
(6)%
0%
(12)%
(149)
253
(161)
(128)
24
(587)
(748)
(756)
(134)
312
(175)
(137)
(41)
(124)
(299)
(302)
(197)
299
(205)
(131)
(12)
(415)
(661)
(675)
Net operating capital (NOC)1)
(4,500)
(2,922)
(3,718)
Cash flows before financing
activities1)
(851)
(2,140)
(1,586)
Employees (in FTEs)
11,697
12,703
13,853
1) For a reconciliation to the most directly comparable GAAP measures,
see chapter 15, Reconciliation of non-GAAP information, of this Annual
Report
In 2014, sales amounted to EUR 605 million, and were
mainly related to IP Royalty income and our OEM
Remote Control business. Sales were EUR 60 million
lower than in 2013, mainly due to lower income from
Group Innovation and IP Royalties.
EBITA amounted to a loss of EUR 661 million, compared
to a loss of EUR 299 million in 2013. In 2014, EBITA
included EUR 110 million of restructuring and
acquisition-related charges, EUR 244 million of
provisions related to various legal matters and a EUR 27
million past-service pension gain in the Netherlands.
2013 EBITA included EUR 3 million of restructuring and
acquisition-related charges and a pension settlement
loss of EUR 25 million.
EBITA at Group Innovation was a EUR 63 million higher
net cost than in 2013, mainly due to higher restructuring
charges and higher investments in emerging business
areas.
EBITA at Group and Regional Overhead costs were EUR
30 million lower than in 2013, mainly due to higher
restructuring costs.
Accelerate! investments amounted to EUR 131 million in
2014, and include investments in IT infrastructure,
internal departments and external consultancy
dedicated to the Accelerate! program.
EBITA at Pensions amounted to a net cost of EUR 12
million, and represent costs related to deferred
pensioners covered by company plans. In 2013,
Pensions amounted to a net cost of EUR 41 million and
Annual Report 2014
65
Sector performance 6.4.2
was impacted by a EUR 31 million settlement loss
arising from a lump-sum offering to terminated vested
employees in our US pension plan.
EBITA at Service Units and Other decreased from a loss
of EUR 124 million in 2013 to a loss of EUR 415 million in
2014. The decrease was largely driven by EUR 243
million of charges related to legal matters.
Net operating capital decreased to negative EUR 3.7
billion, mainly due to an increase in working capital.
Cash flows before financing activities improved from an
outflow of EUR 2,140 million in 2013 to an outflow of
EUR 1,586 million.
6.4.3 2015 and beyond
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities.
The establishment of the two stand-alone companies
will also involve the split and allocation of the current
Innovation, Group & Services sector to each company
in 2015. This means that in the course of 2015 the IG&S
sector as currently described in this Annual Report will
disappear and no longer be presented as a separate
segment for reporting purposes.
Further updates will be provided in the course of 2015.
66
Annual Report 2014
7 Risk management
Risk management 7
7.1 Our approach to risk management
and business control
The following section presents an overview of Philips’
approach to risk management and business controls
and a description of the nature and the extent of its
exposure to risks. Philips’ risk management focuses on
the following risk categories: Strategic, Operational,
Compliance and Financial risks. These categories are
further described in section 7.2, Risk categories and
factors, of this Annual Report. The risk overview
highlights the main risks known to Philips, which could
hinder it in achieving its strategic and financial business
objectives. The risk overview may, however, not include
all the risks that may ultimately affect Philips. Some
risks not yet known to Philips, or currently believed not
to be material, could ultimately have a major impact on
Philips’ businesses, objectives, revenues, income,
assets, liquidity or capital resources.
All oral and written forward-looking statements made
on or after the date of this Annual Report and
attributable to Philips are expressly qualified in their
entirety by the factors described in the cautionary
statement included in chapter 19, Forward-looking
statements and other information, of this Annual
Report and the overview of risk factors described in
section 7.2, Risk categories and factors, of this Annual
Report.
Risk management and controls forms an integral part of
the business planning and review cycle. The company’s
risk and control policy is designed to provide
reasonable assurance that objectives are met by
integrating management control into the daily
operations, by ensuring compliance with legal
requirements and by safeguarding the integrity of the
company’s financial reporting and its related
disclosures. It makes management responsible for
identifying the critical business risks and for the
implementation of fit-for-purpose risk responses.
Philips’ risk management approach is embedded in the
areas of corporate governance, Philips Business
Control Framework and Philips General Business
Principles.
Corporate governance
Corporate governance is the system by which a
company is directed and controlled. Philips believes
that good corporate governance is a critical factor in
achieving business success. Good corporate
governance derives from, amongst other things, solid
internal controls and high ethical standards.
The quality of Philips’ systems of business controls and
the findings of internal and external audits are reported
to and discussed by the Audit Committee of the
Supervisory Board. Internal auditors monitor the quality
of the business controls through risk-based operational
audits, inspections of financial reporting controls and
compliance audits. Audit committees at group level
(Group, Finance, Innovation and IT), at Global Market
level and at Business level (Healthcare, Lighting,
Consumer Lifestyle) meet quarterly to address
weaknesses in the business controls infrastructure as
reported by internal and external auditors or revealed
by self-assessment of management, and to take
corrective action where necessary. These audit
committees are also involved in determining the
desired company-wide internal audit planning as
approved by the Audit Committee of the Supervisory
Board. An in-depth description of Philips’ corporate
governance structure can be found in chapter 11,
Corporate governance, of this Annual Report.
Philips Business Control Framework
The Philips Business Control Framework (BCF) sets the
standard for risk management and business control in
Philips. The objectives of the BCF are to maintain
integrated management control of the company’s
operations, in order to ensure the integrity of the
financial reporting, as well as compliance with laws and
regulations. Philips has designed its BCF based on the
“Internal Control-Integrated Framework (2013)”
established by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO).
As part of the BCF, Philips has implemented a global
standard for internal control over financial reporting
(ICS). The ICS, together with Philips’ established
accounting procedures, is designed to provide
reasonable assurance that assets are safeguarded, that
the books and records properly reflect transactions
necessary to permit preparation of financial
statements, that policies and procedures are carried out
by qualified personnel and that published financial
statements are properly prepared and do not contain
any material misstatements. ICS has been deployed in
all material reporting units, where business process
owners perform an extensive number of controls,
document the results each quarter, and take corrective
action where necessary. ICS supports business and
functional management in a quarterly cycle of
assessment and monitoring of its control environment.
The findings of management’s evaluation are reported
to the Executive Committee and the Supervisory Board
quarterly.
As part of the Annual Report process, management’s
accountability for business controls is enforced through
the formal issuance of a Statement on Business
Controls and a Letter of Representation by business
and functional management to the Executive
Committee. Any deficiencies noted in the design and
Annual Report 2014
67
Principles, more detailed underlying policies have been
developed. Where necessary, these policies can be
adapted to reflect ongoing (regulatory) developments,
both internal and external. In addition, there are
separate Codes of Ethics that apply to employees
working in specific areas of our business, i.e. the
Procurement Code of Ethics and the Financial Code of
Ethics. Details can be found at www.philips.com/gbp.
The relevant employees sign off on the Financial and
the Procurement Codes of Ethics each year to confirm
that they are aware of, and will comply with, the
respective codes.
Financial Code of Ethics
The Company recognizes that its businesses have
responsibilities within the communities in which they
operate. The Company has a Financial Code of Ethics
which applies to the CEO (the principal executive
officer) and CFO (the principal financial and principal
accounting officer), and to the heads of the Group
Control, Group Treasury, Group Fiscal and Group
Internal Audit departments of the Company. The
Company has published its Financial Code of Ethics
within the investor section of its website located at
www.philips.com. No changes were considered
necessary and no changes have been made to the
Financial Code of Ethics since its adoption and no
waivers have been granted therefrom to the officers
mentioned above in 2014.
For more information, please refer to sub-section 5.2.7,
Philips’ General Business Principles renewed, of this
Annual Report.
Risk management 7.1
operating effectiveness of controls over financial
reporting which were not completely remediated are
evaluated at year-end by the Executive Committee. The
Executive Committee’s report, including its conclusions
regarding the effectiveness of internal control over
financial reporting, can be found in section 12.1,
Management’s report on internal control, of this Annual
Report.
Philips General Business Principles
The Philips General Business Principles (GBP) set the
standard for our core behavior − ‘Acting with integrity’
− and they apply to the behavior of individual
employees as well as to corporate actions. They
incorporate the fundamental principles adopted within
Philips for conducting business. The GBP have been
revised in 2014 to make the GBP more accessible to
Philips employees and to reflect certain changes in the
business environment.
The GBP form an integral part of virtually all labor
contracts. It is the responsibility of each employee to
live up to our GBP. In addition, the management of each
business unit signs off on compliance with the GBP, with
this confirmation forming part of the annual Statement
on Business Controls.
As part of the Philips Business Control Framework, a
GBP self-assessment process is fully embedded in an
automated workflow application (ICS), which helps
management to monitor the internal controls. With the
GBP self-assessment forming part of ICS, GBP
compliance necessarily forms part of management’s
quarterly ICS/SOx (Sarbanes-Oxley) monitoring
process. Non-compliance issues are highlighted and, if
significant, they are reported to the Board of
Management/Executive Committee through the
Quarterly Certification Statement process.
Managers are viewed as the principal point of contact
in cases where employees wish to raise a concern. To
further facilitate this process, the GBP include a
reporting policy, standardized complaint reporting and
a formal escalation procedure. The Philips Ethics Line
platform enables employees to file a complaint by
telephone in their native language. Additionally,
concerns can now also be raised using an online
reporting form, a facility that is available as part of the
Philips Ethics Line. Every country organization and all
main production sites are supported by a GBP
Compliance Officer. This network of Compliance
Officers is supervised by the General Business
Principles Review Committee. Alleged violations of the
GBP, which are either filed directly through the Philips
Ethics Line or raised through a GBP Compliance Officer,
are registered consistently in a single database and are
investigated in accordance with standardized
investigation procedures.
Since 2013 it has become mandatory for all executives
to sign off on the General Business Principles. To drive
the practical deployment of the General Business
68
Annual Report 2014
Risk management 7.2
7.2 Risk categories and factors
Risks
Strategic
Operational
Compliance
Financial
• Macroeconomic changes
• Changes in industry/
market
• Growth of emerging
markets
• Joint ventures
• Acquisitions
• Intellectual property rights
• Transformation programs
• Innovation process
• Intellectual Property
• Supply chain
• IT
• People
• Product quality and liability
• Reputation
• Legal
• Market practices
• Regulatory
• General Business Principles
• Internal controls
• Data privacy/Product
security
• Treasury
• Tax
• Pensions
• Accounting and reporting
Corporate Governance
Philips Business Control Framework
Philips General Business Principles
Taking risks is an inherent part of entrepreneurial
behavior. A structured risk management process allows
management to take risks in a controlled manner. In
order to provide a comprehensive view of Philips’
business activities, risks and opportunities are identified
in a structured way combining elements of a top-down
and bottom-up approach. Risks are reported on a
regular basis as part of the ‘Business Performance
Management’ process. All relevant risks and
opportunities are prioritized in terms of impact and
likelihood, considering quantitative and/or qualitative
aspects. The bottom-up identification and prioritization
process is supported by workshops with the respective
management at Business, Market and Group Function
level. The top-down element allows potential new risks
and opportunities to be discussed at management level
and included in the subsequent reporting process, if
found to be applicable. Reported risks and
opportunities are analyzed for potential cumulative
effects and are aggregated at Business, Market and
Group level. Philips has a structured risk management
process to address different risk categories: Strategic,
Operational, Compliance and Financial risks.
Strategic risks and opportunities may affect Philips’
strategic ambitions. Operational risks include adverse
unexpected developments resulting from internal
processes, people and systems, or from external events
that are linked to the actual running of each business
(examples are solution and product creation, and
supply chain management). Compliance risks cover
unanticipated failures to implement, or comply with,
appropriate laws, regulations, policies and procedures.
Within the area of Financial risks, Philips identifies risks
related to Treasury, Accounting and reporting, Pensions
and Tax. Philips does not classify these risk categories
in order of importance. Separation risk is covered in
section 7.7, Separation risk, of this Annual Report.
Philips describes the risk factors within each risk
category in order of Philips’ current view of expected
significance, to give stakeholders an insight into which
risks and opportunities it considers more prominent
than others at present. The risk overview highlights the
main risks and opportunities known to Philips, which
could hinder it in achieving its strategic and financial
business objectives. The risk overview may, however,
not include all the risks that may ultimately affect
Philips. Describing risk factors in their order of expected
significance within each risk category does not mean
that a lower listed risk factor may not have a material
and adverse impact on Philips’ business, strategic
objectives, revenues, income, assets, liquidity, capital
resources or achievement of Philips’ 2016 goals.
Furthermore, a risk factor described after other risk
factors may ultimately prove to have more significant
adverse consequences than those other risk factors.
Over time Philips may change its view as to the relative
significance of each risk factor.
7.3 Strategic risks
As Philips’ business is global, its operations are exposed
to economic and political developments in countries
across the world that could adversely impact its
revenues and income.
Philips’ business environment is influenced by political
and economic conditions in the domestic and global
markets. Philips experienced changes in macro
economic development in various geographies during
2014 in particular in China where customer demand was
negatively affected by the lowest level of economic
growth in the last 24 years. The monetary easing policy
in Japan did not result in the targeted economic growth.
Macro economic conditions in the Eurozone weakened
with increasing concerns about lack of growth and
potential deflation, adversely affecting the recovery of
southern European economies and reintroducing
concerns about the stability of the Eurozone and the
euro. On the other the hand the US economy provided
a more favorable environment with increasing macro
economic growth. Significant downward movement of
the oil price negatively affected the currencies of
countries depending on oil and gas revenues. In
particular for Russia the lower oil price in combination
with the political conflict with Ukraine had a significant
negative impact on the Russian economy and currency.
Annual Report 2014
69
Risk management 7.3
The very disparate macroeconomic outlook for the
main geographies, political conflicts and the unknown
potential impact of new initiatives in Eurozone
monetary policy continues to provide uncertainty on
the levels of capital expenditures in general,
unemployment levels and consumer and business
confidence, which could adversely affect demand for
products and services offered by Philips.
General political developments in 2014 were
unfavorable for the business environment due to
increasing political conflicts and terrorism, e.g. the
financial/economic sanctions imposed on Russia and
the response from the Russian government. Numerous
other factors, such as sustained lower levels of energy
and raw material prices, as well as global political
conflicts in the Middle East, Russia and Ukraine and
other regions, could continue to impact
macroeconomic factors and the international capital
and credit markets. Economic and political uncertainty
may have a material adverse impact on Philips’ financial
condition or results of operations and can also make it
more difficult for Philips to budget and forecast
accurately. Philips may encounter difficulty in planning
and managing operations due to the lack of adequate
infrastructure and unfavorable political factors,
including unexpected legal or regulatory changes such
as foreign exchange import or export controls,
increased healthcare regulation, nationalization of
assets or restrictions on the repatriation of returns from
foreign investments. Given that growth geographies are
becoming increasingly important in Philips’ operations,
the above-mentioned risks are also expected to grow
and could have a material adverse effect on Philips’
financial condition and operating results.
Philips may be unable to adapt swiftly to changes in
industry or market circumstances, which could have a
material adverse impact on its financial condition and
results.
Fundamental shifts in the industry, like the transition
from traditional lighting to LED lighting, may drastically
change the business environment. If Philips is unable to
recognize these changes in good time, is late in
adjusting its business models, or if circumstances arise
such as pricing actions by competitors, then this could
have a material adverse effect on Philips’ growth
ambitions, financial condition and operating result.
Philips’ overall performance in the coming years is
dependent on realizing its growth ambitions in growth
geographies.
Growth geographies are becoming increasingly
important in the global market. In addition, Asia is an
important production, sourcing and design center for
Philips. Philips faces strong competition to attract the
best talent in tight labor markets and intense
competition from local companies as well as other
global players for market share in growth geographies.
Philips needs to maintain and grow its position in
70
Annual Report 2014
growth geographies, invest in local talents, understand
developments in end-user preferences and localize the
portfolio in order to stay competitive. If Philips fails to
achieve this, then this could have a material adverse
effect on growth ambitions, financial condition and
operating result.
The growth ambitions of Philips may be adversely
affected by economic volatility inherent in growth
geographies and the impact of changes in
macroeconomic circumstances on growth economies.
Philips may not control joint ventures or associated
companies in which it invests, which could limit the
ability of Philips to identify and manage risks.
Philips has invested or will invest in joint ventures or
associated companies in which Philips will have a non-
controlling interest. In these cases, Philips has limited
influence over, and limited or no control of, the
governance, performance and cost of operations of
joint ventures or associated companies. Some of these
joint ventures or associated companies may represent
significant investments. The joint ventures and
associated companies that Philips does not control
may make business, financial or investment decisions
contrary to Philips’ interests or decisions different from
those, which Philips itself may have made. Additionally,
Philips partners or members of a joint venture or
associated company may not be able to meet their
financial or other obligations, which could expose
Philips to additional financial or other obligations, as
well as have a material adverse effect on the value of its
investments in those entities or potentially subject
Philips to additional claims.
Acquisitions could expose Philips to integration risks
and challenge management in continuing to reduce the
complexity of the company.
Philips’ acquisitions may continue to expose Philips in
the future to integration risks in areas such as sales and
service force integration, logistics, regulatory
compliance, information technology and finance.
Integration difficulties and complexity may adversely
impact the realization of an increased contribution from
acquisitions. Philips may incur significant acquisition,
administrative and other costs in connection with these
transactions, including costs related to the integration
of acquired businesses.
Furthermore, organizational simplification and
resulting cost savings may be difficult to achieve.
Acquisitions may also lead to a substantial increase in
long-lived assets, including goodwill. Write-downs of
these assets due to unforeseen business developments
may have a material adverse effect on Philips’ earnings,
particularly in Healthcare and Lighting, which have
significant amounts of goodwill (see also note 11,
Goodwill).
Philips’ inability to secure and retain intellectual
property rights for products, whilst maintaining overall
competitiveness, could have a material adverse effect
on its results.
Philips is dependent on its ability to obtain and retain
licenses and other intellectual property (IP) rights
covering its products and its design and manufacturing
processes. The IP portfolio is the result of an extensive
patenting process that could be influenced by a number
of factors, including innovation. The value of the IP
portfolio is dependent on the successful promotion and
market acceptance of standards developed or co-
developed by Philips. This is particularly applicable to
Consumer Lifestyle where third-party licenses are
important and a loss or impairment could have a
material adverse impact on Philips’ financial condition
and operating results.
7.4 Operational risks
Transformation programs
In 2011 Philips started a very extensive transformation
program (Accelerate!) to unlock Philips’ full potential.
Accelerate! spans a time period of several years. In 2014
as a next phase in the Accelerate! transformation
program Philips announced that it would separate its
businesses into two new fit for purpose companies,
HealthTech and Lighting Solutions. Failure to achieve
the objectives of the transformation programs may
have a material adverse effect on the mid and long term
financial targets.
In addition the transformation program of the Finance
function may expose Philips to adverse changes in the
quality of its systems of internal control.
Failure to achieve improvements in Philips’ solution and
product creation process and/or increased speed in
innovation-to-market could hamper Philips’ profitable
growth ambitions.
Further improvements in Philips’ solution and product
creation process, ensuring timely delivery of new
solutions and products at lower cost and upgrading of
customer service levels to create sustainable
competitive advantage, are important in realizing
Philips’ profitable growth ambitions. The emergence of
new low-cost competitors, particularly in Asia, further
underlines the importance of improvements in the
product creation process. The success of new solution
and product creation, however, depends on a number
of factors, including timely and successful completion
of development efforts, market acceptance, Philips’
ability to manage the risks associated with new
products and production ramp-up issues, the ability of
Philips to attract and retain employees with the
appropriate skills, the availability of products in the
right quantities and at appropriate costs to meet
anticipated demand and the risk that new products and
services may have quality or other defects in the early
Risk management 7.3
stages of introduction. Accordingly, Philips cannot
determine in advance the ultimate effect that new
solutions and product creations will have on its financial
condition and operating results. If Philips fails to
accelerate its innovation-to-market processes and fails
to ensure that end-user insights are fully captured and
translated into solution and product creations that
improve product mix and consequently contribution, it
may face an erosion of its market share and
competitiveness, which could have a material adverse
effect on its financial condition and operating results.
Risk of unauthorized use of intellectual property rights
Philips produces and sells products and services which
incorporates technology protected by intellectual
property rights. Philips develops and acquires
intellectual property rights on regular basis. Philips is
exposed to the risk that intellectual property rights on
technology applied in its products and services is
claimed to be owned by third parties, who, in case their
claims of infringement of such intellectual property
rights are awarded, would be entitled to damages and
fines.
If Philips is unable to ensure effective supply chain
management, e.g. facing an interruption of its supply
chain, including the inability of third parties to deliver
parts, components and services on time, and if it is
subject to rising raw material prices, it may be unable to
sustain its competitiveness in its markets.
If Philips is unable to ensure effective supply chain
management, e.g. facing an interruption of its supply
chain, including the inability of third parties to deliver
parts, components and services on time, Philips may be
unable to sustain its competitiveness in its markets.
Philips is continuing the process of creating a leaner
supply base with fewer suppliers, while maintaining
dual / multiple sourcing strategies where possible. This
strategy very much requires close cooperation with
suppliers to enhance, among other things, time to
market and quality. In addition, Philips is continuing its
initiatives to reduce assets through outsourcing. These
processes may result in increased dependency on
external suppliers and providers. Although Philips
works closely with its suppliers to avoid supply-related
problems, there can be no assurance that it will not
encounter supply problems in the future or that it will
be able to timely replace a supplier that is not able to
meet its demand.
Shortages or delays could materially harm its business.
Most of Philips’ activities are conducted outside of the
Netherlands, and international operations bring
challenges. For example, production and procurement
of products and parts in Asian countries are increasing,
and this creates a risk that production and shipping of
products and parts could be interrupted by regional
conflicts or a natural disaster, such as occurred in Japan
in 2011. A general shortage of materials, components or
subcomponents as a result of natural disasters also
Annual Report 2014
71
Risk management 7.4
bears the risk of unforeseeable fluctuations in prices
and demand, which could have a material adverse
effect on its financial condition and operating results.
Businesses purchase raw materials including so-called
rare earth metals, copper, steel, aluminum, noble gases
and oil-related products, which exposes them to
fluctuations in energy and raw material prices. In recent
times, commodities have been subject to volatile
markets, and such volatility is expected to continue. If
Philips is not able to compensate for increased costs or
pass them on to customers, price increases could have
a material adverse impact on Philips’ results. In contrast,
in times of falling commodity prices, Philips may not
fully benefit from such price decreases as Philips
attempts to reduce the risk of rising commodity prices
by several means, such as including long-term
contracting or physical and financial hedging.
Diversity in information technology (IT) could result in
ineffective or inefficient business management. IT
outsourcing and off-shoring strategies could result in
complexities in service delivery and contract
management.
Philips is engaged in a continuous drive to create a more
open, standardized and consequently, more cost-
effective IT landscape. This is leading to an approach
involving further outsourcing, off-shoring,
commoditization and ongoing reduction in the number
of IT systems. This could introduce additional risk with
regard to the delivery of IT services, the availability of
IT systems and the scope and nature of the
functionality offered by IT systems.
Philips observes a global increase in IT security threats
and higher levels of sophistication in computer crime,
posing a risk to the confidentiality, availability and
integrity of data and information.
The global increase in security threats and higher levels
of professionalism in computer crime have increased
the importance of effective IT security measures,
including proper identity management processes to
protect against unauthorized systems access.
Nevertheless, Philips’ systems, networks, products,
solutions and services remain potentially vulnerable to
attacks, which could potentially lead to the leakage of
confidential information, improper use of its systems
and networks or defective products, which could in turn
materially adversely affect Philips’ financial condition
and operating results. In recent years, the risks that we
and other companies face from cyber-attacks have
increased significantly. The objectives of these cyber-
attacks vary widely and may include, among things,
disruptions of operations including provision of services
to customers or theft of intellectual property or other
sensitive information belonging to us or other business
partners. Successful cyber-attacks may result in
substantial costs and other negative consequences,
which may include, but are not limited to, lost revenues,
reputational damage, remediation costs, and other
72
Annual Report 2014
liabilities to customers and partners. Furthermore,
enhanced protection measures can involve significant
costs. Although we have experienced cyber-attacks but
to date have not incurred any significant damage as a
result and did not incur significant monetary cost in
taking corrective action, there can be no assurance that
in the future Philips will be as successful in avoiding
damages from cyber-attacks. Additionally, the
integration of new companies and successful
outsourcing of business processes are highly
dependent on secure and well controlled IT systems.
Due to the fact that Philips is dependent on its
personnel for leadership and specialized skills, the loss
of its ability to attract and retain such personnel would
have an adverse effect on its business.
The attraction and retention of talented employees in
sales and marketing, research and development,
finance and general management, as well as of highly
specialized technical personnel, especially in
transferring technologies to low-cost countries, is
critical to Philips’ success. This is particularly valid in
times of economic recovery. The loss of specialized
skills could also result in business interruptions. There
can be no assurance that Philips will continue to be
successful in attracting and retaining all the highly
qualified employees and key personnel needed in the
future.
Warranty and product liability claims against Philips
could cause Philips to incur significant costs and affect
Philips’ results as well as its reputation and
relationships with key customers.
Philips is from time to time subject to warranty and
product liability claims with regard to product
performance and effects. Philips could incur product
liability losses as a result of repair and replacement
costs in response to customer complaints or in
connection with the resolution of contemplated or
actual legal proceedings relating to such claims. In
addition to potential losses arising from claims and
related legal proceedings, product liability claims could
affect Philips’ reputation and its relationships with key
customers (both customers for end products and
customers that use Philips’ products in their production
process). As a result, product liability claims could
materially impact Philips’ financial condition and
operating results.
Any damage to Philips’ reputation could have an
adverse effect on its businesses.
Philips is exposed to developments which could affect
its reputation. Such developments could be of an
environmental or social nature, or connected to the
behavior of individual employees or suppliers and
could relate to adherence to regulations related to
labor, health and safety, environmental and chemical
management. Reputational damage could materially
impact Philips’ financial condition and operating
results.
7.5 Compliance risks
Legal proceedings covering a range of matters are
pending in various jurisdictions against Philips and its
current and former group companies. Due to the
uncertainty inherent in legal proceedings, it is difficult
to predict the final outcome.
Philips, including a certain number of its current and
former group companies, is involved in legal
proceedings relating to such matters as competition
issues, commercial transactions, product liability,
participations and environmental pollution. Since the
ultimate outcome of asserted claims and proceedings,
or the impact of any claims that may be asserted in the
future, cannot be predicted with certainty, Philips’
financial position and results of operations could be
affected materially by adverse outcomes.
Please refer to note 26, Contingent assets and
liabilities, for additional disclosure relating to specific
legal proceedings.
Philips is exposed to governmental investigations and
legal proceedings with regard to possible anti-
competitive market practices.
Philips is facing increased scrutiny by national and
European authorities of possible anti-competitive
market practices. Philips’ financial position and results
could be materially affected by an adverse final
outcome of governmental investigations and litigation,
as well as any potential related claims.
Philips’ global presence exposes the company to
regional and local regulatory rules, changes to which
may affect the realization of business opportunities and
investments in the countries in which Philips operates.
Philips has established subsidiaries in over 80
countries. These subsidiaries are exposed to changes in
governmental regulations and unfavorable political
developments, which may affect the realization of
business opportunities or impair Philips’ local
investments. Philips’ increased focus on the healthcare
sector increases its exposure to highly regulated
markets, where obtaining clearances or approvals for
new products is of great importance, and where there
is a dependency on the available funding for healthcare
systems. In addition, changes in reimbursement
policies may affect spending on healthcare.
Philips is exposed to non-compliance with General
Business Principles.
Philips’ attempts to realize its growth ambitions could
expose it to the risk of non-compliance with the Philips
General Business Principles, such as anti-bribery
Risk management 7.4
provisions. This risk is heightened in growth
geographies as the legal and regulatory environment is
less developed in growth geographies compared to
mature geographies. Examples include commission
payments to third parties, remuneration payments to
agents, distributors, consultants and the like, and the
acceptance of gifts, which may be considered in some
markets to be normal local business practice. (See also
note 26, Contingent assets and liabilities.)
Defective internal controls would adversely affect our
financial reporting and management process.
The reliability of reporting is important in ensuring that
management decisions for steering the businesses and
managing both top-line and bottom-line growth are
based on top-quality data. Flaws in internal control
systems could adversely affect the financial position
and results and hamper expected growth.
The correctness of disclosures provides investors and
other market professionals with significant information
for a better understanding of Philips’ businesses.
Imperfections or lack of clarity in the disclosures could
create market uncertainty regarding the reliability of the
data presented and could have a negative impact on
the Philips share price.
The reliability of revenue and expenditure data is key
for steering the business and for managing top-line and
bottom-line growth. The long lifecycle of healthcare
sales, from order acceptance to accepted installation,
together with the complexity of the accounting rules for
when revenue can be recognized in the accounts,
presents a challenge in terms of ensuring there is
consistency of application of the accounting rules
throughout Philips Healthcare’s global business.
Philips is exposed to non-compliance with data privacy
and product safety laws.
Philips’ brand image and reputation would be
adversely impacted by non-compliance with various
data protection and product security laws. In light of
Philips digital strategy, data privacy laws are
increasingly important. Also, Philips Healthcare is
subject to various (patient) data protection and safety
laws. In Philips Healthcare, privacy and product safety
and security issues may arise, especially with respect to
remote access or monitoring of patient data or loss of
data on our customers’ systems.
Philips operates in a highly regulated product safety
and quality environment. Philips’ products are subject
to regulation by various government agencies,
including the FDA (US) and comparable foreign
agencies. Obtaining their approval is costly and time
consuming, but a prerequisite for market introduction.
A delay or inability to obtain the necessary regulatory
approvals for new products could have a material
adverse effect on business. The risk exists that product
safety incidents or user concerns could trigger FDA
Annual Report 2014
73
Risk management 7.5
business reviews which, if failed, could lead to business
interruption which in turn could adversely affect Philips’
financial condition and operating results. E.g. the
voluntary, temporary suspension of new production at
our Healthcare facility in Cleveland, Ohio targets to
further strengthen manufacturing process controls after
certain issues in this area were identified during an
ongoing FDA inspection.
7.6 Financial risks
Philips is exposed to a variety of treasury risks and other
financial risks including liquidity risk, currency risk,
interest rate risk, commodity price risk, credit risk,
country risk and other insurable risk.
Negative developments impacting the global liquidity
markets could affect the ability of Philips to raise or re-
finance debt in the capital markets or could lead to
significant increases in the cost of such borrowing in the
future. If the markets expect a downgrade or
downgrades by the rating agencies or if such a
downgrade has actually taken place, it could increase
the cost of borrowing, reduce our potential investor
base and adversely affect our business.
Philips operates in approximately 100 countries and its
earnings are therefore inevitably exposed to
fluctuations in exchange rates of foreign currencies
against the euro. Philips’ sales are sensitive in particular
to movements in the US dollar, Japanese yen and a
wide range of other currencies from developed and
emerging markets. However, Philips’ sourcing and
manufacturing spend is concentrated in the Eurozone,
United States and China. Therefore the net (revenues
less spend) sensitivity of Income from Operations to US
dollar and Chinese renminbi is relatively small. Income
from Operations is sensitive to movements in currencies
from countries where the Group has none or small
manufacturing/sourcing activity such as Japan and a
range of emerging markets such as Russia, Korea,
Indonesia, India and Brazil.
The credit risk of financial and non-financial
counterparties with outstanding payment obligations
creates exposures for Philips, particularly in relation to
accounts receivable with customers and liquid assets
and fair values of derivatives and insurance receivables
contracts with financial counterparties. A default by
counterparties in such transactions can have a material
adverse effect on Philips’ financial condition and
operating results.
Philips’ supply chain is exposed to fluctuations in
energy and raw material prices. Commodities such as
oil are subject to volatile markets and significant price
increases from time to time. If Philips is not able to
compensate for, or pass on, its increased costs to
customers, such price increases could have an adverse
impact on its financial condition and operating results.
74
Annual Report 2014
Philips is exposed to interest rate risk, particularly in
relation to its long-term debt position; this risk can take
the form of either fair value or cash flow risk. Failure to
effectively hedge this risk can impact Philips’ financial
condition and operating results.
For further analysis, please refer to note 31, Details of
treasury / other financial risks.
Philips is exposed to a number of different fiscal
uncertainties which could have a significant impact on
local tax results.
Philips is exposed to a number of different tax
uncertainties which could result in double taxation,
penalties and interest payments. These include transfer
pricing uncertainties on internal cross-border deliveries
of goods and services, tax uncertainties related to
acquisitions and divestments, tax uncertainties related
to the use of tax credits and permanent establishments,
tax uncertainties due to losses carried forward and tax
credits carried forward and potential changes in tax law
that could result in higher tax expense and payments.
Those uncertainties may have a significant impact on
local tax, results which in turn could adversely affect
Philips’ financial condition and operating results.
The value of the losses carried forward is subject to
having sufficient taxable income available within the
loss-carried-forward period, but also to having
sufficient taxable income within the foreseeable future
in the case of losses carried forward with an indefinite
carry-forward period. The ultimate realization of the
Company’s deferred tax assets, including tax losses and
credits carried forward, is dependent upon the
generation of future taxable income in the countries
where the temporary differences, unused tax losses
and unused tax credits were incurred and during the
periods in which the deferred tax assets become
deductible. Additionally, in certain instances,
realization of such deferred tax assets is dependent
upon the successful execution of tax planning
strategies. Accordingly, there can be no absolute
assurance that all (net) tax losses and credits carried
forward will be realized.
For further details, please refer to the tax risks
paragraph in note 8, Income taxes.
Philips has defined-benefit pension plans in a number
of countries. The funded status and the cost of
maintaining these plans are influenced by movements
in financial market and demographic developments,
creating volatility in Philips’ financials.
A significant proportion of employees in Europe and
North America is covered by defined-benefit pension
plans. The accounting for defined-benefit pension
plans requires management to make estimates on
discount rates, inflation, longevity and expected rates
of compensation. Movements (e.g. due to the
movements of financial markets) in these assumptions
can have a significant impact on the Defined Benefit
Obligation and pension cost. A negative performance
of the financial markets could have a material impact on
cash funding requirements and pension costs and also
affect the value of certain financial assets and liabilities
of the company.
Philips is exposed to a number of reporting risks.
A risk rating is assigned for each risk identified, based
on the likelihood of occurrence and the potential
impact of the risk on the financial statements and
related disclosures. In determining the probability that
a risk will result in a misstatement of a more than
inconsequential amount or material nature, the
following factors are considered to be critical:
complexity of the associated accounting activity or
transaction process, history of accounting and
reporting errors, likelihood of significant (contingent)
liabilities arising from activities, exposure to losses,
existence of a related party transaction, volume of
activity and homogeneity of the individual transactions
processed and changes to the prior period in
accounting characteristics compared to the previous
period.
For important critical reporting risk areas identified
within Philips we refer to the “Use of estimates” section
in the note 1, Significant accounting policies, as the
Company assessed that reporting risk is closely related
to the use of estimates and application of judgment.
7.7 Separation risk
Philips is exposed to risks associated with the planned
separation into HealthTech and Lighting Solutions.
In September 2014 Philips announced its plan to
separate into two standalone companies in the
HealthTech and Lighting Solutions, positioning each
one to better capitalize on the highly attractive
HealthTech and Lighting solutions opportunities. This is
a complex process which involves certain risks to
Philips.
The separation into HealthTech and Lightings Solutions
is unlike divestments or carve out transactions that
Philips has implemented in the past, which affected
very specific parts of the business of Philips. The
proposed separation impacts all businesses and
markets as well as all supporting functions and all
assets and liabilities of the Group and will require
complex and time consuming disentanglement efforts.
The design and implementation of the separation
requires the devotion of substantial time and attention
from management and staff. Although Philips has set-
up a dedicated senior project team to work on a
successful separation, the separation efforts could
distract from and have an adverse effect on the conduct
of normal business and our strategy. The separation
could increase the likelihood of occurrence and/or
Risk management 7.6
potential impact of the risks as described in section 7.2,
Risk categories and factors, of this Annual Report, such
as strategic risks (e.g. insufficient integration of
acquisitions), operational risks (e.g. delays in
innovation-to-market), compliance risk (e.g. ineffective
internal controls) and financial risks (e.g. reporting risks).
Philips has made no final decision as to what actions it
may take with respect to Lighting Solutions once it has
become a separate company. Such actions may include
public offerings of ownership stakes in Lighting
Solutions.
The design and implementation of the separation will
involve and depend on support from external legal, tax,
financial and other professional consultants and as a
result Philips will incur substantial cost. The separation
could take more time than originally anticipated, which
may expose Philips to risks of additional cost and other
adverse consequences.
The separation of businesses, assets, liabilities,
contractual or contingent rights and obligations and
legal entities may require Philips to recognize expenses
and/or incur financial payments, which otherwise
would not have been incurred.
While it is the firm intention to complete the separation,
Philips has reserved the right not to proceed with the
separation if it determines that it would be in the
Company’s interest not to do so. If it does proceed with
the separation, no assurances can be given that the
separation will ultimately lead to the increased benefits
contemplated by Philips currently.
Annual Report 2014
75
Management 8
8 Management
Koninklijke Philips N.V. is managed by an Executive
Committee which comprises the members of the Board
of Management and certain key officers from functions,
businesses and markets.
The Executive Committee operates under the
chairmanship of the Chief Executive Officer and shares
responsibility for the deployment of Philips’ strategy
and policies, and the achievement of its objectives and
results.
Under Dutch Law, the Board of Management is
accountable for the actions and decisions of the
Executive Committee and has ultimate responsibility
for the management and external reporting of
Koninklijke Philips N.V. and is answerable to
shareholders at the Annual General Meeting of
Shareholders. Pursuant to the two-tier corporate
structure, the Board of Management is accountable for
its performance to a separate and independent
Supervisory Board.
The Rules of Procedure of the Board of Management
and Executive Committee are published on the
Company’s website (www.philips.com/investor).
Corporate governance
A full description of the Company’s corporate
governance structure is published in chapter 11,
Corporate governance, of this Annual Report.
76
Annual Report 2014
Frans van Houten
Born 1960, Dutch
President/Chief Executive Officer (CEO)
Chairman of the Board of Management since April 2011
Group responsibilities: Chairman of the Executive Committee,
Sector Healthcare, Internal Audit, Information Technology,
Supply Management, Marketing & Communication, Accelerate! -
Overall transformation, End2End
Jim Andrew
Born 1962, American
Executive Vice President &
Chief Strategy and Innovation Officer
Group responsibilities: Strategy, Innovation, Design,
Sustainability, Accelerate! - Resource to win
Marnix van Ginneken
Born 1973, Dutch/American
Executive Vice President & Chief Legal Officer
Corporate responsibilities: Legal and General Secretary
Management 8
Denise Haylor
Born 1964, English/American
Pieter Nota
Born 1964, Dutch
Executive Vice President &
Chief Human Resources Officer
Corporate responsibilities: Human Resources, Accelerate! -
Culture
Executive Vice President &
Chief Executive Officer of Philips Consumer Lifestyle
Member of the Board of Management since April 2011
Group responsibilities: Sector Consumer Lifestyle, Accelerate! -
Resource to Win
Ronald de Jong
Born 1967, Dutch
Executive Vice President &
Chief Market Leader
Group responsibilities: Markets, Areas & Countries (except
Greater China & North America), Accelerate! - Customer
Centricity
Eric Rondolat
Born 1966, Italian/French
Executive Vice President &
Chief Executive Officer Philips Lighting
Group responsibilities: Sector Lighting
Patrick Kung
Born 1951, American
Executive Vice President &
Chief Executive Officer Philips Greater China
Group responsibilities: Philips Greater China
Ron Wirahadiraksa
Born 1960, Dutch
Executive Vice President &
Chief Financial Officer (CFO)
Member of the Board of Management since April 2011
Group responsibilities: Finance, Mergers & Acquisitions,
Accelerate! - Operating Model
Annual Report 2014
77
Supervisory Board 9
9 Supervisory
Board
The Supervisory Board supervises the policies of the
executive management and the general course of
affairs of Koninklijke Philips N.V. and advises the
executive management thereon. The Supervisory
Board, in the two-tier corporate structure under Dutch
law, is a separate and independent corporate body.
The Rules of Procedure of the Supervisory Board are
published on the Company’s website. For details on the
activities of the Supervisory Board, see chapter 10,
Supervisory Board report, of this Annual Report and
section 11.2, Supervisory Board, of this Annual Report.
78
Annual Report 2014
Jeroen van der Veer
Born 1947, Dutch ** ***
Chairman
Chairman of the Corporate Governance and
Nomination & Selection Committee
Member of the Supervisory Board since 2009;
second term expires in 2017
Former Chief Executive of Royal Dutch Shell and Chairman of
the Supervisory Board of ING Group. Member of the Supervisory
Board of Concertgebouw N.V.
Orit Gadiesh
Born 1951, Israeli/American *
Member of the Supervisory Board since 2014;
first term expires in 2018
Currently Chairman of Bain & Company. Member of the
International Business Leaders’ Advisory Council for the Mayor
of Shanghai (IBLAC) and the Foundation Board of the World
Economic Forum (WEF) and its International Business Council.
Member of the Supervisory Board of privately held RMAG-
Renova. Also serves on the Advisory Board for the British-
American Business council
Kees van Lede
Born 1942, Dutch *
Member of the Supervisory Board since 2003;
third term expires in 2015
Former Chairman of the Board of Management of Akzo Nobel
and currently Chairman of the Supervisory Board of Royal
Imtech N.V. Member of the Supervisory Boards of AirFrance/
KLM, Air Liquide and Senior Advisor JP Morgan Plc.
Supervisory Board 9
Ewald Kist
Born 1944, Dutch **
Jackson Tai
Born 1950, American *
Member of the Supervisory Board since 2004;
third term expires in 2016
Former Chairman of the Executive Board of ING Group and
currently member of the Supervisory Boards of DSM, Moody’s
Investor Service and Stage Entertainment
Chairman of Audit Committee
Member of the Supervisory Board since 2011;
first term expires in 2015
Former Vice-Chairman and CEO of DBS Group and DBS Bank
Ltd and former Managing Director at J.P. Morgan &Co.
Incorporated. Currently a member of the Boards of Directors of
The Bank of China Limited, MasterCard Incorporated and Eli Lilly
and Company. Also Non-Executive Director of privately-held
Russell Reynolds Associates and of Vapor Stream
Heino von Prondzynski
Born 1949, German * ** ***
Christine Poon
Born 1952, American ** ***
Chairman of the Remuneration Committee
Member of the Supervisory Board since 2007;
second term expires in 2015
Former member of the Corporate Executive Committee of the F.
Hofmann-La Roche Group and former CEO of Roche
Diagnostics, currently Chairman of the Supervisory Boards of
HTL Strefa and Epigenomics AG. Member of the Supervisory
Boards of Hospira, Inc. and Quotient Ltd.
Vice-chairman and Secretary
Member of the Supervisory Board since 2009;
second term expires in 2017
Former Vice-Chairman of Johnson & Johnson, member of the
Board of Directors, and Worldwide Chairman of the
Pharmaceuticals Group. Currently Professor of management of
Ohio State University’s Fisher College of Business and member
of the Board of Directors of Prudential, Regeneron and Sherwin-
Williams
* member of the Audit Committee
** member of the Remuneration Committee
*** member of the Corporate Governance and Nomination & Selection
Committee
Neelam Dhawan
Born 1959, Indian *
Member of the Supervisory Board since 2012;
first term expires in 2016
Currently Managing Director of Hewlett-Packard India
Annual Report 2014
79
Supervisory Board report
10
10 Supervisory Board report
Introduction
We as members of the Supervisory Board are fully
committed to our role and responsibility in respect of
the proper functioning of the corporate governance of
Philips. The Supervisory Board supervises and advises
the Board of Management and Executive Committee in
performing their management tasks and setting the
direction of the business of the Philips Group. The
Supervisory Board acts, and we as individual members
of the Board act, in the interests of Koninklijke Philips
N.V., its business and all its stakeholders. This report
includes a more specific description of the Supervisory
Board’s activities during the financial year 2014 and
other relevant information on its functioning.
Activities of the Supervisory Board
The overview below indicates a number of matters that
we discussed during meetings throughout 2014:
• Performance of the Philips Group and its underlying
businesses and financial headroom;
• Philips’ strategic direction and the proposal to
separate the group into two companies: one focused
on HealthTech businesses and one focused on
Lighting Solutions businesses, which was announced
during the Capital Markets Day in September 2014. As
part of this discussion, the Supervisory Board
discussed the various strategic options available to
Philips and the benefits and challenges presented by
each option, the strategic rationale for a separation
and the aspects of why a separation is favored over
other options;
• In connection with this, we discussed the
combination of the Healthcare Sector and the
Consumer Lifestyle Sector and the organizational
changes that would occur as a consequence of this;
• Philips’ annual management commitment and
annual operating plan for 2015;
• The strategic rationale and implications behind the
decision to make a tender offer to acquire Volcano
Corporation;
• Enterprise risk management (which included an
annual risk assessment and discussion of the
changing nature of the risks faced by Philips and the
possible impact of such risks). Such risks included the
impact of negative market conditions and the
transition to new business models;
• Changes in the composition of the Executive
Committee;
• Comprehensive review of underlying production
processes and standards, as well as regulatory
compliance, within the Healtcare sector, and
necessary remedial efforts at the Company’s
Healthcare factory in Cleveland;
• Significant civil litigation claims and public
investigations against or into the company;
• The tender process for selecting a new external
auditor and the resulting proposal to appoint Ernst &
Young Accountants LLP;
• Quality and regulatory matters; and
• Intended divestment of the combined Lumileds and
Automotive Lighting components businesses.
The Supervisory Board conducted “deep dives” on a
range of topics such as: the Philips Integrated
Landscape (which concerns the IT infrastructure for the
company), and a review of the company’s quality and
regulatory systems.
The Board reviewed the company’s deployment of its
General Business Principles (GBP) and approved an
updated version of the GBP.
Additionally, we received updates on the Company’s
sustainability efforts and initiatives in the area of the
“circular economy”, the annual dividend, the share buy-
back program and the impact of currency headwinds
on results.
On multiple occasions, we were briefed on the various
aspects of the Accelerate! program. This included the
transformation of the Finance and IT functions and also
the progress made in transforming the culture within
Philips and simplifying its operating model.
The Supervisory Board also reviewed Philips’ annual
and interim financial statements, including non-
financial information, prior to publication thereof.
Supervisory Board meetings and attendance
In 2014, the Supervisory Board convened for seven
regular meetings and two extraordinary meetings.
Moreover, we collectively and individually interacted
with members of the Executive Committee and with
senior management outside the formal Supervisory
Board meetings. The Chairman of the Supervisory
Board and the CEO met regularly for bilateral
discussions about the progress of the Company on a
variety of matters. The Chairman also held bilateral
meetings with several members of the Executive
Committee to discuss a range of topics.
The Supervisory Board meetings were well attended in
2014. The attendance percentage at the meetings -
including the committee meetings - was again high (in
excess of 95%). The Supervisory Board committees also
convened regularly (see the separate reports of the
committees below) and all of the committees regularly
reported back on their activities to the full Supervisory
Board. In addition to the formal meetings of the Board
and its Committees, the Board members also held
private meetings. We as members of the Board devoted
80
Annual Report 2014
sufficient time to engage (proactively if the
circumstances so required) in our supervisory
responsibilities.
Composition, diversity and self-evaluation by
the Supervisory Board
The Supervisory Board is a separate corporate body
that is independent of the Board of Management (and
the Executive Committee). Its independence is also
reflected in the requirement that a member of the
Supervisory Board cannot be a member of the Board of
Management, of the Executive Committee or an
employee of Philips. The Supervisory Board
furthermore considers all its members to be
independent pursuant to the Dutch Corporate
Governance Code. We will continue to pay close
attention to applicable independence criteria.
The Supervisory Board currently consists of eight
members.
We were deeply saddened in 2014 by the passing of
James Schiro, shortly after he stepped down from the
Supervisory Board. James became a member of Philips’
Supervisory Board in 2005 and he was appointed for
three consecutive terms. In 2012, James became the
Vice-Chairman of the Supervisory Board, the Chairman
of the Remuneration Committee and a member of the
Nomination & Selection Committee; he also served on
the Audit Committee from 2005 until 2011. James was
instrumental in the introduction of the new
Remuneration Policy and Long-term Incentive Plan
that was approved by shareholders in 2013. James was
an excellent Supervisory Board member and a loyal
friend, he was full of integrity, modest and humble: truly
a fine man. Philips and we as members of the
Supervisory Board will miss him dearly.
Ms Orit Gadiesh was appointed as a member of the
Supervisory Board at the 2014 Annual General Meeting
of Shareholders. The agenda for the upcoming 2015
Annual General Meeting of Shareholders includes a
proposal to reappoint Mr Heino von Prondzynski and
Mr Jackson Tai to the Supervisory Board for an
additional term of four years. The Supervisory Board
will also recommend to the General Meeting of
Shareholders to re-appoint Mr Kees van Lede for an
additional term of two years. The re-appointment
would represent Kees fourth term on the Supervisory
Board. The Board proposes to re-appoint Mr van Lede
because his past experience and strong knowledge of
corporate governance will be of particular benefit as the
company goes through a period of transition.
In 2014, there were also a number of changes to the
chairmanships and memberships within the Board.
Christine Poon was appointed as Vice-Chairman of the
Supervisory Board and Heino von Prondzynski was
appointed as Chairman of the Remuneration
Committee. Mr von Prondzynski also joined the
Corporate Governance and Nomination & Selection
Committee. Orit Gadiesh joined the Audit Committee.
Supervisory Board report
10
The profile of the Supervisory Board remains
unchanged and aims for an appropriate combination of
knowledge and experience among its members,
encompassing marketing, manufacturing, technology,
financial, economic, social and legal aspects of
international business, government and public
administration in relation to the global and multi-
product character of Philips’ businesses. The
Supervisory Board pays great value to diversity in its
composition. More particular it aims for having
members with both European and non-European
backgrounds (nationality, working experience or
otherwise) and one or more members who have held
an executive or similar position in business or society.
In addition, we support Philips’ policy to appoint a well-
balanced mix of women and men to its Board of
Management, Executive Committee and Supervisory
Board, including the requirement under Dutch
legislation for companies to pursue a policy of having
at least 30% of the seats on the Board of Management
and the Supervisory Board held by women and at least
30% of the seats held by men.
We believe we are making good progress in
implementing this policy, the appointment of Orit
Gadiesh brought the Supervisory Board’s gender
diversity within the statutory criteria. We note that there
may be various pragmatic reasons – such as other
relevant selection criteria and the availability of suitable
candidates within Philips – that could play a role in the
achievement of our diversity targets.
In 2014, the members of the Supervisory Board again
completed a questionnaire to verify compliance in 2014
with applicable corporate governance rules and its
Rules of Procedure. The outcome of this survey was
satisfactory.
In addition, we each submitted to the Chairman
responses to a questionnaire designed to self-evaluate
the functioning of the Supervisory Board. As in previous
years, the questionnaire covered topics such as the
composition and competence of the Supervisory Board
(for example, the Board’s size and the education and
training requirements of its members), access to
information, the frequency and quality of the meetings,
quality and timeliness of the meeting materials, the
nature of the topics discussed during meetings and the
functioning of the Supervisory Board’s committees.
The responses to the questionnaire were aggregated
into a report, which was discussed by the Supervisory
Board in a private meeting. Certain areas were identified
that could be improved and it was decided that the
Chairman would follow-up with individual members to
address specific issues. The Chairman was evaluated by
the Vice-Chairman. The responses provided by the
Supervisory Board members indicated that the Board
continues to be a well-functioning team and we believe
a diversity of experience and skills is represented on the
Board. The Board has spent time throughout 2014
Annual Report 2014
81
Supervisory Board report
10
considering its composition and it will continue to
devote attention to this topic during 2015. The
functioning of the Supervisory Board committees was
considered to be commendable (or better) and specific
feedback will be addressed by the Chairman of each
committee with its members.
In 2015, the use of an external evaluator to measure the
functioning of the Supervisory Board may be re-
considered.
Supervisory Board committees
The Supervisory Board has assigned certain of its tasks
to three permanent committees: the Corporate
Governance and Nomination & Selection Committee,
the Remuneration Committee and the Audit
Committee. The function of the committees is to
prepare the decision-making of the full Supervisory
Board, and the committees currently have no
independent or assigned powers. The full Board retains
overall responsibility for the activities of its committees.
The separate reports of the committees are part of this
Supervisory Board report and are published below.
Supervisory Board remuneration
As the base fee for the remuneration of the Supervisory
Board was not changed since 2008, and in view of the
increased activities and responsibilities of the
Supervisory Board, the agenda for the upcoming 2015
Annual General Meeting of Shareholders will include a
proposal to determine the remuneration of the
members of the Supervisory Board and its Committees.
Composition Board of Management
The agenda for the upcoming 2015 Annual General
Meeting of Shareholders will include proposals to re-
appoint the members of the Board of Management for
an additional term of four years. The Supervisory Board
is very pleased that Messrs. Van Houten, Wirahadiraksa
and Nota remain available as members of the Board of
Management. Their re-appointment is recommended
in view of their performance and the importance of
continuity in the ongoing transformation process of the
Philips Group and the proposed separation of the
Lighting business from Royal Philips.
Financial Statements 2014
The financial statements of the company for 2014, as
presented by the Board of Management, have been
audited by KPMG Accountants N.V. as independent
external auditor appointed by the General Meeting of
Shareholders. Its reports have been included in section
13.5, Independent auditor’s report, of this Annual
Report. We have approved these financial statements,
and all individual members of the Supervisory Board
(together with the members of the Board of
Management) have signed these documents.
We recommend to shareholders that they adopt the
2014 financial statements. We likewise recommend to
shareholders that they adopt the proposal of the Board
of Management to make a distribution of EUR 0.80 per
82
Annual Report 2014
common share (up to EUR 735 million), in cash or in
shares at the option of the shareholder, against the net
income for 2014 and retained earnings.
Finally, we would like to express our thanks to the
members of the Executive Committee and all other
employees for their continued contribution during the
year.
February 24, 2015
The Supervisory Board
Jeroen van der Veer
Christine Poon
Neelam Dhawan
Orit Gadiesh
Ewald Kist
Kees van Lede
Heino von Prondzynski
Jackson Tai
Further information
To gain a better understanding of the responsibilities of
the Supervisory Board and the internal regulations and
procedures governing for its functioning and that of its
committees, please refer to chapter 11, Corporate
governance, of this Annual Report and to the following
documents published on the company’s website:
• Articles of Association
• Rules of Procedure Supervisory Board, including the
Charters of the Board committees
• Rules of Conduct with respect to Inside Information
• (Re)appointment scheme
Changes Supervisory Board and committees
2014
• James Schiro stepped down from the Supervisory
Board shortly before he passed away.
• Christine Poon was appointed as Vice-Chairman of
the Supervisory Board.
• Heino von Pronzynski was appointed as Chairman
of the Remuneration Committee and as a member
of the Corporate Governance and Nomination &
Selection Committee.
• Orit Gadiesh was appointed as a member of the
Supervisory Board and was appointed as a member
of the Audit Committee.
Changes and re-appointments Supervisory
Board 2015
• It is proposed to re-appoint Kees van Lede, Heino
von Prondzynski and Jackson Tai as members of
the Supervisory Board.
(Appointment subject to approval by the General Meeting of Shareholders.)
Changes Management 2014
• Denise Haylor was appointed as Chief Human
Resources Officer.
• Marnix van Ginneken was appointed as Chief Legal
Officer.
• Deborah DiSanzo left the company.
Board of Management 2015
• It is proposed to re-appoint Frans van Houten, Ron
Wirahadiraksa and Pieter Nota as members of the
Board of Management.
10.1 Report of the Corporate Governance
and Nomination & Selection
Committee
The Corporate Governance and Nomination & Selection
Committee is chaired by Jeroen van der Veer and its
other members are Christine Poon and Heino von
Prondzynski. James Schiro was also a member of the
Committee until he stepped down in July 2014.
The Committee is responsible for the review of
selection criteria and appointment procedures for the
Board of Management, the Executive Committee, as
well as the Supervisory Board.
In 2014, the Committee devoted time on the
appointment or reappointment of candidates to fill
current and future vacancies on the Board of
Management, Executive Committee and Supervisory
Board. The Committee consulted with the CEO and
other members of the Board of Management. Following
those consultations it prepared decisions and advised
the Supervisory Board on the candidates for
appointment. This resulted in the proposed re-
appointment at the upcoming 2015 Annual General
Meeting of Shareholders of members of the Board of
Management and Supervisory Board, as explained in
chapter 10, Supervisory Board report, of this Annual
Report. In 2014 this also resulted in the appointment of
Denise Haylor as Chief Human Resources Officer and
Marnix van Ginneken as Chief Legal Officer. As it does
each year, the Committee discussed succession
planning for Executive Committee members. The
Supervisory Board report
10
Committee also discussed the departure of Deborah
DiSanzo. The Committee has also started to consider
the implications of the Company into two companies
for governance, succession and talent development.
As indicated in its report above, the Supervisory Board
believes it is making good progress in implementing a
policy of gender diversity. The Committee strives to
continue this trend and give appropriate weight to the
diversity policy in the nomination and appointment
process on future vacancies, while taking into account
the overall profile and selection criteria for
appointments of suitable candidates to the Board of
Management, Executive Committee and Supervisory
Board.
Under its responsibility for the selection criteria and
appointment procedures for Philips’ senior
management, the Committee reviewed the succession
plans for top 70 positions and emergency candidates
for key roles in the Company.
With respect to corporate governance matters, the
Committee discussed relevant developments and
legislative changes. Finally, the Committee discussed
possible agenda items for the upcoming 2015 Annual
General Meeting of Shareholders.
10.2 Report of the Remuneration
Committee
Introduction
The Remuneration Committee is chaired per
September 1, 2014, by Heino von Prondzynski, who took
over the chairmanship from James Schiro. Its other
members are Jeroen van der Veer, Ewald Kist and
Christine Poon. The Committee is responsible for
preparing decisions of the Supervisory Board on the
remuneration of individual members of the Board of
Management and the Executive Committee. In
performing its duties and responsibilities the
Remuneration Committee is assisted by an external
consultant and in-house remuneration expert acting on
the basis of a protocol which ensures that he acts on
the instructions of the Remuneration Committee.
Currently, no member of the Remuneration Committee
is a member of the management board of another listed
company. In line with applicable statutory and other
regulations, this report focuses on the employment and
remuneration of the members of the Board of
Management.
10.2.1 Remuneration policy
The objective of the remuneration policy for members
of the Board of Management, as adopted by the
General Meeting of Shareholders, is in line with that for
executives throughout the Philips Group: to attract,
motivate and retain qualified senior executives of the
highest caliber with an international mindset and the
background essential for the successful leadership and
effective management of a large global company. The
Board of Management remuneration policy is
Annual Report 2014
83
Supervisory Board report
10.2.1
benchmarked regularly against companies in the
general industry and aims at the median market
position.
One of the goals behind the policy is to focus on
improving the performance of the company and to
enhance the value of the Philips Group. Consequently,
the remuneration package includes a variable part in
the form of an annual cash incentive and a long-term
incentive consisting of performance shares. The policy
does not encourage inappropriate risk-taking.
The performance targets for the members of the Board
of Management are determined annually at the
beginning of the year. The Supervisory Board
determines whether performance conditions have
been met and can adjust the payout of the annual cash
incentive and the long-term incentive grant upward or
downward if the predetermined performance criteria
were to produce an inappropriate result in
extraordinary circumstances. The authority for such
adjustments exists on the basis of contractual ultimum-
remedium and claw-back clauses. In addition, pursuant
to Dutch legislation effective January 1, 2014, incentives
may, under certain circumstances, be amended or
clawed back pursuant to statutory powers. For more
information please refer to chapter 11, Corporate
governance, of this Annual Report. Further information
on the performance targets is given in the chapters on
the Annual Incentive (see sub-section 10.2.6, Annual
Incentive, of this Annual Report) and the Long-Term
Incentive Plan (see sub-section 10.2.7, Long-Term
Incentive Plan, of this Annual Report) respectively.
Key features of our Executive Committee
Compensation Program
The list below highlights Philips’ approach to
remuneration, in particular taking into account
Corporate Governance practices in the Netherlands.
What we do
• We pay for performance
• We conduct scenario analyses
• We have robust stock ownership guidelines
• We have claw-back policies incorporated into our
incentive plans
• We have a simple and transparent remuneration
structure in place
What we do not do
• We do not pay dividend equivalents on stock options
and unvested restricted share or performance share
units
• We do not offer executive contracts with longer than
12 months’ separation payments
• We do not have a remuneration policy in place that
encourages our Board of Management to take any
inappropriate risks or to act in their own interests
• We do not reward failing members of the Board of
Management upon termination of employment
• We do not grant loans or give guarantees to the Board
of Management
84
Annual Report 2014
10.2.2 Contracts
Below, the main elements of the contracts of the
members of the Board of Management are included.
These contracts expire at the end of the Annual General
Meeting on May 7, 2015. Please refer to sub-section
10.2.11, Year 2015, of this Annual Report at the end of this
section.
Term of appointment
The members of the Board of Management are
appointed for a period of 4 years it being understood
that this period expires no later than at the end of the
following general meeting of shareholders (AGM) held
in the fourth year after the year of appointment.
Philips Group
Contract terms for current members
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
end of term
AGM 2015
AGM 2015
AGM 2015
Notice period
Termination of the contract by a member of the Board
of Management is subject to three months’ notice. A
notice period of six months will be applicable in the
case of termination by the Company.
Severance payment
The severance payment is set at a maximum of one
year’s salary.
Share ownership
Simultaneously with the introduction of the current LTI
Plan in 2013, the guideline for members of the Board of
Management to hold a certain number of shares in the
Company has been increased to the level of at least
200% of base pay (300% for the CEO). Until this level
has been reached the members of the Board of
Management are required to retain all after-tax shares
derived from any long-term incentive plan.
Both Ron Wirahadiraksa and Pieter Nota have reached
the required level and the CEO has increased his
ownership significantly throughout the year to currently
70% of his target.
10.2.3 Scenario analysis
The Remuneration Committee conducts a scenario
analysis annually. This includes the calculation of
remuneration under different scenarios, whereby
different Philips performance assumptions and
corporate actions are examined. The Supervisory Board
concluded that the current policy has proven to
function well in terms of a relationship between the
strategic objectives and the chosen performance
criteria and believes that the Annual and Long-Term
Incentive Plans support this relationship.
Supervisory Board report
10.2.4
10.2.4 Remuneration costs
The table below gives an overview of the costs incurred
by the Company in the financial year in relation to the
remuneration of the Board of Management. Costs
related to performance shares, stock option and
restricted share right grants are taken by the Company
over a number of years. As a consequence, the costs
mentioned below in the performance shares, stock
options and restricted share rights columns are the
accounting cost of multi-year grants given to members
of the Board of Management during their board
membership.
Philips Group
Remuneration Board of Management1) in EUR
2014
annual
base
salary2)
base
salary
realized
annual
incentive
perfor-
mance
shares
F.A. van Houten
1,150,000
1,137,500
349,600
860,564
R.H. Wirahadiraksa
725,000
P.A.J. Nota
650,000
712,500
643,750
156,600
258,180
446,337
406,358
Costs in the year
stock
options
101,344
68,914
68,914
2,493,750
764,380
1,713,259
239,172
restricted
share
rights
76,951
52,965
57,200
187,116
pension
costs
485,655
298,995
267,037
other
compen-
sation
86,554
35,909
63,507
1,051,687
185,970
1) Reference date for board membership is December 31, 2014
2) Salary as of April 1, 2014
10.2.5 Base salary
The base salaries of the members of the Board of
Management have been reviewed in April 2014 as part
of the regular remuneration review. The salary of Frans
van Houten has been increased per April 1, 2014, from
EUR 1,100,000 to EUR 1,150,000. The salary of the CFO,
Ron Wirahadiraksa, has been increased from EUR
675,000 to EUR 725,000. The salary of Pieter Nota has
been increased from EUR 625,000 to EUR 650,000. All
increases were made to move base salary levels closer
to market levels.
10.2.6 Annual Incentive
Each year, a variable cash incentive (Annual Incentive)
can be earned, based on the achievement of specific
and challenging targets. The Annual Incentive criteria
are made up for 80% of the financial indicators of the
Company and for 20% of the team targets comprising,
among others, sustainability targets as part of our
EcoVision program.
The on-target Annual Incentive percentage is set at
80% of the base salary for the CEO and at 60% of the
base salary for other members of the Board of
Management. The maximum Annual Incentive
achievable is 160% of the annual base salary for the
CEO and 120% of the annual base salary for members
of the Board of Management.
To support the performance culture, the Annual
Incentive plan is based on (financial) targets at ‘own
level’ and ‘group’ level results (line-of-sight). The 2014
payouts, shown in the table below, reflect the below
target performance of EBITA, CSG and ROIC at the
Group level. In addition, the average Team Target
payout was also less than the target level.
Philips Group
Annual Incentive realization in EUR
2014 (payout in 2015)
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
realized annual
incentive
as a % of base
salary (2014)
349,600
156,600
258,180
30.4%
21.6%
39.7%
10.2.7 Long-Term Incentive Plan
Grants made under the 2014 LTI Plan consist of
performance shares only.
Grant size
The annual grant size is set by reference to a multiple
of base salary. For the CEO the annual grant size is set
at 120% of base salary and for the other members of the
Board of Management at 100% of base salary. This is
broadly at a mid-market level against leading European
listed companies. The actual number of performance
shares to be awarded is determined by reference to the
average of the closing price of the Philips share on the
day of publication of the quarterly results and the four
subsequent dealing days.
Vesting schedule
Dependent upon the achievement of the performance
conditions, cliff-vesting applies three years after the
date of grant. During the vesting period, the value of
dividends will be added to the performance shares in
the form of shares. These dividend-equivalent shares
will only be delivered to the extent that the award
actually vests.
Performance conditions
Vesting of the performance shares is based on two
equally weighted performance conditions:
▪ 50% Adjusted Earnings per Share growth (“EPS”) and
▪ 50% Relative Total Shareholder Return (“TSR”)
Annual Report 2014
85
Supervisory Board report
10.2.7
EPS
EPS growth is calculated by applying the simple point-
to-point method at year end. Earnings are the income
from continued operations attributable to
shareholders, as reported in the Annual Report.
The following performance-incentive zone applies for
EPS:
Philips Group
Performance-incentive zone for EPS in %
Below
threshold
Threshold
TSR
The TSR peer group for the LTI Plan consists of the
following 21 companies:
Philips Group
TSR peer group
ABB
Covidien
Danaher
Eaton
Electrolux
Hitachi
Panasonic
Honeywell Int.
Procter & Gamble
Johnson Controls
Schneider Electric
Johnson &
Johnson
Legrand
Siemens
Smiths Group
Target Maximum
Emerson Electric
LG Electronics
Toshiba
Payout
0
40
100
200
General Electric
Medtronic
3M
The EPS targets are set annually by the Supervisory
Board. Given that these targets are considered to be
company sensitive, disclosure will take place
retrospectively at the end of the performance period.
EPS targets and the achieved performance are
published in the Annual Report after the relevant
performance period.
A ranking approach to TSR applies with Philips itself
excluded from the peer group to permit interpolation.
The performance incentive-zone is outlined in the table
below:
Philips Group
Performance-incentive zone for TSR in %
≥
9
≥
21-14
Position
≥
10
≥
12
≥
11
≥
13
≥
8
≥
7
≥
6-1
Payout
0 60 60
100
120
140
160
180 200
Under the LTI Plan members of the Board of
Management were granted 117,936 performance shares
in 2014.
The following tables provide an overview of granted but
not yet vested (locked up) stock option grants, an
overview of performance shares granted but not yet
vested and an overview of restricted share rights
granted but not yet released. The reference date for
board membership is December 31, 2014.
Philips Group
Performance shares1)
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
number of
performance
shares
originally
granted
grant date
20132)
2013
2014
20132)
2013
2014
20132)
2013
2014
55,000
62,559
59,075
38,500
31,991
31,036
38,500
29,621
27,825
value at
grant date
1,233,650
1,320,000
1,380,000
863,555
675,000
725,000
863,555
625,000
650,000
end of
vesting
period
number of
performance
shares
vested in 2014
value
at vesting
date in 2014
2014
2016
2017
2014
2016
2017
2014
2016
2017
55,000
1,425,600
n.a.
n.a.
n.a.
n.a.
38,500
997,920
n.a.
n.a.
n.a.
n.a.
38,500
997,920
n.a.
n.a.
n.a.
n.a.
1) Dividend performance shares not included
2) Accelerate! Grant
86
Annual Report 2014
Supervisory Board report
10.2.7
Philips Group
Stock options
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
1) Value based on Black & Scholes value
2) Accelerate! Grant
Philips Group
Restricted share rights
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
grant date
number of
stock options
2011
2012
20132)
2011
2012
20132)
2011
2012
20132)
75,000
75,000
55,000
51,000
51,000
38,500
51,000
51,000
38,500
value at
grant date1)
366,000
212,550
242,534
248,880
144,534
169,773
248,880
144,534
169,773
end of
lock-up period
value at
end of
lock-up period1)
2014
2015
2016
2014
2015
2016
2014
2015
2016
368,468
n.a.
n.a.
250,558
n.a.
n.a.
250.558
n.a.
n.a.
number of
restricted share
rights originally
granted
grant date
2011
2012
2011
2012
2011
2012
20,001
20,001
13,602
13,602
13,602
13,602
value at
grant date
418,021
296,415
284,282
201,582
284,282
201,582
number of
restricted share
rights
released in 2014
value at
release date
in 2014
6,667
6,667
4,534
4,534
4,534
4,534
145,607
136,807
99,023
93,038
99,023
93,038
For more details of the LTI Plan see note 28, Share-
based compensation.
10.2.8 Pensions
In 2014 Members of the Board of Management
participated in the Executives Pension Plan in the
Netherlands consisting of a combination of a defined-
benefit (career average) and defined-contribution plan.
The target retirement age under the plan is 62.5. The
plan does not require employee contributions. For
more details, see note 29, Information on
remuneration. With effect from January 1, 2015, a
revised approach to pensions was implemented driven
by changes in Dutch pension legislation, see 2015
outlook at the end of this section for more details.
10.2.9 Additional arrangements
In addition to the main conditions of employment, a
number of additional arrangements apply to members
of the Board of Management. These additional
arrangements, such as expense and relocation
allowances, medical insurance, accident insurance and
company car arrangements, are in line with those for
Philips executives in the Netherlands. In the event of
disablement, members of the Board of Management
are entitled to benefits in line with those for other
Philips executives in the Netherlands.
Unless the law provides otherwise, the members of the
Board of Management and of the Supervisory Board
shall be reimbursed by the Company for various costs
and expenses, like reasonable costs of defending
claims, as formalized in the Articles of Association.
Under certain circumstances, described in the Articles
of Association, such as an action or failure to act by a
member of the Board of Management or a member of
the Supervisory Board that can be characterized as
intentional (“opzettelijk”), intentionally reckless
(“bewust roekeloos”) or seriously culpable (“ernstig
verwijtbaar”), there will be no entitlement to this
reimbursement. The Company has also taken out
liability insurance (D&O - Directors & Officers) for the
persons concerned.
10.2.10 Remuneration of Supervisory Board
The table below gives an overview of the remuneration
structure, which has remained unchanged since 2008.
Philips Group
Remuneration Supervisory Board1) in EUR
2014
Supervisory Board
Audit Committee
Remuneration Committee
Corporate Governance and
Nomination & Selection Committee
Fee for intercontinental traveling per
trip
Entitlement to Philips product
arrangement
Chairman
Member
110,000
15,000
12,500
65,000
10,000
8,000
12,500
6,000
3,000
3,000
2,000
2,000
1) For more details, see note 29, Information on remuneration
Annual Report 2014
87
Supervisory Board report
10.2.11
10.2.11 Year 2015
10.3 Report of the Audit Committee
Services agreements Board of Management
For the members of the Board of Management, who will
be proposed to be re-appointed at the Annual General
Meeting on May 7, 2015, an agreement of provision of
services for a fixed 4-year period will be concluded
instead of a contract of employment pursuant to Dutch
law, effective January 1, 2013. In future this will apply to
all newly appointed members of the Board of
Management.
These agreements will be made public no later than the
date on which the 2015 Annual General Meeting of
Shareholders will be convened.
The main elements of the (proposed) services
agreements will be materially the same as the main
elements of the current contracts described above.
The Audit Committee is chaired by Jackson Tai, and its
other members are Neelam Dhawan, Kees van Lede,
Heino von Prondzynski and Orit Gadiesh. Jeroen van
der Veer also regularly participated in Audit Committee
meetings. The Committee assists the Supervisory Board
in fulfilling its supervisory responsibilities for (inter alia)
ensuring the integrity of the Company’s financial
statements and reviewing the Company’s internal
controls.
The Audit Committee met for four quarterly meetings
and one education and training session during 2014 and
reported its findings to the plenary Supervisory Board.
The CEO, the CFO, the Chief Legal Officer, the Head of
Internal Audit, the Group Controller and the external
auditor (KPMG Accountants N.V.) attended all regular
meetings.
Pensions
Due to legislative changes in the Netherlands, the
pension arrangement applicable to the members of the
Board of Management, the other members of the
Executive Committee and the Executives, all working in
the Netherlands, needed to be reviewed as of January
1, 2015.
Furthermore, the Committee met each quarter
separately with each of the CEO, the CFO, the Chief
Legal Officer, the Head of Internal Audit and the
external auditor as well as on an ad hoc basis with other
company employees, such as the Group Treasurer, the
Group Controller and Head of Financial Risk and
Pensions Management.
As of this date pension plans which allow pension
accrual based on a pensionable salary exceeding an
amount of EUR 100,000 are, for fiscal purposes,
considered to be non-qualifying schemes. For this
reason the Executive Pension Plan in the Netherlands
will be terminated.
The following pension arrangement will apply to the
members of the Board of Management with effect from
January 1, 2015:
• members will participate in the Flex Pension Plan in
the Netherlands (retirement age: 67), which is a
defined-benefit plan with an accrual percentage of
1.85 and a maximum pensionable salary of EUR
100,000;
• a gross Pension Allowance will be paid equal to 25%
of the base salary exceeding EUR 100,000;
• for a maximum period of 8 years (first 5 years in full;
year 6: 75%; year 7: 50%, year 8: 25%) a gross
Transition Allowance will be paid to those members
who were eligible to it under the former pension
arrangement and will be based on the age and salary
of the Executive on December 31, 2014.
The total contribution of the Company towards this new
pension arrangement (including the temporary
Transition Allowance) will be comparable to the
contribution made under the former pension
arrangement.
The overview below indicates some of the matters that
were discussed during meetings throughout 2014:
• The Company’s 2014 annual and interim financial
statements, including non-financial information,
prior to publication thereof. The Committee also
assessed in its quarterly meetings the adequacy and
appropriateness of internal control policies and
internal audit programs and their findings.
• Matters relating to accounting policies, financial risks
and compliance with accounting standards.
Compliance with statutory and legal requirements
and regulations, particularly in the financial domain,
was also reviewed. Important findings, Philips’ major
areas of risk (including the internal auditor’s reporting
thereon, and the Chief Legal Officer’s review of
litigation and other claims) and follow-up action and
appropriate measures were examined thoroughly.
Specifically, the Committee reviewed the Company’s
pension liabilities and its program to de-risk future
pension liabilities and related economic, accounting
and legal implications. The Committee reviewed the
Company’s cash flow generation, liquidity and
headroom throughout the year to undertake its
financial commitments, including the Company’s
share repurchase program and payment of
dividends. The Committee also reviewed the
goodwill impairment test performed in the second
quarter, risk management, tax issues, IT strategy and
transformation (including information security) and
remediation of IT-related internal control findings,
the company’s finance transformation,
88
Annual Report 2014
developments in regulatory investigations as well as
legal proceedings including antitrust investigations
and related provisions, environmental exposures, the
Company’s outsourcing of certain services, specific
finance topics including non-manufacturing costs,
the Company’s currency hedging practices and the
impact of certain potential acquisitions.
• With regard to the internal audit, the Committee
reviewed, and if required approved, the internal audit
charter, audit plan, audit scope and its coverage in
relation to the scope of the external audit, as well as
the staffing, independence and organizational
structure of the internal audit function.
• With regard to the external audit, the Committee
reviewed the proposed audit scope, approach and
fees, the independence of the external auditor, non-
audit services provided by the external auditor in
conformity with the Philips Auditor Policy, as well as
any changes to this policy. The Committee also
reviewed the independence as well as its
professional fitness and good standing of the
external auditor and its engagement partners. For
information on the fees of KPMG Accountants N.V.,
please refer to the table ‘Fees KPMG’ in note 6,
Income from operations.
• The Company’s policy on business controls, the
General Business Principles including the
deployment thereof and amendments thereto. The
Committee was informed on, and it discussed and
monitored closely the Company’s internal control
certification processes, in particular compliance with
section 404 of the US Sarbanes-Oxley Act and its
requirements regarding assessment, review and
monitoring of internal controls. It also discussed on a
regular basis the developments in and findings
resulting from investigations into alleged violations of
the Philips GBP and, if required, any measures taken.
Under Dutch legislation on mandatory auditor rotation,
which has also been reflected in the Auditor Policy
(please refer to chapter 11, Corporate governance, of
this Annual Report for more information), Philips must
engage a new audit firm for its statutory audit for the
financial year starting January 1, 2016. The Committee,
jointly with management, conducted a comprehensive
tender and selection process for a new external auditor
(incorporating an interim period of one year with the
current external auditor) and resolved to recommend to
the Supervisory Board the appointment of a new
auditor. This resulted in the Supervisory Board
proposing and recommending the appointment of
Ernst & Young Accountants LLP as the company’s new
auditor at the upcoming 2015 Annual General Meeting
of Shareholders. Please refer to the agenda and
explanatory notes thereto for such meetings for more
information.
Supervisory Board report
10.3
During each Audit Committee meeting, the Committee
reviewed the report from the external auditor in which
the auditor set forth its findings and attention points
during the relevant period. The Committee also
assessed the overall performance of the external
auditor, as required by the Auditor Policy. Please refer
to the agenda and explanatory notes thereto for the
upcoming 2015 Annual General Meeting of
Shareholders for more information on the proposed
appointment of the external auditor.
Finally, the Audit Committee also participated in an
education session during 2014 on the quality and
regulatory aspects of the industries in which the
company is active.
Annual Report 2014
89
Corporate governance 11
11 Corporate governance
Corporate governance of the Philips Group -
Introduction
Koninklijke Philips N.V., a company organized under
Dutch law, is the parent company of the Philips Group.
The Company, which started as a limited partnership
with the name Philips & Co in Eindhoven, the
Netherlands, in 1891, was converted into the company
with limited liability N.V. Philips’ Gloeilampenfabrieken
on September 11, 1912. The Company’s name was
changed to Philips Electronics N.V. on May 6, 1994, to
Koninklijke Philips Electronics N.V. on April 1, 1998, and
to Koninklijke Philips N.V. on May 15, 2013. Its shares
have been listed on the Amsterdam Stock Exchange,
Euronext Amsterdam, since 1912. The shares have been
traded in the United States since 1962 and have been
listed on the New York Stock Exchange since 1987.
Over the last decades the Company has pursued a
consistent policy to improve its corporate governance
in line with Dutch, US and international (codes of) best
practices. The Company has incorporated a fair
disclosure practice in its investor relations policy, has
strengthened the accountability of its executive
management and its independent supervisory
directors, and has increased the rights and powers of
shareholders and the communication with investors.
The Company is required to comply with, inter alia,
Dutch Corporate Governance rules, the US Sarbanes-
Oxley Act, other US securities laws and related
regulations (including applicable stock exchange rules),
insofar as applicable to the Company. A summary of
significant differences between the Company’s
corporate governance practice and the New York Stock
Exchange corporate governance standards is
published on the Company’s website
(www.philips.com/investor).
In this report, the Company addresses its overall
corporate governance structure and states to what
extent and how it applies the principles and best
practice provisions of the Dutch Corporate Governance
Code (as revised on December 10, 2008; the ‘Dutch
Corporate Governance Code’). This report also includes
the information which the Company is required to
disclose pursuant to the Dutch governmental decree on
Article 10 Takeover Directive and the governmental
decree on Corporate Governance. Deviations from
aspects of the corporate governance structure of the
Company, when deemed necessary in the interests of
the Company, will be disclosed in the Annual Report.
Substantial changes in the Company’s corporate
governance structure and in the Company’s compliance
with the Dutch Corporate Governance Code, if any, will
be submitted to the General Meeting of Shareholders
for discussion under a separate agenda item. The
Supervisory Board and the Board of Management,
which are responsible for the corporate governance
structure of the Company, are of the opinion that the
principles and best practice provisions of the Dutch
Corporate Governance Code that are addressed to the
Board of Management and the Supervisory Board,
interpreted and implemented in line with the best
practices followed by the Company, are being applied.
11.1 Board of Management
Introduction
The Board of Management is entrusted with the
management of the Company. Certain key officers have
been appointed to manage the Company together with the
Board of Management. The members of the Board of
Management and these key officers together constitute the
Executive Committee (the ‘Executive Committee’). Under the
chairmanship of the President/Chief Executive Officer
(‘CEO’) the members of the Executive Committee share
responsibility for the deployment of its strategy and policies,
and the achievement of its objectives and results. The
Executive Committee has, for practical purposes, adopted a
division of responsibilities indicating the functional and
business areas monitored and reviewed by the individual
members. For the purpose of this document, where the
Executive Committee is mentioned this also includes the
Board of Management unless the context requires otherwise.
The Board of Management remains accountable for the
actions and decisions of the Executive Committee and
has ultimate responsibility for the Company’s
management and the external reporting and is
answerable to shareholders of the Company at the
Annual General Meeting of Shareholders.
All resolutions of the Executive Committee are adopted by
majority vote comprising the majority of the members of
the Board of Management present or represented, such
majority comprising the vote of the CEO. The Board of
Management retains the authority to, at all times and in all
circumstances, adopt resolutions without the participation
of the other members of the Executive Committee. In
discharging its duties, the Executive Committee shall be
guided by the interests of the Company and its affiliated
enterprise, taking into consideration the interests of the
Company’s stakeholders.
The Executive Committee is supervised by the Supervisory
Board and provides the latter with all information the
Supervisory Board needs to fulfill its own responsibilities.
Major decisions of the Board of Management and
Executive Committee require the approval of the
Supervisory Board; these include decisions concerning (a)
the operational and financial objectives of the Company,
(b) the strategy designed to achieve the objectives, (c) if
necessary, the parameters to be applied in relation to the
strategy and (d) corporate social responsibility issues that
are relevant to the Company.
90
Annual Report 2014
The Executive Committee follows the Rules of
Procedure of the Board of Management and Executive
Committee, which set forth procedures for meetings,
resolutions and minutes. These Rules of Procedure are
published on the Company’s website.
(Term of) Appointment and conflicts of
interests
Members of the Board of Management as well as the CEO
are appointed by the General Meeting of Shareholders
upon a binding recommendation drawn up by the
Supervisory Board after consultation with the CEO. This
binding recommendation may be overruled by a resolution
of the General Meeting of Shareholders adopted by a
simple majority of the votes cast and representing at least
one-third of the issued share capital. If a simple majority
of the votes cast is in favor of the resolution to overrule the
binding recommendation, but such majority does not
represent at least one-third of the issued share capital, a
new meeting may be convened at which the resolution
may be passed by a simple majority of the votes cast,
regardless of the portion of the issued share capital
represented by such majority. In the event a binding
recommendation has been overruled, a new binding
recommendation shall be submitted to the General
Meeting of Shareholders. If such second binding
recommendation has been overruled, the General
Meeting of Shareholders shall be free to appoint a board
member.
Members of the Board of Management and the CEO are
appointed for a term of four years, it being understood
that this term expires at the end of the General Meeting
of Shareholders to be held in the fourth year after the
year of their appointment. Reappointment is possible
for consecutive terms of four years or, if applicable, until
a later retirement date or other contractual termination
date in the fourth year, unless the General Meeting of
Shareholders resolves otherwise. Members may be
suspended by the Supervisory Board and by the
General Meeting of Shareholders and dismissed by the
latter. Individual data on the members of the Board of
Management and Executive Committee are published
in chapter 8, Management, of this Annual Report.
The other members of the Executive Committee are
appointed, suspended and dismissed by the CEO,
subject to approval by the Supervisory Board.
The acceptance by a member of the Board of
Management of a position as a member of a
supervisory board or a position of non-executive
director in a one-tier board (a ‘Non-Executive
Directorship’) at another company requires the
approval of the Supervisory Board. The Supervisory
Board is required to be notified of other important
positions (to be) held by a member of the Board of
Management. Under the Dutch Corporate Governance
Code, no member of the Board of Management shall
hold more than two Non-Executive Directorships at
listed companies, or is a chairman of a supervisory
board or one-tier board, other than of a Group
Corporate governance 11.1
company or participating interest of the Company.
Dutch legislation provides for further limitations on the
Non-Executive Directorships. No member of the Board
of Management shall hold more than two Non-
Executive Directorships at ‘large’ companies (naamloze
vennootschappen or besloten vennootschappen) or
‘large’ foundations (stichtingen) as defined under Dutch
law and no member of the Board of Management shall
hold the position of chairman of another one-tier board
or the position of chairman of another supervisory
board. In order for a company or foundation to be
regarded as large, it must meet at least two of the
following criteria: (i) the value of the assets according
to the balance sheet with explanatory notes,
considering the acquisition or manufacturing price,
exceeds EUR 17.5 million; (ii) the net turnover exceeds
EUR 35 million; or (iii) the average number of employees
equals or exceeds 250. During the financial year 2014
all members of the Board of Management complied
with the limitations on Non-Executive Directorships
described above.
Pursuant to Dutch legislation on board diversity, the
Company must pursue a policy of having at least 30% of the
seats on the Board of Management held by men and at least
30% of the seats held by women. The rule will cease to have
effect on January 1, 2016. For more details on board diversity
please be referred to section 10.1, Report of the Corporate
Governance and Nomination & Selection Committee, of
this Annual Report.
Dutch legislation on conflicts of interests provides that a
member of the Board of Management may not participate
in the adoption of resolutions if he or she has a direct or
indirect personal conflict of interest with the Company or
related enterprise. If all members of the Board of
Management have a conflict, the resolution concerned will
be adopted by the Supervisory Board. The Company’s
corporate governance includes rules to specify situations
in which a (potential) conflict may exist, to avoid (potential)
conflicts of interests as much as possible, and to deal with
such conflicts should they arise. The rules on conflicts of
interests apply to the other members of the Executive
Committee correspondingly.
Relevant matters relating to conflicts of interests, if any,
shall be mentioned in the Annual Report for the
financial year in question. No such matters have
occurred during the financial year 2014.
Amount and composition of the remuneration
of the Board of Management
The remuneration of the individual members of the Board
of Management is determined by the Supervisory Board
on the proposal of the Remuneration Committee of the
Supervisory Board, and must be consistent with the policy
thereon as adopted by the General Meeting of
Shareholders. The current remuneration policy applicable
to the Board of Management was adopted by the 2013
Annual General Meeting of Shareholders, and is published
on the Company’s website. A full and detailed description
of the composition of the remuneration of the individual
Annual Report 2014
91
Corporate governance 11.1
members of the Board of Management is included in
section 10.2, Report of the Remuneration Committee, of
this Annual Report.
Pursuant to Dutch legislation, the remuneration of the
members of the Board of Management and the Supervisory
Board must be included as a separate agenda item in the
convening notice for a General Meeting of Shareholders and
must be dealt with before the meeting can proceed to
consider and adopt the Annual Accounts.
The remuneration structure of the Company, including
severance pay, is such that it promotes the interests of
the Company in the medium and long-term, does not
encourage members of the Board of Management to
act in their own interests and neglect the interests of the
Company, and does not reward failing members of the
Board of Management upon termination of their
employment. The level and structure of remuneration
shall be determined in the light of factors such as the
results, the share price performance and other
developments relevant to the Company. Deviations on
elements of the remuneration policy in extraordinary
circumstances, when deemed necessary in the
interests of the Company, will be disclosed in the
Annual Report or, in case of an appointment, in good
time prior to the appointment of the person concerned.
All current members of the Board of Management are
employed by means of a contract of employment.
Pursuant to Dutch legislation, effective January 1, 2013,
a newly appointed or a re-appointed member of the
Board of Management will be engaged by means of a
services agreement (‘overeenkomst van opdracht’). The
main elements of the services agreement - including
the amount of the fixed base compensation, the
structure and amount of the variable compensation
component, any severance plan, pension
arrangements and the general performance criteria -
shall be made public no later than at the time of
issuance of the notice convening the General Meeting
of Shareholders in which a proposal for
(re-)appointment of that member of the Board of
Management has been placed on the agenda. In
compliance with the Dutch Corporate Governance
Code, the term of the services agreement of the
members of the Board of Management is set at four
years, and in case of termination, severance payment is
limited to a maximum of one year’s base compensation;
if the maximum of one-year’s base compensation
would be manifestly unreasonable for a member of the
Board of Management who is dismissed during his first
term of office, the member of the Board of Management
shall be eligible for a severance payment not exceeding
twice the annual base compensation.
From 2003 until 2013, Philips maintained a Long-Term
Incentive Plan (‘LTI Plan’) consisting of a mix of restricted
shares rights and stock options for members of the Board of
Management, Philips executives and other key employees.
Since the full revision in 2013 of the LTI Plan applicable to
members of the Board of Management, the plan consists of
92
Annual Report 2014
performance shares only, with a three year post-grant
performance measurement. For more details please be
referred to section 10.2, Report of the Remuneration
Committee, of this Annual Report.
The so-called ultimum remedium clause and claw-back
clause of best practice provisions II.2.10 and II.2.11 of the
Dutch Corporate Governance Code are applicable to
Annual Incentive payments and LTI grants for the year
2009 onwards to all members of the Board of
Management. In respect of the LTI grants, the ultimum
remedium clause can be applied to the performance-
related actual number of stock options, restricted share
rights and/or performance shares that is granted. In
addition, pursuant to new Dutch legislation, effective
January 1, 2014, the Supervisory Board will be authorized
to change unpaid bonuses awarded to members of the
Board of Management if payment or delivery of the bonus
would be unacceptable according to the principles of
reasonableness and fairness. The Company, which in this
respect may also be represented by the Supervisory Board
or a special representative appointed for this purpose by
the General Meeting of Shareholders, may also claim
repayment of bonuses paid or delivered (after December
31, 2013) insofar as these have been granted on the basis
of incorrect information on the fulfillment of the relevant
performance criteria or other conditions. Bonuses are
broadly defined as ‘non-fixed’ remuneration, either in cash
or in the form of share-based compensation, that is
conditional in whole or in part on the achievement of
certain targets or the occurrence of certain circumstances.
The explanatory notes to the balance sheet shall report on
any moderation and/or claim for repayment of board
remuneration. No such moderation or claim for repayment
has occurred during the financial year 2014. The new
legislation also introduces an obligation for the Company
to reduce the remuneration of a member of the Board of
Management, if and to the extent the value of such
member’s share-based remuneration would have
increased as a result of the announcement of a large
transaction (requiring shareholder approval) or a public
offer for the Company.
Members of the Board of Management hold shares in the
Company for the purpose of long-term investment and are
required to refrain from short-term transactions in Philips
securities. According to the Philips Rules of Conduct on
Inside Information, members of the Board of Management
are only allowed to trade in Philips securities (including the
exercise of stock options) during ‘windows’ of twenty
business days following the publication of annual and
quarterly results (provided the person involved has no
‘inside information’ regarding Philips at that time unless an
exemption is available). Furthermore, the Rules of
Procedure of the Board of Management and Executive
Committee contain provisions concerning ownership of
and transactions in non-Philips securities by members of
the Board of Management. Members of the Board of
Management are prohibited from trading, directly or
indirectly, in securities of any of the companies belonging
to the peer group, during one week preceding the
disclosure of Philips’ annual or quarterly results. The rules
referred to above in this paragraph apply to members of
the Executive Committee correspondingly. Transactions in
shares in the Company carried out by members of the
Board of Management or members of the Supervisory
Board and other Insiders (if applicable) are notified to the
Netherlands Authority for the Financial Markets (AFM) in
accordance with Dutch law and, if necessary, to other
relevant authorities.
Indemnification of members of the Board of
Management and Supervisory Board
Unless the law provides otherwise, the members of the
Board of Management and of the Supervisory Board
shall be reimbursed by the Company for various costs
and expenses, such as the reasonable costs of
defending claims, as formalized in the Articles of
Association. Under certain circumstances, described in
the Articles of Association, such as an act or failure to
act by a member of the Board of Management or a
member of the Supervisory Board that can be
characterized as intentional (‘opzettelijk’), intentionally
reckless (‘bewust roekeloos’) or seriously culpable
(‘ernstig verwijtbaar’), there will be no entitlement to
this reimbursement unless the law or the principles of
reasonableness and fairness require otherwise. The
Company has also taken out liability insurance (D&O -
Directors & Officers) for the persons concerned.
In line with regulatory requirements, the Company’s
policy forbids personal loans to and guarantees on
behalf of members of the Board of Management or the
Supervisory Board, and no loans and guarantees have
been granted and issued, respectively, to such
members in 2014, nor are any loans or guarantees
outstanding as of December 31, 2014.
The aggregate share ownership of the members of the
Board of Management and the Supervisory Board
represents less than 1% of the outstanding ordinary
shares in the Company.
Risk management approach
Within Philips, risk management forms an integral part
of business management. The Company has
implemented a risk management and internal control
system that is designed to provide reasonable
assurance that strategic objectives are met by creating
focus, by integrating management control over the
Company’s operations, by ensuring compliance with
applicable laws and regulations and by safeguarding
the reliability of the financial reporting and its
disclosures. The Executive Committee reports on and
accounts for internal risk management and control
systems to the Supervisory Board and its Audit
Committee. The Company has designed its internal
control system based on the “Internal Control-
Integrated Framework (2013)” established by the
Committee of Sponsoring Organizations of the
Treadway Commission (COSO).
Corporate governance 11.1
The Company’s risk management approach is
embedded in the periodic business planning and
review cycle and forms an integral part of business
management. On the basis of risk assessments,
management determines the risks and appropriate risk
responses related to the achievement of business
objectives and critical business processes. Risk factors
and the risk management approach, as well as the
sensitivity of the Company’s results to external factors
and variables, are described in more detail in chapter 7,
Risk management, of this Annual Report. Significant
changes and improvements in the Company’s risk
management and internal control system have been
discussed with the Supervisory Board’s Audit
Committee and the external auditor and are disclosed
in that section as well.
With respect to financial reporting a structured self-
assessment and monitoring process is used company-
wide to assess, document, review and monitor
compliance with internal control over financial
reporting. Internal representations received from
management, regular management reviews, reviews of
the design and effectiveness of internal controls and
reviews in group and sector audit committees are
integral parts of the Company’s risk management
approach. On the basis thereof, the Board of
Management confirms that internal controls over
financial reporting provide a reasonable level of
assurance that the financial reporting does not contain
any material inaccuracies, and confirms that these
controls have properly functioned in 2014. The financial
statements fairly represent the financial condition and
result of operations of the Company and provide the
required disclosures.
It should be noted that the above does not imply that
these systems and procedures provide certainty as to
the realization of operational and financial business
objectives, nor can they prevent all misstatements,
inaccuracies, errors, fraud and non-compliances with
rules and regulations.
In view of the above the Board of Management believes
that it is in compliance with the requirements of
recommendation II.1.4. of the Dutch Corporate
Governance Code. The above statement on internal
controls should not be construed as a statement in
response to the requirements of section 404 of the US
Sarbanes-Oxley Act. The statement as to compliance with
section 404 is set forth in the section section 12.1,
Management’s report on internal control, of this Annual
Report.
Philips has a financial code of ethics which applies to
certain senior officers, including the CEO and CFO, and
to employees performing an accounting or financial
function (the financial code of ethics has been
published on the Company’s website). The Company,
through the Supervisory Board’s Audit Committee, also
has appropriate procedures in place for the receipt,
retention and treatment of complaints received by the
Annual Report 2014
93
Corporate governance 11.1
Company regarding accounting, internal accounting
controls or auditing matters and the confidential,
anonymous submission by employees of concerns
regarding questionable accounting or auditing matters.
Internal ‘whistleblowers’ have the opportunity, without
jeopardizing their position, to report on irregularities of
a general, operational or financial nature and to report
complaints about members of the Executive Committee
to the Chairman of the Supervisory Board.
In view of the requirements under the US Securities
Exchange Act, procedures are in place to enable the
CEO and the CFO to provide certifications with respect
to the Annual Report on Form 20-F.
A Disclosure Committee is in place, which advises the
various officers and departments involved, including
the CEO and the CFO, on the timely review, publication
and filing of periodic and current (financial) reports. In
addition to the certification by the CEO and CFO under
US law, each individual member of the Board of
Management and the Supervisory Board must under
Dutch law, sign the Group and Company financial
statements being disclosed and submitted to the
General Meeting of Shareholders for adoption. If one or
more of their signatures is missing, this shall be stated,
and the reasons given for this. The members of the
Board of Management issue the responsibility
statement with regard to chapter 12, Group financial
statements, of this Annual Report, as required by
applicable Dutch company law and securities law.
11.2 Supervisory Board
Introduction
The Supervisory Board supervises the policies of the
Board of Management and Executive Committee and
the general course of affairs of Philips and advises the
executive management thereon. The Supervisory
Board, in the two-tier corporate structure under Dutch
law, is a separate body that is independent of the Board
of Management. Its independent character is also
reflected in the requirement that members of the
Supervisory Board can be neither a member of the
Board of Management nor an employee of the
Company. The Supervisory Board considers all its
members to be independent pursuant to the Dutch
Corporate Governance Code and under the applicable
US Securities and Exchange Commission standards.
The Supervisory Board, acting in the interests of the
Company and the Group and taking into account the
relevant interest of the Company’s stakeholders,
supervises and advises the Board of Management and
Executive Committee in performing its management
tasks and setting the direction of the Group’s business,
including (a) the Philips group’s performance, (b) the
Philips group’s general strategy and the risks connected
to its business activities, (c) the operational and
financial objectives, (d) the parameters to be approved
in relation to the strategy, (e) corporate social
responsibility issues (f) the structure and management
94
Annual Report 2014
of the systems of internal business controls, (g) the
financial reporting process, (h) the compliance with
applicable laws and regulations, (i) the company-
shareholders relationship, and (j) the corporate
governance structure of the Company. The Group’s
strategy and major management decisions are
discussed with and approved by the Supervisory Board.
For a description of further responsibilities and tasks of
the Supervisory Board please refer to the Supervisory
Board’s Rules of Procedure which is published on the
Company’s website.
In its report, the Supervisory Board describes the
composition and functioning of the Supervisory Board
and its committees, the activities of the board and its
committees in the financial year, the number of
committee meetings and the main items discussed.
Rules of Procedure of the Supervisory Board
The Supervisory Board’s Rules of Procedure set forth its
own governance rules (including meetings, items to be
discussed, resolutions, appointment and re-election,
committees, conflicts of interests, trading in securities,
profile of the Supervisory Board). Its composition
follows the profile, which aims for an appropriate
combination of knowledge and experience among its
members encompassing marketing, technological,
manufacturing, financial, economic, social and legal
aspects of international business and government and
public administration in relation to the global and multi-
product character of the Group’s businesses. The
Supervisory Board attaches great importance to
diversity in its composition. More particularly, it aims at
having members with a European and a non-European
background (nationality, working experience or
otherwise) and one or more members with an executive
or similar position in business or society no longer than
5 years ago.
Pursuant to Dutch legislation on board diversity, the
Company shall pursue a policy of having at least 30%
of the seats on the Supervisory Board held by men and
at least 30% of the seats held by women. The rule will
cease to have effect on January 1, 2016. For more details
on board diversity please be referred to section 10.1,
Report of the Corporate Governance and Nomination &
Selection Committee, of this Annual Report.
The Rules of Procedure of the Supervisory Board are
published on the Company’s website. They include the
charters of its committees, to which the plenary
Supervisory Board, while retaining overall
responsibility, has assigned certain tasks: the Corporate
Governance and Nomination & Selection Committee,
the Audit Committee and the Remuneration
Committee. Each committee reports, and submits its
minutes for information, to the Supervisory Board.
In line with US and Dutch best practices, the Chairman
of the Supervisory Board must be independent
pursuant to the Dutch Corporate Governance Code and
under the applicable US standards. Furthermore, the
Dutch Corporate Governance Code allows a maximum
of one member of each Supervisory Board committee
not to be independent (as defined by the Code). As
mentioned in the introduction of this section 11.2 above,
the Supervisory Board considers all its members to be
independent.
The Supervisory Board is assisted by the General
Secretary of the Company. The General Secretary sees
to it that correct procedures are followed and that the
Supervisory Board acts in accordance with its statutory
obligations and its obligations under the Articles of
Association. Furthermore the General Secretary assists
the Chairman of the Supervisory Board in the actual
organization of the affairs of the Supervisory Board
(information, agenda, evaluation, introductory
program) and is the contact person for interested
parties who want to make concerns known to the
Supervisory Board. The General Secretary shall, either
on the recommendation of the Supervisory Board or
otherwise, be appointed and may be dismissed by the
Board of Management, after the approval of the
Supervisory Board has been obtained.
(Term of) Appointment, individual data and
conflicts of interests
The Supervisory Board consists of at least five members
(currently eight), including a Chairman, Vice-Chairman
and Secretary. The Dutch ‘structure regime’ does not
apply to the Company itself. Members are currently
appointed by the General Meeting of Shareholders for
fixed terms of four years, upon a binding
recommendation from the Supervisory Board.
According to the Company’s Articles of Association, this
binding recommendation may be overruled by a
resolution of the General Meeting of Shareholders
adopted by a simple majority of the votes cast and
representing at least one-third of the issued share
capital. If a simple majority of the votes cast is in favor
of the resolution to overrule the binding
recommendation, but such majority does not represent
at least one-third of the issued share capital, a new
meeting may be convened at which the resolution may
be passed by a simple majority of the votes cast,
regardless of the portion of the issued share capital
represented by such majority. In the event a binding
recommendation has been overruled, a new binding
recommendation shall be submitted to the General
Meeting of Shareholders. If such second binding
recommendation has been overruled, the General
Meeting of Shareholders shall be free to appoint a
board member.
There is no age limit applicable, and members are
eligible for re-election twice (unless the Supervisory
Board resolves to deviate in a specific case). The date
of expiration of the terms of Supervisory Board
members is published on the Company’s website.
Individual data on the members of the Supervisory
Board are published in the Annual Report, and updated
on the Company’s website. Members may be
suspended and dismissed by the General Meeting of
Corporate governance 11.2
Shareholders. In the event of inadequate performance,
structural incompatibility of interests, and in other
instances in which resignation is deemed necessary in
the opinion of the Supervisory Board, the Supervisory
Board shall submit to the General Meeting of
Shareholders a proposal to dismiss the respective
member of the Supervisory Board.
After their appointment, all members of the Supervisory
Board shall follow an introductory program, which
covers general financial and legal affairs, financial
reporting by the Company, any specific aspects that are
unique to the Company and its business activities, and
the responsibilities of a Supervisory Board member.
Any need for further training or education of members
will be reviewed annually, also on the basis of an annual
evaluation survey.
Under the Dutch Corporate Governance Code, no
member of the Supervisory Board shall hold more than
five supervisory board memberships of Dutch listed
companies, the chairmanship of a supervisory board
counting as two regular memberships. In addition,
Dutch legislation provides that no member of the
Supervisory Board shall hold more than five Non-
Executive Directorships at ‘large’ companies or
foundations as defined under Dutch law (see section
11.1, Board of Management, of this Annual Report), with
a position as chairman counting for two. During the
financial year 2014 all members of the Supervisory
Board complied with the limitations on Non-Executive
Directorships described above.
Dutch legislation on conflicts of interests provides that
a member of the Supervisory Board may not participate
in the adoption of resolutions if he or she has a direct
or indirect personal conflict of interest with the
Company or related enterprise. If all members of the
Supervisory Board have a conflict, the resolution
concerned will be adopted by the General Meeting of
Shareholders. The Company’s corporate governance
includes rules to specify situations in which a (potential)
conflict may exist, to avoid (potential) conflicts of
interests as much as possible, and to deal with such
conflicts should they arise.
Relevant matters relating to conflicts of interests, if any,
shall be mentioned in the Annual Report for the
financial year in question. No decisions to enter into
material transactions in which there are conflicts of
interest with members of the Supervisory Board were
taken during the financial year 2014.
Meetings of the Supervisory Board
The Supervisory Board meets at least six times per year,
including a meeting on strategy. The Supervisory Board,
on the advice of its Audit Committee, also discusses, in
any event at least once a year, the main risks of the
business, and the result of the assessment of the
structure and operation of the internal risk
management and control systems, as well as any
significant changes thereto. The members of the
Annual Report 2014
95
Corporate governance 11.2
Executive Committee attend meetings of the
Supervisory Board except in matters such as the
desired profile, composition and competence of the
Supervisory Board and the Executive Committee, as
well as the remuneration and performance of individual
members of the Executive Committee and the
conclusions that must be drawn on the basis thereof. In
addition to these items, the Supervisory Board, being
responsible for the quality of its own performance,
discusses, at least once a year on its own, without the
members of the Executive Committee being present, (i)
both its own functioning and that of the individual
members, and the conclusions that must be drawn on
the basis thereof, as well as (ii) both the functioning of
the Board of Management and that of the individual
members, and the conclusions that must be drawn on
the basis thereof. The President/CEO and other
members of the Executive Committee have regular
contacts with the Chairman and other members of the
Supervisory Board. The Executive Committee is
required to keep the Supervisory Board informed of all
facts and developments concerning Philips that the
Supervisory Board may need in order to function as
required and to properly carry out its duties, to consult
it on important matters and to submit certain important
decisions to it for its prior approval. The Supervisory
Board and its individual members each have their own
responsibility to request from the Executive Committee
and the external auditor all information that the
Supervisory Board needs in order to be able to carry out
its duties properly as a supervisory body. If the
Supervisory Board considers it necessary, it may obtain
information from officers and external advisers of the
Company. The Company provides the necessary means
for this purpose. The Supervisory Board may also
require that certain officers and external advisers
attend its meetings.
The Chairman of the Supervisory Board
The Supervisory Board’s Chairman will see to it that: (a)
the members of the Supervisory Board follow their
introductory program, (b) the members of the
Supervisory Board receive in good time all information
which is necessary for the proper performance of their
duties, (c) there is sufficient time for consultation and
decision-making by the Supervisory Board, (d) the
committees of the Supervisory Board function properly,
(e) the performance of the Executive Committee
members and Supervisory Board members is assessed
at least once a year, and (f) the Supervisory Board elects
a Vice-Chairman. The Vice-Chairman of the
Supervisory Board shall deputize for the Chairman
when the occasion arises. The Vice- Chairman shall act
as contact of individual members of the Supervisory
Board or the Board of Management concerning the
functioning of the Chairman of the Supervisory Board.
Remuneration of the Supervisory Board and
share ownership
The remuneration of the individual members of the
Supervisory Board, as well as the additional
remuneration for its Chairman and the members of its
96
Annual Report 2014
committees is determined by the General Meeting of
Shareholders. The remuneration of a Supervisory Board
member is not dependent on the results of the
Company. Further details are published in the
Supervisory Board report.
Shares or rights to shares shall not be granted to a
Supervisory Board member. In accordance with the
Rules of Procedure of the Supervisory Board, any
shares in the Company held by a Supervisory Board
member are long-term investments. The Supervisory
Board has adopted a policy on ownership of and
transactions in non-Philips securities by members of
the Supervisory Board. This policy is included in the
Rules of Procedure of the Supervisory Board.
The Corporate Governance and Nomination &
Selection Committee
The Corporate Governance and Nomination & Selection
Committee consists of at least the Chairman and Vice-
Chairman of the Supervisory Board. The Committee
reviews the corporate governance principles applicable
to the Company at least once a year, and advises the
Supervisory Board on any changes to these principles
as it deems appropriate. It also (a) draws up selection
criteria and appointment procedures for members of
the Supervisory Board, the Board of Management and
the Executive Committee; (b) periodically assesses the
size and composition of the Supervisory Board, the
Board of Management and the Executive Committee,
and makes the proposals for a composition profile of
the Supervisory Board, if appropriate; (c) periodically
assesses the functioning of individual members of the
Supervisory Board, the Board of Management and the
Executive Committee, and reports on this to the
Supervisory Board. The Committee also consults with
the President/CEO and the Executive Committee on
candidates to fill vacancies on the Supervisory Board,
the Executive Committee, and advises the Supervisory
Board on the candidates for appointment. It further
supervises the policy of the Executive Committee on
the selection criteria and appointment procedures for
Philips Executives.
The Remuneration Committee
The Remuneration Committee meets at least twice a
year and is responsible for preparing decisions of the
Supervisory Board on the remuneration of individual
members of the Board of Management and the
Executive Committee.
The Remuneration Committee prepares an annual
remuneration report. The remuneration report contains
an account of the manner in which the remuneration
policy has been implemented in the past financial year,
as well as an overview of the implementation of the
remuneration policy planned by the Supervisory Board
for the next year(s). The Supervisory Board aims to have
appropriate experience available within the
Remuneration Committee. No more than one member
of the Remuneration Committee shall be an executive
board member of another Dutch listed company.
In performing its duties and responsibilities the
Remuneration Committee is assisted by an in-house
remuneration expert acting on the basis of a protocol
ensuring that the expert acts on the instructions of the
Remuneration Committee and on an independent basis
in which conflicts of interests are avoided.
The Audit Committee
The Audit Committee meets at least four times a year,
before the publication of the annual, semi-annual and
quarterly results. All of the members of the Audit
Committee are considered to be independent under
the applicable US Securities and Exchange Commission
rules and at least one of the members of the Audit
Committee, which currently consists of five members of
the Supervisory Board, is a financial expert as set out in
the Dutch Corporate Governance Code and each
member is financially literate. In accordance with this
code, a financial expert has relevant knowledge and
experience of financial administration and accounting
at the company in question. None of the members of
the Audit Committee is designated as an Audit
Committee financial expert as defined under the
regulations of the US Securities and Exchange
Commission. The Supervisory Board considers the fact
of being compliant with the Dutch Corporate
Governance Code, in combination with the expertise
and experience available in the Audit Committee as
well as the possibility to take advice from internal and
external experts and advisors, to be sufficient for the
fulfillment of the tasks and responsibilities of the Audit
Committee. The Audit Committee may not be chaired
by the Chairman of the Supervisory Board or by a
(former) member of the Board of Management.
The tasks and functions of the Audit Committee, as
described in its charter, which is published on the
Company’s website as part of the Rules of Procedure of
the Supervisory Board, include the duties
recommended in the Dutch Corporate Governance
Code. More specifically, the Audit Committee assists the
Supervisory Board in fulfilling its oversight
responsibilities for the integrity of the Company’s
financial statements, the financial reporting process,
the system of internal business controls and risk
management, the internal and external audit process,
the internal and external auditor’s qualifications, its
independence and its performance, as well as the
Company’s process for monitoring compliance with
laws and regulations and the General Business
Principles (GBP). It reviews the Company’s annual and
interim financial statements, including non-financial
information, prior to publication and advises the
Supervisory Board on the adequacy and
appropriateness of internal control policies and internal
audit programs and their findings.
In reviewing the Company’s annual and interim
statements, including non-financial information, and
advising the Supervisory Board on internal control
policies and internal audit programs, the Audit
Committee reviews matters relating to accounting
Corporate governance 11.2
policies and compliance with accounting standards,
compliance with statutory and legal requirements and
regulations, particularly in the financial domain.
Important findings and identified risks are examined
thoroughly by the Audit Committee in order to allow
appropriate measures to be taken. With regard to the
internal audit, the Audit Committee, in cooperation with
the external auditor, reviews the internal audit charter,
audit plan, audit scope and its coverage in relation to
the scope of the external audit, staffing, independence
and organizational structure of the internal audit
function.
With regard to the external audit, the Audit Committee
reviews the proposed audit scope, approach and fees,
the independence of the external auditor, its
performance and its (re-)appointment, audit and
permitted non-audit services provided by the external
auditor in conformity with the Philips Policy on Auditor
Independence, as well as any changes to this policy.
The Audit Committee also considers the report of the
external auditor and its report with respect to the
annual financial statements. According to the
procedures, the Audit Committee acts as the principal
contact for the external auditor if the auditor discovers
irregularities in the content of the financial reports. It
also advises on the Supervisory Board’s statement to
shareholders in the annual accounts. The Audit
Committee periodically discusses the Company’s
policy on business controls, the GBP including the
deployment thereof, overviews on tax, IT, litigation and
legal proceedings, environmental exposures, financial
exposures in the area of treasury, real estate, pensions,
and the Group’s major areas of risk. The Company’s
external auditor, in general, attends all Audit Committee
meetings and the Audit Committee meets separately at
least on a quarterly basis with each of the President/
CEO, the CFO, the internal auditor and the external
auditor.
11.3 General Meeting of Shareholders
Introduction
A General Meeting of Shareholders is held at least once
a year to discuss the Annual Report, including the report
of the Board of Management, the annual financial
statements with explanatory notes thereto and
additional information required by law, and the
Supervisory Board report, any proposal concerning
dividends or other distributions, the appointment of
members of the Board of Management and Supervisory
Board (if any), important management decisions as
required by Dutch law, and any other matters proposed
by the Supervisory Board, the Board of Management or
shareholders in accordance with the provisions of the
Company’s Articles of Association. The Annual Report,
the financial statements and other regulated
information such as defined in the Dutch Act on
Financial Supervision (Wet op het Financieel Toezicht),
will solely be published in English. As a separate
agenda item and in application of Dutch law, the
General Meeting of Shareholders discusses the
Annual Report 2014
97
Corporate governance 11.3
discharge of the members of the Board of Management
and the Supervisory Board from responsibility for the
performance of their respective duties in the preceding
financial year. However, this discharge only covers
matters that are known to the Company and the
General Meeting of Shareholders when the resolution
is adopted. The General Meeting of Shareholders is
held in Eindhoven, Amsterdam, Rotterdam, The Hague,
Utrecht or Haarlemmermeer (Schiphol Airport) no later
than six months after the end of the financial year.
Meetings are convened by public notice, via the
Company’s website or other electronic means of
communication and to registered shareholders by letter
or by the use of electronic means of communication, at
least 42 days prior to the (Extraordinary) General
Meeting of Shareholders. Extraordinary General
Meetings of Shareholders may be convened by the
Supervisory Board or the Board of Management if
deemed necessary and must be held if shareholders
jointly representing at least 10% of the outstanding
share capital make a written request to that effect to the
Supervisory Board and the Board of Management,
specifying in detail the business to be dealt with. The
agenda of a General Meeting of Shareholders shall
contain such business as may be placed thereon by the
Board of Management or the Supervisory Board, and
agenda items will be explained where necessary in
writing. The agenda shall list which items are for
discussion and which items are to be voted upon.
Material amendments to the Articles of Association and
resolutions for the appointment of members of the
Board of Management and Supervisory Board shall be
submitted separately to the General Meeting of
Shareholders, it being understood that amendments
and other proposals that are connected in the context
of a proposed (part of the) governance structure may
be submitted as one proposal. In accordance with the
Articles of Association and Dutch law, requests from
shareholders for items to be included on the agenda
will generally be honored, subject to the Company’s
rights to refuse to include the requested agenda item
under Dutch law, provided that such requests are made
in writing at least 60 days before a General Meeting of
Shareholders to the Board of Management and the
Supervisory Board by shareholders representing at
least 1% of the Company’s outstanding capital or,
according to the official price list of Euronext
Amsterdam, representing a value of at least EUR 50
million. Written requests may be submitted
electronically and shall comply with the procedure
stipulated by the Board of Management, which
procedure is posted on the Company’s website.
Pursuant to Dutch legislation, shareholders requesting
an item to be included on the agenda, have an
obligation to disclose their full economic interest (i.e.
long position and short position) to the Company. The
Company has the obligation to publish such disclosures
on its website.
98
Annual Report 2014
Main powers of the General Meeting of
Shareholders
All outstanding shares carry voting rights. The main
powers of the General Meeting of Shareholders are to
appoint, suspend and dismiss members of the Board of
Management and of the Supervisory Board, to adopt
the annual accounts, declare dividends and to
discharge the Board of Management and the
Supervisory Board from responsibility for the
performance of their respective duties for the previous
financial year, to appoint the external auditor as
required by Dutch law, to adopt amendments to the
Articles of Association and proposals to dissolve or
liquidate the Company, to issue shares or rights to
shares, to restrict or exclude pre-emptive rights of
shareholders and to repurchase or cancel outstanding
shares. Following common corporate practice in the
Netherlands, the Company each year requests limited
authorization to issue (rights to) shares, to restrict or
exclude pre-emptive rights and to repurchase shares.
In compliance with Dutch law, decisions of the Board of
Management that are so far-reaching that they would
greatly change the identity or nature of the Company
or the business require the approval of the General
Meeting of Shareholders. This includes resolutions to
(a) transfer the business of the Company, or almost the
entire business of the Company, to a third-party (b)
enter into or discontinue long-term cooperation by the
Company or a subsidiary with another legal entity or
company or as a fully liable partner in a limited
partnership or ordinary partnership, if this cooperation
or its discontinuation is of material significance to the
Company or (c) acquire or dispose of a participating
interest in the capital of a company to the value of at
least one-third of the amount of the assets according
to the balance sheet and notes thereto or, if the
Company prepares a consolidated balance sheet,
according to the consolidated balance sheet and notes
thereto as published in the last adopted annual
accounts of the Company, by the Company or one of its
subsidiaries. Thus the Company applies principle IV.1 of
the Dutch Corporate Governance Code within the
framework of the Articles of Association and Dutch law
and in the manner as described in this corporate
governance report.
The Board of Management and Supervisory Board are
also accountable, at the Annual General Meeting of
Shareholders, for the policy on the additions to reserves
and dividends (the level and purpose of the additions
to reserves, the amount of the dividend and the type of
dividend). This subject is dealt with and explained as a
separate agenda item at the Annual General Meeting of
Shareholders. A resolution to pay a dividend is dealt
with as a separate agenda item at the General Meeting
of Shareholders.
The Board of Management and the Supervisory Board
are required to provide the General Meeting of
Shareholders with all requested information, unless this
would be prejudicial to an overriding interest of the
Company. If the Board of Management and the
Supervisory Board invoke an overriding interest in
refusing to provide information, reasons must be given.
If a serious private bid is made for a business unit or a
participating interest and the value of the bid exceeds
a certain threshold (currently one-third of the amount
of the assets according to the balance sheet and notes
thereto or, if the Company prepares a consolidated
balance sheet, according to the consolidated balance
sheet and notes thereto as published in the last
adopted annual accounts of the Company), and such
bid is made public, the Board of Management shall, at
its earliest convenience, make public its position on the
bid and the reasons for this position.
A resolution to dissolve the Company or change its
Articles of Association can be adopted at a General
Meeting of Shareholders by at least three-fourths of the
votes cast, at which meeting more than half of the
issued share capital is represented. If the requisite share
capital is not represented, a further meeting shall be
convened, to be held within eight weeks of the first
meeting, to which no quorum requirement applies.
Furthermore, the resolution requires the approval of the
Supervisory Board. If the resolution is proposed by the
Board of Management, the adoption needs an absolute
majority of votes and no quorum requirement applies
to the meeting.
Repurchase and issue of (rights to) own shares
At the 2014 Annual General Meeting of Shareholders it
was resolved to authorize the Board of Management,
subject to the approval of the Supervisory Board, to
acquire shares in the Company within the limits of the
Articles of Association and within a certain price range
up to and including October 31, 2015. The maximum
number of shares the company may hold, will not
exceed 10% of the issued share capital as of May 1, 2014,
which number may be increased by 10% of the issued
capital as of that same date in connection with the
execution of share repurchase programs for capital
reduction programs.
In addition, at the 2014 Annual General Meeting of
Shareholders it was resolved to authorize the Board of
Management, subject to the approval of the
Supervisory Board, to issue shares or grant rights to
acquire shares in the Company as well as to restrict or
exclude the pre-emption right accruing to shareholders
up to and including October 31, 2015. This authorization
is limited to a maximum of 10% of the number of shares
issued as of May 1, 2014 plus 10% of the issued capital
in connection with or on the occasion of mergers and
acquisitions.
11.4 Meeting logistics and other
information
Introduction
Pursuant to Dutch law, the record date for the exercise
of the voting rights and the rights relating to General
Meetings of Shareholders is set at the 28th day prior to
the day of the meeting. Shareholders registered at such
Corporate governance 11.3
date are entitled to attend the meeting and to exercise
the other shareholder rights (in the meeting in question)
notwithstanding subsequent sale of their shares
thereafter. This date will be published in advance of
every General Meeting of Shareholders.
Information which is required to be published or
deposited pursuant to the provisions of company law
and securities law applicable to the Company and
which is relevant to the shareholders, is placed and
updated on the Company’s website, or hyperlinks are
established. The Board of Management and
Supervisory Board shall ensure that the General
Meeting of Shareholders is informed of facts and
circumstances relevant to proposed resolutions in
explanatory notes to the agenda and, if deemed
appropriate, by means of a ‘shareholders circular’
published on the Company’s website.
Resolutions adopted at a General Meeting of
Shareholders shall be recorded by a civil law notary and
co-signed by the chairman of the meeting; such
resolutions shall also be published on the Company’s
website within 15 days after the meeting. A draft
summary of the discussions during the General Meeting
of Shareholders, in the language of the meeting, is
made available to shareholders, on request, no later
than three months after the meeting. Shareholders shall
have the opportunity to respond to this summary for
three months, after which a final summary is adopted
by the chairman of the meeting in question. Such final
summary shall be made available on the Company’s
website.
Registration, attending meetings and proxy
voting
Holders of common shares who wish to exercise the
rights attached to their shares in respect of a General
Meeting of Shareholders, are required to register for
such meeting. Shareholders may attend a General
Meeting of Shareholders in person, or may grant a
power of attorney to a third-party to attend the meeting
and to vote on their behalf. Holders of common shares
in bearer form will also be able to give voting
instructions via Internet (assuming the agenda for such
meeting includes voting items). In addition, the
Company will distribute a voting instruction form for a
General Meeting of Shareholders. By giving voting
instructions via Internet or by returning the form,
shareholders grant power to an independent proxy
holder who will vote according to the instructions
expressly given on the voting instruction form. Also
other persons entitled to vote shall be given the
possibility to give voting proxies or instructions to an
independent third-party prior to the meeting. Details
on the registration for meetings, attending and proxy
voting will be included in the notice convening a
General Meeting of Shareholders.
Annual Report 2014
99
Corporate governance 11.4
Preference shares and the Stichting Preferente
Aandelen Philips
As a means to protect the Company and its
stakeholders against an unsolicited attempt to obtain
(de facto) control of the Company, the General Meeting
of Shareholders in 1989 adopted amendments to the
Company’s Articles of Association that allow the Board
of Management and the Supervisory Board to issue
(rights to) preference shares to a third-party. As a result,
the Stichting Preferente Aandelen Philips (the
‘Foundation’) was created, which was granted the right
to acquire preference shares in the Company. The mere
notification that the Foundation wishes to exercise its
rights, should a third-party ever seem likely in the
judgment of the Foundation to obtain (de facto) control
of the Company, will result in the preference shares
being effectively issued. The Foundation may exercise
this right for as many preference shares as there are
ordinary shares in the Company outstanding at that
time. No preference shares have been issued as of
December 31, 2014. In addition, the Foundation has the
right to file a petition with the Enterprise Chamber of
the Amsterdam Court of Appeal to commence an
inquiry procedure within the meaning of section 2:344
Dutch Civil Code.
The object of the Foundation is to represent the
interests of the Company, the enterprises maintained
by the Company and its affiliated companies within the
Group, in such a way that the interests of Philips, those
enterprises and all parties involved with them are
safeguarded as effectively as possible, and that they
are afforded maximum protection against influences
which, in conflict with those interests, may undermine
the autonomy and identity of Philips and those
enterprises, and also to do anything related to the
above ends or conducive to them. In the event of (an
attempt at) a hostile takeover or other attempt to obtain
(de facto) control of the Company this arrangement will
allow the Company and its Board of Management and
Supervisory Board to determine its position in relation
to the third-party and its plans, seek alternatives and
defend Philips’ interests and those of its stakeholders
from a position of strength. The members of the self-
electing Board of the Foundation are Messrs P.A.F.W.
Elverding, M.W. den Boogert and F.J.G.M. Cremers. No
Philips board members or officers are represented on
the board of the Foundation.
The Company does not have any other anti-takeover
measures in the sense of other measures which
exclusively or almost exclusively have the purpose of
frustrating future public bids for the shares in the capital
of the Company in case no agreement is reached with
the Board of Management on such public bid.
Furthermore, the Company does not have measures
which specifically have the purpose of preventing a
bidder who has acquired 75% of the shares in the capital
of the Company from appointing or dismissing
members of the Board of Management and
subsequently amending the Articles of Association of
the Company. It should be noted that also in the event
100
Annual Report 2014
of (an attempt at) a hostile takeover or other attempt to
obtain (de facto) control of the Company, the Board of
Management and the Supervisory Board are authorized
to exercise in the interests of Philips all powers vested
in them.
Audit of the financial reporting and the
position of the external auditor
The annual financial statements are prepared by the
Board of Management and reviewed by the
Supervisory Board upon the advice of its Audit
Committee and taking into account the report of the
external auditor. Upon approval by the Supervisory
Board, the accounts are signed by all members of both
the Board of Management and the Supervisory Board
and are published together with the opinion of the
external auditor. The Board of Management is
responsible, under the supervision of the Supervisory
Board, for the quality and completeness of such
publicly disclosed financial reports. The annual
financial statements are presented for discussion and
adoption at the Annual General Meeting of
Shareholders, to be convened subsequently. The
Company, under US securities regulations, separately
files its Annual Report on Form 20-F, incorporating
major parts of the Annual Report as prepared under the
requirements of Dutch law.
Internal controls and disclosure policies
Comprehensive internal procedures, compliance with
which is supervised by the Supervisory Board, are in
place for the preparation and publication of the Annual
Report, the annual accounts, the quarterly figures and
ad hoc financial information. As from 2003, the internal
assurance process for business risk assessment has
been strengthened and the review frequency has been
upgraded to a quarterly review cycle, in line with best
practices in this area.
As part of these procedures, a Disclosure Committee
has been appointed by the Board of Management to
oversee the Company’s disclosure activities and to
assist the Executive Committee in fulfilling its
responsibilities in this respect. The Committee’s
purpose is to ensure that the Company implements and
maintains internal procedures for the timely collection,
evaluation and disclosure, as appropriate, of
information potentially subject to public disclosure
under the legal, regulatory and stock exchange
requirements to which the Company is subject. Such
procedures are designed to capture information that is
relevant to an assessment of the need to disclose
developments and risks that pertain to the Company’s
various businesses, and their effectiveness for this
purpose will be reviewed periodically.
Auditor information
In accordance with the procedures laid down in the
Philips Auditor Policy and as mandatorily required by
Dutch law, the external auditor of the Company is
appointed by the General Meeting of Shareholders on
the proposal of the Supervisory Board, after the latter
has been advised by the Audit Committee and the
Board of Management. Under this Auditor Policy, as
updated in 2013, the Supervisory Board and the Audit
Committee assesses the functioning of the external
auditor. The main conclusions of this assessment shall
be communicated to the General Meeting of
Shareholders for the purposes of assessing the
nomination for the appointment of the external auditor.
The current auditor of the Company, KPMG
Accountants N.V., was appointed by the 1995 General
Meeting of Shareholders. In 2002, when the Auditor
Policy was adopted, the appointment of KPMG
Accountants N.V. was confirmed by the Supervisory
Board for an additional three years. The 2008, 2011 and
2014 General Meetings of Shareholders resolved to re-
appoint KPMG Accountants N.V. as auditor, at the latest
meeting up to and including the financial year 2015.
Mr E.H.W. Weusten is the current partner of KPMG
Accountants N.V. in charge of the audit duties for
Philips. The external auditor shall attend the Annual
General Meeting of Shareholders. Questions may be
put to him at the meeting about his report. The Board
of Management and the Audit Committee of the
Supervisory Board shall report on their dealings with
the external auditor to the Supervisory Board on an
annual basis, particularly with regard to the auditor’s
independence. The Supervisory Board shall take this
into account when deciding upon its nomination for the
appointment of an external auditor. Dutch legislation
on mandatory auditor rotation will become effective
January 1, 2016, meaning the Company must engage a
new audit firm for its statutory audit starting per January
1, 2016.
The agenda of the 2015 Annual General Meeting of
Shareholders will include a proposal to appoint Ernst &
Young Accountants LLP as the Company’s new auditor
as of January 1, 2016.
The external auditor attends, in principle, all meetings
of the Audit Committee. The findings of the external
auditor, the audit approach and the risk analysis are
also discussed at these meetings. The external auditor
attends the meeting of the Supervisory Board at which
the report of the external auditor with respect to the
audit of the annual accounts is discussed, and at which
the annual accounts are approved. In its audit report on
the annual accounts to the Board of Management and
the Supervisory Board, the external auditor refers to the
financial reporting risks and issues that were identified
during the audit, internal control matters, and any other
matters, as appropriate, requiring communication
under the auditing and other standards generally
accepted in the Netherlands and the US.
Auditor policy
Dutch law requires the separation of audit and non-
audit services, meaning the Company’s external auditor
is no longer allowed to provide non-audit services, with
an exception (until 2015) for non-audit service
arrangements already in place on December 31, 2012.
Corporate governance 11.4
In light of this legislation, the Auditor Policy was
updated in 2013. The policy is published on the
Company’s website. The policy is also in line with US
Securities and Exchange Commission rules under which
the appointed external auditor must be independent of
the Company both in fact and appearance.
The Auditor Policy includes rules for the pre-approval
by the Audit Committee of all services to be provided
by the external auditor. Proposed services may be pre-
approved at the beginning of the year by the Audit
Committee (annual pre-approval) or may be pre-
approved during the year by the Audit Committee in
respect of a particular engagement (specific pre-
approval). The annual pre-approval is based on a
detailed, itemized list of services to be provided,
designed to ensure that there is no management
discretion in determining whether a service has been
approved and to ensure the Audit Committee is
informed of each services it is pre-approving. Unless
pre-approval with respect to a specific service has been
given at the beginning of the year, each proposed
service requires specific pre-approval during the year.
Any annually pre-approved services where the fee for
the engagement is expected to exceed pre-approved
cost levels or budgeted amounts will also require
specific pre-approval. The term of any annual pre-
approval is 12 months from the date of the pre-approval
unless the Audit Committee states otherwise. During
2014, there were no services provided to the Company
by the external auditor which were not pre-approved
by the Audit Committee.
11.5 Investor Relations
Introduction
The Company is continually striving to improve
relations with its shareholders. In addition to
communication with its shareholders at the Annual
General Meeting of Shareholders, Philips elaborates its
financial results during (public) conference calls, which
are broadly accessible. It publishes informative annual,
semi-annual and quarterly reports and press releases,
and informs investors via its extensive website. The
Company is strict in its compliance with applicable rules
and regulations on fair and non-selective disclosure
and equal treatment of shareholders.
Each year the Company organizes Philips Capital
Market Days and participates in several broker
conferences, announced in advance on the Company’s
website and by means of press releases. Shareholders
can follow in real time, by means of webcasting or
telephone lines, the meetings and presentations
organized by the Company. Thus the Company applies
recommendation IV.3.1 of the Dutch Corporate
Governance Code, which in its perception and in view
of market practice does not extend to less important
analyst meetings and presentations. It is Philips’ policy
to post presentations to analysts and shareholders on
the Company’s website. These meetings and
Annual Report 2014
101
Corporate governance 11.5
presentations will not take place shortly before the
publication of annual, semi-annual and quarterly
financial information.
Furthermore, the Company engages in bilateral
communications with investors. These communications
either take place at the initiative of the Company or at
the initiative of individual investors. During these
communications the Company is generally represented
by its Investor Relations department. However, on a
limited number of occasions the Investor Relations
department is accompanied by one or more members
of the Board of Management. The subject matter of the
bilateral communications ranges from single queries
from investors to more elaborate discussions on the
back of disclosures that the Company has made such
as its annual and quarterly reports. Also here, the
Company is strict in its compliance with applicable rules
and regulations on fair and non-selective disclosure
and equal treatment of shareholders.
The Company shall not, in advance, assess, comment
upon or correct, other than factually, any analyst’s
reports and valuations. No fee(s) will be paid by the
Company to parties for the carrying-out of research for
analysts’ reports or for the production or publication of
analysts’ reports, with the exception of credit-rating
agencies.
Major shareholders and other information for
shareholders
The Dutch Act on Financial Supervision imposes an
obligation on persons holding certain interests to
disclose (inter alia) percentage holdings in the capital
and/or voting rights in the Company when such
holdings reach, exceed or fall below 3, 5, 10, 15, 20, 25,
30, 40, 50, 60, 75 and 95 percent (as a result of an
acquisition or disposal by a person, or as a result of a
change in the company’s total number of voting rights
or capital issued). Certain cash settled derivatives are
also taken into account when calculating the capital
interest. The statutory obligation to disclose capital
interest does not only relate to gross long positions, but
also to gross short positions. Required disclosures must
be made to the Netherlands Authority for the Financial
Markets (AFM) without delay. The AFM then notifies
such disclosures to the Company and includes them in
a register which is published on the AFM’s website.
Furthermore, an obligation to disclose (net) short
positions is set out in the EU Regulation on Short
Selling.
On January 3, 2014 the Company received notification
from the AFM that it had received disclosure under the
Dutch Act on Financial Supervision of a substantial
holding of 3.08% by Norges Bank. On May 9, 2014 the
Company received notification from the AFM that it had
received disclosure under such Act of a substantial
holding of 3.02% by Harris Associates L.P. On February
3, 2015 the Company received notification from the
AFM that it had received disclosure under such Act of a
substantial holding of 3% by State Street Corporation.
102
Annual Report 2014
As per December 31, 2014, approximately 90% of the
common shares were held in bearer form and
approximately 10% of the common shares were
represented by registered shares of New York Registry
issued in the name of approximately 1,167 holders of
record, including Cede & Co. Cede & Co acts as nominee
for the Depository Trust Company holding the shares
(indirectly) for individual investors as beneficiaries.
Citibank, N.A., 388 Greenwich Street, New York, New
York 10013 is the transfer agent and registrar.
Only bearer shares are traded on the stock market of
Euronext Amsterdam. Only shares of New York Registry
are traded on the New York Stock Exchange. Bearer
shares and registered shares may be exchanged for
each other. Since certain shares are held by brokers and
other nominees, these numbers may not be
representative of the actual number of United States
beneficial holders or the number of Shares of New York
Registry beneficially held by US residents.
The provisions applicable to all corporate bonds that
have been issued by the Company in March 2008 and
2012 contain a ‘Change of Control Triggering Event’. This
means that if the Company experienced such an event
with respect to a series of corporate bonds the
Company might be required to offer to purchase the
bonds of that series at a purchase price equal to 101%
of their principal amount, plus accrued and unpaid
interest, if any.
Corporate seat and head office
The statutory seat of the Company is Eindhoven, the
Netherlands, and the statutory list of all subsidiaries
and affiliated companies, prepared in accordance with
the relevant legal requirements (Dutch Civil Code, Book
2, Sections 379 and 414), forms part of the notes to the
consolidated financial statements and is deposited at
the office of the Commercial Register in Eindhoven, the
Netherlands (file no. 17001910).
The executive offices of the Company are located at the
Philips Center, Amstelplein 2, 1096 BC Amsterdam, the
Netherlands, telephone 0031 (0)20 59 77 777.
Compliance with the Dutch Corporate
Governance Code
In accordance with the governmental decree of
December 10, 2009, the Company fully complies with
the Dutch Corporate Governance Code and applies all
its principles and best practice provisions that are
addressed to the Board of Management or the
Supervisory Board. The full text of the Dutch Corporate
Governance Code can be found at the website of the
Monitoring Commission Corporate Governance Code
(www.commissiecorporategovernance.nl).
February 24, 2015
Performance Statements
12 Group financial statements
12.1 Management’s report on internal control
12.2 Report of the independent auditor
12.3 Independent auditors’ report on internal control
over financial reporting
12.4 Consolidated statements of income
12.5 Consolidated statements of comprehensive
income
12.6 Consolidated balance sheets
12.7 Consolidated statements of cash flows
12.8 Consolidated statements of changes in equity
12.9 Notes
13 Company financial statements
13.1 Balance sheets before appropriation of results
13.2 Statements of income
13.3 Statement of changes in equity
13.4 Notes
13.5 Independent auditor’s report
14 Sustainability statements
14.1 Economic indicators
14.2 Social statements
14.3 Environmental statements
14.4 Independent Auditor’s Assurance Report
14.5 Global Reporting Initiative (GRI) table 4.0
105
106
106
107
108
109
110
112
114
115
176
177
178
178
179
183
187
192
192
207
213
214
Annual Report 2014
103
Notes overview
Group financial statements
Company financial statements
A Net income
B Audit fees
C
Intangible assets
D Financial fixed assets
E Other financial assets
F Receivables
G Shareholders’ equity
H Debt
I Other current liabilities
J Employees
K Contractual obligations and contingent
liabilities not appearing in the balance sheet
L Subsequent events
179
179
179
179
180
180
180
182
182
182
182
182
General, sector and main countries information
1 Significant accounting policies
2
Information by sector and main country
3 Discontinued operations and other assets
classified as held for sale
4 Acquisitions and divestments
5
Interests in entities
Notes related to the income statement
Income from operations
6
7 Financial income and expenses
8
Income taxes
9 Earnings per share
Notes related to the balance sheet
10 Property, plant and equipment
11 Goodwill
12
Intangible assets excluding goodwill
15
13 Other financial assets
14 Other assets
Inventories
16 Receivables
17 Equity
18 Debt
19 Provisions
20 Post-employment benefits
21 Accrued liabilities
22 Other liabilities
Notes related to the cash flow statement
23 Cash used for derivatives and current financial
assets
24 Purchase and proceeds from non-current
financial assets
Other notes
25 Contractual obligations
26 Contingent assets and liabilities
27 Related-party transactions
28 Share-based compensation
29 Information on remuneration
30 Fair value of financial assets and liabilities
31 Details of treasury / other financial risks
32 Subsequent events
115
126
129
130
131
132
134
135
139
140
141
143
144
145
145
145
146
149
149
152
157
158
158
158
158
159
162
162
165
168
171
175
104
Annual Report 2014
12 Group financial statements
Group financial statements 12
Introduction
This section of the Annual Report contains the audited
consolidated financial statements including the notes
thereon that have been prepared in accordance with
International Financial Reporting Standards (IFRS) as
endorsed by the European Union (EU) and with the
statutory provisions of Part 9, Book 2 of the Dutch Civil
Code. All standards and interpretations issued by the
International Accounting Standards Board (IASB) and
the IFRS Interpretations Committee effective year-end
2014 have been endorsed by the EU, except that the EU
did not adopt some paragraphs of IAS 39 applicable to
certain hedge transactions. Philips has no hedge
transactions to which these paragraphs are applicable.
Consequently, the accounting policies applied by
Philips also comply fully with IFRS as issued by the
IASB.
Together with the section Company financial
statements, this section contains the statutory financial
statements of the Company.
The following sections and chapters:
▪ chapter 4, Our strategic focus, of this Annual Report
▪ chapter 5, Group performance, of this Annual Report
▪ chapter 6, Sector performance, of this Annual Report
▪ chapter 7, Risk management, of this Annual Report
▪ chapter 10, Supervisory Board report, of this Annual
Report
▪ section 10.1, Report of the Corporate Governance and
Nomination & Selection Committee, of this Annual
Report
▪ section 10.2, Report of the Remuneration
Committee, of this Annual Report
▪ chapter 11, Corporate governance, of this Annual
Report
which allows a simplified Statement of income in the
Company financial statements in the event that a
comprehensive Statement of income is included in the
consolidated Group financial statements.
For ‘Additional information’ within the meaning of
section 2:392 of the Dutch Civil Code, please refer to
section 13.5, Independent auditor’s report, of this
Annual Report on the financial statements, section 5.4,
Proposed distribution to shareholders, of this Annual
Report, and note 32, Subsequent events.
Please refer to chapter 19, Forward-looking statements
and other information, of this Annual Report for more
information about forward-looking statements, third-
party market share data, fair value information, and
revisions and reclassifications.
The Board of Management of the Company hereby
declares that, to the best of our knowledge, the Group
financial statements and Company financial statements
give a true and fair view of the assets, liabilities, financial
position and profit or loss of the Company and the
undertakings included in the consolidation taken as a
whole and that the management report referred to
above gives a true and fair view concerning the position
as per the balance sheet date, the development and
performance of the business during the financial year
of the Company and the undertakings included in the
consolidation taken as a whole, together with a
description of the principal risks that they face.
Board of Management
Frans van Houten
Ron Wirahadiraksa
Pieter Nota
▪ chapter 19, Forward-looking statements and other
February 24, 2015
information, of this Annual Report
form the Management report within the meaning of
section 2:391 of the Dutch Civil Code (and related
Decrees).
The sections Group performance and Sector
performance provide an extensive analysis of the
developments during the financial year 2014 and the
results. The term EBIT has the same meaning as Income
from operations (IFO), and is used to evaluate the
performance of the business. These sections also
provide information on the business outlook,
investments, financing, personnel and research and
development activities.
The Statement of income included in the section
Company financial statements has been prepared in
accordance with section 2:402 of the Dutch Civil Code,
Annual Report 2014
105
The effectiveness of the Company’s internal control
over financial reporting as of December 31, 2014, as
included in this section Group financial statements, has
been audited by KPMG Accountants N.V., an
independent registered public accounting firm, as
stated in their report which follows hereafter.
Board of Management
Frans van Houten
Ron Wirahadiraksa
Pieter Nota
February 24, 2015
12.1.1 Changes in internal control over financial
reporting
During the year ended December 31, 2014, there have
been no changes in our internal control over financial
reporting that have materially affected, or are
reasonably likely to materially affect, our internal
control over financial reporting.
12.2 Report of the independent auditor
Management’s report on internal control over financial
reporting is set out in section 12.1, Management’s report
on internal control, of this Annual Report. The report set
out in section section 12.3, Independent auditors’ report
on internal control over financial reporting, of this
Annual Report, is provided in compliance with auditing
standards of the Public Company Accounting Oversight
Board in the US and includes an opinion on the
effectiveness of internal control over financial reporting
as at December 31, 2014.
KPMG Accountants N.V. has also issued a report on the
consolidated financial statements and the company
financial statements, in accordance with Dutch law,
including the Dutch standards on auditing, of
Koninklijke Philips N.V., which is set out in section 13.5,
Independent auditor’s report, of this Annual Report.
KPMG Accountants N.V. has also issued a report on the
consolidated financial statements in accordance with
the standards of the Public Company Accounting
Oversight Board in the US, which will be included in the
Annual Report on Form 20-F expected to be filed with
the US Securities and Exchange Commission on
February 24, 2015.
Group financial statements 12.1
12.1 Management’s report on internal
control
Management’s report on internal control over
financial reporting pursuant to section 404 of
the US Sarbanes-Oxley Act
The Board of Management of Koninklijke Philips N.V.
(the Company) is responsible for establishing and
maintaining an adequate system of internal control
over financial reporting (as such term is defined in Rule
13a-15(f) under the US Securities Exchange Act).
Internal control over financial reporting is a process to
provide reasonable assurance regarding the reliability
of our financial reporting for external purposes in
accordance with IFRS as issued by the IASB.
Internal control over financial reporting includes
maintaining records that, in reasonable detail,
accurately and fairly reflect our transactions; providing
reasonable assurance that transactions are recorded as
necessary for preparation of our financial statements;
providing reasonable assurance that receipts and
expenditures of company assets are made in
accordance with management authorization; and
providing reasonable assurance that unauthorized
acquisition, use or disposition of company assets that
could have a material effect on our financial statements
would be prevented or detected on a timely basis.
Because of its inherent limitations, internal control over
financial reporting is not intended to provide absolute
assurance that a misstatement of our financial
statements would be prevented or detected. Also,
projections of any evaluation of the effectiveness of
internal control over financial reporting to future
periods are subject to the risk that the controls may
become inadequate because of changes in conditions,
or that the degree of compliance with the policies or
procedures may deteriorate.
The Board of Management conducted an assessment
of the Company’s internal control over financial
reporting based on the “Internal Control- Integrated
Framework (2013)” established by the Committee of
Sponsoring Organizations of the Treadway Commission
(COSO). Based on that assessment, the Board of
Management concluded that, as of December 31, 2014,
the Company’s internal control over Group financial
reporting is considered effective.
The Board of Management’s assessment of the
effectiveness of the Company’s internal control over
financial reporting as of December 31, 2014, excluded
the following company acquired by the Company on
September 2, 2014: Philips Lighting Saudi Arabia (PLSA)
formerly known as General Lighting Company (GLC),
domiciled in The Kingdom of Saudi Arabia. The
Company owns 51% of the shares in PLSA. The total
assets of this acquisition represented 1,5% of
consolidated total assets as of December 31, 2014, the
sales of this acquisition represented less than 1% of
consolidated sales of the Company for the year ended
December 31, 2014.
106
Annual Report 2014
12.3 Independent auditors’ report on
internal control over financial
reporting
Report of Independent Registered Public
Accounting Firm
To: The Supervisory Board and Shareholders of
Koninklijke Philips N.V.
We have audited Koninklijke Philips N.V.’s internal
control over financial reporting as of December 31, 2014,
based on criteria established in Internal Control —
Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway
Commission (COSO). Koninklijke Philips N.V.’s
management is responsible for maintaining effective
internal control over financial reporting and for its
assessment of the effectiveness of internal control over
financial reporting, included in the accompanying
section 12.1, “Management’s report on internal control”,
of this Annual Report. Our responsibility is to express
an opinion on the Company’s internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the
standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we
plan and perform the audit to obtain reasonable
assurance about whether effective internal control over
financial reporting was maintained in all material
respects. Our audit included obtaining an
understanding of internal control over financial
reporting, assessing the risk that a material weakness
exists, and testing and evaluating the design and
operating effectiveness of internal control based on the
assessed risk. Our audit also included performing such
other procedures as we considered necessary in the
circumstances. We believe that our audit provides a
reasonable basis for our opinion.
A company’s internal control over financial reporting is
a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles. A company’s internal control
over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of
the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit
preparation of financial statements in accordance with
generally accepted accounting principles, and that
receipts and expenditures of the company are being
made only in accordance with authorizations of
management and directors of the company; and (3)
provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a
material effect on the financial statements.
Group financial statements 12.2
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk
that controls may become inadequate because of
changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
Koninklijke Philips N.V. acquired Philips Lighting Saudi
Arabia (PLSA), formerly known as General Lighting
Company (GLC) during 2014 and management
excluded from its assessment of the effectiveness of
Koninklijke Philips N.V.’s internal control over financial
reporting as of December 31, 2014, PLSA’s internal
control over financial reporting associated with total
assets of approximately 1.5% of consolidated total
assets and sales of less than 1.0% of consolidated sales
included in the consolidated financial statements of
Koninklijke Philips N.V. and subsidiaries as of and for the
year ended December 31, 2014. Our audit of internal
control over financial reporting of Koninklijke Philips
N.V. also excluded an evaluation of the internal control
over financial reporting of PLSA.
In our opinion, Koninklijke Philips N.V. maintained, in all
material respects, effective internal control over
financial reporting as of December 31, 2014, based on
criteria established in Internal Control — Integrated
Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission
(COSO).
We also have audited, in accordance with the standards
of the Public Company Accounting Oversight Board
(United States), the consolidated balance sheets of
Koninklijke Philips N.V. and subsidiaries as of December
31, 2014 and 2013, and the related consolidated
statements of income, comprehensive income, cash
flows, and changes in equity for each of the years in the
three-year period ended December 31, 2014, and our
report dated February 24, 2015, expressed an
unqualified opinion on those consolidated financial
statements.
Amsterdam, The Netherlands
February 24, 2015
KPMG Accountants N.V.
Annual Report 2014
107
Group financial statements 12.3
12.4 Consolidated statements of income
Philips Group
Consolidated statements of income in millions of EUR unless otherwise stated
For the years ended December 31
Sales
Cost of sales
Gross margin
Selling expenses
Research and development expenses
General and administrative expenses
Impairment of goodwill
Other business income
Other business expenses
Income from operations
Financial income
Financial expenses
Income before taxes
Income tax expense
Income after taxes
Results relating to investments in associates:
Company’s participation in income
Other results
6
7
7
8
5
Income (loss) from continuing operations
3 Discontinued operations - net of income tax
Net income (loss)
Attribution of net income (loss)
Net income (loss) attributable to Koninklijke Philips N.V. shareholders
Net income (loss) attributable to non-controlling interests
Philips Group
Earnings per common share attributable to shareholders1) in EUR unless otherwise stated
For the years ended December 31
Basic earnings per common share in EUR
Income (loss) from continuing operations attributable to shareholders
Net income (loss) attributable to shareholders
Diluted earnings per common share in EUR2)
Income (loss) from continuing operations attributable to shareholders
Net income (loss) attributable to shareholders
9
9
9
9
2012
22,234
(13,505)
8,729
(5,240)
(1,724)
(847)
–
272
(598)
592
106
(435)
263
(218)
45
(5)
(206)
(166)
136
(30)
(35)
5
2012
(0.19)
(0.04)
(0.19)
(0.04)
2013
21,990
(12,653)
9,337
(5,057)
(1,659)
(825)
(28)
122
(35)
1,855
70
(400)
1,525
(466)
1,059
5
(30)
1,034
138
1,172
1,169
3
2013
1.13
1.28
1.12
1.27
2014
21,391
(13,185)
8,206
(5,124)
(1,635)
(747)
(3)
63
(274)
486
114
(415)
185
(26)
159
30
32
221
190
411
415
(4)
2014
0.25
0.45
0.24
0.45
Prior-period financial statements have been restated for the treatment of the combined businesses of Lumileds and Automotive as discontinued operations (see
note 3, Discontinued operations and other assets classified as held for sale) and for two voluntary accounting policy changes (see note 1, Significant accounting
policies). The accompanying notes are an integral part of these consolidated financial statements.
1) Shareholders in this table refer to shareholders of Koninklijke Philips N.V.
2) The Dilutive potential common shares are not taken into account in the periods for which there is a loss, as the effect would be antidilutive
108
Annual Report 2014
12.5 Consolidated statements of comprehensive income
Philips Group
Consolidated statements of comprehensive income in millions of EUR unless otherwise stated
For the years ended December 31
Net income (loss) for the period
Pensions and other post-employment plans:
Remeasurements
Income tax effect on remeasurements
Revaluation reserve:
Release revaluation reserve
Reclassification directly into retained earnings
Total of items that will not be reclassified to profit or loss
Currency translation differences:
Net current period change, before tax
Income tax effect
Reclassification adjustment for gain realized
Available-for-sale financial assets:
Net current period change, before tax
Income tax effect
Reclassification adjustment for loss (gain) realized
Cash flow hedges:
Net current period change, before tax
Income tax effect
Reclassification adjustment for loss (gain) realized
Total of items that are or may be reclassified to profit or loss
Other comprehensive (loss) income for period
Total comprehensive income (loss) for the period
Total comprehensive income (loss) attributable to:
Shareholders of Koninklijke Philips N.V.
Non-controlling interests
The accompanying notes are an integral part of these consolidated financial statements.
Group financial statements 12.5
2012
(30)
(206)
60
(16)
16
(146)
(99)
–
(1)
8
(2)
3
23
(8)
14
(62)
(208)
(238)
(243)
5
2013
1,172
139
(77)
(31)
31
62
(427)
(35)
(14)
(5)
–
6
68
(2)
(62)
(471)
(409)
763
760
3
2014
411
(972)
289
(10)
10
(683)
600
203
(5)
30
(4)
(54)
(40)
10
(7)
733
50
461
465
(4)
Annual Report 2014
109
Group financial statements 12.6
12.6 Consolidated balance sheets
Philips Group
Consolidated balance sheets in millions of EUR unless stated otherwise
As of December 31
Non-current assets
2 10 25 Property, plant and equipment:
- At cost
- Less accumulated depreciation
2 11 Goodwill
2 12
Intangible assets excluding goodwill:
- At cost
- Less accumulated amortization
16 Non-current receivables
5
Investments in associates
13 Other non-current financial assets
8 Deferred tax assets
14 Other non-current assets
Total non-current assets
Current assets
15
Inventories
13 Current financial assets
14 Other current assets
30 Derivative financial assets
8
Income tax receivable
16 27 Receivables:
- Accounts receivable
- Accounts receivable from related parties
- Other current receivables
3
Assets classified as held for sale
31 Cash and cash equivalents
Total current assets
Total assets
2013
2014
7,692
(4,912)
7,638
(4,376)
4,420
39
219
2,780
6,504
3,262
144
161
496
1,675
63
15,085
3,240
10
354
150
70
4,678
507
2,465
11,474
26,559
6,844
(4,749)
8,020
(4,652)
4,476
14
233
2,095
7,158
3,368
177
157
462
2,460
69
15,946
3,314
125
411
207
140
4,723
1,613
1,873
12,406
28,352
110
Annual Report 2014
Equity
17
Shareholders’ equity:
Preference shares, par value EUR 0.20 per share:
- Authorized: 2,000,000,000 shares (2013: 2,000,000,000 shares),
issued none
Common shares, par value EUR 0.20 per share:
- Authorized: 2,000,000,000 shares (2013: 2,000,000,000 shares)
- Issued and fully paid: 934,819,413 shares (2013: 937,845,789 shares)
Capital in excess of par value
Retained earnings
Revaluation reserve
Currency translation differences
Available-for-sale financial assets
Cash flow hedges
Treasury shares, at cost 20,430,544 shares (2013: 24,508,022 shares)
17 Non-controlling interests
Group equity
Non-current liabilities
18 25
Long-term debt
19 20 Long-term provisions
8 Deferred tax liabilities
22 Other non-current liabilities
Total non-current liabilities
Current liabilities
18 25
Short-term debt
30 Derivative financial liabilities
8
Income tax payable
25 27 Accounts and notes payable:
- Trade creditors
- Accounts payable to related parties
21 Accrued liabilities
19 20 Short-term provisions
3
Liabilities directly associated with assets held for sale
22 Other current liabilities
Total current liabilities
Total liabilities and group equity
The accompanying notes are an integral part of these consolidated financial statements.
Group financial statements 12.6
2013
2014
188
1,796
10,415
23
(569)
55
24
(718)
2,458
4
11,214
13
11,227
3,309
1,903
76
1,568
6,856
592
368
143
2,462
2,830
651
348
1,082
8,476
26,559
187
2,181
8,790
13
229
27
(13)
(547)
2,495
4
10,867
101
10,968
3,712
2,500
107
1,838
8,157
392
857
102
2,499
2,692
945
349
1,391
9,227
28,352
Annual Report 2014
111
Group financial statements 12.7
12.7 Consolidated statements of cash flows
Philips Group
Consolidated statements of cash flows in millions of EUR unless otherwise stated
For the years ended December 31
Cash flows from operating activities
Net income (loss)
Result of discontinued operations - net of income tax
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization, and impairments of fixed assets
Impairment of goodwill and other non-current financial assets
Net gain on sale of assets
Interest income
Interest expense on debt, borrowings and other liabilities
Income taxes expense
Results from investments in associates
(Increase) decrease in working capital
Increase in receivables and other current assets
(Increase) decrease in inventories
(Decrease) increase in accounts payable, accrued and other current liabilities
Increase in non-current receivables, other assets and other liabilities
(Decrease) increase in provisions
Other items
Interest paid
Interest received
Dividends received from investments in associates
Dividends paid to non-controlling interests
Income taxes paid
Net cash provided by operating activities
Cash flows from investing activities
Net capital expenditures
Purchase of intangible assets
Proceeds from sale of intangible assets
Expenditures on development assets
Capital expenditures on property, plant and equipment
Proceeds from sales of property, plant and equipment
23 Cash used for derivatives and current financial assets
24 Purchase of other non-current financial assets
24 Proceeds from other non-current financial assets
Purchase of businesses, net of cash acquired
Proceeds from sale of interests in businesses, net of cash disposed of
Net cash used for investing activities
Cash flows from financing activities
Proceeds from issuance (payments) of short-term debt
Principal payments of long-term debt
Proceeds from issuance of long-term debt
Treasury shares transactions
Dividends paid
Net cash used for financing activities
Net cash (used for) provided by continuing operations
112
Annual Report 2014
2012
2013
2014
(30)
(136)
1,242
14
(141)
(37)
283
218
5
586
(109)
18
677
(140)
417
171
(270)
34
15
(4)
(341)
1,886
(241)
(33)
160
(311)
(479)
422
(45)
(167)
3
(261)
(1)
(712)
133
(631)
1,228
(768)
(255)
(293)
881
1,172
(138)
1,177
38
(54)
(54)
258
466
25
(1,272)
(500)
(165)
(607)
(159)
(194)
299
(267)
52
6
(7)
(436)
912
(830)
(49)
–
(326)
(482)
27
(101)
(13)
14
(11)
79
411
(190)
1,187
21
(83)
(39)
231
26
(62)
590
(48)
(77)
715
(690)
640
(242)
(232)
38
41
–
(344)
1,303
(806)
(114)
–
(295)
(437)
40
(7)
(81)
107
(177)
(20)
(862)
(984)
(285)
(186)
64
(562)
(272)
(1,241)
(1,191)
(37)
(333)
69
(596)
(292)
(1,189)
(870)
Cash flows from discontinued operations
Net cash (used for) provided by operating activities
Net cash (used for) provided by investing activities
Net cash (used for) provided by discontinued operations
Net cash (used for) provided by continuing and discontinued operations
Effect of changes in exchange rates on cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Group financial statements 12.7
2012
2013
(183)
40
(143)
738
(51)
3,147
3,834
(68)
(47)
(115)
(1,306)
(63)
3,834
2,465
2014
105
88
193
(677)
85
2,465
1,873
Prior-period financial statements have been restated for the treatment of the combined businesses of Lumileds and Automotive as discontinued operations (see
note 3, Discontinued operations and other assets classified as held for sale) and for two voluntary accounting policy changes (see note 1, Significant accounting
policies). The accompanying notes are an integral part of these consolidated financial statements.
For a number of reasons, principally the effects of translation differences and consolidation changes, certain items in the statements of cash flows do not
correspond to the differences between the balance sheet amounts for the respective items.
Annual Report 2014
113
Group financial statements 12.8
12.8 Consolidated statements of changes in equity
Philips Group
Consolidated statements of changes in equity in millions of EUR unless otherwise stated
For the year ended December 31
ca pital in excess of p ar valu e
retain e d e arnin gs
availa ble-for-sale fin a ncial assets
curre ncy tra nslatio n differe nces
revalu atio n reserve
cash flo w h e d g es
tre asury sh ares at cost
total sh are h old ers’ e q uity
n o n-co ntrollin g interests
Gro u p e q uity
m o n sh ares
co m
45
9
54
1
(9)
(1,690)
12,328
34
12,362
29
–
1,238
5
(5)
(243)
(259)
–
–
(769)
(816)
118
50
84
7
(238)
(259)
(5)
–
(816)
50
84
7
20
(1,103)
11,151
34
11,185
4
–
787
760
(272)
–
–
(631)
(669)
229
118
105
21
3
763
(272)
(24)
(24)
–
(669)
118
105
21
Dividend distributed
6
422
Dividend distributed
4
402
202
813
12,890
70
7
(16)
(100)
(165)
(687)
–
(1,221)
(47)
(17)
–
–
(22)
(46)
84
7
–
–
191
1,304
10,724
54
(93)
(31)
(476)
1,262
(678)
–
(780)
(38)
(75)
(7)
(36)
105
21
(4)
Balance as of Jan. 1,
2012
Total comprehensive
income (loss)
Movement in non-
controlling interests
Cancellation of
treasury shares
Purchase of treasury
shares
Re-issuance of
treasury shares
Share-based
compensation plans
Income tax share-
based compensation
plans
Balance as of Dec. 31,
2012
Total comprehensive
income (loss)
Movement in non-
controlling interests
Cancellation of
treasury shares
Purchase of treasury
shares
Re-issuance of
treasury shares
Share-based
compensation plans
Income tax share-
based compensation
plans
Balance as of Dec. 31,
2013
Total comprehensive
income (loss)
Movement in non-
controlling interests
Cancellation of
treasury shares
Purchase of treasury
shares
Re-issuance of
treasury shares
Share-based
compensation plans
Income tax share-
based compensation
plans
Balance as of Dec. 31,
2014
Dividend distributed
3
433
188
1,796
10,415
23
(569)
55
24
(718)
11,214
13
11,227
(258)
(729)
–
(529)
(26)
(10)
798
(28)
(37)
–
533
(4)
92
465
(293)
–
–
(688)
(714)
(127)
(83)
326
88
(9)
116
88
(9)
461
(293)
92
–
(714)
116
88
(9)
187
2,181
8,790
13
229
27
(13)
(547)
10,867
101
10,968
The accompanying notes are an integral part of these consolidated financial statements.
114
Annual Report 2014
12.9 Notes
Separation - HealthTech and Lighting Solutions
In September 2014 Philips announced its plan to
sharpen its strategic focus by establishing two stand-
alone companies focused on the HealthTech and
Lighting Solutions opportunities.
To achieve this transformation, from January 1, 2015,
Philips started to integrate the sectors Consumer
Lifestyle and Healthcare into one operating company
focused on our HealthTech businesses. At the same
time Philips is taking the next step in the
implementation of its new operating model which will
give the company a dedicated, focused and lean
management structure, as a result of the planned
integration of the relevant sector and group layers.
The establishment of the two stand-alone companies
will also involve the split and allocation of the current
Innovation, Group & Services sector to each company
in 2015. This means that in the course of 2015 the IG&S
sector as currently described in these financial
statements will disappear and no longer be presented
as a separate segment for reporting purposes.
Philips also started the process to carve out its Lighting
business into a separate legal structure and will
consider various options for ownership structures with
direct access to capital markets. The proposed
separation of the Lighting business impacts all
businesses and markets as well as all supporting
functions and all assets and liabilities of the Group and
may require complex and time consuming
disentanglement efforts.
Prior-period restatements
Prior-period financial statements have been restated
for the treatment of the combined businesses of
Lumileds and Automotive as discontinued operations
(see note 3, Discontinued operations and other assets
classified as held for sale) and for two voluntary
accounting policy changes (see note 1, Significant
accounting policies). Movement schedules of balance
sheet items include items from continuing and
discontinued operations and therefore cannot be
reconciled to income from continuing operations and
cash flow from continuing operations only.
Notes to the Consolidated financial statements
of the Philips Group
1 Significant accounting policies
The Consolidated financial statements in the Group
financial statements section have been prepared in
accordance with International Financial Reporting
Standards (IFRS) as endorsed by the European Union
(EU) and with the statutory provisions of Part 9, Book 2
of the Dutch Civil Code. All standards and
interpretations issued by the International Accounting
Standards Board (IASB) and the IFRS Interpretations
1
Group financial statements 12.9
Committee effective year-end 2014 have been
endorsed by the EU, except that the EU did not adopt
some of the paragraphs of IAS 39 applicable to certain
hedge transactions. Koninklijke Philips N.V. (hereafter:
the ‘Company’ or ‘Philips’) has no hedge transactions to
which these paragraphs are applicable. Consequently,
the accounting policies applied by Philips also comply
with IFRS as issued by the IASB. These accounting
policies have been applied by group entities.
The Consolidated financial statements have been
prepared under the historical cost convention, unless
otherwise indicated. The Consolidated financial
statements are presented in euros, which is the
Company’s presentation currency.
On February 24, 2015, the Board of Management authorized
the Consolidated financial statements for issue. The
Consolidated financial statements as presented in this report
are subject to adoption by the Annual General Meeting of
Shareholders, to be held on May 7, 2015.
Use of estimates
The preparation of the Consolidated financial statements in
conformity with IFRS requires management to make
judgments, estimates and assumptions that affect the
application of accounting policies and the reported amounts
of assets, liabilities, income and expenses. These estimates
inherently contain a degree of uncertainty. Actual results may
differ from these estimates under different assumptions or
conditions.
These estimates and assumptions affect the reported
amounts of assets and liabilities, the disclosure of contingent
liabilities at the date of the Consolidated financial
statements, and the reported amounts of revenues and
expenses during the reporting period. We evaluate these
estimates and judgments on an ongoing basis and base our
estimates on historical experience, current and expected
future outcomes, third-party evaluations and various other
assumptions that we believe are reasonable under the
circumstances. The results of these estimates form the basis
for making judgments about the carrying values of assets and
liabilities as well as identifying and assessing the accounting
treatment with respect to commitments and contingencies.
We revise material estimates if changes occur in the
circumstances or there is new information or experience on
which an estimate was or can be based.
The areas where the most significant judgments and
estimates are made are goodwill and other intangibles
acquired, deferred tax asset recoverability, impairments,
financial instruments, the accounting for an arrangement
containing a lease, revenue recognition (multiple element
arrangements), assets and liabilities from employee
benefit plans, other provisions, uncertain tax positions and
other contingencies, classification of assets and liabilities
held for sale and the presentation of items of profit and
loss and cash flows as continued or discontinued, as well
as when determining the fair values of acquired
identifiable intangible assets based on an assessment of
future cash flows.
Annual Report 2014
115
Group financial statements 12.9
Further judgment is applied when analyzing impairments
of goodwill and intangible assets not yet ready for use that
are performed annually and whenever a triggering event
has occurred to determine whether the carrying value
exceeds the recoverable amount. These analyses
generally are based on estimates of future cash flows.
Furthermore, the Company applies judgment when
actuarial assumptions are established to anticipate future
events and are used in calculating post-employment
benefit expenses and liabilities. These factors include
assumptions with respect to interest rates, rates of
increase in health care costs, rates of future compensation
increases, turnover rates and life expectancy.
Changes in accounting policies
The accounting policies set out in this section have been
applied consistently for all periods presented in these
Consolidated financial statements, except for certain
voluntary accounting policy changes as explained below and
changes in accounting policies as a result of New Standards
and Interpretations (see next section).
Prior-period financial statements have been
reclassified for two accounting policy changes applied
as of January 1, 2014:
• A reclassification of cost by function in the income
statement. Company-wide overhead and indirect
Business function costs will be brought more in line
with the actual activities performed in the markets.
This change has no net effect on Income from
operations.
Philips Group
Reclassification of cost by function1) in millions of EUR
2012 - 2013
Cost of sales
Selling expenses
Research and development
expenses
General and administrative
expenses
Income from operations
2012
87
(53)
(4)
(30)
−
2013
73
(123)
(44)
94
−
1) Excludes the reclassification made for the combined businesses of
Lumileds and Automotive.
• A change in the presentation in the Statements of
cash flows. Up and until 2013 the cash flows related
to interest, tax and pensions were presented in a
table separate from the primary Statements of cash
flows. The presentation change results in the
separate presentation of the interest and tax cash
flows in cash flow from operating activities. The
pension cash flows are separately presented as part
of the pension disclosures. The presentation change
has no impact on the net cash flows from operating
activities nor the total net cash balance as these cash
flows previously used to be part of other aggregated
sub lines of the Statements of cash flows.
116
Annual Report 2014
Prior-year information
The presentation of certain prior-year disclosures have
been adjusted to align with the current year disclosures.
New Standards and Interpretations
IFRS accounting standards adopted as from 2014
The Company has adopted the following new and
amended Standards and Interpretations as of January
1, 2014:
IFRIC 21 Levies
IFRIC 21 provides guidance on the accounting for
certain outflows imposed on entities by governments in
accordance with laws and/or regulations (levies). The
Interpretation identifies the obligating event for the
recognition of a liability as the activity that triggers the
payment of the levy in accordance with the relevant
legislation. This Interpretation does not have a material
impact on the financial statements. The Company
early-adopted IFRIC 21, as endorsed by the EU, to align
with the IASB effective date of January 1, 2014.
Changes to other standards, following from
Amendments and the Annual Improvement Cycles, do
not have a material impact on the Company’s financial
statements. In case of the absence of explicit transition
requirements for new accounting pronouncements, the
Company accounts for any change in accounting
policies retrospectively.
IFRS accounting standards adopted as from 2015
and onwards
A number of new standards and amendments to
existing standards have been published and are
mandatory for the Company beginning on or after
January 1, 2015 or later periods, and the Company has
not adopted them. Those which may be the most
relevant to the Company are set out below. Changes to
other standards, following from Amendments and the
Annual Improvement Cycles, do not have a material
impact on the Company’s financial statements.
IFRS 9 Financial Instruments
IFRS 9 Financial Instruments brings together the
classification and measurement, impairment and hedge
accounting phases of the IASB’s project to replace IAS
39 Financial Instruments: Recognition and
Measurement. IFRS 9 adds a new expected loss
impairment model and limited amendments to
classification and measurement for financial assets. The
impairment model is based on the concept of providing
for expected losses at inception of a contract, except in
the case of purchased or originated credit-impaired
financial assets, where expected credit losses are
incorporated into the effective interest rate. The
Standard supersedes all previous versions of IFRS 9
and is effective for periods beginning on or after
January 1, 2018. The Company is currently assessing the
impact of the new Standard.
IFRS 15 Revenue from Contracts with Customers
IFRS 15 specifies how and when revenue is recognized
as well as describes more informative and relevant
disclosures. The Standard supersedes IAS 18 Revenue,
IAS 11 Construction Contracts and a number of revenue-
related interpretations.
The new Standard provides a single, principles based
five-step model to be applied to all contracts with
customers. Furthermore, it provides new guidance on
whether revenue should be recognized at a point in
time or over time. The standard also introduces new
guidance on costs of fulfilling and obtaining a contract,
specifying the circumstances in which such costs
should be capitalized. Costs that do not meet the
criteria must be expensed when incurred.
IFRS 15 must be applied for periods beginning on or
after January 1, 2017. The Company is currently
assessing the impact of the new Standard.
Specific choices within IFRS
Sometimes IFRS allows alternative accounting
treatments for measurement and/or disclosure. The
most important of these alternative treatments are
mentioned below.
Tangible and intangible fixed assets
Under IFRS, an entity shall choose either the cost model
or the revaluation model as its accounting for tangible
and intangible fixed assets. In this respect, items of
property, plant and equipment are measured at cost
less accumulated depreciation and accumulated
impairment losses. The useful lives and residual values
are evaluated annually. Furthermore, the Company
chose to apply the cost model meaning that costs
relating to product development, the development and
purchase of software for both internal use and software
intended to be sold and other intangible assets are
capitalized and subsequently amortized over the
estimated useful life.
Employee benefit accounting
IFRS does not specify how an entity should present its
service costs related to pensions and net interest on the
net defined benefit liability (asset) in the Statement of
income. With regards to these elements, the Company
presents service costs in Income from operations and
the net interest expenses related to defined benefit
plans in Financial expense.
Cash flow statements
Under IFRS, an entity shall report cash flows from
operating activities using either the direct method
(whereby major classes of gross cash receipts and gross
cash payments are disclosed) or the indirect method
(whereby profit or loss is adjusted for the effects of
transactions of a non-cash nature, any deferrals or
accruals of past or future operating cash receipts or
payments, and items of income or expense associated
Group financial statements 12.9
with investing or financing cash flows). In this respect,
the Company chose to prepare the cash flow
statements using the indirect method.
Furthermore, interest cash flows are presented in cash flows
from operating activities rather than financing or investing
cash flows, because they enter into the determination of
profit or loss. The Company choose to present dividends paid
to shareholders of Koninklijke Philips N.V. as a component
of cash flows from financing activities, rather than to present
such dividends as operating cash flows which is an allowed
alternative under IFRS.
Policies that are more critical in nature
Revenue recognition
Revenue from the sale of goods in the course of the
ordinary activities is measured at the fair value of the
consideration received or receivable, net of returns,
trade discounts and volume rebates. Revenue for sale
of goods is recognized when the significant risks and
rewards of ownership have been transferred to the
buyer, recovery of the consideration is probable, the
associated costs and possible return of the goods can
be estimated reliably, there is no continuing
involvement with goods, and the amount of revenue
can be measured reliably. If it is probable that discounts
will be granted and the amount can be measured
reliably, then the discount is recognized as a reduction
of revenue as the sales are recognized.
Transfer of risks and rewards varies depending on the
individual terms of the contract of sale. For consumer-type
products in the sectors Lighting and Consumer Lifestyle
these criteria are met at the time the product is shipped
and delivered to the customer and title and risk have
passed to the customer (depending on the delivery
conditions) and acceptance of the product has been
obtained. Examples of delivery conditions are ‘Free on
Board point of delivery’ and ‘Costs, Insurance Paid point
of delivery’, where the point of delivery may be the
shipping warehouse or any other point of destination as
agreed in the contract with the customer and where title
and risk for the goods pass to the customer.
Revenues of transactions that have separately
identifiable components are recognized based on their
relative fair values. These transactions mainly occur in
the Healthcare sector and include arrangements that
require subsequent installation and training activities in
order to become operable for the customer. However,
since payment for the equipment is contingent upon
the completion of the installation process, revenue
recognition is generally deferred until the installation
has been completed and the product is ready to be
used by the customer in the way contractually agreed.
Revenues are recorded net of sales taxes, customer
discounts, rebates and similar charges. For products for
which a right of return exists during a defined period,
revenue recognition is determined based on the
historical pattern of actual returns, or in cases where
Annual Report 2014
117
Group financial statements 12.9
such information is not available, revenue recognition
is postponed until the return period has lapsed. Return
policies are typically based on customary return
arrangements in local markets.
In case of loss under a sales agreement, the loss is
recognized immediately.
Shipping and handling billed to customers is
recognized as revenues. Expenses incurred for shipping
and handling of internal movements of goods are
recorded as cost of sales. Shipping and handling related
to sales to third parties are recorded as selling
expenses. When shipping and handling is part of a
project and billed to the customer, then the related
expenses are recorded as cost or sales. Service revenue
related to repair and maintenance activities for goods
sold is recognized ratably over the service period or as
services are rendered.
A provision for product warranty is made at the time of
revenue recognition and reflects the estimated costs of
replacement and free-of-charge services that will be
incurred by the Company with respect to the products.
For certain products, the customer has the option to
purchase an extension of the warranty, which is
subsequently billed to the customer. Revenue
recognition occurs on a straight-line basis over the
contract period.
Revenue from services is recognized when the
Company can reliably measure the amount of revenue
and the associated cost related to the stage of
completion of a contract or transaction, and the
recovery of the consideration is considered probable.
Royalty income, which is generally earned based upon
a percentage of sales or a fixed amount per product
sold, is recognized on an accrual basis based on actual
or reliably estimated sales made by the licensees.
Grants from the government are recognized at their fair
value where there is a reasonable assurance that the grant
will be received and the Company will comply with all
attached conditions. Government grants relating to costs
are deferred and recognized in the Statement of income
over the period necessary to match them with the costs
that they are intended to compensate.
Income tax
Income tax comprises current and deferred tax. Income
tax is recognized in the Statement of income except to
the extent that it relates to items recognized directly
within equity or in other comprehensive income.
Current tax is the expected tax payable on the taxable
income for the year, using tax rates enacted or
substantially-enacted at the reporting date, and any
adjustment to tax payable in respect of previous years.
Deferred tax assets and liabilities are recognized, using
the balance sheet method, for the expected tax
consequences of temporary differences between the
carrying amounts of assets and liabilities and the
118
Annual Report 2014
amounts used for taxation purposes. Deferred tax is not
recognized for the following temporary differences: the
initial recognition of goodwill, the initial recognition of
assets and liabilities in a transaction that is not a
business combination and that affects neither
accounting nor taxable profit, and differences relating
to investments in subsidiaries to the extent that they
probably will not reverse in the foreseeable future.
Deferred tax is measured at the tax rates that are
expected to be applied to temporary differences when
they reverse, based on the laws that have been enacted
or substantially-enacted by the reporting date.
Deferred tax assets and liabilities are offset if there is a
legally-enforceable right to offset current tax liabilities
and assets, and they relate to income taxes levied by
the same tax authority on the same taxable entity, or on
different tax entities, but they intend to settle current
tax liabilities and assets on a net basis or their tax assets
and liabilities will be realized simultaneously.
A deferred tax asset is recognized for unused tax losses,
tax credits and deductible temporary differences, to the
extent that it is probable that future taxable profits will
be available against which they can be utilized. The
ultimate realization of deferred tax assets is dependent
upon the generation of future taxable income in the
countries where the deferred tax assets originated and
during the periods when the deferred tax assets
become deductible. Management considers the
scheduled reversal of deferred tax liabilities, projected
future taxable income, and tax planning strategies in
making this assessment.
Deferred tax liabilities for withholding taxes are
recognized for subsidiaries in situations where the
income is to be paid out as dividend in the foreseeable
future and for undistributed earnings of unconsolidated
companies to the extent that these withholding taxes
are not expected to be refundable or deductible.
Changes in tax rates are reflected in the period when
the change has been enacted or substantially-enacted
by the reporting date.
Provisions
Provisions are recognized if, as a result of a past event,
the Company has a present legal or constructive
obligation that can be estimated reliably, and it is
probable that an outflow of economic benefits will be
required to settle the obligation. Provisions are
measured at the present value of the expenditures
expected to be required to settle the obligation using a
pre-tax discount rate that reflects current market
assessments of the time value of money. The increase
in the provision due to passage of time is recognized as
interest expense. The accounting for some of the
Company’s provisions is as follows:
• A provision for warranties is recognized when the
underlying products or services are sold. The
provision is based on historical warranty data and a
weighing of possible outcomes against their
associated probabilities.
• Measurement of liabilities associated with
environmental obligations, is based on current legal
and constructive requirements. Liabilities and
expected insurance recoveries, if any, are recorded
separately. The carrying amount of environmental
liabilities is regularly reviewed and adjusted for new
facts and changes in law.
• The provision for restructuring relates to the
estimated costs of initiated reorganizations, the most
significant of which have been approved by the
Board of Management, and which generally involve
the realignment of certain parts of the industrial and
commercial organization. When such reorganizations
require discontinuance and/or closure of lines of
activities, the anticipated costs of closure or
discontinuance are included in restructuring
provisions. A liability is recognized for those costs
only when the Company has a detailed formal plan
for the restructuring and has raised a valid
expectation with those affected that it will carry out
the restructuring by starting to implement that plan
or announcing its main features to those affected by
it. Before a provision is established, the Company
recognizes any impairment loss on the assets
associated with the restructuring.
Goodwill
Measurement of goodwill at initial recognition is
described under Basis of consolidation below. Goodwill
is subsequently measured at cost less accumulated
impairment losses. In respect of investments in
associates, the carrying amount of goodwill is included
in the carrying amount of investment, and an
impairment loss on such investment is allocated to the
investment as a whole.
Intangible assets other than goodwill
Acquired finite-lived intangible assets are amortized
using the straight-line method over their estimated
useful life. The useful lives are evaluated annually.
Patents and trademarks with a finite useful life acquired
from third parties either separately or as part of the
business combination are capitalized at cost and
amortized over their remaining useful lives. Intangible
assets acquired as part of a business combination are
capitalized at their acquisition-date fair value.
The Company expenses all research costs as incurred.
Expenditure on development activities, whereby
research findings are applied to a plan or design for the
production of new or substantially improved products
and processes, is capitalized as an intangible asset if
the product or process is technically and commercially
feasible and the Company has sufficient resources and
the intention to complete development.
The development expenditure capitalized comprises of all
directly attributable costs (including the cost of materials and
direct labor). Other development expenditures and
expenditures on research activities are recognized in the
Statement of income. Capitalized development expenditure
Group financial statements 12.9
is stated at cost less accumulated amortization and
impairment losses. Amortization of capitalized development
expenditure is charged to the Statement of income on a
straight-line basis over the estimated useful lives of the
intangible assets.
Discontinued operations and non-current assets held
for sale
Non-current assets (disposal groups comprising assets
and liabilities) that are expected to be recovered
primarily through sale rather than through continuing
use are classified as held for sale.
A discontinued operation is a component of an entity that
either has been disposed of, or that is classified as held for
sale, and (a) represents a separate major line of business
or geographical area of operations; and (b) is a part of a
single coordinated plan to dispose of a separate major line
of business or geographical area of operations; or (c) is a
subsidiary acquired exclusively with a view to sell. A
component that previously was held for use will have one
or more cash-generating units.
Non-current assets held for sale and discontinued
operations are carried at the lower of carrying amount
or fair value less cost to sell. Any gain or loss from
disposal, together with the results of these operations
until the date of disposal, is reported separately as
discontinued operations. The financial information of
discontinued operations is excluded from the
respective captions in the Consolidated financial
statements and related notes for all periods presented.
Comparatives in the balance sheet are not re-
presented when a non-current asset or disposal group
is classified as held for sale. Comparatives are restated
for presentation of discontinued operations in the
Statement of cash flow and Statement of income.
Adjustments in the current period to amounts previously
presented in discontinued operations that are directly
related to the disposal of a discontinued operation in a
prior period are classified separately in discontinued
operations. Circumstances to which these adjustments
may relate include resolution of uncertainties that arise
from the terms of the disposal transaction, such as the
resolution of a purchase price adjustments and
indemnifications, resolution of uncertainties that arise
from and are directly related to the operations of the
component before its disposal, such as environmental and
product warranty obligations retained by the Company, or
the settlement of employee benefit plan obligations
provided that the settlement is directly related to the
disposal transaction.
Impairment
Impairment of goodwill, intangible assets not yet
ready for use and indefinite-lived intangible assets
Goodwill, intangible assets not yet ready for use and
indefinite-lived intangible assets are not amortized but
tested for impairment annually and whenever impairment
indicators require. In most cases the Company identified
Annual Report 2014
119
Group financial statements 12.9
its cash generating units as one level below that of an
operating segment. Cash flows at this level are
substantially independent from other cash flows and this
is the lowest level at which goodwill is monitored by the
Executive Committee. The Company performed and
completed annual impairment tests in the same quarter of
all years presented in the Statements of income. An
impairment loss is recognized in the Statement of income
whenever and to the extent that the carrying amount of a
cash-generating unit exceeds the unit’s recoverable
amount, which is the greater of its value in use and fair
value less cost to sell. Value in use is measured as the
present value of future cash flows expected to be
generated by the asset.
Impairment of non-financial assets other than
goodwill, intangible assets not yet ready for use,
indefinite-lived intangible assets, inventories and
deferred tax assets
Non-financial assets other than goodwill, intangible
assets not yet ready for use, indefinite-lived intangible
assets, inventories and deferred tax assets are reviewed
for impairment whenever events or changes in
circumstances indicate that the carrying amount of an
asset may not be recoverable. Recoverability of assets
to be held and used is recognized and measured by a
comparison of the carrying amount of an asset with the
greater of its value in use and fair value less cost to sell.
Value in use is measured as the present value of future
cash flows expected to be generated by the asset. If the
carrying amount of an asset is deemed not recoverable,
an impairment charge is recognized in the amount by
which the carrying amount of the asset exceeds the
recoverable amount. The review for impairment is
carried out at the level where cash flows occur that are
independent of other cash flows.
Impairment losses recognized in prior periods are
assessed at each reporting date for any indications that
the loss has decreased or no longer exists. An
impairment loss is reversed if and to the extent there
has been a change in the estimates used to determine
the recoverable amount. The loss is reversed only to the
extent that the asset’s carrying amount does not exceed
the carrying amount that would have been determined,
net of depreciation or amortization, if no impairment
loss had been recognized. Reversals of impairment are
recognized in the Statement of income.
Impairment of financial assets
A financial asset is considered to be impaired if
objective evidence indicates that one or more events
have had a negative effect on the estimated future cash
flows of that asset. In case of available-for-sale
financial assets, a significant or prolonged decline in the
fair value of the financial assets below its cost is
considered an indicator that the financial assets are
impaired. If any such evidence exists for available-for-
sale financial assets, the cumulative loss - measured as
the difference between the acquisition cost and the
current fair value, less any impairment loss on that
financial asset previously recognized in the Statement
120
Annual Report 2014
of income - is reclassified from the fair value reserve in
equity (through Other comprehensive income) to the
Statement of income.
If objective evidence indicates that financial assets that
are carried at cost need to be tested for impairment,
calculations are based on information derived from
business plans and other information available for
estimating their fair value. Any impairment loss is
charged to the Statement of income.
An impairment loss related to financial assets is
reversed if in a subsequent period, the fair value
increases and the increase can be related objectively to
an event occurring after the impairment loss was
recognized. The loss is reversed only to the extent that
the asset’s carrying amount does not exceed the
carrying amount that would have been determined if no
impairment loss had been recognized. Reversals of
impairment are recognized in the Statement of income
except for reversals of impairment of available-for-sale
equity securities, which are recognized in Other
comprehensive income.
Other policies
Foreign currencies
Foreign currency transactions
The financial statements of all group entities are measured
using the currency of the primary economic environment in
which the entity operates (functional currency). The euro
(EUR) is the functional and presentation currency of the
Company. Foreign currency transactions are translated into
the functional currency using the exchange rates prevailing
at the dates of the transactions or valuation where items are
remeasured. Foreign exchange gains and losses resulting
from the settlement of such transactions and from the
translation at year-end exchange rates of monetary assets
and liabilities denominated in foreign currencies are
recognized in the Statement of income, except when
deferred in Other comprehensive income as qualifying cash
flow hedges and qualifying net investment hedges.
Foreign currency differences arising from translation
are recognized in the Statement of income, except for
available-for-sale equity investments which are
recognized in Other comprehensive income, except on
impairment in which case foreign currency differences
that have been recognized in Other comprehensive
income are reclassified to the Statement of income.
All exchange difference items are presented as part of Cost
of sales, with the exception of tax items and financial income
and expense, which are recognized in the same line item as
they relate in the Statement of income.
Non-monetary assets and liabilities denominated in
foreign currencies that are measured at fair value are
retranslated to the functional currency using the exchange
rate at the date the fair value was determined. Non-
monetary items in a foreign currency that are measured
based on historical cost are translated using the exchange
rate at the transaction date.
Foreign operations
The assets and liabilities of foreign operations,
including goodwill and fair value adjustments arising on
acquisition, are translated to euro at exchange rates at
the reporting date. The income and expenses of foreign
operations are translated to euro at exchange rates at
the dates of the transactions.
Foreign currency differences arising on translation of
foreign operations into euro are recognized in Other
comprehensive income, and presented as part of
Currency translation differences in Equity. However, if
the operation is a non-wholly owned subsidiary, then
the relevant proportionate share of the translation
difference is allocated to Non-controlling interests.
When a foreign operation is disposed of such that
control, significant influence or joint control is lost, the
cumulative amount in the Currency translation
differences related to the foreign operation is
reclassified to the Statement of income as part of the
gain or loss on disposal. When the Company disposes
of only part of its interest in a subsidiary that includes
a foreign operation while retaining control, the
respective proportion of the cumulative amount is
reattributed to Non-controlling interests. When the
Company disposes of only part of its investment in an
associate or joint venture that includes a foreign
operation while retaining significant influence or joint
control, the relevant proportion of the cumulative
amount is reclassified to the Statement of income.
Financial instruments
Non-derivative financial instruments
Non-derivative financial instruments are recognized
initially at fair value when the Company becomes a
party to the contractual provisions of the instrument.
Regular way purchases and sales of financial
instruments are accounted for at the trade date.
Dividend and interest income are recognized when
earned. Gains or losses, if any, are recorded in Financial
income and expense.
Non-derivative financial instruments comprise cash
and cash equivalents, receivables, other non-current
financial assets, debt and other financial liabilities that
are not designated as hedges.
Cash and cash equivalents
Cash and cash equivalents include all cash balances
and short-term highly liquid investments with an
original maturity of three months or less that are readily
convertible into known amounts of cash.
Group financial statements 12.9
Receivables
Receivables are carried at the lower of amortized cost
or the present value of estimated future cash flows,
taking into account discounts given or agreed. The
present value of estimated future cash flows is
determined through the use of value adjustments for
uncollectible amounts. As soon as individual trade
accounts receivable can no longer be collected in the
normal way and are expected to result in a loss, they
are designated as doubtful trade accounts receivable
and valued at the expected collectible amounts. They
are written off when they are deemed to be
uncollectible because of bankruptcy or other forms of
receivership of the debtors. The allowance for the risk
of non-collection of trade accounts receivable takes
into account credit-risk concentration, collective debt
risk based on average historical losses, and specific
circumstances such as serious adverse economic
conditions in a specific country or region.
Other non-current financial assets
Other non-current financial assets include held-to-
maturity investments, loans and available-for-sale
financial assets and financial assets at fair value
through profit or loss.
Held-to-maturity investments are those debt securities
which the Company has the ability and intent to hold
until maturity. Held-to-maturity debt investments are
recorded at amortized cost, adjusted for the
amortization or accretion of premiums or discounts
using the effective interest method.
Loans receivable are stated at amortized cost, less
impairment.
Available-for-sale financial assets are non-derivative
financial assets that are designated as available-for-sale and
that are not classified in any of the other categories of
financial assets. Subsequent to initial recognition, they are
measured at fair value and changes therein, other than
impairment losses and foreign currency differences on
available for sale-debt instruments are recognized in Other
comprehensive income and presented in the fair value
reserve in equity. When an investment is derecognized, the
gain or loss accumulated in equity is reclassified to the
Statement of income.
Available-for-sale financial assets including
investments in privately-held companies that are not
associates, and do not have a quoted market price in an
active market and whose fair value could not be reliably
determined, are carried at cost.
A financial asset is classified as fair value through profit
or loss if it is classified as held for trading or is
designated as such upon initial recognition. Financial
assets are designated as fair value through profit or loss
if the Company manages such investments and makes
purchase and sale decisions based on their fair value in
accordance with the Company’s documented risk
management or investment strategy. Financial assets at
Annual Report 2014
121
Group financial statements 12.9
fair value through profit or loss are measured at fair
value, and changes therein are recognized in the
Statement of income. Attributable transaction costs are
recognized in the Statement of income as incurred.
Equity
Common shares are classified as equity. Incremental
costs directly attributable to the issuance of shares are
recognized as a deduction from equity. Where the
Company purchases the Company’s equity share
capital (treasury shares), the consideration paid,
including any directly attributable incremental
transaction costs (net of income taxes), is deducted
from equity attributable to the Company’s equity
holders until the shares are cancelled or reissued.
Where such ordinary shares are subsequently reissued,
any consideration received, net of any directly
attributable incremental transaction costs and the
related income tax effects, is included in equity
attributable to the Company’s equity holders.
Dividends are recognized as a liability in the period in
which they are declared. The income tax consequences
of dividends are recognized when a liability to pay the
dividend is recognized.
Debt and other liabilities
Debt and liabilities other than provisions are stated at
amortized cost. However, loans that are hedged under a fair
value hedge are remeasured for the changes in the fair value
that are attributable to the risk that is being hedged.
Derivative financial instruments, including hedge
accounting
The Company uses derivative financial instruments
principally to manage its foreign currency risks and, to a
more limited extent, for managing interest rate and
commodity price risks. All derivative financial instruments
are classified as current assets or liabilities and are
accounted for at the trade date. Embedded derivatives are
separated from the host contract and accounted for
separately if the economic characteristics and risks of the
host contract and the embedded derivative are not closely
related. The Company measures all derivative financial
instruments at fair value derived from market prices of the
instruments, or calculated as the present value of the
estimated future cash flows based on observable interest
yield curves, basis spread, credit spreads and foreign
exchange rates, or from option pricing models, as
appropriate. Gains or losses arising from changes in fair
value of derivatives are recognized in the Statement of
income, except for derivatives that are highly effective and
qualify for cash flow or net investment hedge accounting.
Changes in the fair value of derivatives that are
designated and qualify as fair value hedges are
recorded in the Statement of income, together with any
changes in the fair value of the hedged asset or liability
that are attributable to the hedged risk. For interest rate
swaps designated as a fair value hedge of an interest
bearing asset or liability that are unwound, the amount
of the fair value adjustment to the asset or liability for
122
Annual Report 2014
the risk being hedged is released to the Statement of
income over the remaining life of the asset or liability
based on the recalculated effective yield.
Changes in the fair value of a derivative that is highly effective
and that is designated and qualifies as a cash flow hedge, are
recorded in Other comprehensive income, until the
Statement of income is affected by the variability in cash
flows of the designated hedged item. To the extent that the
hedge is ineffective, changes in the fair value are recognized
in the Statement of income.
The Company formally assesses, both at the hedge’s
inception and on an ongoing basis, whether the
derivatives that are used in hedging transactions are
highly effective in offsetting changes in fair values or
cash flows of hedged items. When it is established that
a derivative is not highly effective as a hedge or that it
has ceased to be a highly effective hedge, the Company
discontinues hedge accounting prospectively. When
hedge accounting is discontinued because it is
expected that a forecasted transaction will not occur,
the Company continues to carry the derivative on the
Balance sheet at its fair value, and gains and losses that
were accumulated in equity are recognized
immediately in the Statement of income. If there is a
delay and it is expected that the transaction will still
occur, the amount in equity remains there until the
forecasted transaction affects income. In all other
situations in which hedge accounting is discontinued,
the Company continues to carry the derivative at its fair
value on the Balance sheet, and recognizes any
changes in its fair value in the Statement of income.
Foreign currency differences arising on the
retranslation of financial instruments designated as a
hedge of a net investment in a foreign operation are
recognized directly as a separate component of equity
through Other comprehensive income, to the extent
that the hedge is effective. To the extent that the hedge
is ineffective, such differences are recognized in the
Statement of income.
Offsetting and master netting agreements
The Company presents financial assets and financial
liabilities on a gross basis as separate line items in the
Consolidated balance sheet.
Master netting agreements may be entered into when the
Company undertakes a number of financial instrument
transactions with a single counterparty. Such an
agreement provides for a net settlement of all financial
instruments covered by the agreement in the event of
default or certain termination events on any of the
transactions. A master netting agreement may create a
right of offset that becomes enforceable and affects the
realization or settlement of individual financial assets and
financial liabilities only following a specified termination
event. However, if this contractual right is subject to certain
limitations then it does not necessarily provide a basis for
offsetting unless both of the offsetting criteria are met, i.e.
there is a legally enforceable right and an intention to
settle net or simultaneously.
Property, plant and equipment
Assets manufactured by the Company include direct
manufacturing costs and production overheads.
Government grants are deducted from the cost of the related
asset.
Depreciation is calculated using the straight-line
method over the useful life of the asset. Depreciation of
special tooling is generally also based on the straight-
line method. Gains and losses on the sale of property,
plant and equipment are included in Other business
income. Costs related to repair and maintenance
activities are expensed in the period in which they are
incurred unless leading to an extension of the original
lifetime or capacity.
Plant and equipment under finance leases and
leasehold improvements are amortized using the
straight-line method over the shorter of the lease term
or the estimated useful life of the asset. The gain
realized on sale and operating leaseback transactions
that are concluded based upon market conditions is
recognized at the time of the sale.
Leased assets
Leases in which the Company is the lessee and has
substantially all the risks and rewards of ownership are
classified as finance leases. Finance leases are
capitalized at the commencement of the lease at the
lower of the fair value of the leased assets and the
present value of the minimum lease payments. Each
lease payment is allocated between the liability and
finance charges. The interest element of the finance
cost is charged to the Statement of income over the
lease period so as to produce a constant periodic rate
of interest on the remaining balance of the liability for
each period. The corresponding rental obligations, net
of finance charges, are included in other short-term and
other non-current liabilities. The property, plant and
equipment acquired under finance leases is
depreciated over the shorter of the useful life of the
assets and the lease term.
Leases in which substantially all risks and rewards of
ownership are retained by the lessor are classified as
operating leases. Payments made under operating
leases (net of any incentives received from the lessor)
are recognized in the Statement of income on a
straight-line basis over the term of the lease.
Inventories
Inventories are stated at the lower of cost or net
realizable value. The cost of inventories comprises all
costs of purchase, costs of conversion and other costs
incurred in bringing the inventories to their present
location and condition. The costs of conversion of
inventories include direct labor and fixed and variable
production overheads, taking into account the stage of
Group financial statements 12.9
completion and the normal capacity of production
facilities. Costs of idle facility and abnormal waste are
expensed. The cost of inventories is determined using
the first-in, first-out (FIFO) method. Inventory is
reduced for the estimated losses due to obsolescence.
This reduction is determined for groups of products
based on purchases in the recent past and/or expected
future demand.
Employee benefit accounting
A defined contribution plan is a post-employment
benefit plan under which an entity pays fixed
contributions into a separate entity and will have no
legal or constructive obligation to pay further amounts.
Obligations for contributions to defined contribution
pension plans are recognized as an employee benefit
expense in the Statement of income in the periods
during which services are rendered by employees.
A defined benefit plan is a post-employment benefit
plan other than a defined contribution plan. The net
pension asset or liability recognized in the
Consolidated balance sheets in respect of defined
benefit post-employment plans is the fair value of plan
assets less the present value of the projected defined
benefit obligation (DBO) at the balance sheet date. The
projected defined benefit obligation is calculated
annually by qualified actuaries using the projected unit
credit method. Recognized assets are limited to the
present value of any reductions in future contributions
or any future refunds.
For the Company’s major plans, a full discount rate
curve of high-quality corporate bonds is used to
determine the defined benefit obligation. The curves
are based on Towers Watson’s RATE:Link which uses
data of corporate bonds rated AA or equivalent. For the
other plans a single point discount rate is used based
on corporate bonds for which there is deep market and
the plan’s maturity. Plans in countries without a deep
corporate bond market use a discount rate based on the
local sovereign curve and the plan’s maturity.
Pension costs in respect of defined benefit post-
employment plans primarily represent the increase of the
actuarial present value of the obligation for post-
employment benefits based on employee service during the
year and the interest on the net recognized asset or liability
in respect of employee service in previous years.
Remeasurements of the net defined benefit liability
comprise actuarial gains and losses, the return on plan
assets (excluding interest) and the effect of the asset
ceiling (excluding interest). The Company immediately
recognizes all remeasurements in Other
comprehensive income.
The Company recognizes gains and losses on the
settlement of a defined benefit plan when the
settlement occurs. The gain or loss on settlement
comprises any resulting change in the fair value of plan
assets and change in the present value of defined
Annual Report 2014
123
Group financial statements 12.9
benefit obligation. Past service costs following from the
introduction of a change to the benefit payable under
a plan or a significant reduction of the number of
employees covered by a plan, are recognized in full in
the Statement of income.
Short-term employee benefit obligations are measured
on an undiscounted basis and are expensed as the
related service is provided. The Company recognizes a
liability and an expense for bonuses and profit-sharing,
based on a formula that takes into consideration the
profit attributable to the Company’s shareholders after
certain adjustments. The Company recognizes a
provision where contractually obliged or where there is
a past practice that has created a constructive
obligation and the obligation can be measured reliably.
The Company’s net obligation in respect of long-term
employee benefits is the amount of future benefit that
employees have earned in return for their service in the
current and prior periods, such as jubilee entitlements.
That benefit is discounted to determine its present
value. Remeasurements are recognized in the income
statement in the period in which they arise.
Share-based payment
The grant-date fair value of equity-settled share-
based payment awards granted to employees is
recognized as personnel expense, with a
corresponding increase in equity, over the vesting
period of the award. The Company uses the Black-
Scholes option-pricing model and Monte Carlo
sampling to determine the fair value of the awards,
depending on the type of instruments granted and
certain vesting conditions.
Financial income and expenses
Financial income comprises interest income on funds
invested (including available-for-sale financial assets),
dividend income, net gains on the disposal of available-
for-sale financial assets, net fair value gains on financial
assets at fair value through profit or loss, net gains on
the remeasurement to fair value of any preexisting
available-for-sale interest in an acquiree, and net gains
on hedging instruments that are recognized in the
Statement of income.
Interest income is recognized on accrual basis in the
Statement of income, using the effective interest method.
Dividend income is recognized in the Statement of income
on the date that the Company’s right to receive payment is
established, which in the case of quoted securities is
normally the ex-dividend date.
Financial expenses comprise interest expenses on
borrowings and on the net defined benefit liability,
unwinding of the discount on provisions and contingent
consideration, losses on disposal of available-for-sale
financial assets, net fair value losses on financial assets
at fair value through profit or loss, impairment losses
recognized on financial assets (other than trade
124
Annual Report 2014
receivables), net interest expenses related to defined
benefit plans and net losses on hedging instruments
that are recognized in the Statement of income.
Financial guarantees
The Company recognizes a liability at the fair value of
the obligation at the inception of a financial guarantee
contract. The guarantee is subsequently measured at
the higher of the best estimate of the obligation or the
amount initially recognized.
Basis of consolidation
The Consolidated financial statements include the
accounts of Koninklijke Philips N.V. and all subsidiaries
that the Company controls, i.e. when it is exposed, or
has rights, to variable returns from its involvement with
the investee and has the ability to affect those returns
through its power over the investee. The existence and
effect of potential voting rights are considered when
assessing whether the Company controls another
entity. Subsidiaries are fully consolidated from the date
that control commences until the date that control
ceases. All intercompany balances and transactions
have been eliminated in the Consolidated financial
statements. Unrealized losses are eliminated in the
same way as unrealized gains, but only to the extent
that there is no evidence of impairment.
Business combinations
Business combinations are accounted for using the
acquisition method. Under the acquisition method, the
identifiable assets acquired, liabilities assumed and any
non-controlling interest in the acquiree are recognized
at the acquisition date, which is the date on which
control is transferred to the Company.
The Company measures goodwill at the acquisition
date as:
• the fair value of the consideration transferred; plus
• the recognized amount of any non-controlling
interest in the acquiree; plus
• if the business combination is achieved in stages, the
fair value of the existing equity interest in the
acquiree; less
• the net recognized amount (generally fair value) of
the identifiable assets acquired and liabilities
assumed.
Costs related to the acquisition, other than those
associated with the issue of debt or equity securities,
that the Company incurs are expensed as incurred.
Any contingent consideration payable is recognized at
fair value at the acquisition date and initially is
presented as Long-term provisions. When the timing
and amount of the consideration become more certain,
it is reclassified to Accrued liabilities. If the contingent
consideration is classified as equity, it is not remeasured
and settlement is accounted for within equity.
Group financial statements 12.9
Otherwise, subsequent changes to the fair value of the
contingent consideration are recognized in the
Statement of income.
equity stake resulting from gaining control over the
investee previously recorded as associate are recorded
under Results relating to investments in associates.
Acquisitions of and adjustments to non-controlling
interests
Acquisitions of non-controlling interests are accounted
for as transactions with owners in their capacity as
owners and therefore no goodwill is recognized.
Adjustments to non-controlling interests arising from
transactions that do not involve the loss of control are
based on a proportionate amount of the net assets of
the subsidiary.
Loss of control
Upon the loss of control, the Company derecognizes
the assets and liabilities of the subsidiary, any non-
controlling interests and the other components of
equity related to the subsidiary. Any surplus or deficit
arising on the loss of control is recognized in the
Statement of income. If the Company retains any
interest in the previous subsidiary, then such interest is
measured at fair value at the date the control is lost.
Subsequently it is accounted for as either an equity-
accounted investee (associate) or as an available-for-
sale financial asset, depending on the level of influence
retained.
Investments in associates (equity-accounted
investees)
Associates are all entities over which the Company has
significant influence, but does not control. Significant
influence is presumed with a shareholding of between
20% and 50% of the voting rights. Investments in
associates are accounted for using the equity method
of accounting and are initially recognized at cost. The
Company’s investments in associates includes goodwill
identified on acquisition, net of any accumulated
impairment loss.
The Company’s share of the net income of these
companies is included in Results relating to
investments in associates in the Statement of income,
after adjustments to align the accounting policies with
those of the Company, from the date that significant
influence commences until the date that significant
influence ceases. Dilution gains and losses arising from
investments in associates are recognized in the
Statement of income as part of Other results relating to
investments in associates. When the Company’s share
of losses exceeds its interest in an associate, the
carrying amount of that interest (including any long-
term loans) is reduced to zero and recognition of further
losses is discontinued except to the extent that the
Company has incurred legal or constructive obligations
or made payments on behalf of the associate.
Unrealized gains on transactions between the
Company and its associates are eliminated to the
extent of the Company’s interest in the associates.
Unrealized losses are also eliminated unless the
transaction provides evidence of an impairment of the
asset transferred. Remeasurement differences of
Cash flow statements
Cash flows arising from transactions in a foreign
currency are translated in the Company’s functional
currency using the exchange rate at the date of the cash
flow. Cash flows from derivative instruments that are
accounted for as fair value hedges or cash flow hedges
are classified in the same category as the cash flows
from the hedged items. Cash flows from other
derivative instruments are classified consistent with the
nature of the instrument.
Segment information
Operating segments are components of the Company’s
business activities about which separate financial
information is available that is evaluated regularly by
the chief operating decision maker (the Executive
Committee of the Company). The Executive Committee
decides how to allocate resources and assesses
performance. Reportable segments comprise the
operating sectors Healthcare, Consumer Lifestyle and
Lighting. Innovation, Group & Services (IG&S) is a sector
but not a separate reportable segment and holds,
amongst others, headquarters, overhead and regional/
country organization expenses. Segment accounting
policies are the same as the accounting policies as
applied to the Group.
Earnings per Share
The Company presents basic and diluted earnings per
share (EPS) data for its common shares. Basic EPS is
calculated by dividing the Net income (loss)
attributable to shareholders by the weighted average
number of common shares outstanding during the
period, adjusted for own shares held. Diluted EPS is
determined by adjusting the Net income (loss)
attributable to shareholders and the weighted average
number of common shares outstanding during the
period, adjusted for own shares held, for the effects of
all dilutive potential common shares, which comprises
of restricted shares, performance shares and share
options granted to employees.
Annual Report 2014
125
Group financial statements 12.9
2
2
Information by sector and main country
Philips Group
Information on income statement and cash flow by sector in millions of EUR unless otherwise stated
2012 - 2014
sales including
intercompany
research and
development
expenses
income from
operations
income from
operations as a
% of sales
cash flow before
financing
activities
(822)
(263)
(330)
(220)
(1,635)
(810)
(268)
(313)
(268)
456
520
185
(675)
486
1,315
429
413
(302)
5.0%
11.0%
2.7%
−
2.3%
13.7%
9.3%
5.8%
−
910
553
442
(1,586)
319
1,292
480
418
(2,140)
(1,659)
1,855
8.4%
50
(858)
(256)
(341)
(269)
1,026
400
(78)
(756)
10.3%
9.3%
(1.1)%
−
(1,724)
592
2.7%
1,298
413
314
(851)
1,174
Innovation, Group & Services: Consists of group
headquarters, as well as the overhead expenses of
regional and country organizations. Also included are
the net results of group innovation, intellectual
property & services, the global service units and Philips’
pension and other postretirement benefit costs not
directly allocated to the other sectors.
Transactions between the sectors mainly relate to
services provided by the sector Innovation, Group &
Services to the other sectors. The pricing of such
transactions is determined on an arm’s length basis.
2014
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Inter-sector eliminations
Philips Group
2013
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Inter-sector eliminations
sales
9,186
4,731
6,869
605
21,391
9,575
4,605
7,145
665
Philips Group
21,990
2012
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Inter-sector eliminations
9,983
4,319
7,303
629
Philips Group
22,234
9,209
4,739
6,927
934
(418)
21,391
9,600
4,622
7,211
977
(420)
21,990
10,005
4,329
7,366
900
(366)
22,234
Our sectors are organized based on the nature of the
products and services. The four sectors comprise
Healthcare, Consumer Lifestyle, Lighting and
Innovation, Group & Services as shown in the table
above. A short description of these sectors is as follows:
Healthcare: Consists of the following businesses -
Imaging Systems, Healthcare Informatics, Services &
Solutions, Patient Care & Monitoring Solutions, and
Customer Services.
Consumer Lifestyle: Consists of the following
businesses - Personal Care, Domestic Appliances, and
Health & Wellness.
Lighting: Consists of the following businesses - Light
Sources & Electronics, Professional Lighting Solutions,
and Consumer Luminaires.
126
Annual Report 2014
Group financial statements 12.9
Philips Group
Information on balance sheet and capital expenditure in millions of EUR
2012 - 2014
2014
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Sector totals
total
assets
11,274
3,049
5,739
6,677
26,739
Assets classified as held for sale
1,613
Total assets/liabilities (excl.
debt)
28,352
2013
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Sector totals
10,465
2,832
6,711
6,044
26,052
Assets classified as held for sale
507
Total assets/liabilities (excl.
debt)
26,559
2012
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Sector totals
11,248
3,280
6,970
7,540
29,038
Assets classified as held for sale
43
Total assets/liabilities (excl.
debt)
29,081
net
operating
capital
total
liabilities
excl. debt
current accounts
receivable, net
tangible and
intangible
assets
depreciation
and
amortization1)
capital
expenditures
7,565
1,353
3,638
(3,718)
8,838
7,437
1,261
4,462
(2,922)
10,238
7,976
1,205
4,635
(4,500)
9,316
3,629
1,696
2,081
5,525
12,931
349
13,280
2,943
1,571
2,229
4,340
11,083
348
11,431
3,186
2,075
2,313
5,761
13,335
27
13,362
2,112
791
1,438
135
4,476
1,978
743
1,567
132
4,420
1,967
865
1,364
138
4,334
6,934
1,647
3,167
873
12,621
6,467
1,574
3,857
648
12,546
7,130
1,694
4,293
521
(480)
(198)
(351)
(158)
(1,187)
(517)
(199)
(333)
(128)
(1,177)
(543)
(198)
(388)
(113)
13,638
(1,242)
127
109
84
117
437
132
135
117
98
482
135
128
111
105
479
1)
Includes impairments of tangible and intangible assets excluding goodwill
Philips Group
Goodwill assigned to sectors in millions of EUR
2013 - 2014
carrying
value
at
January 1
reclassifi-
cation
acquisitions
purchase
price
allocation
adjustment
impairments
divestments
and transfers
to assets
classified as
held for sale
translation
differences
carrying
value at
December 31
2014
Healthcare
Consumer
Lifestyle
Lighting
Innovation, Group
& Services
Philips Group
2013
Healthcare
Consumer
Lifestyle
Lighting
Innovation, Group
& Services
Philips Group
4,275
632
1,586
11
6,504
4,573
668
1,707
–
6,948
–
–
–
–
–
–
–
(8)
8
–
1
–
58
9
68
3
–
1
–
4
8
–
–
–
8
11
–
(15)
–
(4)
–
–
–
–
–
–
–
(26)
–
(26)
(2)
–
(155)
(3)
(160)
(40)
(18)
–
3
(55)
497
54
187
–
738
4,779
686
1,676
17
7,158
(272)
4,275
(18)
(73)
–
(363)
632
1,586
11
6,504
Annual Report 2014
127
Group financial statements 12.9
Philips Group
Main countries in millions of EUR
2012 - 2014
2014
Netherlands
United States
China
Germany
Japan
France
United Kingdom
Other countries
Total main countries
Assets classified as held for sale
Total tangible and intangible assets
20132)
Netherlands
United States
China
Germany
Japan
France
United Kingdom
Other countries
Total main countries
Assets classified as held for sale
Total tangible and intangible assets
20122)
Netherlands
United States
China
Germany
Japan
France
United Kingdom
Other countries
Total main countries
Assets classified as held for sale
Total tangible and intangible assets
sales1)
tangible and intangible assets
594
6,160
2,362
1,351
908
839
722
8,455
21,391
649
6,325
2,616
1,316
943
890
677
8,574
21,990
619
6,733
2,391
1,277
1,068
920
664
8,562
22,234
937
7,649
1,135
153
379
52
594
1,722
12,621
989
13,610
915
7,384
1,057
288
401
80
573
1,848
12,546
62
12,608
886
8,007
1,114
271
537
90
628
2,105
13,638
6
13,644
1) The sales are reported based on country of destination.
2) The previous years’ presentation reflects the sales and tangible and intangible assets of the main countries of 2014 for the respective years.
128
Annual Report 2014
3
Group financial statements 12.9
3 Discontinued operations and other assets
classified as held for sale
Philips Group
Assets and liabilities of combined Lumileds and Automotive
Lighting businesses in millions of EUR
2014
Discontinued operations included in the Consolidated
statements of income and the Consolidated statements
of cash flows consist of the combined Lumileds and
Automotive businesses, the Audio, Video, Multimedia
and Accessories (AVM&A) business and certain other
divestments reported as discontinued operations.
Discontinued operations: Combined Lumileds and
Automotive businesses
Philips announced in a press release on June 30, 2014,
that it will start the process to combine its Lumileds
(LED components) and Automotive businesses into a
stand-alone company within the Philips Group and that
it will explore strategic options to attract capital from
third-party investors for this business.
The company is in discussion with external investors for
the combined Lumileds and Automotive Lighting
businesses and expects to complete a transaction in
the first half of 2015.
The combined businesses of Lumileds and Automotive
were reported as discontinued operations in the
Consolidated statements of income and Consolidated
statements of cash flows with the related assets and
liabilities as per the end of November 2014 included as
Assets classified as held for sale and Liabilities directly
associated with assets held for sale in the Consolidated
balance sheet.
The following table summarizes the results of the
combined businesses of Lumileds and Automotive
included in the Consolidated statements of income as
discontinued operations.
Philips Group
Results of combined Lumileds and Automotive Lighting
businesses in millions of EUR
2012 - 2014
Sales
Costs and expenses
Income before taxes
Income taxes
Results from discontinued
operations
2012
1,139
2013
1,268
2014
1,416
(1,083)
(1,134)
(1,202)
56
33
89
134
(1)
214
(73)
133
141
Upon disposal, the associated currency translation
differences, part of Shareholders’ equity, will be
recognized in the Consolidated statement of income. At
December 31, 2014, the estimated release amounts to a
EUR 24 million gain.
The following table presents the assets and liabilities of
the combined Lumileds and Automotive business, as
Assets classified as held for sale and Liabilities directly
associated with assets classified as held for sale in the
Consolidated balance sheet as of 2014.
Property, plant and equipment
Intangible assets including goodwill
Inventories
Accounts receivable
Other assets
Assets classified as held for sale
Accounts payable
Provisions
Other liabilities
Liabilities directly associated with assets held for
sale
2014
666
295
248
278
14
1,501
(134)
(34)
(149)
(317)
Non-transferrable balance sheet positions, such as
certain accounts receivable, accounts payable, accrued
liabilities and provisions are reported on the respective
balance sheet captions.
Discontinued operations: Audio, Video, Multimedia
and Accessories business
As announced on April 28, 2014, the AVM&A business
was divested to Gibson Brands, Inc. The transfer was
effected on June 29, 2014 and in December 2014 a final
settlement closed the deal.
The following table summarizes the results of the
AVM&A business included in the Consolidated
statements of income as Discontinued operations.
Philips Group
Results of Audio, Video, Multimedia and Accessories business
in millions of EUR
2012 - 2014
Sales
Costs and expenses
Gain on sale of business
Income before taxes
Income taxes
Investments in associates
Results from discontinued
operations
2012
1,414
2013
1,189
(1,295)
(1,180)
2014
469
(473)
10
6
12
–
9
(3)
6
18
–
119
(38)
(3)
78
The following table shows the components of the gain
on the sale of the AVM&A business.
Philips Group
Gain on the sale of the Audio, Video, Multimedia and Accessories
business in millions of EUR
2014
Consideration
Carrying value of net assets disposed
Cost of disposal
Gain on sale of business
Income taxes
Net gain on sale of business
2014
74
(61)
(3)
10
12
22
Assets classified as held for sale amounted to EUR 484
million at moment of disposal (December 31, 2013: EUR
400 million). Liabilities directly associated with the
Annual Report 2014
129
Group financial statements 12.9
4
assets held for sale amounted to EUR 423 million at
moment of disposal (December 31, 2013: EUR 348
million) in the Consolidated balance sheets.
acquisition of EUR 125 million. Acquisition related costs
that were recognized in General and administrative
expenses amounted to EUR 4 million.
Discontinued operations: Other
Certain results of other divestments including the
Television business formerly reported as discontinued
operations are included with a net gain of EUR 31 million
in 2014 (2013: a net loss of EUR 1 million; 2012: a net loss
of EUR 31 million).
Other assets classified as held for sale
On July 1, 2013, Philips announced to transfer certain
assets and cash proceeds from the sale of certain assets
to the Dutch pension plan. In total EUR 38 million of
related assets are classified as held for sale as of
December 31, 2014 (December 31, 2013: EUR 94 million).
For more details see note 20, Post-employment
benefits.
Assets and liabilities directly associated with assets
held for sale relate to property, plant and equipment for
an amount of EUR 23 million (December 31, 2013: EUR
13 million) and businesses classified as held for sale
amounted to EUR 19 million at December 31, 2014
(December 31, 2013 EUR nil million).
In 2014, property, plant and equipment divested assets
classified as held for sale amounted to EUR 17 million
with proceeds of EUR 19 million. Other non-current
financial assets divested assets classified as held for
sale amounted to EUR 76 million with proceeds of EUR
76 million. Businesses divested assets classified as held
for sale amounted to EUR 49 million and liabilities
directly associated with the assets held for sale
amounted to EUR 3 million. The businesses divested
had proceeds of EUR 45million.
4 Acquisitions and divestments
2014
Acquisitions
Philips completed three acquisitions in 2014. These
acquisitions involved an aggregated purchase price of
EUR 171 million.
One of the acquisitions in 2014, was General Lighting
Company (GLC), domiciled in The Kingdom of Saudi
Arabia (KSA). This acquisition enables Philips to grow
its business in KSA, the largest economy in the Middle
East by GDP, particularly in LED lighting.
On September 2, 2014, the Company acquired 51% of
GLC from a consortium of shareholders for a total
amount of EUR 146 million (on a cash-free, debt-free
basis). Taking into account closing conditions, Philips
paid an amount of EUR 148 million. The overall cash
position of GLC on the transaction date was EUR 23
million resulting in a net cash outflow related to this
130
Annual Report 2014
Subsequent to the acquisition, Philips’ existing Lighting
activities in KSA were combined with GLC. This
combined entity was renamed Philips Lighting Saudi
Arabia.
Alliance Holding Ltd. is the company that holds a 49%
non-controlling interest in Philips Lighting Saudi
Arabia.
As of September 2, 2014, Philips Lighting Saudi Arabia
is consolidated as part of the Professional Lighting
Solutions business within the Lighting sector. The
condensed balance sheet of GLC, immediately before
and after the acquisition is as follows:
GLC
Balance sheet in millions of EUR
2014
Goodwill
Other intangible assets
Property, plant and equipment
Working capital
Provisions
Cash
Total assets and liabilities
Group equity
Non-controlling interests
Loans
Financed by
before
acquisition
date
after
acquisition
date
58
158
18
122
(56)
23
323
146
86
91
323
18
112
(15)
23
138
47
–
91
138
The fair value of assets and liabilities after the
acquisition is provisional pending a final assessment in
the course of 2015.
The goodwill is primarily related to the synergies
expected to be achieved from integrating GLC in the
Lighting sector. The goodwill is not tax deductible.
Other intangible assets are comprised of the following:
GLC
Other intangible assets in millions of EUR
2014
Order backlog
Brand name
Customer relationships
Total other intangible assets
amount
amortization
period in years
17
57
84
158
0.2
20
10
For the period from September 2, 2014, Philips Lighting
Saudi Arabia contributed sales of EUR 86 million and
loss from operations of EUR 19 million mainly due to
amortization of other intangible assets.
Divestments
Apart from the divestment of the Lifestyle Entertainment
activities described in note 3, Discontinued operations
and other assets classified as held for sale, Philips
completed two other divestments of business activities
during 2014, which related to Healthcare and Lighting
activities. The two transactions involved an aggregate
consideration of EUR 43 million.
2013
There were four acquisitions in 2013. These acquisitions
involved an aggregated purchase price of EUR 10 million.
Philips completed five divestments of business activities
during 2013, mainly related to certain Healthcare service
activities. The transactions involved an aggregate
consideration of EUR 99 million.
5
Interests in entities
In this section we discuss the nature of, and risks associated
with, the Company’s interests in its consolidated entities and
associates, and the effects of those interests on the
Company’s financial position and financial performance.
Interests in entities relates to:
• Interests in subsidiaries
• Investments in associates
Interests in subsidiaries
Wholly owned subsidiaries
The Group financial statements comprise the assets and
liabilities of approximately 400 legal entities. Set out below
is a list of material subsidiaries representing greater than 5%
of either the consolidated group sales, income from
operations or net income (before any intra-group
eliminations). All of the entities are 100% owned and have
been for the last 3 years.
5
Group financial statements 12.9
Philips Group
Interests in materially wholly owned subsidiaries
in alphabetical order
2014
Legal entity name
Invivo Corporation
Philips (China) Investment Company, Ltd.
Philips Consumer Lifestyle B.V.
Philips Domestic Appliances and Personal Care Co
Philips Electronics China B.V.
Philips Electronics Japan, Ltd.
Principal country
of business
United States
China
Netherlands
China
Netherlands
Japan
Philips Electronics North America Corporation
United States
Philips Electronics UK Limited
United Kingdom
Philips GmbH
Philips Lighting Poland S.A.
Philips Lumileds Lighting Company Sdn. Bhd.
Philips Medical Systems Technologies Ltd.
Philips Nederland B.V.
Philips Oral Healthcare, Inc.
Philips Respironics GK
Philips Societa per Azioni
Philips Ultrasound, Inc.
RI Finance, Inc.
RIC Investments, LLC
Germany
Poland
Malaysia
Israel
Netherlands
United States
Japan
Italy
United States
United States
United States
Not wholly owned subsidiaries
In total, 21 consolidated subsidiaries are not wholly
owned by the Company. Among the consolidated legal
entities is Philips Lighting Saudi Arabia created after the
acquisition of General Lighting Company (GLC) where
the Company owns 51% of the voting power. GLC was
acquired on September 2, 2014. The Company controls
this entity. The sales, income from operations and net
income of this entity is less than 1% of the consolidated
financial data. The non-controlling interest of 49%
represents an amount of EUR 86 million as per
December 31, 2014. The non-controlling interest related
to GLC at the acquisition date was measured at the
holders’ proportionate interest in the recognized
amount of the identifiable net assets, which means that
goodwill recognized by Philips in this transaction
relates only to the 51% interest acquired.
Also among the consolidated legal entities is Philips
India Limited where the Company owns 96% of the
voting power. The non-controlling interest of 4%
represents an amount of EUR 8 million as per December
31, 2014.
The sales, income from operations and net income of
the remaining not wholly owned subsidiaries (before
any intra-group eliminations) are less than 3% of the
consolidated financial data of the Company and are
therefore not considered material.
Investments in associates
Philips has investments in a number of associates, none
of them are regarded as individually material.
Annual Report 2014
131
Group financial statements 12.9
6
The changes during 2014 are as follows:
Philips Group
Investments in associates in millions of EUR
2014
Total investments
Balance as of January 1, 2014
Changes:
Acquisitions/additions
Sales/Redemption
Reclassifications
Share in income
Dividends declared
Translation and exchange rate differences
Transfer to assets classified as held for sale
Balance as of December 31, 2014
161
10
(1)
(8)
30
(41)
16
(10)
157
Included in the line acquisitions/additions is an
investment of EUR 6 million where the Company owns
less than 20% in the capital of the underlying company
but is able to exercise significant influence and is
therefore accounted for as an Investment in associate.
During 2014 the Company’s shareholding in one of its
investments in associates was diluted and
subsequently an amount of EUR 8 million was
reclassified to available-for-sale financial assets, this
movement is shown in the reclassifications line in the
table above. The dilution gain of EUR 32 million is
recognized in Results relating to investments in
associates.
The Company owns three equity interests which
represent more than 20% in the capital of the
underlying companies. With respect to these equity
interests, the Company cannot exercise significant
influence based on governance agreements concluded
among shareholders. These equity interests are
accounted for as Other non-current financial assets. In
2014, the Company’s share in net income of these
entities was insignificant.
Summarized information of investments in
associates
Unaudited summarized financial information on the
Company’s most significant investments in associates,
on a combined basis and not adjusted for the
percentage of ownership held by Philips, is presented
below. It is based on the most recent available financial
information.
Included from April 2012 until December 31, 2013 is the
30%-interest in TP Vision Holding which includes the
former Philips Television business.
Philips Group
Summarized income statement of investments in associates
in millions of EUR
2012 - 2014
Net sales
Income before taxes
Income taxes
Net income
Total share in net income of
associates recognized in the
Consolidated statements of income
2012
2,534
(7)
2
(5)
(5)
2013
2,180
(243)
12
(231)
2014
341
126
(37)
89
5
30
Philips Group
Summarized net asset value of investments in associates
in millions of EUR
2013 - 2014
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Net asset value
2013
1,368
412
1,780
(1,327)
(278)
175
2014
584
190
774
(360)
(45)
369
Investments in associates included in the
Consolidated balance sheet
161
157
6
Income from operations
For information related to Sales and tangible and
intangible assets on a geographical and sector basis,
see note 2, Information by sector and main country.
Philips Group
Sales and costs by nature in millions of EUR
2012 - 2014
Sales
2012
2013
2014
22,234
21,990
21,391
Costs of materials used
(7,852)
(7,494)
(7,296)
Employee benefit expenses
(6,361)
(5,814)
(6,080)
Depreciation and amortization
Shipping and handling
Advertising and promotion
Lease expense
(1,242)
(749)
(829)
(360)
(1,177)
(762)
(869)
(344)
(1,187)
(741)
(913)
(318)1)
Other operational costs
(3,923)
(3,734)
(4,156)2)
Impairment of goodwill
Other business income (expenses)
Income from operations
–
(326)
592
(28)
87
1,855
(3)
(211)
486
1) Lease expense includes EUR 35 million (2013: EUR 42 million) of other
costs, such as fuel and electricity, and taxes to be paid and reimbursed
to the lessor
2) Other operational costs contain items which are dissimilar in nature and
individually insignificant in amount to disclose separately. These costs
contain among others expenses for outsourcing services, mainly in IT
and HR, 3rd party workers, warranty, patents and costs for travelling and
external legal services.
132
Annual Report 2014
Sales composition
Philips Group
Sales composition in millions of EUR
2012 - 2014
Goods
Services
Royalties
Sales
2012
2013
2014
18,715
18,398
17,972
3,121
398
3,130
2,948
462
471
22,234
21,990
21,391
Philips has no single external customer that represents
10% or more of sales.
Costs of materials used
Cost of materials used represents the inventory
recognized in cost of sales.
Employee benefit expenses
Philips Group
Employee benefit expenses in millions of EUR
2012 - 2014
Salaries and wages
Post-employment benefits costs
Other social security and similar
charges:
- Required by law
- Voluntary
2012
5,221
334
2013
4,722
354
2014
5,018
326
639
167
621
117
623
113
Employee benefit expenses
6,361
5,814
6,080
The employee benefit expense relate to employees
who are working on the payroll of Philips, both with
permanent and temporary contracts.
Group financial statements 12.9
Depreciation and amortization
Depreciation of property, plant and equipment and
amortization of intangible assets, including
impairments, are as follows:
Philips Group
Depreciation and amortization in millions of EUR
2012 - 2014
Depreciation of property, plant and
equipment
Amortization of internal-use software
Amortization of other intangible assets
Amortization of development costs
2012
2013
2014
588
45
411
198
521
39
393
224
592
32
332
231
Depreciation and amortization
1,242
1,177
1,187
Depreciation of property, plant and equipment is
primarily included in cost of sales. Amortization of the
categories of other intangible assets are reported in
selling expenses for brand names and customer
relationships and are reported in cost of sales for
technology based and other intangible assets.
Amortization of development cost is included in
research and development expenses.
Shipping and handling
Shipping and handling costs are included in cost of
sales and selling expenses.
Advertising and promotion
Advertising and promotion costs are included in selling
expenses.
Audit fees
For further information on post-employment benefit
costs, see note 20, Post-employment benefits.
Philips Group
Fees KPMG in millions of EUR
2012 - 2014
For details on the remuneration of the members of the
Board of Management and the Supervisory Board, see
note 29, Information on remuneration.
Employees
The average number of employees by category is
summarized as follows:
Philips Group
Employees in FTEs
2012 - 2014
2012
2013
2014
Production
52,055
50,628
48,110
Research and development
Other
Employees
12,470
32,134
11,757
11,714
31,673
32,684
96,659
94,058
92,508
3rd party workers
13,968
12,194
12,562
Continuing operations
110,627
106,252
105,070
Discontinued operations
11,507
10,792
9,222
Employees consist of those persons working on the
payroll of Philips and whose costs are reflected in the
Employee benefit expenses table. 3rd party workers
consist of personnel hired on a per-period basis, via
external companies.
Audit fees
- consolidated financial statements
- statutory financial statements
Audit-related fees 1)
- acquisitions and divestments
- sustainability assurance
- other
Tax fees 2)
- tax compliance services
Other fees
- royalty investigation
- other
Fees KPMG
2012
14.7
9.7
5.0
5.6
2.9
0.8
1.9
1.3
1.3
0.7
0.1
0.6
2013
15.6
10.1
5.5
2.2
0.4
0.7
1.1
0.8
0.8
1.3
0.0
1.3
2014
14.9
9.6
5.3
3.9
2.4
0.6
0.9
0.2
0.2
0.0
0.0
0.0
22.3
19.9
19.0
1) The percentage of audit-related fees in 2014 is 20.5% of the total fees
2) The percentage of tax fees in 2014 is 1.1% of the total fees
This table ’Fees KPMG’ forms an integral part of the
Company Financial Statements, please refer to note B,
Audit fees.
Impairment of goodwill
In 2014, goodwill impairment charges amount to EUR 3
million consisting of impairments on divested
businesses in Healthcare and Lighting. In 2013, goodwill
Annual Report 2014
133
Group financial statements 12.9
7
impairment charges amounted to EUR 28 million,
including EUR 26 million as result of reduced growth
expectations in Consumer Luminaires, see note 11,
Goodwill.
7 Financial income and expenses
Philips Group
Financial income and expenses in millions of EUR
2012 - 2014
Other business income (expenses)
Other business income (expenses) consists of the
following:
Philips Group
Other business income (expenses) in millions of EUR
2012 - 2014
Result on disposal of businesses:
- income
- expense
Result on disposal of fixed assets:
- income
- expense
Result on other remaining businesses:
- income
- expense
Other business income (expenses)
Total other business income
Total other business expense
2012
2013
2014
9
(84)
222
(7)
41
(507)
(326)
272
(598)
50
(1)
18
(13)
54
(21)
87
122
(35)
7
(2)
18
(1)
38
(271)
(211)
63
(274)
In 2014, result on disposal of businesses was mainly due
to divestment of non-strategic businesses. For further
information, see note 4, Acquisitions and divestments.
In 2014, result on disposal of fixed assets was mainly
due to sale of real estate assets.
In 2014, result on other remaining businesses mainly
relates to certain parts of the Cathode Ray Tube
antitrust litigation as mentioned in note 26, Contingent
assets and liabilities for which the Company concluded
it was able to make a reliable estimate of the cash
outflow or was able to reach a settlement with the
relevant plaintiffs.
Interest income
Interest income from loans and
receivables
Interest income from cash and
cash equivalents
Dividend income from available for
sale financial assets
Net gains from disposal of financial
assets
Net change in fair value of financial
liabilities at fair value through profit
or loss
Other financial income
Financial income
Interest expense
Interest on debt and borrowings
Finance charges under finance
lease contract
Interest expenses - pensions
Provision-related accretion and
interest
Net foreign exchange losses
Impairment loss of financial assets
Net change in fair value of financial
assets at fair value through profit or
loss
Net change in fair value of financial
liabilities at fair value through profit
or loss
Other financial expenses
Financial expense
Financial income and expenses
2012
2013
2014
37
20
17
4
1
44
20
106
(363)
(271)
(7)
(85)
(22)
–
(8)
54
32
22
5
–
–
11
70
(323)
(245)
(7)
(71)
(25)
(6)
(10)
39
22
17
4
60
–
11
114
(290)
(224)
(7)
(59)
(80)
(1)
(17)
(2)
(9)
(6)
–
(40)
(435)
(329)
(3)
(24)
(400)
(330)
(2)
(19)
(415)
(301)
Net financial income and expense showed a EUR 301
million expenses in 2014, which was 29 million lower
than in 2013. Interest expense in 2014 was EUR 33
million lower than in 2013, mainly as a result of lower
average outstanding debt and lower interest related to
pensions. The gain from disposal of financial assets in
2014 amounted to EUR 60 million, mainly from Neusoft,
Chimei Innolux, Gilde III and Sapiens. The impairment
charges in 2014 amounted to EUR 17 million, mainly
from shareholdings in Chimei Innolux, Prime
Technology, Timesys and loans to Open Gate Capital.
Provision-related accretion and interest in 2014
primarily consisted of interest expense related to the
jury verdict in the Masimo litigation, and accretion
expense associated with other discounted provisions
and uncertain tax positions.
Interest expense in 2013 was EUR 40 million lower than
in 2012, mainly as a result of lower average outstanding
debt and lower interest related to pensions in 2013. In
2013 impairment charges amounted to EUR 10 million,
mainly from shareholdings in Lighting Science Group
and Gilde III.
134
Annual Report 2014
Net financial income and expense showed a EUR 329
million expense in 2012. Total financial income of EUR
106 million included a EUR 46 million gain related to a
change in estimate on the valuation of long term
derivative contracts.
8
Income taxes
The tax expense on income before tax of continuing
operations amounted to EUR 26 million (2013: EUR 466
million, 2012: EUR 218 million).
The components of income before taxes and income
tax expense are as follows:
Philips Group
Income tax expense in millions of EUR
2012 - 2014
Netherlands
Foreign
Income before taxes of continuing
operations
Netherlands:
Current tax income (expense)
Deferred tax income (expense)
Total tax expense (Netherlands)
Foreign:
Current tax expense
Deferred tax income (expense)
Total tax expense (foreign)
Income tax expense of continuing
operations
Income tax expense of discontinued
operations
Income tax expense
2012
2013
(186)
449
281
1,244
2014
665
(480)
263
1,525
185
(74)
13
(61)
(283)
143
(140)
–
(107)
(107)
(280)
(89)
(369)
17
(29)
(12)
(275)
250
(25)
(218)
(466)
(26)
17
(10)
(201)
(476)
(11)
(37)
The components of income tax expense are as follows:
Philips Group
Current income tax expense in millions of EUR
2012 - 2014
Current tax expense
Prior year results
Current tax expense
2012
(369)
12
2013
(268)
(12)
2014
(281)
23
(357)
(280)
(258)
Philips Group
Deferred income tax expense in millions of EUR
2012 - 2014
Recognition of previously
unrecognized tax losses
Current year tax loss carried
forwards not recognized
Temporary differences (not
recognized) recognized
Prior year results
Tax rate changes
Origination and reversal of
temporary differences
Deferred tax income (expense)
2012
2013
2014
1
20
18
(50)
(29)
(65)
2
(2)
(4)
(3)
15
–
209
156
(199)
(196)
(47)
34
12
269
221
8
Group financial statements 12.9
Philips’ operations are subject to income taxes in
various foreign jurisdictions. The statutory income tax
rates vary from 10.0% to 39.4%, which results in a
difference between the weighted average statutory
income tax rate and the Netherlands’ statutory income
tax rate of 25.0% (2013: 25.0%; 2012: 25.0%).
A reconciliation of the weighted average statutory
income tax rate to the effective income tax rate of
continuing operations is as follows:
Philips Group
Effective tax rate in %
2012 - 2014
Weighted average statutory income
tax rate in %
30.0
29.2
7.9
2012
2013
2014
Tax rate effect of:
Changes related to:
- utilization of previously reserved
loss carryforwards
(0.2)
(1.3)
(9.6)
- new loss carryforwards not
expected to be realized
- addition (releases) of temporary
differences not expected to be
realized
Non-tax-deductible impairment
charges
Non-taxable income
Non-tax-deductible expenses
Withholding and other taxes
Tax rate changes
Prior year tax results
Tax expenses due to other liabilities
Tax incentives and other
Effective tax rate
19.1
1.9
34.9
(0.7)
0.2
25.5
0.8
(22.7)
83.3
8.3
1.4
(3.7)
8.2
(40.9)
82.9
0.7
(8.9)
8.1
0.9
0.0
(0.2)
0.3
(0.3)
30.6
1.8
(100.1)
51.6
13.4
(6.3)
(30.8)
5.6
20.2
14.1
The weighted average statutory income tax rate
decreased in 2014 compared to 2013, as a consequence
of a significant change in the mix of profits and losses
in the various countries.
The effective income tax rate is higher than the
weighted average statutory income tax rate in 2014,
mainly due to the non-deductible expenses, new loss
carryforwards and temporary differences not expected
to be realized which are partly offset by non-taxable
income. Non-taxable income is predominantly
attributable to favorable tax regulations relating to R&D
investments.
Annual Report 2014
135
Group financial statements 12.9
Deferred tax assets and liabilities
Net deferred tax assets relate to the following balance sheet captions and tax loss carryforwards (including tax credit
carryforwards), of which the movements during the years 2014 and 2013 respectively are as follows:
Philips Group
Deferred tax assets and liabilities in millions of EUR
2014
Intangible assets
Property, plant and equipment
Inventories
Prepaid pension assets
Other receivables
Other assets
Provisions:
- pensions
- guarantees
- termination benefits
- other postretirement benefits
- other provisions
Other liabilities
Deferred tax assets on tax loss
carryforwards (including tax credit
carryforwards)
Net deferred tax assets
Balance as of
January 1,
2014
recognized in
income
recognized in
OCI
acquisitions/
divestments
(871)
58
264
(1)
50
32
426
29
97
57
567
192
699
1,599
59
9
24
(40)
6
(8)
(49)
(25)
23
2
126
(1)
95
221
–
–
–
139
–
(9)
146
–
(13)
4
(7)
2
190
452
(40)
–
–
–
–
–
–
–
–
–
–
–
1
(39)
Balance as of
December 31,
2014
(980)
other1)
(128)
6
23
–
(7)
9
39
–
2
8
97
16
55
120
73
311
98
49
24
562
4
109
71
783
209
1,040
2,353
Philips Group
Deferred tax assets and liabilities in millions of EUR
2013
Intangible assets
Property, plant and equipment
Inventories
Prepaid pension costs
Other receivables
Other assets
Provisions:
- pensions
- guarantees
- termination benefits
- other postretirement benefits
- other provisions
Other liabilities
Deferred tax assets on tax loss
carryforwards (including tax credit
carryforwards)
Net deferred tax assets
Balance as of
January 1,
2013
recognized in
income
recognized in
OCI
acquisitions/
divestments
Balance as of
December 31,
2013
other1)
(928)
68
258
–
55
42
598
26
118
72
605
171
742
1,827
13
–
9
(24)
(3)
(4)
(70)
4
(28)
(5)
(32)
27
(83)
(196)
–
–
–
23
1
(2)
(82)
–
8
(7)
16
–
(11)
(54)
–
–
–
–
–
(1)
–
–
–
–
–
–
–
(1)
44
(10)
(3)
–
(3)
(3)
(20)
(1)
(1)
(3)
(22)
(6)
51
23
(871)
58
264
(1)
50
32
426
29
97
57
567
192
699
1,599
1) Primarily includes foreign currency translation differences which were recognized in OCI
136
Annual Report 2014
Deferred tax assets and liabilities relate to the balance
sheet captions, as follows:
Philips Group
Deferred tax assets and liabilities in millions of EUR
2013 - 2014
assets
liabilities
net
2014
Intangible assets
Property, plant and equipment
Inventories
Prepaid pension costs
Other receivables
Other assets
Provisions:
- pensions
- guarantees
- termination benefits
- other postretirement
- other
Other liabilities
Deferred tax assets on tax loss
carryforwards (including tax
credit carryforwards)
Total allocations
Set-off of deferred tax positions
Net deferred tax assets
2013
Intangible assets
Property, plant and equipment
Inventories
Prepaid pension costs
Other receivables
Other assets
Provisions:
- pensions
- guarantees
- termination benefits
- other postretirement
- other
Other liabilities
Deferred tax assets on tax loss
carryforwards (including tax
credit carryforwards)
Set-off of deferred tax positions
Net deferred tax assets
114
120
317
99
58
45
562
4
109
71
791
226
(1,094)
(980)
(47)
(6)
(1)
(9)
(21)
–
–
–
–
(8)
(17)
73
311
98
49
24
562
4
109
71
783
209
1,040
3,556
(1,096)
2,460
–
(1,203)
1,096
1,040
2,353
–
(107)
2,353
116
107
271
1
60
48
426
29
97
57
581
213
(987)
(49)
(7)
(2)
(10)
(16)
–
–
–
–
(14)
(21)
(871)
58
264
(1)
50
32
426
29
97
57
567
192
699
2,705
(1,030)
1,675
–
699
(1,106)
1,599
1,030
–
(76)
1,599
Deferred tax assets are recognized for temporary
differences, unused tax losses, and unused tax credits
to the extent that realization of the related tax benefits
is probable. The ultimate realization of deferred tax
assets is dependent upon the generation of future
taxable income in the countries where the deferred tax
assets originated and during the periods when the
deferred tax assets become deductible. Management
considers the scheduled reversal of deferred tax
liabilities, projected future taxable income, and tax
planning strategies in making this assessment.
Group financial statements 12.9
The net deferred tax assets of EUR 2,353 million (2013:
EUR 1,599 million) consist of deferred tax assets of EUR
2,460 million (2013: EUR 1,675 million) in countries with
a net deferred tax asset position and deferred tax
liabilities of EUR 107 million (2013: EUR 76 million) in
countries with a net deferred tax liability position. Of the
total deferred tax assets of EUR 2,460 million at
December 31, 2014, (2013: EUR 1,675 million), EUR 1,352
million (2013: EUR 543 million) is recognized in respect
of fiscal entities in various countries where there have
been fiscal losses in the current or preceding period.
Management’s projections support the assumption that
it is probable that the results of future operations will
generate sufficient taxable income to utilize these
deferred tax assets.
At December 31, 2014 and 2013, there were no
recognized deferred tax liabilities for taxes that would
be payable on the unremitted earnings of certain
foreign subsidiaries of Philips Holding USA since it has
been determined that undistributed profits of such
subsidiaries will not be distributed in the foreseeable
future. The temporary differences associated with the
investments in subsidiaries of Philips Holding USA, for
which a deferred tax liability has not been recognized,
aggregate to EUR 47 million (2013: EUR 32 million).
At December 31, 2014, operating loss carryforwards
expire as follows:
Philips Group
Expiry year operating loss carryforwards in millions of EUR
Total
2015
2016
2017
2018 2019
2020/
2024
later
un-
limi-
ted
5,889
–
–
5
4
14
817
1,114
3,935
The Company also has tax credit carryforwards of EUR
174 million, which are available to offset future tax, if
any, and which expire as follows:
Philips Group
Expiry year tax credit carryforwards in millions of EUR
Total 2015
2016
2017
2018 2019
2020/
2024
later
un-
limi-
ted
174
1
–
4
3
26
104
29
7
At December 31, 2014, operating loss and tax credit
carryforwards for which no deferred tax assets have
been recognized in the balance sheet, expire as follows:
Philips Group
Operating loss and tax credit carryforwards for which
no deferred tax asset has been recognized in millions of EUR
Total
2015
2016
2017
2018 2019
2020/
2024
later
un-
limi-
ted
2,136
–
–
1
3
2
55
18
2,057
At December 31, 2014, the amount of deductible
temporary differences for which no deferred tax asset
has been recognized in the balance sheet is EUR 190
million (2013: EUR 151 million).
Annual Report 2014
137
Group financial statements 12.9
Classification of the income tax payable and receivable
is as follows:
Philips Group
Income tax payable and receivable in millions of EUR
2013 - 2014
Income tax receivable
Income tax receivable - under non-current
receivables
Income tax payable
Income tax payable - under non-current
liabilities
2013
70
–
(143)
2014
140
–
(102)
(1)
(1)
Tax risks
Philips is exposed to tax uncertainties. These
uncertainties include amongst others the following:
Transfer pricing uncertainties
Philips has issued transfer pricing directives, which are
in accordance with international guidelines such as
those of the Organization of Economic Co-operation
and Development. As transfer pricing has a cross-
border effect, the focus of local tax authorities on
implemented transfer pricing procedures in a country
may have an impact on results in another country. In
order to reduce the transfer pricing uncertainties,
monitoring procedures are carried out by Group Tax
and Internal Audit to safeguard the correct
implementation of the transfer pricing directives.
Tax uncertainties on general and specific
service agreements and licensing agreements
Due to the centralization of certain activities in a limited
number of countries (such as research and
development, centralized IT, group functions and head
office), costs are also centralized. As a consequence,
these costs and/or revenues must be allocated to the
beneficiaries, i.e. the various Philips entities. For that
purpose, specific allocation contracts for costs and
revenues, general service agreements and licensing
agreements are signed with a large number of group
entities. Tax authorities review the implementation of
these intra-group service and licensing agreements or
audit the use of tax credits attached to the resulting
service fee and royalty payments, and may reject the
implemented procedures. Furthermore, buy in/out
situations in the case of (de)mergers could affect the
cost allocation resulting from the service agreements
between countries. The same applies to the specific
allocation contracts.
Tax uncertainties due to disentanglements and
acquisitions
When a subsidiary of Philips is disentangled, or a new
company is acquired, related tax uncertainties arise.
Philips creates merger and acquisition (M&A) teams for
these disentanglements or acquisitions. In addition to
representatives from the involved sector, these teams
consist of specialists from various group functions and
are formed, amongst other things, to identify hidden tax
uncertainties that could subsequently surface when
companies are acquired and to reduce tax claims
related to disentangled entities. These tax uncertainties
are investigated and assessed to mitigate tax
uncertainties in the future of the extent possible.
Several tax uncertainties may surface from M&A
activities. Examples of uncertainties are: applicability of
the participation exemption, allocation issues, and
non-deductibility of parts of the purchase price.
Tax uncertainties due to permanent
establishments
In countries where Philips starts new operations or
alters business models, the issue of permanent
establishment may arise. This is because when
operations in a country involves a Philips organization
in another country, there is a risk that tax claims will
arise in the former country as well as in the latter
country.
138
Annual Report 2014
9
Group financial statements 12.9
9 Earnings per share
Philips Group
Earnings per share in millions of EUR unless stated otherwise1)
2012 - 2014
Income (loss) from continuing operations
Income (loss) attributable to non-controlling interest
Income (loss) from continuing operations attributable
to shareholders
Income from discontinued operations
Net income (loss) attributable to shareholders
Weighted average number of common shares
outstanding (after deduction of treasury shares) during
the year
Plus incremental shares from assumed conversions of:
Options and restricted share rights
Convertible debentures
Dilutive potential common shares
Adjusted weighted average number of shares (after
deduction of treasury shares) during the year
Basic earnings per common share in EUR2)
Income (loss) from continuing operations
Income from discontinued operations
Income (loss) from continuing operations attributable to
shareholders
Net income (loss) attributable to shareholders
Diluted earnings per common share in EUR2,3,4)
Income (loss) from continuing operations
Income from discontinued operations
Income (loss) from continuing operations attributable to
shareholders
Net income (loss) attributable to shareholders
Dividend distributed per common share in euros
2012
2013
2014
(166)
5
(171)
136
(35)
1,034
3
1,031
138
1,169
221
(4)
225
190
415
922,101,005
911,071,970
915,192,683
5,014,991
106,204
10,896,583
103,899
7,521,591
–
5,121,195
11,000,482
7,521,591
927,222,200
922,072,452
922,714,274
(0.18)
0.15
(0.19)
(0.04)
(0.18)
0.15
(0.19)
(0.04)
0.75
1.13
0.15
1.13
1.28
1.12
0.15
1.12
1.27
0.75
0.24
0.21
0.25
0.45
0.24
0.21
0.24
0.45
0.80
1) Shareholders in this table refer to shareholders of Koninklijke Philips N.V.
2) The effect on income of convertible debentures affecting earnings per share is considered immaterial
3)
In 2014, 2013 and 2012, respectively 19 million, 14 million and 36 million securities that could potentially dilute basic EPS were not included in the computation of
dilutive EPS because the effect would have been antidilutive for the periods presented
4) The Dilutive potential common shares are not taken into account in the periods for which there is a loss, as the effect would be antidilutive
Annual Report 2014
139
Group financial statements 12.9
10
10 Property, plant and equipment
Philips Group
Property, plant and equipment in millions of EUR
2014
Balance as of January 1, 2014:
Cost
Accumulated depreciation
Book value
Change in book value:
Capital expenditures
Assets available for use
Acquisitions
Disposals and sales
Depreciation
Impairments
Transfer to assets classified as held
for sale
Translation differences
Total changes
Balance as of December 31, 2014:
Cost
Accumulated depreciation
Book value
land and buildings
machinery and
installations
other equipment
prepayments and
construction in
progress
1,899
(872)
1,027
6
79
7
–
(91)
(26)
(190)
60
(155)
1,803
(931)
872
3,948
(2,885)
1,063
86
220
6
(5)
(295)
(74)
(451)
57
(456)
3,127
(2,520)
607
1,586
(1,155)
431
68
132
4
(7)
(178)
(21)
(10)
28
16
1,745
(1,298)
447
259
–
259
368
(431)
2
–
–
(1)
(37)
9
(90)
169
–
169
Philips Group
Property, plant and equipment in millions of EUR
2013
land and buildings
machinery and
installations
other equipment
prepayments and
construction in
progress
Balance as of January 1, 2013:
Cost
Accumulated depreciation
Book value
Change in book value:
Capital expenditures
Assets available for use
Acquisitions
Disposals and sales
Depreciation
Impairments
Transfer to assets classified as held
for sale
Translation differences
Total changes
Balance as of December 31, 2013:
Cost
Accumulated depreciation
Book value
1,924
(835)
1,089
8
79
–
(1)
(87)
(15)
(17)
(29)
(62)
1,899
(872)
1,027
4,004
(2,851)
1,153
88
244
–
(14)
(321)
(26)
(4)
(57)
(90)
3,948
(2,885)
1,063
1,658
(1,235)
423
61
160
–
(7)
(163)
(22)
(4)
(17)
8
1,586
(1,155)
431
294
–
294
461
(483)
–
(4)
–
–
–
(9)
(35)
259
–
259
total
7,692
(4,912)
2,780
528
–
19
(12)
(564)
(122)
(688)
154
(685)
6,844
(4,749)
2,095
total
7,880
(4,921)
2,959
618
–
–
(26)
(571)
(63)
(25)
(112)
(179)
7,692
(4,912)
2,780
Land with a book value of EUR 89 million at December
31, 2014 (2013: EUR 133 million) is not depreciated.
Impairment charges of EUR 49 million are related to
industrial assets in Lighting in 2014. Transfer to assets
classified as held for sale in 2014 mainly relate to
combined businesses of Lumileds and Automotive.
Property, plant and equipment includes financial lease
assets with a book value of EUR 192 million at
December 31, 2014 (2013: EUR 187 million).
The expected useful lives of property, plant and
equipment are as follows:
Philips Group
Useful lives of property, plant and equipment in years
Buildings
Machinery and installations
Other equipment
from 5 to 50
from 3 to 20
from 1 to 10
140
Annual Report 2014
11 Goodwill
The changes in 2013 and 2014 were as follows:
Philips Group
Goodwill in millions of EUR
2013 - 2014
Balance as of January 1:
Cost
2013
2014
9,119
8,596
Imaging Systems
Respiratory Care & Sleep Management
Amortization and impairments
(2,171)
(2,092)
Patient Care & Monitoring Solutions
6,948
6,504
Professional Lighting Solutions
11
Group financial statements 12.9
goodwill for the Group at December 31, 2014. The
amounts associated as of December 31, 2014, are
presented below:
Philips Group
Goodwill allocated to the cash-generating units in millions of EUR
2013 - 2014
2013
1,544
1,414
1,0631)
1,266
1,217
6,504
2014
1,704
1,592
1,317
1,470
1,075
7,158
Other (units carrying a non-significant
goodwill balance)
Book value
1) Revised to reflect the new organizational structure of the Healthcare
sector
The basis of the recoverable amount used in the
impairment tests for the units disclosed in this note is
the value in use. In the 2014 annual impairment test,
performed in the second quarter, and in the tests
performed in the second half of 2014, the estimated
recoverable amounts of the cash-generating units
tested approximated or exceeded the carrying value of
the units, therefore no impairment loss was recognized.
Key assumptions used in the impairment tests for the
units were sales growth rates, income from operations
and the rates used for discounting the projected cash
flows. These cash flow projections were determined
using management’s internal forecasts that cover an
initial period from 2014 to 2018 that matches the period
used for our strategic process. Projections were
extrapolated with stable or declining growth rates for a
period of 5 years, after which a terminal value was
calculated. For terminal value calculation, growth rates
were capped at a historical long-term average growth
rate.
The sales growth rates and margins used to estimate
cash flows are based on past performance, external
market growth assumptions and industry long-term
growth averages.
Income from operations in all units is expected to
increase over the projection period as a result of volume
growth and cost efficiencies.
Cash flow projections of Respiratory Care & Sleep
Management, Imaging Systems, Patient Care &
Monitoring Solutions and Professional Lighting
Solutions for 2014 were based on the key assumptions
included in the table below. These assumptions are
based on the annual impairment test performed in the
second quarter except for the unit Professional Lighting
Solutions which performed an updated test in Q4 2014
given the acquisition of GLC in the second half of the
year.
Annual Report 2014
141
Book value
Changes in book value:
Acquisitions
Purchase price allocation adjustment
Impairments
Divestments and transfers to assets classified as
held for sale
Translation differences
Balance as of December 31:
Cost
Amortization and impairments
Book value
4
(4)
(26)
(55)
(363)
68
8
–
(160)
738
8,596
9,151
(2,092)
(1,993)
6,504
7,158
Acquisitions in 2014 which included goodwill mainly
related to the acquisition of General Lighting Company
(GLC) for EUR 58 million. In addition, goodwill changed
due to the finalization of purchase price accounting
related to acquisitions in the prior year. Divestments
and transfer to assets classified as held for sale in 2014
relate to the sectors Healthcare and Lighting. In 2014
the movement of EUR 738 million in translation
differences is mainly explained by the increase of the
USD/EUR rate which impacted the goodwill nominated
in USD.
In 2013 the movement of EUR 55 million in divestments
and transfers to assets classified as held for sale mainly
relate to divestments in the Healthcare sector.
For impairment testing, goodwill is allocated to (groups
of) cash-generating units (typically one level below
operating sector level), which represent the lowest level
at which the goodwill is monitored internally for
management purposes.
In 2014, a cash-generating unit Healthcare Informatics
Services & Solutions was created in the Healthcare
sector. As a result of the change, a portion of the
goodwill associated with the unit Patient Care & Clinical
Informatics and the unit Home Monitoring was
allocated to Healthcare Informatics Services &
Solutions. The name of the cash-generating unit
Patient Care & Clinical Informatics was changed in 2014
to Patient Care & Monitoring Solutions.
Goodwill allocated to the cash-generating units
Respiratory Care & Sleep Management, Imaging
Systems, Patient Care & Monitoring Solutions and
Professional Lighting Solutions is considered to be
significant in comparison to the total book value of
The results of the annual impairment test of Imaging
Systems and Patient Care & Monitoring Solutions have
indicated that a reasonably possible change in key
assumptions would not cause the value in use to fall to
the level of the carrying value.
Impairment charge 2013
In the fourth quarter of 2013, the updated impairment
test for Consumer Luminaires resulted in EUR 26 million
impairment. This was mainly a consequence of reduced
growth rate due to slower anticipated recovery of
certain markets and introduction delays of new product
ranges. The pre-tax discount rate applied in the
mentioned Q4 2013 test was 13.5%. The pre-tax
discount rate applied in the 2013 annual impairment
test was 13.4%. Compared to the previous impairment
test there has been no change in the organization
structure which impacts how goodwill is allocated to
this cash-generating unit.
Additional information 2014
In addition to the units with significant goodwill, other
cash-generating units are sensitive to fluctuations in
the assumptions as set out above.
Based on the most recent impairment test, it was noted
that the headroom for the cash-generating unit Home
Monitoring was EUR 30 million. An increase of 150
points in the pre-tax discount rate, a 310 basis points
decline in the compound long-term sales growth rate
or a 21% decrease in terminal value would cause its
value in use to fall to the level of its carrying value. The
goodwill allocated to Home Monitoring at December 31,
2014 amounts to EUR 34 million.
Based on the most recent impairment test, it was noted
that with regard to the headroom for the cash-
generating unit Consumer Luminaires the estimated
recoverable amount approximates the carrying value of
this cash-generating unit. Consequently, any adverse
change in key assumptions would, individually, cause
an impairment loss to be recognized. The goodwill
allocated to Consumer Luminaires at December 31,
2014 amounts to EUR 112 million.
Please refer to note 2, Information by sector and main
country for a specification of goodwill by sector.
Group financial statements 12.9
Philips Group
Key assumptions in %
2014
compound sales growth rate1)
initial
forecast
period
extra-
polation
period2)
used to
calculate
terminal
value
pre-tax
discount
rates
4.2
3.3
4.9
10.1
3.6
3.1
3.8
6.5
2.7
2.7
2.7
2.7
11.4
12.8
12.8
13.8
Respiratory Care &
Sleep Management
Imaging Systems
Patient Care &
Monitoring
Solutions
Professional
Lighting Solutions
1) Compound sales growth rate is the annualized steady growth rate over
the forecast period
2) Also referred to later in the text as compound long-term sales growth
rate
The assumptions used for the 2013 cash flow
projections were as follows:
Philips Group
Key assumptions in %
2013
compound sales growth rate1)
initial
forecast
period
extra-
polation
period2)
used to
calculate
terminal
value
pre-tax
discount
rates
Respiratory Care &
Sleep Management
Imaging Systems
Patient Care &
Clinical Informatics
Professional
Lighting Solutions
4.9
3.9
4.1
7.4
3.7
3.4
3.5
5.4
2.7
2.7
2.7
2.7
11.3
12.4
13.2
12.8
1) Compound sales growth rate is the annualized steady growth rate over
the forecast period
2) Also referred to later in the text as compound long-term sales growth
rate
Among the mentioned units, Respiratory Care & Sleep
Management and Professional Lighting Solutions have
the highest amount of goodwill and the lowest excess
of the recoverable amount over the carrying amount.
Based on the annual impairment test performed in the
second quarter, the headroom of Respiratory Care &
Sleep Management was estimated at EUR 820 million.
Based on the updated test performed in Q4, the
headroom of Professional Lighting Solutions was
estimated at EUR 1,000 million. The following changes
could, individually, cause the value in use to fall to the
level of the carrying value:
Philips Group
Sensitivity analysis
increase in
pre-tax
discount rate,
basis points
decrease in
compound
long-term
sales growth
rate, basis
points
decrease in
terminal value
amount, %
380
680
400
1,030
49
47
Respiratory
Care & Sleep
Management
Professional
Lighting
Solutions
142
Annual Report 2014
12
Group financial statements 12.9
12
Intangible assets excluding goodwill
The changes were as follows:
Philips Group
Intangible assets excluding goodwill in millions of EUR
2014
other intangible assets
product development
software
total
Balance as of January 1, 2014:
Cost
Amortization/ impairments
Book value
Changes in book value:
Additions
Acquisitions
Purchase price allocation adjustment
Amortization
Impairments
Divestments and transfers to assets
classified as held for sale
Translation differences
Total changes
Balance as of December 31, 2014:
Cost
Amortization/ impairments
Book Value
5,533
(3,173)
2,360
15
170
(8)
(355)
(1)
(62)
231
(10)
5,721
(3,371)
2,350
1,761
(916)
845
323
2
(231)
(25)
(96)
71
44
1,853
(964)
889
344
(287)
57
101
1
(31)
(2)
–
3
72
446
(317)
129
7,638
(4,376)
3,262
439
173
(8)
(617)
(28)
(158)
305
106
8,020
(4,652)
3,368
Philips Group
Intangible assets excluding goodwill in millions of EUR
2013
other intangible assets
product development
software
total
Balance as of January 1, 2013:
Cost
Amortization/ impairments
Book value
Changes in book value:
Additions
Acquisitions
Amortization
Impairments
Reversal of impairment
Divestments and transfer to assets
classified as held for sale
Translation differences
Other
Total changes
Balance as of December 31, 2013:
Cost
Amortization/ impairments
Book value
5,868
(2,972)
2,896
19
15
(387)
(50)
5
(28)
(118)
8
(536)
5,533
(3,173)
2,360
The additions for 2014 contain internally generated
assets of EUR 323 million for product development, and
EUR 83 million for software. (2013: EUR 357 million, EUR
0 million). The acquisitions through business
combinations in 2014 mainly consist of the acquired
intangible assets of General Lighting Company (GLC)
for EUR 158 million.
1,584
(817)
767
357
–
(213)
(33)
–
(9)
(25)
1
78
1,761
(916)
845
369
(301)
68
30
–
(37)
(2)
–
(1)
(1)
–
(11)
344
(287)
57
7,821
(4,090)
3,731
406
15
(637)
(85)
5
(38)
(144)
9
(469)
7,638
(4,376)
3,262
In addition, other intangible fixed assets changed due
to the finalization of purchase price accounting related
to acquisitions in the prior year. Transfer to assets
classified as held for sale in 2014 mainly relate to
combined businesses of Lumileds and Automotive.
The impairment charges in 2013 include an impairment
charge of EUR 24 million in Imaging Systems, which
relate to capitalized product development for EUR 7
million and other intangibles for EUR 17 million. The
impairment charge is based on a trigger-based test on
Annual Report 2014
143
Group financial statements 12.9
13
a specific business unit in Imaging Systems. A change in
the business outlook coming from a slower than
expected sales ramp up resulted in the mentioned
impairment charge. The basis of the recoverable
amount used in this test is the value in use and a pre-
tax discount rate of 9,6% is applied. After the
impairment charge the carrying value of the related
intangible assets is zero.
The impairment charges in 2013 include an impairment
charge of EUR 32 million for customer relationships in
Consumer Luminaires. The charge is based on a trigger-
based test on specific mature markets following the
initiated turnaround plan, reconsidering product ranges
and growth rates. The basis of the recoverable amount
used in this test is the value in use and a pre-tax
discount rate of 11.4% is applied. After the impairment
charge the carrying value of the related intangible
assets is zero.
The weighted average expected remaining life of other
intangible assets is 8.5 years as of December 31, 2014
(2013: 8.5 years).
The capitalized product development costs and
software for which amortization has not yet
commenced amounted to EUR 450 million as of
December 31, 2014 (2013: EUR 356 million).
At December 31, 2014 the carrying amount of customer
relationships of Respiratory Care & Sleep Management
was EUR 468 million (USD 569 million) with a remaining
amortization period of 9.2 years (2013: EUR 459 million,
USD 633 million; 10.2 years).
13 Other financial assets
Other non-current financial assets
The changes during 2014 were as follows:
The amortization of intangible assets is specified in
note 6, Income from operations.
Philips Group
Other non-current financial assets in millions of EUR
2014
availa-
ble-for-
sale fi-
nancial
assets
loans
and re-
ceiva-
bles
held-
to-ma-
turity
invest-
ments
finan-
cial as-
sets at
fair val-
ue
through
profit or
loss
total
192
273
3
28
496
5
(119)
23
69
(15)
(10)
(38)
50
3
(2)
(3)
–
6
2
210
226
–
1
–
(1)
–
–
(1)
2
–
–
(2)
–
–
(7)
5
(114)
93
(19)
(14)
(38)
49
9
24
462
Balance as of
January 1, 2014
Changes:
Reclassifica-
tions
Acquisitions/
additions
Sales/
redemptions/
reductions
Impairment
Transfer to
assets
classified as
held for sale
Value
adjustments
Translation and
exchange
differences
Balance as of
December 31,
2014
Available-for-sale financial assets
The Company’s investments in available-for-sale
financial assets mainly consist of investments in
common stock of companies in various industries. An
amount of EUR 38 million has been reclassified to
assets held for sale mainly relating to the contribution
agreement between the Philips Pension Fund, Philips
and Dutch trade unions on July 1, 2013.
Other intangible assets consist of:
Philips Group
Amortization of other intangible assets in millions of EUR
2013 -2014
Balance as of
December 31,
2013
amortization/
impairments
gross
Brand names
909
(424)
Customer
relationships
Technology
Other
Other
intangibles
2,856
1,678
90
(1,447)
(1,226)
(76)
Balance as of
December 31,
2014
amortization/
impairments
(497)
(1,622)
(1,151)
(101)
gross
1,018
3,045
1,543
115
5,533
(3,173)
5,721
(3,371)
The estimated amortization expense for other
intangible assets for each of the next five years is:
Philips Group
Estimated amortization expense for other intangible assets
in years
2015
2016
2017
2018
2019
The expected useful lives of the intangible assets
excluding goodwill are as follows:
Philips Group
Expected useful lives of intangible assets excluding goodwill
in years
Brand names
Customer relationships
Technology
Other
Software
Product development
144
Annual Report 2014
321
290
265
259
244
2-20
2-25
3-20
1-8
1-10
3-7
14
15
16
Group financial statements 12.9
Loans and receivables
The reclassification line includes loans of EUR 121
million transferred to Current financial assets (see
below). The acquisitions/additions line mainly relates
to a new loan of EUR 60 million issued to TPV
Technology Limited.
Financial assets at fair value through profit or loss
In 2010 Philips sold its entire holding of common shares
in NXP Semiconductors B.V. (NXP) to Philips Pension
Trustees Limited (herein referred to as “UK Pension
Fund”). The purchase agreement with the UK Pension
Fund included an arrangement that entitled Philips to
a cash payment from the UK Pension Fund on or after
September 7, 2014, if certain conditions were met. As of
December 31, 2013, management’s best estimate of the
fair value of the arrangement was EUR 7 million. At the
date of expiration on September 7, 2014 the
arrangement did not represent any value. The decline
in fair value in 2014 is reported under value adjustments
in the table above and also recognized in Financial
income and expense.
Current financial assets
The amount of EUR 125 million mostly relates to loans
issued to TPV Technology Limited. These loans are due
in 2015 and have therefore been reclassified from non-
current to Current financial assets.
14 Other assets
sale. For more details, please refer to note 3,
Discontinued operations and other assets classified as
held for sale.
The write-down of inventories to net realizable value
amounted in 2014 to EUR 217 million (2013: EUR 178
million). The write-down is included in cost of sales.
16 Receivables
Non-current receivables
Non-current receivables are associated mainly with
customer financing in Healthcare and insurance
receivables in Innovation, Group & Services. The
balance as per December 31, 2014 includes an
allowance for doubtful accounts of EUR 2 million (2013:
EUR 7 million).
Current receivables
The accounts receivable, net, per sector are as follows:
Philips Group
Accounts receivables-net in millions of EUR
2013 - 2014
Healthcare
Consumer Lifestyle
Lighting
Innovation, Group & Services
Accounts receivable-net
2013
1,978
743
2014
2,112
791
1,567
1,438
132
135
4,420
4,476
Other non-current assets
Other non-current assets in 2014 are comprised of
prepaid pension costs of EUR 2 million (2013: EUR 5
million) and prepaid expenses of EUR 67 million (2013:
EUR 58 million).
The balance of Lighting accounts receivables as per
December 31, 2014 excludes EUR 274 million of account
receivables associated with Lumileds and Automotive
businesses and classified as Assets held for sale. For
more details, please refer to note 3, Discontinued
operations and other assets classified as held for sale.
For further details see note 20, Post-employment
benefits.
The aging analysis of accounts receivable, net, is set out
below:
Other current assets
Other current assets include prepaid expenses of EUR
411 million (2013: EUR 354 million).
Philips Group
Aging analysis in millions of EUR
2013 - 2014
15
Inventories
Inventories are summarized as follows:
current
overdue 1-30 days
overdue 31-180 days
overdue > 180 days
2013
3,671
287
305
157
2014
3,719
251
335
171
Accounts receivable-net
4,420
4,476
The above net accounts receivable represent current
and overdue but not impaired receivables.
Philips Group
Inventories in millions of EUR
2013 - 2014
Raw materials and supplies
Work in process
Finished goods
Inventories
2013
1,029
375
1,836
3,240
2014
962
481
1,871
3,314
The balance as per December 31, 2014 excludes EUR
248 million of inventories associated with Lumileds and
Automotive businesses and classified as Assets held for
Annual Report 2014
145
(rights to acquire) preference shares to a third-party. As
of December 31, 2014, no preference shares have been
issued.
Option rights/restricted and performance
shares
The Company has granted stock options on its common
shares and rights to receive common shares in the
future (see note 28, Share-based compensation).
Treasury shares
In connection with the Company’s share repurchase
programs, shares which have been repurchased and are
held in treasury for (i) delivery upon exercise of options,
performance and restricted share programs and
employee share purchase programs, and (ii) capital
reduction purposes, are accounted for as a reduction of
shareholders’ equity. Treasury shares are recorded at
cost, representing the market price on the acquisition
date. When issued, shares are removed from treasury
shares on a first-in, first-out (FIFO) basis.
When treasury shares are reissued under the
Company’s option plans, the difference between the
cost and the cash received is recorded in retained
earnings.
Dividend withholding tax in connection with the
Company’s purchase of treasury shares is recorded in
retained earnings.
The following transactions took place resulting from
employee option and share plans:
Philips Group
Employee option and share plan transactions
2013 - 2014
Shares acquired
2013
3,984
Average market price
EUR 22.51
2014
7,254,606
EUR 24.53
Amount paid
Shares delivered
Average market price
EUR 0 million
EUR 178 million
8,066,511
EUR 28.35
10,777,489
EUR 30.26
Cost of delivered shares
EUR 229 million
EUR 326 million
Total shares in treasury
at year-end
20,650,427
17,127,544
Total cost
EUR 618 million
EUR 470 million
Group financial statements 12.9
17
The changes in the allowance for doubtful accounts
receivable are as follows:
Philips Group
Allowance for doubtful accounts receivable in millions of EUR
2012 - 2014
Balance as of January 1
Additions charged to expense
Deductions from allowance2)
Other movements
20121)
20131)
265
13
(49)
1
230
29
(33)
(22)
Balance as of December 31
230
204
1) Amounts have been revised following reclassification
2) Write-offs for which an allowance was previously provided
2014
204
48
(46)
21
227
The allowance for doubtful accounts receivable has
been primarily established for receivables that are past
due.
Included in above balances as per December 31, 2014
are allowances for individually impaired receivables of
EUR 200 million (2013: EUR 172 million; 2012: EUR 194
million).
17 Equity
Common shares
As of December 31, 2014, the issued and fully paid share
capital consists of 934,819,413 common shares, each
share having a par value of EUR 0.20.
In June 2014, Philips settled a dividend of EUR 0.80 per
common share, representing a total value of EUR 729
million. Shareholders could elect for a cash dividend or
a share dividend. 60% of the shareholders elected for
a share dividend, resulting in the issuance of 18,811,534
new common shares. The settlement of the cash
dividend resulted in a payment of EUR 293 million
including tax and service charges.
The following table shows the movements in the
outstanding number of shares:
Philips Group
Outstanding number of shares in number of shares
2013 - 2014
2013
2014
Balance as of January 1
914,591,275
913,337,767
Dividend distributed
18,491,337
18,811,534
Purchase of treasury shares
(27,811,356)
(28,537,921)
Re-issuance of treasury shares
8,066,511
10,777,489
Balance as of December 31
913,337,767
914,388,869
Preference shares
The ‘Stichting Preferente Aandelen Philips’ has been
granted the right to acquire preference shares in the
Company. Such right has not been exercised. As a
means to protect the Company and its stakeholders
against an unsolicited attempt to acquire (de facto)
control of the Company, the General Meeting of
Shareholders in 1989 adopted amendments to the
Company’s articles of association that allow the Board
of Management and the Supervisory Board to issue
146
Annual Report 2014
In order to reduce share capital, the following
transactions took place:
Philips Group
Share capital transactions
2013 - 2014
Shares acquired
Average market price
2013
27,807,372
EUR 22.69
2014
21,283,315
EUR 23.95
Amount paid
EUR 631 million
EUR 510 million
Reduction of capital
stock (shares)
Reduction of capital
stock (EUR)
Total shares in treasury
at year-end
37,778,510
21,837,910
EUR 787 million
EUR 533 million
3,857,595
3,303,000
Total cost
EUR 100 million
EUR 77 million
Stock purchase transactions related to employee
option and share plans, as well as transactions related
to the reduction of share capital involved a cash outflow
of EUR 712 million, which includes the impact of taxes.
Settlements of stock based compensation plans
involved a cash inflow of EUR 116 million.
Dividend distribution
A proposal will be submitted to the 2015 Annual
General Meeting of Shareholders to pay a dividend of
EUR 0.80 per common share, in cash or shares at the
option of the shareholder, from the 2014 net income
and retained earnings of the Company.
Limitations in the distribution of shareholders’
equity
As at December 31, 2014, pursuant to Dutch law, certain
limitations exist relating to the distribution of
shareholders’ equity of EUR 1,515 million. Such
limitations relate to common shares of EUR 187 million,
as well as to legal reserves required by Dutch law
included under retained earnings of EUR 1,059 million,
revaluation reserves of EUR 13 million, available-for-
sale financial assets EUR 27 million and unrealized
currency translation differences of EUR 229 million. The
unrealized losses related to cash flow hedges of EUR 13
million, although qualifying as a legal reserve, reduce
the distributable amount by their nature.
As at December 31, 2013, these limitations in
distributable amounts were EUR 1,609 million and
related to common shares of EUR 188 million, as well as
to legal reserves required by Dutch law included under
retained earnings of EUR 1,319 million, revaluation
reserves of EUR 23 million, available-for-sale financial
assets of EUR 55 million and cash flow hedges EUR 24
million. The unrealized losses related to currency
translation differences of EUR 569 million, although
qualifying as a legal reserve, reduce the distributable
amount by their nature.
Group financial statements 12.9
The legal reserve required by Dutch law of EUR 1,059
million included under retained earnings relates to any
legal or economic restrictions on the ability of affiliated
companies to transfer funds to the parent company in
the form of dividends.
Non-controlling interests
Non-controlling interests relate to minority stakes held
by third parties in consolidated group companies. The
Net loss attributable to non-controlling interests
amounted to EUR 4 million in 2014 (Net income
attributable to non-controlling interests 2013: EUR 3
million).
In 2014 Philips increased its non-controlling interest
mainly due to the acquisition of General Lighting
Company, in which Alliance Holding domiciled in
Kingdom of Saudi Arabia holds an ownership
percentage of 49% (please refer to note 4, Acquisitions
and divestments).
Objectives, policies and processes for
managing capital
Philips manages capital based upon the measures net
operating capital (NOC), net debt and cash flows before
financing activities.
The Company believes that an understanding of the
Philips Group’s financial condition is enhanced by the
disclosure of net operating capital (NOC), as this figure
is used by Philips’ management to evaluate the capital
efficiency of the Philips Group and its operating sectors.
NOC is defined as: total assets excluding assets
classified as held for sale less: (a) cash and cash
equivalents, (b) deferred tax assets, (c) other non-
current financial assets and current financial assets, (d)
investments in associates, and after deduction of: (e)
provisions (f) accounts and notes payable, (g) accrued
liabilities, (h) other non-current liabilities and other
current liabilities.
Net debt is defined as the sum of long- and short-term
debt minus cash and cash equivalents. The net debt
position as a percentage of the sum of group equity
(shareholders’ equity and non-controlling interests)
and net debt is presented to express the financial
strength of the Company. This measure is widely used
by management and investment analysts and is
therefore included in the disclosure. Our net debt
position is managed in such a way that we expect to
continuously meet our objective to retain our target at
A3 rating with stable outlook (Moody’s,) and A-rating
with negative outlook (Standard and Poor’s).
Furthermore, the Group’s objective when managing the
net debt position is to fulfill our commitment to a stable
dividend policy with a 40% to 50% target pay-out from
continuing net income.
Annual Report 2014
147
Group financial statements 12.9
Cash flows before financing activities, being the sum of
net cash from operating activities and net cash from
investing activities, are presented separately to
facilitate the reader’s understanding of the Company’s
funding requirements.
Philips Group
Net operating capital composition in millions of EUR
2012 - 2014
Intangible assets
Property, plant and equipment
Remaining assets
Provisions
Other liabilities
Net operating capital
Philips Group
Composition of net debt to group equity in millions of EUR unless otherwise stated
2012 - 2014
Long-term debt
Short-term debt
Total debt
Cash and cash equivalents
Net debt1)
Shareholders’ equity
Non-controlling interests
Group equity
Net debt and group equity
Net debt divided by net debt and group equity (in %)
Group equity divided by net debt and group equity (in %)
1) Total debt less cash and cash equivalents
Philips Group
Composition of cash flows in millions of EUR
2012 - 2014
Cash flows from operating activities
Cash flows from investing activities
Cash flows before financing activities
2012
10,679
2,959
8,921
(2,956)
(10,287)
9,316
2012
3,725
809
4,534
3,834
700
11,151
34
11,185
11,885
6%
94%
2012
1,886
(712)
1,174
2013
9,766
2,780
8,699
(2,554)
(8,453)
10,238
2013
3,309
592
3,901
2,465
1,436
11,214
13
11,227
12,663
11%
89%
2013
912
(862)
50
2014
10,526
2,095
9,041
(3,445)
(9,379)
8,838
2014
3,712
392
4,104
1,873
2,231
10,867
101
10,968
13,199
17%
83%
2014
1,303
(984)
319
148
Annual Report 2014
18
19
Group financial statements 12.9
18 Debt
Long-term debt
Philips Group
Long-term debt in millions of EUR unless otherwise stated
2013 - 2014
(range of)
interest rates
average rate
of interest
amount
outstanding
2014
amount due
in 1 year
amount due
after 1 year
amount due
after 5 years
average
remaining
term (in
years)
amount
outstanding
2013
USD bonds
3.8 - 7.8%
Bank borrowings
0 - 7.8%
Other long-term
debt
Institutional
financing
2.1 - 19.9%
Finance leases
0 - 14.4%
Long-term debt
Corresponding
data of previous
year
5.6%
1.9%
4.9%
3.8%
5.2%
3,355
258
52
3,665
195
3,860
–
51
43
94
54
148
3,355
207
9
3,571
141
3,712
2,333
201
1
2,535
43
2,578
12.7
5.7
1.4
3.8
5.0%
3,671
362
3,309
2,315
2,958
466
48
3,472
199
3,671
3,976
The following amounts of long-term debt as of
December 31, 2014, are due in the next five years:
Philips Group
Long-term debts due in the next five years in millions of EUR
2013 - 2014
2015
2016
2017
2018
2019
Long term debt
Corresponding amount of previous year
148
43
32
1,046
13
1,282
1,356
Philips Group
Unsecured USD Bonds in millions of EUR unless otherwise stated
2013 - 2014
Due 5/15/25; 7 3/4%
Due 6/01/26; 7 1/5%
Due 5/15/25; 7 1/8%
Due 3/11/18; 5 3/4%1)
Due 3/11/38; 6 7/8%1)
Due 3/15/22; 3 3/4%1)
Due 3/15/42; 5%1)
Adjustments2)
effective
rate
7.429%
6.885%
6.794%
6.066%
7.210%
3.906%
5.273%
2013
2014
72
120
74
907
726
726
363
(30)
81
136
84
1,028
823
823
411
(31)
Short-term debt
Philips Group
Short-term debt in millions of EUR
2013 - 2014
Short-term bank borrowings
Other short-term loans
Current portion of long-term debt
Short-term debt
2013
2014
207
23
362
592
225
19
148
392
During 2014, the weighted average interest rate on the
bank borrowings was 8.3% (2013: 6.4%).
Philips has a USD 2.5 billion Commercial Paper Program
and a EUR 1.8 billion revolving credit facility that can be
used for general group purposes and as a backstop of
its commercial paper program. In January 2013, the EUR
1.8 billion facility was extended by 2 years until
February 18, 2018. As of December 31, 2014 Philips did
not have any loans outstanding under either facility.
19 Provisions
Philips Group
Provisions in millions of EUR
2013 - 2014
Unsecured USD Bonds
2,958
3,355
1) The provisions applicable to these bonds, issued in March 2008 and in
March 2012, contain a ‘Change of Control Triggering Event’. If the
Company would experience such an event with respect to a series of
corporate bonds, the Company may be required to offer to purchase the
bonds of the series at a purchase price equal to 101% of the principal
amount, plus accrued and unpaid interest, if any.
Provisions for defined-
benefit plans (see note 20)
Other postretirement
benefits (see note 20)
2) Adjustments relate to issued bond discounts, transaction costs and fair
Product warranty
value adjustments for interest rate derivatives
Secured liabilities
In 2014, none of the long-term and short-term debt was
secured by collateral (2013: EUR nil million).
Environmental provisions
Restructuring-related
provisions
Litigation provisions
Other provisions
Provisions
2013
2014
long-
term
short-
term
long-
term
short-
term
754
51
881
52
200
59
249
75
232
334
1,903
14
207
62
128
4
185
651
226
77
301
150
480
385
2,500
16
225
59
230
173
190
945
Annual Report 2014
149
Group financial statements 12.9
Product warranty
The provision for product warranty reflects the
estimated costs of replacement and free-of-charge
services that will be incurred by the Company with
respect to products sold. The Company expects the
provision will be utilized mainly within the next year.
Philips Group
Provision for product warranty in millions of EUR
2012 - 2014
Balance as of January 1
Changes:
Additions
Utilizations
Transfer to assets classified as held
for sale
Translation differences
Changes in consolidation
2012
378
370
(427)
–
(4)
2
2013
319
350
(363)
(24)
(16)
–
2014
266
332
(316)
(3)
23
–
Balance as of December 31
319
266
302
Environmental provisions
The environmental provisions include accrued losses
recorded with respect to environmental remediation in
various countries. In the United States, subsidiaries of
the Company have been named as potentially
responsible parties in state and federal proceedings for
the clean-up of certain sites.
Provisions for environmental remediation can change
significantly due to the emergence of additional
information regarding the extent or nature of the
contamination, the need to utilize alternative
technologies, actions by regulatory authorities as well
as changes in judgments and discount rates.
Approximately half of this provision is expected to be
utilized within the next five years. The remaining portion
relates to longer-term remediation activities.
Philips Group
Environmental provisions in millions of EUR
2012 - 2014
Balance as of January 1
2012
305
2013
375
2014
311
Changes:
Additions
Utilizations
Releases
Changes in discount rate
Accretion
Translation differences
Purchase price allocation adjustment
Changes in consolidation
Balance as of December 31
48
(22)
(1)
18
6
(4)
–
25
375
30
(21)
(16)
(40)
6
(8)
(15)
–
311
29
(23)
(15)
30
8
16
–
4
360
Restructuring-related provisions
The most significant projects in 2014
In 2014, the most significant restructuring projects
related to Lighting and IG&S and were driven by
industrial footprint rationalization and the Accelerate!
transformation program.
Restructuring projects at Lighting centered on Light
Sources & Electronics and Professional Lighting
Solutions, the largest of which took place in Belgium,
the Netherlands and France.
Innovation, Group & Services restructuring projects mainly
were related to IT and group and country overheads and
centered primarily in the Netherlands, US and Belgium.
Restructuring projects at Healthcare mainly took place
in the US and Netherlands.
Consumer Lifestyle restructuring projects were mainly
in the Netherlands.
The Company expects the provision will be utilized
mainly within the next year. The movements in the
provisions and liabilities for restructuring in 2014 are
presented by sector as follows:
Philips Group
Restructuring-related provisions in millions of EUR
2014
Jan. 1,
2014
addi-
tions
uti-
liza-
tions
relea-
ses
other
changes1)
Healthcare
17
67
(27)
(9)
21
130
7
180
(10)
(90)
(7)
(16)
Dec.
31,
2014
48
12
195
–
1
(9)
35
110
(15)
(5)
–
125
203
364
(142)
(37)
(8)
380
1) Other changes primarily relate to translation differences and assets
classified as held for sale reclassifications
The most significant projects in 2013
In 2013, the most significant restructuring projects
related to Lighting and were driven by the industrial
footprint rationalization.
In Healthcare, the largest projects were undertaken in
Customer Services, Home Healthcare Solutions and
Imaging Systems in the United States, Italy and the
Netherlands to reduce the operating costs and simplify
the organization.
Consumer
Lifestyle
Lighting
Innovation,
Group and
Services
Philips
Group
The increase of provision due to changes in discount
rate in 2014 relates to an overall decrease of the market
rates used in discounting.
Consumer Lifestyle restructuring charges were mainly
related to Personal Care (primarily in the Netherlands
and Austria) and Coffee (mainly Italy).
For more details on the environmental remediation
reference is made to note 26, Contingent assets and
liabilities.
150
Annual Report 2014
Consumer
Lifestyle
Lighting
Innovation,
Group and
Services
Philips
Group
Restructuring projects at Lighting centered on
Luminaires businesses and Light Sources & Electronics,
the largest of which took place in the United States,
France and Belgium.
Innovation, Group & Services restructuring projects
mainly focused on the Financial Operations Service
Unit, primarily in Italy, France and the United States.
The movements in the provisions and liabilities for
restructuring in 2013 are presented by sector as follows:
Philips Group
Restructuring-related provisions in millions of EUR
2013
Jan. 1,
2013
addi-
tions
uti-
liza-
tions
relea-
ses
other
changes1)
Healthcare
77
14
(50)
(23)
48
198
11
64
(27)
(110)
(10)
(19)
Dec
31,
2013
17
21
130
(1)
(1)
(3)
62
16
(30)
(15)
2
35
385
105
(217)
(67)
(3)
203
1) Other changes primarily relate to translation differences and transfers
between sectors
The most significant projects in 2012
In 2012, the most significant restructuring projects
related to Lighting and Healthcare and were driven by
our change program Accelerate!.
In Healthcare, the largest projects were undertaken in
Imaging Systems and Patient Care & Clinical Informatics
in various locations in the United States, the
Netherlands and Germany to reduce the operating
costs and simplify the organization.
Consumer Lifestyle restructuring charges were mainly
related to Lifestyle Entertainment (primarily in Hong
Kong and the United States) and Coffee (mainly Italy).
Restructuring projects at Lighting centered on
Luminaires businesses and Light Sources & Electronics,
the largest of which took place in the Netherlands,
Belgium and in various locations in the US.
Innovation, Group & Services restructuring projects
focused on the IT and Financial Operations Service
Units (primarily in the Netherlands), Group & Regional
Overheads (mainly in the Netherlands and Italy) and
Philips Innovation Services (in the Netherlands and
Belgium).
Consumer
Lifestyle
Lighting
Innovation,
Group and
Services
Philips
Group
Group financial statements 12.9
The movements in the provisions and liabilities for
restructuring in 2012 are presented by sector as follows:
Philips Group
Restructuring-related provisions in millions of EUR
2012
Jan.1,
2012
addi-
tions
uti-
liza-
tions
relea-
ses
other
changes1)
Healthcare
18
100
(29)
(7)
39
52
58
225
(41)
(61)
(8)
(16)
Dec.
31,
2012
77
48
198
(5)
–
(2)
60
67
(47)
(10)
(8)
62
169
450
(178)
(41)
(15)
385
1) Other changes primarily relate to translation differences and transfers
between sectors
Litigation provisions
The Company and certain of its group companies and
former group companies are involved as a party in legal
proceedings, including regulatory and other
governmental proceedings.
Philips Group
Litigation provisions in millions of EUR
2012 - 2014
Balance as of January 1
Changes:
Additions
Utilizations
Releases
Accretion
Translation differences
2012
101
2013
238
2014
236
234
(85)
(7)
–
(5)
48
(17)
(15)
–
(18)
563
(170)
(23)
6
41
Balance as of December 31
238
236
653
The additions in 2014 include the patent infringement
lawsuit by Masimo Corporation in the Unites States
District Court for the District of Delaware against Philips
in which Masimo was awarded a compensation of USD
467 million (EUR 366 million).
The majority of the remaining 2014 additions and of the
utilization of the provisions, as well as of the remaining
ending balance as of December 31, 2014 relates to
certain parts of the Cathode Ray Tube antitrust litigation
as mentioned in note 26, Contingent assets and
liabilities for which the Company concluded it was able
to make a reliable estimate of the cash outflow or was
able to reach a settlement.
The Company expects to use the provisions within the
next five years. For more details reference is made to
note 26, Contingent assets and liabilities.
Other provisions
The main elements of other provisions are: provision for
post-employment benefits and obligatory severance
payments of EUR 50 million (2013: 66 million), onerous
contract provisions for unfavorable supply contracts as
part of divestment transactions, onerous (sub)lease
Annual Report 2014
151
Group financial statements 12.9
20
contracts and expected losses on existing projects /
orders totaling EUR 103 million (2013: 93 million),
provision for employee jubilee funds EUR 74 million
(2013: EUR 76 million), self-insurance liabilities of EUR
65 million (2013: EUR 56 million), provisions for rights of
return of EUR 52 million (2013: EUR 45 million),
provision for possible taxes/social security of EUR 97
million (2013: EUR 65 million) and provision for
decommissioning costs of EUR 36 million (2013: EUR 33
million).
Less than half of the provision for employee jubilee
funds, provision for possible taxes/social security and
provision for decommissioning costs is expected to be
utilized within next five years. The provision for self-
insurance liabilities is expected to be used within the
next five years. All other provisions are expected to be
utilized mainly within the next three years, except for
provision for rights of return, which the Company
expects to use within the next year.
Philips Group
Other provisions in millions of EUR
2012 - 2014
Balance as of January 1
Changes:
Additions
Utilizations
Releases
Reclassification
Liabilities directly associated with
assets held for sale
Accretion
Translation differences
Balance as of December 31
2012
640
2013
529
2014
519
322
(489)
(28)
84
–
1
(1)
529
198
(224)
(48)
80
(3)
–
(13)
519
213
(153)
(37)
17
(13)
6
23
575
20 Post-employment benefits
Employee post-employment plans have been
established in many countries in accordance with the
legal requirements, customs and the local practice in
the countries involved.
The Company sponsors a number of defined-benefit
pension plans. The benefits provided by these plans are
based on employees’ years of service and
compensation levels. The Company also sponsors a
limited number of defined-benefit retiree medical
plans. The benefits provided by these plans are
typically covering a part of the healthcare insurance
costs after retirement. Most employees that take part in
a Company pension plan however are covered by
defined-contribution (DC) pension plans.
The largest defined-benefit pension plans are in:
• The Netherlands,
• The United Kingdom (UK) and
• The United States (US).
152
Annual Report 2014
Together these plans account for more than 90% of the
total defined-benefit obligation and plan assets. Philips
is one of the sponsors of Philips Pensionskasse VVaG
in Germany, which is a multi-employer plan and is
accounted for as a DC plan.
The Netherlands
The pension plan in the Netherlands (the Flexplan) was
changed in 2014 following the new funding agreement
agreed with the Trustees of the Company Pension
Fund. Under the new funding agreement, which
became effective January 1, 2014, the Company has no
further financial obligation to the Pension Fund other
than to pay an agreed fixed contribution for the annual
accrual of active members. Executives are in a ‘hybrid
plan’ with an accrual rate of 1.25% per service year next
to a DC contribution, the level of which depends on the
executive grade. Both plans are executed by the
Company Pension Fund.
Although the new funding agreement de-risked the
plan, the annual premium can be subject to variability
after five years due to potential discounts and as a
result, the plan continued to be accounted for as a
defined-benefit plan. The other 2014 changes in the
plan were a new pensionable age of 67 (was 65) and
the introduction of an employee contribution. These
changes had no material impact on the existing
defined-benefit obligation.
As part of the above changes, the Company agreed to
transfer a one-off EUR 600 million to the Company
Pension Fund of which EUR 433 million has been paid
in 2014. The remainder is to be settled before July 2015
and is included in the 2015 cash projection in this note.
In 2014 the Fund adopted the Prognosis mortality table
2014 with new experience rating which resulted in a
decrease of the Company’s defined-benefit obligation.
This effect is recognized in Other comprehensive
income under Remeasurements for pension and other
post-employment plans.
New legislation effective January 1, 2015 introduces a
mandatory cap of EUR 100 thousand on the pension
salary for future pension accrual. The Company has
changed the pension plan accordingly at the end of
2014. For employees earning more than this cap the
Company has announced certain compensatory
measures and the introduction of a voluntary net
pension saving scheme for the salary part above the
cap. To limit the number of plans the Company further
announced to cease the executive pension plan and
transfer its members and their accrued defined-benefit
rights to the Flexplan. Accrued defined-contribution
rights in the executive pension plan are optionally
transferred to either the Flexplan or an individual
product. The net pension saving scheme and the
individual product are with an external provider other
than the Company Pension Fund.
The net result of these changes was a EUR 68 million
Group financial statements 12.9
decrease in the Company’s defined-benefit obligation
which is recognized in the 2014 income statement as a
past service cost gain of which EUR 1 million in
discontinued operations.
either governed by independent Boards or by Trustees
who have a legal obligation to evenly balance the
interests of all stakeholders and operate under the local
regulatory framework.
United Kingdom
The UK plan is executed by a Company Pension Fund.
In the UK plan the accrual of new benefits ceased in
2011. A legally mandatory indexation for accrued
benefits still applies. The Company does not pay
regular contributions, other than an agreed portion of
the administration costs.
In 2014 the Trustee of the UK Fund entered into two
further bulk insurance contracts - buy-ins - which
provide for payment in respect of a part of the Fund’s
pensioners. The asset value related to the buy-ins
included in the UK plan assets equals the defined-
benefit obligation of the related pensioners and is EUR
1,299 million per December 31, 2014 which is some 30%
of the total assets.
United States
The US defined-benefit plan covers certain hourly
workers and salaried workers hired before January 1,
2005.
The accrual for salaried workers in the US plan will end
per December 31, 2015 after which the remaining
members become eligible for the existing US DC plan.
In 2014 the Company adopted a new Mortality table as
published by the US Society of Actuaries which
increased the US plan’s defined-benefit obligation with
some 6%. This effect is recognized in Other
comprehensive income under Remeasurements for
pension and other post-employment plans.
Indexation of benefits is not mandatory. The Company
pays contributions for the annual service costs as well
as additional contributions to cover a deficit. The assets
of the US plan are in a Trust governed by Trustees.
Risks related to defined-benefit plans
These defined-benefit plans except the Netherlands
plan expose the Company to various demographic and
economic risks such as longevity risk, investment risks,
currency and interest rate risk and in some cases
inflation risk. The latter plays a role in the assumed
wage increase and in the UK plan where indexation is
mandatory. Pension fund Trustees are responsible for
and have full discretion over the investment strategy of
the plan assets. In general Trustees manage pension
fund risks by diversifying the investments of plan assets
and by (partially) matching interest rate risk of liabilities.
The Company has an active de-risking strategy in which
it constantly looks for opportunities to reduce the risks
associated with its defined-benefit plans. Liability
driven investment strategies, lump sum cash-out
options, buy-ins, buy-outs and the above mentioned
2014 change in the funding agreement of the Dutch
plan are examples of that strategy. The larger plans are
Balance sheet positions
The net balance sheet position presented in this note
can be explained as follows:
• The surpluses in our plans in the Netherlands, UK as
well some other countries are not recognized as a net
defined-benefit asset because in The Netherlands
the current surplus will not bring sufficient future
economic benefits to the Company (asset ceiling
restrictions) whereas the regulatory framework in the
other countries involved explicitly prohibits refunds
to the employer.
• The deficit of the US defined-benefit plan presented
under other liabilities and the provisions of the
unfunded plans therefore count for the largest part
of the net balance sheet position.
The measurement date for all defined-benefit plans is
December 31.
Summary of pre-tax costs for post-
employment benefits
The below table contains the total of current- and past
service costs, administration costs and settlement
results as included in Income from operations and the
interest cost as included in Financial expenses.
Philips Group
Pre-tax costs for post-employment benefits in millions of EUR
2012 - 2014
2012
2013
2014
Defined-benefit plans
included in operating cost
included in financial expense
included in discontinued
operations
Defined-contribution plans including
multi-employer plans
included in operating cost
included in discontinued
operations
290
200
85
5
144
134
10
297
220
71
6
142
134
245
182
59
4
148
144
8
4
Annual Report 2014
153
Group financial statements 12.9
Defined-benefit plans: Pensions
Movements in the net liabilities and assets for defined benefit pension plans:
Philips Group
Defined-benefit obligations in millions of EUR
2013 - 2014
Balance as of January 1
Service cost
Interest cost
Employee contributions
Actuarial (gains) / losses
- demographic assumptions
- financial assumptions
- experience adjustment
(Negative) past service cost
Acquisitions
Divestments
Settlements
Benefits paid
Exchange rate differences
Miscellaneous
Balance as of December 31
2013
2014
Netherlands
other
total
Netherlands
other
total
14,433
9,021
23,454
14,294
7,911
22,205
183
467
–
205
(214)
(75)
(1)
–
–
–
(704)
–
–
77
351
4
17
(385)
(32)
(80)
–
(3)
(279)
(462)
(318)
–
260
818
4
222
(599)
(107)
(81)
–
(3)
(279)
(1,166)
(318)
–
174
478
5
(80)
3,487
23
(68)
–
–
–
65
361
4
197
782
25
(1)
12
–
(9)
239
839
9
117
4,269
48
(69)
12
–
(9)
(699)
(506)
(1,205)
–
2
624
–
624
2
14,294
7,911
22,205
17,616
9,465
27,081
Present value of funded obligations at December 31
14,288
7,112
21,400
17,609
8,532
26,141
Present value of unfunded obligations at December 31
6
799
805
7
933
940
Philips Group
Plan assets in millions of EUR
2013 - 2014
Balance as of January 1
Interest income on plan assets
Admin expenses paid
Return on plan assets excluding interest income
Employee contributions
Employer contributions
Divestments
Settlements
Benefits paid
Exchange rate differences
Balance as of December 31
Funded status
Unrecognized net assets
Net balance sheet position
2013
2014
Netherlands
other
total
Netherlands
other
total
15,203
7,588
22,791
14,843
6,728
21,571
496
(9)
(426)
–
283
–
–
(704)
–
317
(5)
813
(14)
(338)
(764)
4
187
(1)
(311)
(407)
(306)
4
470
(1)
(311)
(1,111)
(306)
508
(9)
2,534
5
665
–
–
(699)
–
330
(6)
674
4
199
–
(8)
(445)
540
838
(15)
3,208
9
864
–
(8)
(1,144)
540
14,843
6,728
21,571
17,847
8,016
25,863
549
(555)
(1,183)
(428)
(634)
(983)
231
(1,449)
(1,218)
(238)
(554)
(792)
(6)
(1,611)
(1,617)
(7)
(2,003)
(2,010)
The classification of the net balance is as follows:
Philips Group
Net balance of defined-benefit pension plans in millions of EUR
2013 - 2014
Prepaid pension costs under other non-current assets
Accrued pension costs under other liabilities
Provision for pensions under provisions
Provision in assets held for sale
Net balance of defined-benefit plans
2013
2014
Netherlands
other
total
Netherlands
other
total
–
–
(6)
5
(817)
(799)
5
(817)
(805)
(6)
(1,611)
(1,617)
–
–
(7)
–
(7)
2
2
(1,072)
(1,072)
(926)
(933)
(7)
(7)
(2,003)
(2,010)
154
Annual Report 2014
Group financial statements 12.9
Philips Group
Changes in the effect of the asset ceiling in millions of EUR
2013 - 2014
Balance as of January 1
Interest on unrecognized assets
Remeasurements
Exchange rate differences
Balance as of December 31
2013
Netherlands
other
777
25
(247)
–
555
586
31
(155)
(34)
428
total
1,363
56
(402)
(34)
983
2014
Netherlands
other
555
19
(336)
–
238
428
28
73
25
554
total
983
47
(263)
25
792
Plan assets allocation
The asset allocation in the Company’s pension plans at
December 31 was as follows:
The weighted averages of the assumptions used to
calculate the defined-benefit obligations as of
December 31 were as follows:
Philips Group
Plan assets allocation in millions of EUR
2013 - 2014
Philips Group
Assumptions used for defined-benefit obligations in %
2013 - 2014
2013
2014
2013
2014
Netherlands
other
Netherlands
other
Netherlands
other
Netherlands
other
Matching
portfolio:
- Debt
securities
11,238
4,282
10,663
5,051
- Other
Return portfolio:
- Equity
securities
- Real estate
- Other
Total assets
–
508
–
1,299
2,524
790
291
910
9
1,019
5,088
1,784
388
13
312
1,265
14,843
6,728
17,847
8,016
Asset values related to buy-in contracts are now
included in the Matching portfolio under Other.
The assets in 2014 contain 17% (2013: 14%) unquoted
assets, the increase compared to 2013 mainly related to
the new buy-in value in the UK plan. Plan assets in 2014
do not include property occupied by or financial
instruments issued by the Company.
Assumptions
The mortality tables used for the Company’s major
schemes are:
• Netherlands: Prognosis table 2014 including
experience rating TW2014.
• UK: SAPS 2002- Core CMI 2011 projection
• US: RP2014 HA/EE Fully Generational scaled with
MP2014
Discount rate
Rate of
compensation
increase1)
3.4%
4.5%
2.1%
3.7%
2.0%
3.2%
2.0%
3.0%
1) The rate of compensation increase for the Netherlands consists of a
general 2% compensation increase and an individual salary increase
based on merit, seniority and promotion. The Company regularly
determines new turnover and disability rates and individual salary rates
for all active participants. Current figures are based on the period
2010-2012. The individual increase at the average age of 45 is 1.75%
(2013: 1.75%). The indexation assumption used to calculate the defined-
benefit obligations for the Netherlands is 1.0% (2013: 1.0%).
Due to the nature of the pension plan in the
Netherlands an assumption is required for the future
pension accrual rate. If the fixed premium does not
cover the cost of the target accrual of 1,85% per annum
a lower percentage must be applied for which the cost
will be covered by the fixed premium. The Fund in the
Netherlands has set aside part of the EUR 600 million
received for active members accrual or indexation. The
accrual rate for the next 5 years starting 2015 is
expected to be 1,85%. Per 31 December 2014 the
average future accrual rate used to calculate the
defined-benefit obligation and service cost is fixed at
1,74% (2013: 1,85%) as after the five year period a lower
percentage will apply assuming the current fixed
premium level.
The (average) duration of the defined-benefit
obligation of the pension plans is 17 years for the
Netherlands (2013: 15 years) and 12 years for other
countries (2013: 11 years).
Annual Report 2014
155
Group financial statements 12.9
Defined-benefit plans: retiree medical plans
Movements in the net liability for retiree medical plans:
Philips Group
Liability for retiree medical plans in millions of EUR
2013 - 2014
Balance as of January 1
Service cost
Interest cost
Actuarial (gains) or losses arising from:
- Demographic assumptions
- Financial assumptions
- Experience adjustment
Past service cost
Benefits paid
Exchange rate differences
Balance as of December 31
2013
250
1
10
–
(17)
–
–
(15)
(16)
213
2014
213
2
11
3
9
(3)
–
(15)
21
241
Present value of funded obligations as of
December 31
Present value of unfunded obligations as of
December 31
Funded status
Net balances
–
–
213
(213)
(213)
241
(241)
(241)
Classification of the net balance is as follows:
Provision for other postretirement benefits
(213)
(241)
The weighted average assumptions used to calculate
the defined-benefit obligations for retiree medical
plans as of December 31 were as follows:
Philips Group
Weighted average assumptions for retiree medical plans in %
2013 - 2014
Discount rate
Compensation increase (where applicable)
2013
4.8%
0.0%
2014
5.0%
0.0%
Assumed healthcare cost trend rates at December 31:
Philips Group
Assumed healthcare cost trend rates in %
2013 - 2014
Healthcare cost trend rate assumed for next
year
Rate that the cost trend rate will gradually reach
Year of reaching the rate at which it is assumed
to remain
2013
2014
7.5%
5.2%
7.0%
5.3%
2019
2024
The average duration of the define-benefit obligation
of the retiree medical plans is 8 years (2013: 9 years).
Investment policy in our largest pension plans
It must be acknowledged that trustees of the Philips
pension plans are responsible for and have full
discretion over the investment strategy of the plan
assets.
The objective of the investment strategy of the Philips
pension Plan in the Netherlands, is to achieve its agreed
ambition, i.e. an indexed retirement income for all
participants. The fund’s indexation policy is dependent
156
Annual Report 2014
on the funding ratio and requires a sustainable
(regulatory required) basis before allowing any
indexation. To meet its ambitions, the fund has
strategically allocated 60% of its assets to fixed income
and 40% to return assets. Within fixed income circa 90%
is invested in so called liability-driven assets (euro and
global government bonds, investment grade credits,
interest rate and inflation swaps and mortgages) and
the remaining part in high yield bonds and emerging
market debt. The return assets mainly consist of global
equities and real estate.
The Philips pension plan in the UK operates a fixed
income portfolio that aims to fully hedge the interest
rate and inflation rate sensitivities of the fair value of
the plan’s pension liabilities. Some 30% of the portfolio
is now invested in a buy-in policy, in which an insurance
company guarantees all future benefit payments to the
plan, thereby matching the investment and longevity
risks of the pension liabilities covered in the buy-in
policy.
The plan assets of the Philips pension plan in the US are
invested in a well diversified portfolio. The interest rate
sensitivity of the fixed income portfolio is closely
aligned to that of the plan’s pension liabilities. Any
contributions from the sponsoring company are used to
further increase the fixed income part of the assets. As
part of the investment strategy, any additional
investment returns of the return portfolio are used to
further decrease the interest rate mismatch between
the plan assets and the pension liabilities.
Cash flows and costs in 2015
The Company expects considerable cash outflows in
relation to post-employment benefits which are
estimated to amount to EUR 1,032 million in 2015,
consisting of:
• EUR 819 million employer contributions to defined
benefit pension plans
• EUR 140 million employer contributions to defined
contribution pension plans
• EUR 54 million expected cash outflows in relation to
unfunded pension plans and
• EUR 19 million in relation to unfunded retiree medical
plans.
The employer contributions to defined benefit pension
plans are expected to amount to EUR 196 million for the
Netherlands and EUR 623 million for other countries. The
Company continues to fund a part of the existing deficit in
the US pension plan in 2015. For the funding of the deficit
in the US plan the Group adheres to the minimum funding
requirements of the US Pension Protection Act and in 2015
plans to contribute an additional EUR 300 million which
amount is included in the amounts aforementioned. The
UK plan is currently in a surplus on a regulatory basis and
does not require any funding in 2015 other than the agreed
administration cost. A new regulatory valuation is
scheduled to be performed for the UK Fund during 2015.
The funding of the pension fund in the Netherlands for
2015 consists of a fixed percentage of payroll which
applies for a period of 5 years i.e. 2014-2018. The
remaining part of the EUR 600 million additional
contribution to the pension fund for the Netherlands for
2015 is not included in the above figures and is
estimated at EUR 167 million excluding interest.
The service and administration cost for 2015 is expected
to amount to EUR 332 million, consisting of EUR 331
million for defined-benefit pension plans and EUR 1
million for defined-benefit retiree medical plans. The
net interest expense for 2015 is expected to amount to
EUR 59 million, consisting of EUR 48 million for
defined-benefit pension plans and EUR 11 million for
defined-benefit retiree medical plans. The cost for
defined-contribution pension plans in 2015 is expected
to amount to EUR 140 million.
Sensitivity analysis
The table below illustrates the approximate impact on
the defined-benefit obligation (DBO) if the Company
were to change key assumptions. The DBO was
recalculated using a change in the assumptions of 1%
which overall is considered a reasonably possible
change. The impact on the DBO because of changes in
discount rate is normally accompanied by offsetting
movements in plan assets, especially when using
matching strategies.
21
Group financial statements 12.9
Philips Group
Key assumptions in millions of EUR
2013
Defined benefit obligation
Pension
Netherlands
Pension
other
Retiree
medical
Increase
Discount rate (1% movement)
(1,708)
(822)
(12)
Wage change (1% movement)
Inflation (1% movement)
Longevity (see explanation)
Medical benefit level (1% price
increase)
Decrease
Discount rate (1% movement)
Wage change (1% movement)
Inflation (1% movement)
165
979
355
28
461
232
–
–
2,158
(147)
(876)
962
(26)
(418)
–
–
7
12
16
–
–
Longevity also impacts post-employment defined-
benefit obligation. The above sensitivity table
illustrates the impact on the defined-benefit obligation
of a further 10% decrease in the assumed rates of
mortality for the Company’s major schemes. A 10%
decrease in assumed mortality rates equals
improvement of life expectancy by 0.5 - 1 year.
Changes in assumed health care cost trend rates can
have a significant effect on the amounts reported for the
retiree medical plans. A 1%-point increase in medical
benefit level is therefore included in the above table as
a likely scenario.
Philips Group
Key assumptions in millions of EUR
2014
21 Accrued liabilities
Defined benefit obligation
Pension
Netherlands
Pension
other
Retiree
medical
Accrued liabilities are summarized as follows:
Increase
Discount rate (1% movement)
(2,309)
(1,056)
(18)
Philips Group
Accrued liabilities in millions of EUR
2013 - 2014
Wage change (1% movement)
Inflation (1% movement)
Longevity (see explanation)
Medical benefit level (1% price
increase)
Decrease
107
1,341
492
31
555
267
–
–
Discount rate (1% movement)
2,998
1,250
Wage change (1% movement)
Inflation (1% movement)
(132)
(1,185)
(28)
(486)
–
–
7
14
19
–
–
Personnel-related costs:
- Salaries and wages
- Accrued holiday entitlements
- Other personnel-related costs
Fixed-asset-related costs:
- Gas, water, electricity, rent and other
Communication and IT costs
Distribution costs
Sales-related costs:
- Commission payable
- Advertising and marketing-related costs
- Other sales-related costs
Material-related costs
Interest-related accruals
Deferred income
Other accrued liabilities
Accrued liabilities
2013
2014
560
184
130
61
38
104
24
159
98
175
57
812
428
502
179
119
47
51
112
17
161
68
132
56
869
379
2,830
2,692
Annual Report 2014
157
Group financial statements 12.9
22
23
24
25
22 Other liabilities
Other non-current liabilities
Other non-current liabilities are summarized as follows:
Philips Group
Other non-current liabilities in millions of EUR
2013 - 2014
In 2013, there were no significant cash flows resulting
from investing activities.
In 2012, the cash outflow was mainly due to loans
provided to TPV Technology Limited and TP Vision
venture in connection with the divestment of the
Television business (EUR 151 million in aggregate).
Accrued pension costs
Deferred income
Other tax liability
Other liabilities
2013
813
214
444
97
2014
1,061
176
499
102
25 Contractual obligations
Philips Group
Contractual cash obligations1) in millions of EUR
2014
Other non-current liabilities
1,568
1,838
payments due by period
less
than 1
year
total
1-3
years
3-5
years
after 5
years
Long-term debt2)
3,665
94
6
1,030
2,535
Finance lease
obligations
Short-term debt
Operating lease
obligations
Derivative
liabilities
Interest on debt3)
Purchase
obligations4)
Trade and other
payables
Contractual cash
obligations
232
244
61
244
80
–
37
–
54
–
986
236
293
159
298
860
2,617
353
198
131
70
2,499
2,499
166
387
51
–
253
299
88
1,733
10
–
–
–
11,234
3,755
983
1,788
4,708
1) Obligations in this table are undiscounted
2) Long-term debt includes short-term portion of long-term debt and
excludes finance lease obligations
3) Approximately 15% of the debt bears interest at a floating rate. Majority
of the interest payments on variable interest rate loans in the table
above reflect market forward interest rates at the period end and these
amounts may change as market interest rate changes
4) Philips has commitments related to the ordinary course of business
which in general relate to contracts and purchase order commitments
for less than 12 months. In the table, only the commitments for multiple
years are presented, including their short-term portion
The Company entered into contracts with several
venture capitalists where it committed itself to make,
under certain conditions, capital contributions to
investment funds for an aggregated remaining amount
of EUR 35 million (2013: EUR 40 million) until June 30,
2021. As at December 31, 2014 capital contributions
already made to these investment funds are recorded
as available-for-sale financial assets within Other non-
current financial assets.
The operating lease obligations are mainly related to
the rental of buildings. A number of these leases
originate from sale-and-leaseback arrangements.
Operating lease payments under sale-and-leaseback
arrangements for 2014 totaled EUR 42 million (2013:
EUR 42 million).
The increase in the accrued pension costs is mainly
attributable to the US defined benefit plan. See also
note 20, Post-employment benefits.
For further details on tax related liabilities refer to
note 8, Income taxes.
Other current liabilities
Other current liabilities are summarized as follows:
Philips Group
Other current liabilities in millions of EUR
2013 - 2014
2013
2014
Accrued customer rebates that cannot be offset
with accounts receivables for those customers
530
535
Advances received from customers on orders
not covered by work in process
Other taxes including social security premiums
Other liabilities
Other current liabilities
240
193
119
312
176
368
1,082
1,391
The increase of the balance of other liabilities as per
December 31, 2014 mainly relates to certain parts of the
Cathode Ray Tube antitrust litigation as mentioned in
note 26, Contingent assets and liabilities for which the
Company was able to reach a settlement. It includes
utilization of provisions previously recognized.
23 Cash used for derivatives and current
financial assets
A total of EUR 13 million cash was paid with respect to
foreign exchange derivative contracts related to
financing activities (2013: EUR 93 million outflow; 2012:
EUR 47 million outflow).
A total of EUR 6 million was received with respect to
current financial assets (2013: EUR 8 million outflow;
2012: EUR 2 million inflow).
24 Purchase and proceeds from non-current
financial assets
In 2014, the net cash inflow of EUR 26 million was
mainly due to the sale of stakes in Neusoft, Chimei
Innolux, and Sapiens, offset by loans provided to TPV
Technology Limited.
158
Annual Report 2014
61
7
54
61
7
54
Contingent liabilities
The remaining minimum payments under sale-and-
leaseback arrangements included in operating lease
obligations above are as follows:
Philips Group
Operating lease - minimum payments under sale-and-leaseback
arrangements in millions of EUR
2014
2015
2016
2017
2018
2019
Thereafter
36
36
35
33
33
142
Finance lease liabilities
Philips Group
Finance lease liabilities in millions of EUR
2013 - 2014
2013
2014
future
mini-
mum
lease
pay-
ments
present
value
of min-
imum
lease
pay-
ments
future
mini-
mum
lease
pay-
ments
inter-
est
present
value
of min-
imum
lease
pay-
ments
inter-
est
Less
than one
year
Between
one and
five
years
More
than five
years
Finance
lease
112
20
92
117
19
98
68
15
53
54
11
43
241
42
199
232
37
195
26 Contingent assets and liabilities
Contingent assets
Zoll
In June 2010, Philips filed a patent infringement lawsuit
against Zoll Medical Corporation claiming that its
defibrillator related patents were infringed by Zoll’s
Automatic External Defibrillator (AED) products. Zoll
filed a countersuit claiming patent infringement by
Philips’ Advanced Life Support (ALS) products and a
method for testing defibrillator electrodes.
In December 2013, the liability phase of the Zoll lawsuit
was tried before a jury in the United States District Court
for the District Massachusetts. Philips and Zoll were
both held to infringe each other’s patents. Philips
expects that it will result in a net difference in favor of
Philips. The Zoll liability judgment is now pending
before the United States Court of Appeals for the
Federal Circuit (CAFC). Resolution of the amount
ultimately owed to Philips in the Zoll lawsuit is
contingent upon both the CAFC affirming the December
2013 jury decision on liability (expected in the second
half of 2015) and the subsequent damages trial
(expected to take place during the first half of 2016).
26
Group financial statements 12.9
Suframa
In 1996, CIEM (Labor Union of Manaus) representing,
amongst other companies Philips Brazil, filed a fiscal
claim against Manaus Free Trade Zone
Superintendence (SUFRAMA), in order to obtain a
judicial declaration of the illegality and
unconstitutionality of the Public Price tax, charged by
SUFRAMA. The Lower Court ruled favorable for Philips.
In September 2007, Philips requested the Settlement of
Declaratory Judgment, in order to refund the amounts
unduly paid to SUFRAMA during 1992 to 1999. In
August 2011, a ruling was issued to approve Philips
credit for the amount of EUR 36 million. The estimated
amount as of year-end 2014 is EUR 43 million, the
increase explained by interest.
In 2014 an agreement was made with an external
investor under which agreement Philips received
upfront EUR 14 million in cash and has the right to
receive (“upward potential”) future amounts depending
on a favorable outcome of the case and the timeline in
which this outcome is reached (EUR 5 million – EUR 1.7
million). In case Philips will lose the case there is no
requirement to repay the upfront amount (no recourse
basis).
Guarantees
Philips’ policy is to provide guarantees and other letters
of support only in writing. Philips does not stand by
other forms of support. At the end of 2014, the total fair
value of guarantees recognized on the balance sheet
amounted to less than EUR 1 million (December 31,
2013: less than EUR 1 million). Remaining off-balance-
sheet business and credit-related guarantees provided
on behalf of third parties and associates decreased by
EUR 13 million during 2014 to EUR 21 million. Off-
balance-sheet guarantees for year end 2013 were
restated from EUR 333 million to EUR 34 million to
reflect guarantees related to associates and third-party
only.
Environmental remediation
The Company and its subsidiaries are subject to
environmental laws and regulations. Under these laws,
the Company and/or its subsidiaries may be required to
remediate the effects of certain chemicals on the
environment.
Legal proceedings
The Company and certain of its group companies and
former group companies are involved as a party in legal
proceedings, regulatory and other governmental
proceedings, including discussions on potential
remedial actions, relating to such matters as
competition issues, commercial transactions, product
liability, participations and environmental pollution.
Annual Report 2014
159
Group financial statements 12.9
Since the ultimate disposition of asserted claims and
proceedings and investigations cannot be predicted
with certainty, an adverse outcome could have a
material adverse effect on the Company’s consolidated
financial position, results of operations and cash flows.
individual plaintiffs. Several of the remaining individual
plaintiff cases are scheduled for trial in 2015, with the
remainder expected to be transferred back to their
original venues for further proceedings. Trial dates in
these other cases have not yet been set.
Provided below are disclosures of the more significant
cases:
Cathode-Ray Tubes (CRT)
On November 21, 2007, the Company announced that
competition law authorities in several jurisdictions had
commenced investigations into possible
anticompetitive activities in the Cathode-Ray Tubes, or
CRT industry. On December 5, 2012, the European
Commission issued a decision imposing fines on
(former) CRT manufacturers including the Company.
The European Commission imposed a fine of EUR 313
million on the Company and a fine of EUR 392 million
jointly and severally on the Company and LG
Electronics, Inc. In total a payable of EUR 509 million
was recognized in 2012 and the fine was paid in the first
quarter of 2013. The Company appealed the decision of
the European Commission and in November 2014 the
Company presented its defense at a Hearing with the
General Court.
United States
Subsequent to the public announcement of these
investigations in 2007, certain Philips Group companies
were named as defendants in class action antitrust
complaints by direct and indirect purchasers of CRTs
filed in various federal district courts in the United
States. These actions allege anticompetitive conduct by
manufacturers of CRTs and seek treble damages on a
joint and several liability basis under federal antitrust
law, as well as various state antitrust and unfair
competition laws. These actions have been
consolidated for pretrial proceedings in the United
States District Court for the Northern District of
California. In addition, sixteen individual plaintiffs,
principally large retailers of CRT products who opted-
out of the direct purchaser class, filed separate
complaints against the Company and other defendants
based on the same substantive allegations as the
putative class plaintiff complaints. These cases also are
consolidated for pre-trial purposes with the putative
class actions in the Northern District of California.
In 2012 a settlement agreement was approved between
the Company and counsel for direct purchaser plaintiffs
fully resolving all claims of the direct purchaser class.
Also, the Company recently reached a settlement with
the indirect purchaser class, subject to court approval,
that would fully resolve all claims of the indirect
purchaser class and release all claims of the indirect
purchaser class. The Company reached in the past year
settlements with a number of the individual plaintiffs
resolving all claims by those retailers on a global basis.
The settlements reached to date represent the majority
of CRT sales attributed to the Company by the
160
Annual Report 2014
In addition, the state attorneys general of California,
Florida, Illinois, Oregon and Washington filed actions
against Philips and other defendants seeking to recover
damages on behalf of the states and, acting as parens
patriae, their consumers. In 2012 the Florida complaint
was withdrawn. In 2013 a settlement agreement was
reached with the state attorney general of California
that has been approved subject to review by the
California Court of Appeal. The actions brought by the
state attorneys general of Illinois, Oregon and
Washington are pending in the respective state courts
of the plaintiffs. The Oregon Attorney General action
has been set for trial in July 2016. Trial dates for the
Washington and Illinois actions have not been set and
there is no timetable for resolution of these cases.
Canada
In 2007, certain Philips Group companies were also
been named as defendants, in proposed class
proceedings in Ontario, Quebec and British Columbia,
Canada, along with numerous other participants in the
industry. After years of inactivity, in 2014, plaintiffs in the
Ontario action initiated the class certification
proceedings with class certification hearings scheduled
for late April 2015.
Other civil claims related to CRT
In 2014, the Company was named as a defendant in a
consumer class action lawsuit filed in Israel in which
damages are claimed against several defendants based
on alleged anticompetitive activities in the CRT
industry. In addition, an electronics manufacturer filed
a claim against the Company and several co-
defendants with a court in the Netherlands, also
seeking compensation for the alleged damage
sustained as a result from the alleged anticompetitive
activities in the CRT industry. The Company has
received indications that more civil claims may be filed
in other jurisdictions in due course.
Except for what has been provided or accrued for as
disclosed in note 19, Provisions and note 21, Accrued
liabilities, the Company has concluded that due to the
considerable uncertainty associated with certain of
these matters, on the basis of current knowledge,
potential losses cannot be reliably estimated with
respect to these matters. These investigations and
litigation could have a materially adverse effect on the
Company’s consolidated financial position, results of
operations and cash flows.
Optical Disc Drive (ODD)
On October 27, 2009, the Antitrust Division of the
United States Department of Justice confirmed that it
had initiated an investigation into possible
anticompetitive practices in the Optical Disc Drive
(ODD) industry. Philips Lite-On Digital Solutions Corp.
(PLDS), a joint venture owned by the Company and
Lite-On IT Corporation, as an ODD market participant,
is included in this investigation. PLDS and the Company
have been accepted under the Corporate Leniency
program of the US Department of Justice and have
continued to cooperate with the authorities in these
investigations. On this basis, the Company expects to
be immune from governmental fines.
In July 2012, the European Commission issued a
Statement of Objections addressed to (former) ODD
suppliers including the Company and PLDS. The
European Commission granted the Company and PLDS
immunity from fines, conditional upon the Company’s
continued cooperation. The Company responded to
the Statement of Objections both in writing and at an
oral hearing. The Company and PLDS are also subject
to similar investigations outside the US and Europe
relating to the ODD market. Where relevant, they are
cooperating with the authorities.
Subsequent to the public announcement of these
investigations in 2009, the Company, PLDS and Philips
& Lite-On Digital Solutions USA, Inc. (PLDS USA),
among other industry participants, were named as
defendants in numerous class action antitrust
complaints filed in various federal district courts in the
United States. These actions allege anticompetitive
conduct by manufacturers of ODDs and seek treble
damages on behalf of direct and indirect purchasers of
ODDs and products incorporating ODDs. These
complaints assert claims under federal antitrust law, as
well as various state antitrust and unfair competition
laws and may involve joint and several liability among
the named defendants. These actions have been
consolidated for pre-trial proceedings in the United
States District Court for the Northern District of
California. The plaintiffs’ applications for certification of
both the direct and indirect purchaser classes were
denied on October 3, 2014. The representatives of these
putative classes tried appealing the denial of class
certification to the United States Court of Appeals for
the Ninth Circuit. However, the Ninth Circuit declined
this request to appeal.
In addition, various individual entities have filed
separate actions against the Company, PLDS, PLDS
USA and other defendants. The allegations contained
in these individual complaints are substantially
identical to the allegations in the direct purchaser class
complaints. All of these matters have been
consolidated into the action in the Northern District of
California for pre-trial purposes and discovery is being
coordinated. The Company intends to vigorously
defend all of the civil actions in the US courts.
Group financial statements 12.9
Also, in June 2013, the State of Florida filed a separate
complaint in the Northern District of California against
the Company, PLDS, PLDS USA and other defendants
containing largely the same allegations as the class and
individual complaints. Florida seeks to recover
damages sustained in its capacity as a buyer of ODDs
and, in its parens patriae capacity, on behalf of its
citizens. The defendants’ motion to dismiss has been
denied and Philips filed an answer to the complaint.
This case has been joined with the ODD class action
cases in the Northern District of California for pre-trial
purposes.
The Company and certain Philips Group companies
have also been named as defendants, in proposed
class proceedings in Ontario, Quebec, British Columbia,
Manitoba and Saskatchewan, Canada along with
numerous other participants in the industry. These
complaints assert claims against various ODD
manufacturers under federal competition laws as well
as tort laws and may involve joint and several liability
among the named defendants. Philips intends to
vigorously defend these lawsuits. Plaintiffs in the British
Columbia case have proceeded with their application
to certify that proceeding as a class action. The hearing
was held in January 2015 and the Court’s decision is
pending.
Due to the considerable uncertainty associated with
these matters, on the basis of current knowledge, the
Company has concluded that potential losses cannot
be reliably estimated with respect to these matters.
These matters could have a materially adverse effect on
the Company’s consolidated financial position, results
of operations and cash flows.
Consumer Electronics products and small Domestic
Appliances
Several companies, amongst which the Company, are
involved in an investigation by the European
Commission into alleged restrictions of online sales of
consumer electronic products and small domestic
appliances. This investigation commenced in
December 2013 when Philips was one of the companies
that was inspected by officials of the European
Commission. Philips is fully cooperating with the
European Commission.
Due to the considerable uncertainty associated with
this matter, on the basis of current knowledge, the
Company has concluded that potential losses cannot
be reliably estimated with respect to these matters. This
investigation could have a materially adverse effect on
the Company’s consolidated financial position, results
of operations and cash flows.
Masimo
On October 1, 2014 a jury awarded USD 467 million (EUR
366M) to Masimo Corporation (Masimo) in the patent
infringement lawsuit by Masimo in the United States
District Court for the District of Delaware against Philips.
Annual Report 2014
161
Group financial statements 12.9
27
28
The decision by the jury is part of extensive litigation,
which started in 2009, between Masimo and Philips
involving several claims and counterclaims related to a
large number of patents in the field of pulse oximetry.
The lawsuit filed by Masimo alleges that certain Philips
products infringe certain Masimo patents. In response
to these claims, Philips filed its answer and
counterclaims alleging infringement of a number of
Philips’ patents and violation of US antitrust laws and
patent misuse by Masimo. The Court has decided to
handle the litigation in several phases, the first phase of
which was tried in September 2014. The October 2014
decision by the jury is associated with this first phase of
the litigation. Philips intends to pursue all avenues of
appeal of this verdict at both the District and Appellate
courts in the US.
Due to the considerable uncertainty associated with
the next phases of this litigation, including the impact
of the appeals thereon, the Company has concluded
that, on the basis of current knowledge, potential losses
cannot be reliably estimated with respect to the
remaining phases of the litigation. The outcome of the
litigation could have a materially adverse effect on the
company’s consolidated financial position, results of
operations and cash flows.
27 Related-party transactions
In the normal course of business, Philips purchases and
sells goods and services from/to various related parties
in which Philips typically holds a 50% or less equity
interest and has significant influence. These
transactions are generally conducted with terms
comparable to transactions with third parties.
Philips Group
Related-party transactions in millions of EUR
2012 - 2014
Sales of goods and services
Purchases of goods and services
Receivables from related parties
Payables to related parties
2012
288
130
13
4
2013
305
143
39
4
2014
215
85
14
4
Non-recourse financing of third-party receivables
provided by an associate amounted to EUR 103 million
in 2014 (2013: EUR 84 million; 2012: EUR 52 million).
In light of the composition of the Executive Committee,
the Company considers the members of the Executive
Committee and the Supervisory board to be the key
management personnel as defined in IAS 24 ‘Related
parties’.
For remuneration details of the Executive Committee,
the Board of Management and the Supervisory Board
see note 29, Information on remuneration.
For employee benefit plans see note 20, Post-
employment benefits.
162
Annual Report 2014
28 Share-based compensation
The purpose of the share-based compensation plans is
to align the interests of management with those of
shareholders by providing incentives to improve the
Company’s performance on a long-term basis, thereby
increasing shareholder value.
The Company has the following plans:
• performance shares: rights to receive common shares
in the future based on performance and service
conditions;
• restricted shares: rights to receive common shares in
the future based on a service condition;
• Options on its common shares, including the 2012
and 2013 Accelerate! grant.
Since 2013 the Board of Management and other
members of the Executive Committee, executives and
certain selected employees are granted performance
shares. Restricted shares are granted only to new
employees or certain selected employees. Prior to 2013
restricted shares and options were granted to members
of the Board of Management and other members of the
Executive Committee, executives and certain selected
employees.
Furthermore, as part of the Accelerate! program, the
Company has granted options (Accelerate! options)
and restricted shares (Accelerate! shares). These
Accelerate! options and shares were granted to a group
of approximately 500 key employees below the level
of Board of Management in January 2012 and to the
Board of Management in January 2013. On January 28,
2014 the Supervisory Board resolved that all
performance targets under the Accelerate! program,
which were based on the 2013 mid-term financial
targets have been met. Accelerate! shares fully vested
at December 31, 2013.
Share-based compensation costs were EUR 85 million
(2013: EUR 104 million, 2012: EUR 80 million). The
amount recognized as an expense is adjusted for
forfeiture. USD-denominated performance shares,
restricted shares and options are granted to employees
in the United States only.
Performance shares
The performance is measured over a three-year
performance period. The performance shares have two
performance conditions, relative Total Shareholders’
Return compared to a peer group of 21 companies and
adjusted Earnings Per Share growth. The performance
shares vest three years after the grant date. The number
of performance shares that will vest is dependent on
achieving the two performance conditions, which are
equally weighted, and provided that the grantee is still
employed with the Company.
The amount recognized as an expense is adjusted for
actual performance of adjusted Earnings Per Share
growth since this is a non-market performance
condition. It is not adjusted for non-vesting or extra
vesting of performance shares due to a relative Total
Shareholders’ Return performance that differs from the
performance anticipated at the grant date, since this is
a market-based performance condition.
The fair value of the performance shares is measured
based on Monte-Carlo simulation, which takes into
account dividend payments between the grant date
and the vesting date by including reinvested dividends,
the market conditions expected to impact relative Total
Shareholders’ Return performance in relation to
selected peers, and the following weighted-average
assumptions:
Philips Group
Assumptions used in Monte-Carlo simulation for valuation in %
2014
EUR-denominated
Risk-free interest rate
Expected dividend yield
Expected share price volatility
USD-denominated
Risk-free interest rate
Expected dividend yield
Expected share price volatility
2014
0.35%
3.9%
25%
0.35%
3.9%
27%
The assumptions were used for these calculations only
and do not necessarily represent an indication of
Management’s expectation of future developments for
other purposes. The Company has based its volatility
assumptions on historical experience measured over a
ten-year period.
A summary of the status of the Company’s performance
share plans as of December 31, 2014 and changes
during the year are presented below:
Philips Group
Performance share plans
2014
weighted
average
grant-date
fair value
shares1)
EUR-denominated
Outstanding at January 1, 2014
3,442,923
Granted
Forfeited
3,405,781
544,702
Outstanding at December 31, 2014
6,304,002
USD-denominated
Outstanding at January 1, 2014
Granted
Forfeited
2,298,226
2,264,889
362,215
Outstanding at December 31, 2014
4,200,900
23.53
22.36
23.29
22.92
30.77
30.10
30.42
30.44
1) Excludes dividend declared between grant date and vesting date (EUR-
denominated: 332,757 and USD-denominated: 238,833)
Group financial statements 12.9
At December 31, 2014, a total of EUR 173 million of
unrecognized compensation costs relate to non-vested
performance shares. These costs are expected to be
recognized over a weighted-average period of 2.0
years.
Restricted shares
The fair value of restricted shares is equal to the share
price at grant date less the present value, using the risk-
free interest rate, of estimated future dividends which
will not be received up to the vesting date.
The Company issues restricted shares that, in general,
vest in equal annual installments over a three-year
period, starting one year after the date of grant. For
grants up to and including January 2013 the Company
granted 20% additional (premium) shares, provided the
grantee still holds the shares after three years from the
delivery date and the grantee is still with the Company
on the respective delivery dates.
A summary of the status of the Company’s restricted
shares as of December 31, 2014 and changes during the
year are presented below:
Philips Group
Restricted shares
2014
weighted
average
grant-date
fair value
shares1)
EUR-denominated
Outstanding at January 1, 2014
1,065,169
Granted
Vested/Issued
Forfeited
Outstanding at December 31, 2014
USD-denominated
Outstanding at January 1, 2014
Granted
Vested/Issued
Forfeited
Outstanding at December 31, 2014
169,800
657,566
51,941
525,462
1,140,246
173,906
642,209
71,264
600,679
15.31
21.93
16.19
14.66
16.44
20.33
29.99
21.27
25.47
21.51
1) Excludes 20% additional (premium) shares that may be received if
shares delivered under the restricted share rights plan are not sold for a
three-year period
At December 31, 2014, a total of EUR 12 million of
unrecognized compensation costs relate to non-vested
restricted shares. These costs are expected to be
recognized over a weighted-average period of 1.5 years.
Option plans
The Company granted options that expire after 10
years. These options vest after 3 years, provided that
the grantee is still employed with the Company. A
limited number of options granted to certain employees
of acquired business may contain accelerated vesting.
As of December 31, 2014 there are no non-vested
options which contain non-market performance
conditions.
Annual Report 2014
163
Group financial statements 12.9
The following tables summarize information about the
Company’s options as of December 31, 2014 and
changes during the year:
Philips Group
Options on EUR-denominated listed share
2014
weighted
average
exercise price
options
Outstanding at January 1, 2014
18,657,828
Exercised
Forfeited
Expired
2,436,583
908,220
236,071
Outstanding at December 31, 2014
15,076,954
21.63
21.03
22.33
24.13
21.65
Exercisable at December 31, 2014
11,763,646
23.54
The exercise prices range from EUR 12.63 to EUR 32.04.
The weighted average remaining contractual term for
options outstanding and options exercisable at
December 31, 2014, was 4.6 years and 3.8 years,
respectively. The aggregate intrinsic value of the
options outstanding and options exercisable at
December 31, 2014, was EUR 57 million and EUR 26
million, respectively.
The total intrinsic value of options exercised during
2014 was EUR 11 million (2013: EUR 15 million, 2012: EUR
3 million).
Philips Group
Options on USD-denominated listed share
2014
weighted
average
exercise price
options
Outstanding at January 1, 2014
13,449,570
Exercised
Forfeited
Expired
1,271,182
675,761
140,791
Outstanding at December 31, 2014
11,361,836
29.74
28.00
31.37
28.79
29.84
Exercisable at December 31, 2014
8,724,979
32.93
The exercise prices range from USD 16.76 to USD 44.15.
The weighted average remaining contractual term for
options outstanding and options exercisable at
December 31, 2014, was 4.6 years and 3.8 years,
respectively. The aggregate intrinsic value of the
options outstanding and options exercisable at
December 31, 2014, was USD 34 million and USD 10
million, respectively.
The total intrinsic value of options exercised during
2014 was USD 9 million (2013: USD 17 million, 2012: USD
4 million).
At December 31, 2014, a total of EUR 2 million of
unrecognized compensation costs relate to non-vested
EUR and USD denominated options. These costs are
expected to be recognized over a weighted-average
period of 0.3 years. Cash received from exercises under
the Company’s option plans amounted to EUR 77
164
Annual Report 2014
million in 2014 (2013: EUR 84 million, 2012: EUR 19
million. The actual tax deductions realized as a result of
option exercises totaled approximately EUR 3 million in
2014 (2013: EUR 5 million, 2012: EUR 1 million).
The outstanding options as of December 31,2014 are
categorized in exercise price ranges as follows:
Philips Group
Outstanding options
2014
exercise price
options
EUR-denominated
10-15
15-20
20-25
25-30
30-35
4,259,713
777,934
6,413,918
1,502,505
2,122,884
Outstanding options
15,076,954
USD-denominated
15-20
20-25
25-30
30-35
35-40
40-55
3,025,421
297,375
2,359,334
2,478,397
1,627,434
1,573,875
weighted
average
remaining
contractual
term
intrinsic
value in
millions
42
4
11
–
–
57
30
2
2
–
–
–
6.6 yrs
1.7 yrs
5.2 yrs
1.3 yrs
2.3 yrs
4.6 yrs
6.7 yrs
7.0 yrs
5.2 yrs
3.7 yrs
3.2 yrs
2.3 yrs
Outstanding options
11,361,836
34
4.6 yrs
The aggregate intrinsic value in the tables and text
above represents the total pre-tax intrinsic value (the
difference between the Company’s closing share price
on the last trading day of 2014 and the exercise price,
multiplied by the number of in-the-money options)
that would have been received by the option holders if
the options had been exercised on December 31, 2014.
The following table summarizes information about the
Company’s Accelerate! options as of December 31, 2014
and changes during the year:
Philips Group
Accelerate! options
2014
weighted
average
exercise price
options
EUR-denominated
Outstanding at January 1, 2014
2,854,000
Exercised
Forfeited
1,048,117
37,083
Outstanding at December 31, 2014
1,768,800
15.62
15.24
15.24
15.86
Exercisable at December 31, 2014
1,616,800
15.24
USD-denominated
Outstanding at January 1, 2014
Exercised
Outstanding at December 31, 2014
795,000
336,200
458,800
20.02
20.02
20.02
Exercisable at December 31, 2014
458,800
20.02
29
Group financial statements 12.9
Other plans
Employee share purchase plan
Under the terms of employee stock purchase plans
established by the Company in various countries,
substantially all employees in those countries are
eligible to purchase a limited number of Philips shares
at discounted prices through payroll withholdings, of
which the maximum ranges from 10% to 20% of total
salary. Generally, the discount provided to the
employees is in the range of 10% to 20%. A total of
1,326,548 shares were bought by employees in 2014
under the plan at an average price of EUR 24.94 (2013:
1,425,048 shares at EUR 21.92; 2012: 1,906,183 shares at
EUR 15.69).
29
Information on remuneration
Remuneration of the Executive Committee
In 2014, the total remuneration costs relating to the
members of the Executive Committee (including the
members of the Board of Management) amounted to
EUR 16,878,909 (2013: EUR 24,773,537, 2012: EUR
18,585,112) consisting of the elements in the table
below.
The exercise prices of the Accelerate! options are EUR
15.24 and EUR 22.43 for EUR-denominated options and
is USD 20.02 for USD-denominated options. The
weighted average remaining contractual term for EUR-
denominated Accelerate! options outstanding and
exercisable at December 31, 2014 is 7.2 and 7.1 years,
respectively. The weighted average remaining
contractual term for USD-Accelerate! options
outstanding and exercisable at December 31, 2014 is 7.1
years. The aggregate intrinsic value of the EUR-
denominated Accelerate! options outstanding and
exercisable at December 31, 2014, was EUR 15 million
and EUR 14 million, respectively. The aggregate intrinsic
value of the USD-denominated Accelerate! options
outstanding and exercisable at December 31, 2014, was
USD 4 million and USD 4 million, respectively.
Cash received from exercises for EUR-denominated
and USD-denominated Accelerate! options amounted
to EUR 21 million in 2014. The actual tax deductions
realized as a result of Accelerate! options exercises
totaled approximately EUR 1 million in 2014.
The total intrinsic value of Accelerate! options exercised
during 2014 was EUR 10 million for EUR-denominated
options and USD 5 million for USD-denominated
options.
Philips Group
Remuneration costs of the Executive Committee in EUR
2012 - 2014
Salary
Annual incentive1)
Performance shares2)
Stock options2)
Restricted share rights2)
Pension costs
Other compensation3)
2012
5,640,090
4,839,949
1,049,205
1,194,444
1,566,448
2,054,516
2,240,460
2013
6,011,557
4,422,732
6,478,554
2,020,040
1,115,504
2,277,705
2,447,445
2014
6,513,027
1,526,658
3,357,142
583,755
409,809
2,458,759
2,029,759
1) The annual incentives are related to the performance in the year reported which are paid out in the subsequent year
2) Costs of performance shares, stock options and restricted share rights are based on accounting standards (IFRS) and do not reflect the value of stock options at
the end of the lock up period and the value of performance shares and restricted share rights at the vesting/release date. Costs for the Accelerate! Grant are
included in 2012 and 2013
3) The stated amounts mainly concern (share of) allowances to members of the Executive Committee that can be considered as remuneration. In a situation where
such a share of an allowance can be considered as (indirect) remuneration (for example, private use of the company car), then the share is both valued and
accounted for here. The method employed by the fiscal authorities in the Netherlands is the starting point for the value stated. In 2012 and 2013 a crisis levy tax
has been imposed by the Dutch government, amounting in total to EUR 1,245,944 for 2013 and to EUR 702,940 for 2012. These amounts are included in the
amounts stated under Other compensation.
At December 31, 2014, the members of the Executive
Committee (including the members of the Board of
Management) held 1,050,080 (2013: 1,479,498, 2012:
1,376,913) stock options at a weighted average exercise
price of EUR 18.53 (2013: EUR 18.69, 2012: EUR 18.23).
Remuneration of the Board of Management
In 2014, the total remuneration costs relating to the
members of the Board of Management amounted to
EUR 6,635,334 (2013: EUR 10,928,951, 2012: EUR
7,301,335).
At December 31, 2014, the members of the Board of
Management held 586,500 stock options (2013:
586,500; 2012: 454,500) at a weighted average exercise
price of EUR 19.60 (2013: EUR 19.60; 2012: EUR 18.78).
Annual Report 2014
165
Group financial statements 12.9
Philips Group
Remuneration costs of individual members of the Board of Management in EUR
2012 - 2014
salary
annual
incentive1)
performance
shares2)
stock
options2)
2014
F.A. van Houten
1,137,500
349,600
860,564
R.H. Wirahadiraksa
P.A.J. Nota
712,500
643,750
156,600
258,180
446,337
406,358
2,493,750
764,380
1,713,259
101,344
68,914
68,914
239,172
restricted
share
rights2)
76,951
52,965
57,200
187,116
pension
costs
485,655
298,995
267,037
other
compen-
sation3)
total
costs
86,554
3,098,168
35,909
63,507
1,772,220
1,764,946
1,051,687
185,970
6,635,334
20134)
F.A. van Houten
1,100,000
1,081,520
1,594,675
R.H. Wirahadiraksa
656,250
497,745
1,040,393
P.A.J. Nota
618,750
561,713
1,025,153
461,215
307,699
352,608
190,441
128,856
146,626
468,407
263,451
253,605
75,906
35,732
4,972,164
2,930,126
68,206
3,026,661
2,375,000
2,140,978
3,660,221
1,121,522
465,923
985,463
179,844
10,928,951
20124)
F.A. van Houten
1,100,000
1,279,520
R.H. Wirahadiraksa
600,000
P.A.J. Nota
S.H. Rusckowski 5)
600,000
233,333
523,440
556,200
178,500
2,533,333
2,537,660
−
−
−
−
−
209,589
149,067
188,029
315,760
217,020
253,836
422,845
243,438
247,883
47,154
34,961
3,374,868
1,767,926
60,754
1,906,702
(200,400)
(209,638)
90,211
159,833
251,839
346,285
576,978
1,004,377
302,702
7,301,335
1) The annual incentives are related to the performance in the year reported which are paid out in the subsequent year. For more details on the annual incentives,
see sub-section 10.2.6, Annual Incentive, of this Annual Report
2) Costs of performance shares, stock options and restricted share rights (including the once-only Accelerate! Grant) are based on accounting standards (IFRS) and
do not reflect the value of stock options at the end of the lock up period and the value of performance shares and restricted share rights at the vesting/release
date
3) The stated amounts mainly concern (share of) allowances to members of the Board of Management that can be considered as remuneration. In a situation
where such a share of an allowance can be considered as (indirect) remuneration (for example, private use of the company car), then the share is both valued
and accounted for here. The method employed by the fiscal authorities in the Netherlands is the starting point for the value stated.
4) A crisis levy of 16% has been imposed by the Dutch government amounting to in total EUR 413,405 for 2012 and EUR 681,596 for 2013. This crisis tax levy was
payable by the employer and was charged over income of employees exceeding a EUR 150,000 threshold in 2012 and 2013. These expenses do not form part of
the remuneration costs mentioned.
5) The amount stated relate to the period January 1 - April 30, 2012.
For further information on remuneration costs, see sub-
section 10.2.4, Remuneration costs, of this Annual
Report.
The tables below give an overview of the performance
share plans, restricted share rights and the stock option
plans of the Company, held by the members of the
Board of Management:
Philips Group
Number of performance shares (holdings) in number of shares
2014
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
January 1,
2014
64,671
55,0001)
awarded
2014
−
−
−
59,075
33,071
38,5001)
−
30,621
38,5001)
−
−
−
31,036
−
−
27,825
117,936
awarded
dividend
shares
2014
2,232
−
2,038
1,141
−
1,071
1,057
−
960
realized
2014
December 31,
2014
vesting date
−
55,000
−
−
66,903
05.03.2016
−
01.28.2014
61,113
34,212
04.28.2017
05.03.2016
38,500
−
01.28.2014
−
−
38,500
−
32,107
31,678
04.28.2017
05.03.2016
−
01.28.2014
28,785
04.28.2017
8,499
132,000
254,798
Performance shares (holdings)
260,363
1) Once-only Accelerate! Grant
166
Annual Report 2014
Group financial statements 12.9
Philips Group
Number of restricted share rights (holdings) in number of shares
2014
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
Restricted share rights
(holdings)
January 1, 2014
awarded 2014
released 2014
December 31, 2014
20,001
13,602
13,602
47,205
−
−
−
−
13,334
9,068
9,068
31,470
6,667
4,534
4,534
15,735
potential premium
shares
8,684
6,206
6,802
21,692
Philips Group
Stock options (holdings) in number of shares
2014
January 1,
2014
granted
exercised
expired
December
31, 2014
grant
price
(in euros)
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
20,4001)
75,000
75,000
55,000
10,8001)
12,0001)
16,5001)
51,000
51,000
38,500
40,8001)
51,000
51,000
38,500
Stock options (holdings)
586,500
−
–
−
−
−
−
−
–
−
−
−
–
−
−
−
−
−
−
−
−
−
−
−
–
−
−
−
−
−
−
−
−
−
−
−
−
−
−
–
−
−
−
−
−
−
20,400
75,000
75,000
55,000
10,800
12,000
16,500
51,000
51,000
38,500
40,800
51,000
51,000
38,500
586,500
22.88
20.90
14.82
22.43
23.11
12.63
24.90
20.90
14.82
22.43
22.88
20.90
14.82
22.43
share
(closing)
price on
exercise
date
−
−
−
−
−
−
−
−
–
−
−
−
−
−
expiry date
10.18.2020
04.18.2021
04.23.2022
01.29.2023
04.14.2018
04.14.2019
04.19.2020
04.18.2021
04.23.2022
01.29.2023
10.18.2020
04.18.2021
04.23.2022
01.29.2023
1) Awarded before date of appointment as a member of the Board of Management
See note 28, Share-based compensation for further
information on performance shares, stock options and
restricted share rights as well sub-section 10.2.7, Long-
Term Incentive Plan, of this Annual Report.
The accumulated annual pension entitlements and the
pension costs of individual members of the Board of
Management are as follows (in EUR):
Philips Group
Accumulated annual pension entitlements and the pension costs
in EUR
2014
age at
December 31,
2014
accumulated
annual
pension as of
December 31,
20141) pension costs2)
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
Pension costs
54
54
50
233,910
42,068
32,747
485,655
298,995
267,037
1,051,687
1) Under average pay plan, including - if applicable - transferred pension
2)
entitlements under pension scheme(s) of previous employer(s)
Including costs related to employer contribution in defined-contribution
pension plan
When pension rights are granted to members of the
Board of Management, necessary payments (if insured)
and all necessary provisions are made in accordance
with the applicable accounting principles. In 2014, no
(additional) pension benefits were granted to former
members of the Board of Management.
Remuneration of the Supervisory Board
The remuneration of the members of the Supervisory
Board amounted to EUR 816,668 (2013: EUR 747,000;
2012: EUR 799,500); former members received no
remuneration.
At December 31, 2014, the members of the Supervisory
Board held no stock options.
The individual members of the Supervisory Board
received, by virtue of the positions they held, the
following remuneration (in EUR):
Annual Report 2014
167
Group financial statements 12.9
30
Philips Group
Remuneration of the Supervisory Board in EUR
2012 - 2014
membership
committees
other compensation1)
total
20142)
J.A. van der Veer
J.J. Schiro (Jan.-Aug.)
C. Poon
C.J.A. van Lede
E. Kist
H. von Prondzynski
J.P. Tai
N. Dhawan
O. Gadiesh (May-Dec.)
20132)
J. van der Veer
J.J. Schiro
C.J.A. van Lede
E. Kist
H. von Prondzynski
C. Poon
J.P. Tai
N. Dhawan
2012
J. van der Veer
J.M. Thompson (Jan. - Apr.)
C.J.A. van Lede
E. Kist
J.J. Schiro
H. von Prondzynski
C. Poon
J.P. Tai
N. Dhawan (Apr. - Dec.)
110,000
65,000
65,000
65,000
65,000
65,000
65,000
65,000
65,000
630,000
110,000
65,000
65,000
65,000
65,000
65,000
65,000
65,000
20,500
12,334
14,000
10,000
8,000
15,167
15,000
10,000
6,667
111,668
20,500
18,500
10,000
8,000
10,000
14,000
15,000
10,000
565,000
106,000
110,000
32,500
65,000
65,000
65,000
65,000
65,000
65,000
65,000
597,500
20,500
4,667
10,834
10,333
17,000
10,000
12,666
13,333
6,667
2,000
2,000
17,000
2,000
2,000
2,000
23,000
23,000
2,000
75,000
5,000
8,000
5,000
5,000
5,000
11,000
20,000
17,000
76,000
5,000
11,000
5,000
5,000
17,000
5,000
14,000
17,000
17,000
132,500
79,334
96,000
77,000
75,000
82,167
103,000
98,000
73,667
816,668
135,500
91,500
80,000
78,000
80,000
90,000
100,000
92,000
747,000
135,500
48,167
80,834
80,333
99,000
80,000
91,666
95,333
88,667
106,000
96,000
799,500
1) The amounts mentioned under other compensation relate to the fee for intercontinental travel and the entitlement of EUR 2,000 under the Philips product
arrangement
2) As of 2013, part of the remuneration of members of the Supervisory Board living in the Netherlands is subject to VAT. The amounts mentioned in this table are
excluding VAT.
Supervisory Board members’ and Board of
Management members’ interests in Philips
shares
Members of the Supervisory Board and of the Board of
Management are not allowed to hold any derivatives of
Philips securities.
Philips Group
Shares held by Board members1) in number of shares
2014
J. van der Veer
H. von Prondzynski
J.P. Tai
F.A. van Houten
R.H. Wirahadiraksa
P.A.J. Nota
December
31, 2013
December
31, 2014
17,192
3,402
2,175
37,258
27,879
24,937
17,784
3.519
3,284
109,570
65,780
59,491
1) Reference date for board membership is December 31, 2014
30 Fair value of financial assets and liabilities
The estimated fair value of financial instruments has
been determined by the Company using available
market information and appropriate valuation
methods. The estimates presented are not necessarily
indicative of the amounts that will ultimately be
realized by the Company upon maturity or disposal.
The use of different market assumptions and/or
estimation methods may have a material effect on the
estimated fair value amounts.
For cash and cash equivalents, current receivables,
accounts payable, interest accrual and short-term
debts, the carrying amounts approximate fair value
because of the short maturity of these instruments, and
therefore fair value information is not included in the
table below.
168
Annual Report 2014
Group financial statements 12.9
tenors of the borrowing arrangement. Accrued interest
is not included within the carrying amount or estimated
fair value of debt.
The fair value of Philips’ debt is estimated on the basis
of the quoted market prices for certain issues, or on the
basis of discounted cash flow analysis based upon
market rates plus Philips’ spread for the particular
Philips Group
Fair value of financial assets and liabilities in millions of EUR
2014
Financial assets
Carried at fair value:
Available-for-sale financial assets - non-current
Available-for-sale financial assets - current
Securities classified as assets held for sale
Fair value through profit and loss - non-current
Derivative financial instruments
Financial assets carried at fair value
Carried at (amortized) cost:
Cash and cash equivalents
Loans and receivables:
Loans - current
Non-current loans and receivables
Other non-current loans and receivables
Loans classified as assets held for sale
Receivables - current
Receivables - non-current
Held-to-maturity investments
Available-for-sale financial assets
Financial assets carried at (amortized) costs
Financial liabilities
Carried at fair value:
Fair value through profit and loss - non-current
Derivative financial instruments
Financial liabilities carried at fair value
Carried at (amortized) cost:
Accounts payable
Interest accrual
Debt (Corporate bond and finance lease)
Debt (Bank loans, overdrafts etc.)
Financial liabilities carried at (amortized) costs
Balance as of December 31, 2013
Balance as of December 31, 2014
carrying amount
estimated fair value
carrying amount
estimated fair value
96
10
62
29
150
347
2,465
143
129
30
4,678
144
3
96
7,688
(13)
(368)
(381)
(2,462)
(57)
(3,157)
(744)
(6,420)
96
10
62
29
150
143
144
(13)
(368)
(3,545)
115
–
38
24
207
384
1,873
125
86
140
–
4,723
177
2
95
7,221
–
(857)
(857)
(2,499)
(56)
(3,551)
(553)
(6,659)
115
–
38
24
207
125
86
177
–
(857)
(4,164)
Annual Report 2014
169
Group financial statements 12.9
Philips Group
Fair value hierarchy in millions of EUR
2014
Balance as of December 31, 2014
Available-for-sale financial assets - non-current
Securities classified as assets held for sale
Financial assets designated at fair value through profit and
loss - non-current
Derivative financial instruments - assets
Loans - current
Non-current loans and receivables
Receivables - non-current
Total financial assets
Derivative financial instruments - liabilities
Debt
Total financial liabilities
Balance as of December 31, 2013
Available-for-sale financial assets - non-current
Available-for-sale financial assets - current
Securities classified as assets held for sale
Financial assets designated at fair value through profit and
loss - non-current
Derivative financial instruments - assets
Non-current loans and receivables
Receivables - non-current
Total financial assets
Financial liabilities designated at fair value through profit
and loss - non-current
Derivative financial instruments - liabilities
Debt
Total financial liabilities
level 1
level 2
level 3
total
51
1
24
–
–
–
–
76
–
(3,969)
(3,969)
42
6
62
22
–
–
–
132
–
–
(3,345)
(3,345)
43
–
–
207
125
86
177
638
(857)
(195)
(1,052)
–
4
–
–
150
143
144
441
–
(368)
(200)
(568)
21
37
–
–
–
–
–
58
–
–
–
54
–
–
7
–
–
–
61
(13)
–
–
(13)
115
38
24
207
125
86
177
772
(857)
(4,164)
(5,021)
96
10
62
29
150
143
144
634
(13)
(368)
(3,545)
(3,926)
The table above represents categorization of
measurement of the estimated fair values of financial
assets and liabilities.
Specific valuation techniques used to value financial
instruments include:
Level 1
Instruments included in level 1 are comprised primarily
of listed equity investments classified as available-for-
sale financial assets, investees and financial assets
designated at fair value through profit and loss.
The fair value of financial instruments traded in active
markets is based on quoted market prices at the
balance sheet date. A market is regarded as active if
quoted prices are readily and regularly available from
an exchange, dealer, broker, industry group, pricing
service, or regulatory agency, and those prices
represent actual and regularly occurring market
transactions on an arm’s length basis.
Level 2
The fair value of financial instruments that are not
traded in an active market (for example, over-the-
counter derivatives or convertible bond instruments)
are determined by using valuation techniques. These
valuation techniques maximize the use of observable
market data where it is available and rely as little as
possible on entity-specific estimates. If all significant
inputs required to fair value an instrument are based on
observable market data, the instrument is included in
level 2.
The fair value of derivatives is calculated as the present
value of the estimated future cash flows based on
observable interest yield curves, basis spread and
foreign exchange rates.
The valuation of convertible bond instruments uses
observable market quoted data for the options and
present value calculations using observable yield
curves for the fair value of the bonds.
Level 3
If one or more of the significant inputs are not based on
observable market data, the instrument is included in
level 3.
The arrangement with the UK Pension Fund in
conjunction with the sale of NXP is a financial
instrument carried at fair value classified as level 3. In
170
Annual Report 2014
31
Group financial statements 12.9
September 2014 the option matured with the changes
of fair value of EUR 7 million recorded as financial
income and expense.
Philips Group
Financial liabilities subject to offsetting, enforceable master
netting arrangements or similar agreements in millions of EUR
2013 - 2014
Deferred consideration and loan extension options to
TP Vision were included in level 3 in 2013. In May, 2014
Philips transferred the loans from TP Vision to TPV
Technology Limited. As a result, the extension options
ceased to exist with the changes of fair value of EUR 13
million recorded in the profit and loss.
The table below shows the reconciliation from the
beginning balance to the end balance for fair value
measured in Level 3 of the fair value hierarchy.
Philips Group
Reconciliation of the fair value hierarchy in millions of EUR
2014
financial
assets
financial
liabilities
Balance as of January 1, 2014
Total gains and losses recognized in:
- profit or loss
- other comprehensive income
Balance as of December 31, 2014
61
5
(8)
58
(13)
13
–
–
Philips has the following balances related to its
derivative activities. These transactions are subject to
master netting and set-off agreements. In case of
certain termination events, under the terms of the
Master Agreement, Philips can terminate the
outstanding transactions and aggregate their positive
and negative values to arrive at a single net termination
sum (or close-out amount). This contractual right is
subject to the following:
• The right may be limited by local law if the
counterparty is subject to bankruptcy proceedings;
• The right applies on a bilateral basis.
Philips Group
Financial assets subject to offsetting, enforceable master netting
arrangements or similar agreements in millions of EUR
2013 - 2014
2013
2014
Derivatives
Gross amounts of recognized financial assets
150
207
Gross amounts of recognized financial liabilities
offset in the balance sheet
Net amounts of financial assets presented in
the balance sheet
–
–
150
207
Related amounts not offset in the balance sheet
Financial instruments
Cash collateral received
Net amount
(85)
–
65
(161)
–
46
2013
2014
Derivatives
Gross amounts of recognized financial liabilities
(368)
(857)
Gross amounts of recognized financial assets
offset in the balance sheet
–
–
Net amounts of financial liabilities presented in
the balance sheet
(368)
(857)
Related amounts not offset in the balance sheet
Financial instruments
Cash collateral received
Net amount
85
–
161
–
(283)
(696)
31 Details of treasury / other financial risks
Philips is exposed to several types of financial risks. This
note further analyzes financial risks. Philips does not
purchase or hold derivative financial instruments for
speculative purposes. Information regarding financial
instruments is included in note 30, Fair value of financial
assets and liabilities.
Liquidity risk
Liquidity risk is the risk that an entity will encounter
difficulty in meeting obligations associated with
financial liabilities.
Liquidity risk for the group is monitored through the
Treasury liquidity committee which tracks the
development of the actual cash flow position for the
group and uses input from a number of sources in order
to forecast the overall liquidity position both on a short
and long term basis. Group Treasury invests surplus
cash in money market deposits with appropriate
maturities to ensure sufficient liquidity is available to
meet liabilities when due.
The rating of the Company’s debt by major rating
services may improve or deteriorate. As a result, Philips’
future borrowing capacity may be influenced and its
financing costs may fluctuate. Philips has various
sources to mitigate the liquidity risk for the group. At
December 31, 2014, Philips had EUR 1,873 million in cash
and cash equivalents (2013: EUR 2,465 million), within
which short-term deposits of EUR 1,057 million (2013:
EUR 1,714 million) and other liquid assets of EUR 121
million (2013: EUR 18 million). Philips pools cash from
subsidiaries to the extent legally and economically
feasible; cash not pooled remains available for
operational or investment needs by the Company.
Furthermore, Philips has a USD 2.5 billion Commercial
Paper Program and a EUR 1.8 billion revolving credit
facility that can be used for general group purpose and
as a backstop for its commercial paper program. In
January 2013 the EUR 1.8 billion facility was extended
by 2 years until February 18, 2018. The facility has no
financial covenants and repetitive material adverse
Annual Report 2014
171
Group financial statements 12.9
change clauses and can be used for general group
purposes. As of December 31, 2014, Philips did not have
any amounts outstanding under any of these facilities.
Additionally Philips also held EUR 75 million of equity
investments in available-for-sale financial assets (fair
value at December 31, 2014).
Currency risk
Currency risk is the risk that the fair value or future cash
flows of a financial instrument will fluctuate because of
changes in foreign exchange rates. Currency
fluctuations may impact Philips’ financial results.
Philips is exposed to currency risk in the following
areas:
• Transaction exposures, related to forecasted sales
and purchases and on-balance-sheet receivables/
payables resulting from such transactions
• Translation exposure of net income in foreign entities
• Translation exposure of foreign-currency
intercompany and external debt and deposits
• Translation exposure of foreign-currency-
denominated equity invested in consolidated
companies
• Translation exposure to equity interests in non-
functional-currency investments in associates and
available-for-sale financial assets.
It is Philips’ policy that significant transaction exposures
are hedged by the businesses. Accordingly, all
businesses are required to identify and measure their
exposures resulting from material transactions
denominated in currencies other than their own
functional currency. Philips’ policy generally requires
committed foreign currency exposures to be fully
hedged using forwards. Anticipated transactions may
be hedged using forwards or options or a combination
thereof. The amount hedged as a proportion of the total
anticipated exposure identified varies per business and
is a function of the ability to project cash flows, the time
horizon for the cash flows and the way in which the
businesses can adapt to changing levels of foreign-
currency exchange rates. As a result, hedging activities
cannot and will not eliminate all currency risks for these
anticipated transaction exposures. Generally, the
maximum tenor of these hedges is 18 months.
172
Annual Report 2014
The following table outlines the estimated nominal
value in millions of euros for transaction exposure and
related hedges for Philips’ most significant currency
exposures consolidated as of December 31, 2014:
Philips Group
Estimated transaction exposure and related hedges
in millions of euros
2014
maturity 0-60 days
maturity over 60 days
exposure
hedges
exposure
hedges
Balance as of
December 31,
2014
Receivables
Functional vs. exposure currency
584
161
80
37
40
44
16
45
14
14
193
1,228
971
(564)
(145)
(63)
(35)
(39)
(41)
(16)
(43)
(11)
(12)
(176)
(1,145)
(874)
1,887
(1,295)
737
372
173
173
107
95
82
74
68
(378)
(192)
(106)
(122)
(81)
(71)
(44)
(31)
(33)
561
4,329
3,691
(302)
(2,655)
(2,239)
EUR vs. USD
USD vs. EUR
EUR vs. GBP
USD vs. JPY
EUR vs. JPY
EUR vs. CNY
GBP vs. USD
EUR vs. PLN
EUR vs. RON
EUR vs. CHF
Others
Total 2014
Total 2013
Payables
Functional vs. exposure currency
EUR vs. USD
USD vs. CNY
EUR vs. PLN
BRL vs. USD
EUR vs. GBP
USD vs. EUR
IDR vs. USD
INR vs. USD
USD vs. SGD
USD vs. MYR
Others
Total 2014
Total 2013
(281)
269
(1,069)
603
(75)
(43)
(33)
(32)
(28)
(26)
(21)
(13)
(12)
(52)
(616)
(457)
72
34
24
26
18
16
21
12
12
48
552
502
(141)
(38)
(27)
(147)
(78)
–
(18)
(21)
(10)
(112)
96
19
14
76
31
–
18
17
10
56
(1,661)
(1,397)
940
831
The derivatives related to transactions are, for hedge
accounting purposes, split into hedges of on-balance-
sheet accounts receivable/payable and forecasted
sales and purchases. Changes in the value of on-
balance-sheet foreign-currency accounts receivable/
payable, as well as the changes in the fair value of the
hedges related to these exposures, are reported in the
income statement under costs of sales. Hedges related
to forecasted transactions, where hedge accounting is
applied, are accounted for as cash flow hedges. The
results from such hedges are deferred in other
comprehensive income within equity to the extent that
the hedge is effective. As of December 31, 2014, a loss
of EUR 13 million was deferred in equity as a result of
these hedges. The result deferred in equity will be
released to earnings mostly during 2015 at the time
when the related hedged transactions affect the
income statement. During 2014, a net gain of EUR 1
million was recorded in the consolidated statement of
income as a result of ineffectiveness on certain
anticipated cash flow hedges.
The total net fair value of hedges related to transaction
exposure as of December 31, 2014 was an unrealized
liability of EUR 27 million. An instantaneous 10%
increase in the value of the euro against all currencies
would lead to an increase of EUR 96 million in the value
of the derivatives; including a EUR 73 million increase
related to foreign exchange transactions of the US
dollar against the euro, a EUR 14 million increase related
to foreign exchange transactions of the Japanese yen
against euro, a EUR 14 million increase related to foreign
exchange transactions of the Pound sterling, partially
offset by a EUR 46 million decrease related to foreign
exchange transactions of the euro against the US dollar.
The EUR 96 million increase includes a gain of EUR 28
million that would impact the income statement, which
would largely offset the opposite revaluation effect on
the underlying accounts receivable and payable, and
the remaining gain of EUR 68 million would be
recognized in equity to the extent that the cash flow
hedges were effective.
The total net fair value of hedges related to transaction
exposure as of December 31, 2013 was an unrealized
asset of EUR 44 million. An instantaneous 10% increase
in the value of the euro against all currencies would lead
to an increase of EUR 63 million in the value of the
derivatives; including a EUR 56 million increase related
to foreign exchange transactions of the US dollar
against the euro, a EUR 15 million increase related to
foreign exchange transactions of the Pound Sterling
against euro, a EUR 13 million increase related to foreign
exchange transactions of the Japanese yen, partially
offset by a EUR 45 million decrease related to foreign
exchange transactions of the euro against the US dollar.
Foreign exchange exposure also arises as a result of
inter-company loans and deposits. Where the
Company enters into such arrangements the financing
is generally provided in the functional currency of the
subsidiary entity. The currency of the Company’s
external funding and liquid assets is matched with the
required financing of subsidiaries either directly
through external foreign currency loans and deposits,
or synthetically by using foreign exchange derivatives,
including cross currency interest rate swaps and foreign
exchange forward contracts. In certain cases where
group companies may also have external foreign
currency debt or liquid assets, these exposures are also
hedged through the use of foreign exchange
derivatives. Changes in the fair value of hedges related
to this exposure are either recognized within financial
income and expenses in the statements of income,
accounted for as cash flow hedges or where such loans
would be considered part of the net investment in the
subsidiary then net investment hedging would be
applied. Translation exposure of foreign-currency
Group financial statements 12.9
equity invested in consolidated entities may be
hedged. If a hedge is entered into, it is accounted for as
a net investment hedge. Net current period change,
before tax, of the currency translation reserve of EUR
600 million relates to the positive impact of the weaker
EURO against the foreign currencies of countries in
which Philips’ operations are located, partially offset by
net investment hedging instruments. The change in
currency translation reserve was mostly related to
development of the USD and to a lesser extent to other
currencies such as the CNY, GBP and INR.
As of December 31, 2014 cross currency interest rate
swaps and foreign exchange forward contracts with a
fair value liability of EUR 655 million and external bond
funding for a nominal value of USD 4,059 million were
designated as net investment hedges of our financing
investments in foreign operations. During 2014 a total
gain of EUR 0.2 million was recognized in the income
statement as ineffectiveness on net investment hedges.
The total net fair value of these financing derivatives as
of December 31, 2014, was a liability of EUR 623 million.
An instantaneous 10% increase in the value of the euro
against all currencies would lead to an increase of EUR
301 million in the value of the derivatives, including a
EUR 323 million increase related to the US dollar.
As of December 31, 2013 cross currency interest rate
swaps and foreign exchange forward contracts with a
fair value liability of EUR 262 million and external bond
funding for a nominal value of USD 4,059 million
were designated as net investment hedges of our
financing investments in foreign operations. During
2013 a total gain of EUR 2 million was recognized in the
income statement as ineffectiveness on net investment
hedges. The total net fair value of these financing
derivatives as of December 31, 2013, was a liability of
EUR 260 million. An instantaneous 10% increase in the
value of the euro against all currencies would lead to an
increase of EUR 228 million in the value of the
derivatives, including a EUR 255 million increase related
to the US dollar.
Philips does not currently hedge the foreign exchange
exposure arising from equity interests in non-
functional-currency investments in associates and
available-for-sale financial assets.
Interest rate risk
Interest rate risk is the risk that the fair value or future
cash flows of a financial instrument will fluctuate
because of changes in market interest rates. Philips had
outstanding debt of EUR 4,104 million, which created
an inherent interest rate risk. Failure to effectively
hedge this risk could negatively impact financial results.
At year-end, Philips held EUR 1,873 million in cash and
cash equivalents, total long-term debt of EUR 3,712
million and total short-term debt of EUR 392 million. At
December 31, 2014, Philips had a ratio of fixed-rate
long-term debt to total outstanding debt of
approximately 85%, compared to 80% one year earlier.
Annual Report 2014
173
Group financial statements 12.9
A sensitivity analysis conducted as of January 2015
shows that if long-term interest rates were to decrease
instantaneously by 1% from their level of December 31,
2014, with all other variables (including foreign
exchange rates) held constant, the fair value of the
long-term debt would increase by approximately EUR
342 million. If there was an increase of 1% in long-term
interest rates, this would reduce the market value of the
long-term debt by approximately EUR 341 million.
If interest rates were to increase instantaneously by 1%
from their level of December 31, 2014, with all other
variables held constant, the annualized net interest
expense would decrease by approximately EUR 13
million. This impact was based on the outstanding net
cash position at December 31, 2014.
A sensitivity analysis conducted as of January 2014
shows that if long-term interest rates were to decrease
instantaneously by 1% from their level of December 31,
2013, with all other variables (including foreign
exchange rates) held constant, the fair value of the
long-term debt would increase by approximately EUR
317 million. If there was an increase of 1% in long-term
interest rates, this would reduce the market value of the
long-term debt by approximately EUR 251 million.
If interest rates were to increase instantaneously by 1%
from their level of December 31, 2013, with all other
variables held constant, the annualized net interest
expense would decrease by approximately EUR 18
million. This impact was based on the outstanding net
cash position at December 31, 2013.
Equity price risk
Equity price risk is the risk that the fair value or future
cash flows of a financial instrument will fluctuate
because of changes in equity prices.
Philips is a shareholder in some publicly listed
companies, including TPV Technology Limited. As a
result, Philips is exposed to potential financial loss
through movements in their share prices. The aggregate
equity price exposure in such financial assets
amounted to approximately EUR 12 million at year-end
2014 (2013: EUR 71 million). Philips does not hold
derivatives in its own stock or in the abovementioned
listed companies. Philips is also a shareholder in several
privately-owned companies amounting to EUR 117
million. As a result, Philips is exposed to potential value
adjustments.
Commodity price risk
Commodity price risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate
because of changes in commodity prices.
Philips is a purchaser of certain base metals, precious
metals and energy. Philips hedges certain commodity
price risks using derivative instruments to minimize
significant, unanticipated earnings fluctuations caused
by commodity price volatility. The commodity price
174
Annual Report 2014
derivatives that Philips enters into are accounted for as
cash flow hedges to offset forecasted purchases. As of
December 2014, a loss of EUR 0.7 million was deferred
in equity as a result of these hedges. A 10% increase in
the market price of all commodities as of December 31,
2014 would increase the fair value of the derivatives by
EUR 0.7 million.
As of December 2013, a loss of EUR 2.2 million was
deferred in equity as a result of these hedges. A 10%
increase in the market price of all commodities as of
December 31, 2013 would increase the fair value of the
derivatives by EUR 1.4 million.
Credit risk
Credit risk represents the loss that would be recognized
at the reporting date, if counterparties failed
completely to perform their payment obligations as
contracted. Credit risk is present within Philips trade
receivables. To have better insights into the credit
exposures, Philips performs ongoing evaluations of the
financial and non-financial condition of its customers
and adjusts credit limits when appropriate. In instances
where the creditworthiness of a customer is determined
not to be sufficient to grant the credit limit required,
there are a number of mitigation tools that can be
utilized to close the gap including reducing payment
terms, cash on delivery, pre-payments and pledges on
assets.
Philips invests available cash and cash equivalents with
various financial institutions and is exposed to credit
risk with these counterparties. Philips is also exposed
to credit risks in the event of non-performance by
financial institutions with respect to financial derivative
instruments. Philips actively manages concentration
risk and on a daily basis measures the potential loss
under certain stress scenarios, should a financial
institution default. These worst-case scenario losses
are monitored and limited by the Company.
The Company does not enter into any financial
derivative instruments to protect against default by
financial institutions. However, where possible the
Company requires all financial institutions with whom it
deals in derivative transactions to complete legally
enforceable netting agreements under an International
Swap Dealers Association master agreement or
otherwise prior to trading, and whenever possible, to
have a strong credit rating from Standard & Poor’s and
Moody’s Investor Services. Philips also regularly
monitors the development of the credit risk of its
financial counterparties. Wherever possible, cash is
invested and financial transactions are concluded with
financial institutions with strong credit ratings or with
governments or government-backed institutions.
Below table shows the credit ratings of the financial
institutions with which Philips had short-term deposits
above EUR 25 million as of December 31, 2014:
Philips Group
Credit risk with number of counterparties
for deposits above EUR 25 million
2014
25-100 million
100-500
million
500-2,000
million
AA-rated
governments
AA-rated
government
banks
AAA-rated bank
counterparties
AA-rated bank
counterparties
A-rated bank
counterparties
–
–
–
2
7
9
–
–
–
1
3
4
–
–
–
–
–
–
For an overview of the overall maximum credit
exposure of the group’s financial assets, please refer to
note 30, Fair value of financial assets and liabilities for
details of carrying amounts and fair value.
Country risk
Country risk is the risk that political, legal, or economic
developments in a single country could adversely
impact our performance. The country risk per country is
defined as the sum of the equity of all subsidiaries and
associated companies in country cross-border
transactions, such as intercompany loans, accounts
receivable from third parties and intercompany
accounts receivable. The country risk is monitored on a
regular basis.
As of December 31, 2014, the Company had country risk
exposure of EUR 8.5 billion in the United States, EUR
2.6 billion in Belgium and EUR 1.8 billion in China
(including Hong Kong). Other countries higher than EUR
500 million are United Kingdom (EUR 709 million) and
Japan (EUR 576 million). Countries where the risk
exceeded EUR 300 million but was less than EUR 500
million are Germany, Malaysia, Poland and Saudi
Arabia. The degree of risk of a country is taken into
account when new investments are considered. The
Company does not, however, use financial derivative
instruments to hedge country risk.
Other insurable risks
Philips is covered for a broad range of losses by global
insurance policies in the areas of property damage/
business interruption, general and product liability,
transport, directors’ and officers’ liability, employment
practice liability, crime, and aviation product liability.
The counterparty risk related to the insurance
companies participating in the above mentioned global
insurance policies are actively managed. As a rule
Philips only selects insurance companies with a S&P
credit rating of at least A-. Throughout the year the
counterparty risk is monitored on a regular basis.
32
Group financial statements 12.9
To lower exposures and to avoid potential losses,
Philips has a global Risk Engineering program in place.
The main focus of this program is on property damage
and business interruption risks including company
interdependencies. Regular on-site assessments take
place at Philips locations and business critical suppliers
by risk engineers of the insurer in order to provide an
accurate assessment of the potential loss and its
impact. The results of these assessments are shared
across the Company’s stakeholders. On-site
assessments are carried out against the predefined Risk
Engineering standards which are agreed between
Philips and the insurers. Recommendations are made
in a Risk Improvement report and are monitored
centrally. This is the basis for decision-making by the
local management of the business as to which
recommendations will be implemented.
For all policies, deductibles are in place, which vary
from EUR 250,000 to EUR 2,500,000 per occurrence
and this variance is designed to differentiate between
the existing risk categories within Philips. Above this
first layer of working deductibles, Philips operates its
own re-insurance captive, which during 2014 retained
EUR 2.5 million per occurrence for property damage
and business interruption losses and EUR 5 million in
the aggregate per year. For general and product liability
claims, the captive retained EUR 1.5 million per claim
and EUR 6 million in the aggregate. New contracts were
signed on December 31, 2014, for the coming year,
whereby the re-insurance captive retentions remained
unchanged.
32 Subsequent events
Acquisition of Volcano
On December 17, 2014, Philips and Volcano Corporation
(Volcano) announced that they had entered into a
definitive merger agreement. Volcano is a US-based
global leader in catheter based imaging and
measurement solutions for cardio vascular applications
and is very complementary to the Philips vision,
strategy, and portfolio in image-guided therapy. On
February 17, 2015, Philips completed a tender offer to
acquire all of the issued and outstanding shares of
Volcano for USD 18.00 per share. The total equity
purchase price and the settlement of stock option rights
involved an amount of USD 955 million (approximately
EUR 840 million) and was paid in cash at closing date.
Philips is financing the acquisition through a
combination of cash on hand and the issuance of debt.
Philips will consolidate 100% of Volcano as of February
17, 2015. Due to the recent closing date, additional IFRS
disclosures cannot be made until the initial accounting
for the business combination has been completed.
Annual Report 2014
175
Company financial statements 13
13 Company financial
statements
Introduction
Statutory financial statements
The sections Group financial statements and Company
financial statements contain the statutory financial
statements of Koninklijke Philips N.V. (the Company).
A description of the Company’s activities and group
structure is included in the Consolidated Financial
Statements.
Accounting policies applied
The financial statements of the Company included in
this section are prepared in accordance with Part 9 of
Book 2 of the Dutch Civil Code. Section 362 (8), Book 2,
Dutch Civil Code, allows companies that apply IFRS as
endorsed by the European Union in their consolidated
financial statements to use the same measurement
principles in their company financial statements. The
Company has prepared these Company financial
statements using this provision.
The accounting policies are described in note 1,
Significant accounting policies.
Investments in group companies are accounted for
using the equity method in these Company financial
statements.
Presentation of Company financial statements
The structure of the Company balance sheets is aligned
with the Consolidated balance sheets in order to
achieve optimal transparency between the Group
financial statements and the Company financial
statements. Consequently, the presentation of the
Company balance sheets deviates from Dutch
regulations.
The Company balance sheet has been prepared before
the appropriation of result.
The Company statement of income has been prepared
in accordance with Section 2:402 of the Dutch Civil
Code, which allows a simplified Statement of income in
the Company financial statements in the event that a
comprehensive Statement of income is included in the
consolidated Group financial statements.
Additional information
For ‘Additional information’ within the meaning of
Section 2:392 of the Dutch Civil Code, please refer to
section 13.5, Independent auditor’s report, of this
Annual Report, and section 5.4, Proposed distribution
to shareholders, of this Annual Report.
176
Annual Report 2014
Company financial statements 13.1
13.1 Balance sheets before appropriation of results
Koninklijke Philips N.V.
Balance sheets in millions of EUR unless otherwise stated
As of December 31
2013
2014
Assets
Non-current assets:
Property, plant and equipment
C
D
Intangible assets
Financial fixed assets
Non-current receivables
Deferred tax assets
E Other non-current financial assets
Total non-current assets
Current assets:
Current financial assets
Receivables
E
F
Assets classified as held for sale
Cash and cash equivalents
Total current assets
Total assets
Liabilities and shareholders’ equity
G
Shareholders’ equity:
Preference shares, par value EUR 0.20 per share:
- Authorized: 2,000,000,000 shares (2013: 2,000,000,000 shares)
- Issued: none
Common shares, par value EUR 0.20 per share:
- Authorized: 2,000,000,000 shares (2013: 2,000,000,000 shares)
- Issued and fully paid: 934,819,413 shares (2013: 937,845,789 shares)
Capital in excess of par value
Legal reserve: revaluation
Legal reserve: available-for-sale financial assets
Legal reserve: cash flow hedges
Legal reserve: affiliated companies
Legal reserve: currency translation differences
Retained earnings
A Net income1)
Treasury shares, at cost: 20,430,544 shares (2013: 24,508,022 shares)
Total equity
Non-current liabilities:
H
Long-term debt
Long-term provisions
Deferred tax liabilities
Other non-current liabilities
Total non-current liabilities
H
I
Current liabilities:
Short-term debt
Other current liabilities
Total current liabilities
K
Contractual obligations and contingent liabilities not appearing in the balance sheet
Liabilities and shareholders’ equity
1) Prepared before appropriation of results
18
55
19,535
32
161
283
7,500
45
1,282
188
1,796
23
55
24
1,319
(569)
7,927
1,169
(718)
3,158
16
15
161
13,645
702
1
57
19,676
46
479
229
20,084
20,488
121
8,469
54
701
8,827
28,911
9,345
29,833
187
2,181
13
27
(13)
1,059
229
7,316
415
(547)
11,214
10,867
3,555
10
12
119
3,350
3,696
14,060
1,210
14,347
28,911
15,270
29,833
Annual Report 2014
177
Company financial statements 13.2
13.2 Statements of income
Koninklijke Philips N.V.
Statements of income in millions of EUR unless otherwise stated
For the year ended December 31
Net income from affiliated companies
Other net income
A Net income
13.3 Statement of changes in equity
Koninklijke Philips N.V.
Statement of changes in equity in millions of EUR unless otherwise stated
For the year ended December 31
2013
1,276
(107)
1,169
2014
(432)
847
415
availa ble-for-sale fin a ncial assets
ca pital in excess of p ar valu e
revalu atio n reserve
cash flo w h e d g es
curre ncy tra nslatio n differe nces
affiliate d co m p a nies
retain e d e arnin gs
n et inco m e
m o n sh ares
co m
tre asury sh ares
sh are h old ers’ e q uity
legal reserves
188
1,796
23
55
24
1,319
(569)
7,927
1,169
(718)
11,214
(10)
30
(4)
(54)
1,169
(1,169)
415
10
(40)
(260)
600
(423)
10
(7)
203
(5)
(729)
(529)
(26)
(83)
415
–
(93)
209
(66)
(293)
533
–
(688)
(714)
326
116
88
(9)
3
(4)
433
(127)
88
(9)
187
2,181
13
27
(13)
1,059
229
7,316
415
(547)
10,867
Balance as of
January 1, 2014
Appropriation of prior
year result
Net income
Release revaluation
reserve
Net current period
change
Income tax on net
current period change
Reclassification into
income
Dividend distributed
Cancellation of treasury
shares
Purchase of treasury
shares
Re-issuance of treasury
shares
Share-based
compensation plans
Income tax on share-
based
compensation plans
Balance as of
December 31, 2014
178
Annual Report 2014
13.4 Notes
Notes to the Company financial statements
A Net income
Net income from affiliated companies represents the share
of the company in the results of these affiliated companies.
B Audit fees
For a summary of the audit fees, please refer to the
Group Financial statements, note 6, Income from
operations, which is deemed incorporated and
repeated herein by reference.
C
Intangible assets
Intangible assets includes mainly licenses and patents.
The changes during 2014 are as follows;
Koninklijke Philips N.V.
Intangible assets in millions of EUR
2014
Balance as of January 1, 2014:
Cost
Amortization/ impairments
Book value
Changes in book value:
Additions
Amortization
Total changes
Balance as of December 31, 2014:
Cost
Amortization/ impairments
Book value
D Financial fixed assets
A
B
C
D
Company financial statements 13.4
Koninklijke Philips N.V.
Financial fixed assets in millions of EUR
2014
investments
in group
companies
investments
in associates
loans
total
13,591
71
5,873
19,535
Balance as of
January 1, 2014
Changes:
Reclassifications
35
Acquisitions/
additions
Sales/
redemptions
Net income from
affiliated
companies
Dividends
received
Translation
differences
Transfer to assets
classified as held
for sale
Other
Balance as of
December 31,
2014
(8)
6
–
16
(19)
–
27
749
3,134
(348)
(1,455)
–
–
(469)
(1,855)
2,379
(1,107)
(485)
(1,836)
687
7
676
1,370
–
(604)
(7)
–
–
–
(7)
(604)
12,660
66
6,950
19,676
67
(12)
55
20
(18)
2
87
(30)
57
During 2014, the increase in acquisitions/additions line is
mainly related to the purchase of a group company
amounting to EUR 2,165 million. The same group company
made a capital repayment of EUR 562 million which is
reflected as part of the movement in sales/redemptions
and issued an interim dividend of EUR 1,458 million shown
in the dividends received line. These transactions were
executed in view of our continued effort to restructure and
optimize our foreign based intra-group finance activities.
The remaining movements in sales/redemptions reflect
restructuring in the group.
Included in other, under Investments in Group
companies, are remeasurements of EUR 683 million
related to defined-benefit plans of group companies.
The investments in group companies and associates are
presented as financial fixed assets in the balance sheet using
the equity method. Goodwill paid upon acquisition of
investments in group companies or associates is included in
the net equity value of the investment and is not shown
separately on the face of the balance sheet.
Loans provided to group companies are stated at
amortized cost, less impairment.
A list of investments in group companies, prepared in
accordance with the relevant legal requirements (Dutch Civil
Code, Book 2, Sections 379 and 414), is deposited at the
Chamber of Commerce in Eindhoven, The Netherlands.
Annual Report 2014
179
Company financial statements 13.4
E
F
G
E Other financial assets
F Receivables
Other non-current financial assets
The changes during 2014 were as follows:
Koninklijke Philips N.V.
Other non-current financial assets in millions of EUR
2014
available
-for-sale
financial
assets
loans and
receivables
financial
assets at
fair value
through
profit and
loss
86
8
10
(12)
(4)
(37)
45
190
(121)
60
–
–
–
4
7
–
–
–
–
–
(7)
total
283
(113)
70
(12)
(4)
(37)
42
96
133
–
229
Balance as of
January 1, 2014
Changes:
Reclassifications
Acquisitions/
additions
Sales/
redemptions/
reductions
Impairments
Transfer to assets
classified as held
for sale
Value adjustments
Balance as of
December 31,
2014
Available-for-sale financial assets
The Company’s investments in available-for-sale
financial assets mainly consist of investments in
common stock of companies in various industries. An
amount of EUR 37 million has been reclassified to
assets held for sale in relation to the contribution
agreement between the Philips Pension Fund, Philips
and Dutch trade unions on July 1, 2013.
Loans and receivables
The reclassification line includes loans of EUR 121 million
transferred to Current financial assets (see below). The
acquisitions/additions line relates to a new loan of EUR 60
million issued to TPV Technology Limited.
Financial assets at fair value through profit and loss
In 2010 Philips sold its entire holding of common shares in
NXP Semiconductors B.V. (NXP) to Philips Pension Trustees
Limited (herein referred to as “UK Pension Fund”). The
purchase agreement with the UK Pension Fund included an
arrangement that entitled Philips to a cash payment from the
UK Pension Fund on or after September 7, 2014, if certain
conditions were met. As of December 31, 2013,
management’s best estimate of the fair value of the
arrangement was EUR 7 million. At the date of expiration on
September 7, 2014 the arrangement did not represent any
value. The decline in fair value in 2014 is reported under value
adjustments in the table above.
Current financial assets
The amount of EUR 121 million relates to loans issued
to TPV Technology Limited. These loans are due in 2015
and have therefore been reclassified from non-current
to Current financial assets.
Koninklijke Philips N.V.
Receivables in millions of EUR
2013 - 2014
Trade accounts receivable
Affiliated companies
Other receivables
Advances and prepaid expenses
Derivative instruments - assets
2013
80
7,177
5
28
210
2014
105
7,916
48
15
385
Receivables
7,500
8,469
G Shareholders’ equity
Common shares
As of December 31, 2014, the issued and fully paid share
capital consists of 934,819,413 common shares, each
share having a par value of EUR 0.20.
In June 2014, Philips settled a dividend of EUR 0.80 per
common share, representing a total value of EUR 729
million. Shareholders could elect for a cash dividend or
a share dividend. 60% of the shareholders elected for
a share dividend, resulting in the issuance of 18,811,534
new common shares. The settlement of the cash
dividend resulted in a payment of EUR 293 million
including tax and service charges.
The following table shows the movements in the
outstanding number of shares:
Koninklijke Philips N.V.
Outstanding number of shares in number of shares
2013 - 2014
2013
2014
Balance as of January 1
914,591,275
913,337,767
Dividend distributed
18,491,337
18,811,534
Purchase of treasury shares
(27,811,356)
(28,537,921)
Re-issuance of treasury shares
8,066,511
10,777,489
Balance as of December 31
913,337,767
914,388,869
Preference shares
The ‘Stichting Preferente Aandelen Philips’ has been granted
the right to acquire preference shares in the Company. Such
right has not been exercised. As a means to protect the
Company and its stakeholders against an unsolicited attempt
to (de facto) take over control of the Company, the General
Meeting of Shareholders in 1989 adopted amendments to
the Company’s articles of association that allow the Board
of Management and the Supervisory Board to issue (rights
to acquire) preference shares to a third-party. As of
December 31, 2014, no preference shares have been issued.
Option rights/restricted and performance
shares
The Company has granted stock options on its common
shares and rights to receive common shares in the
future. Please refer to note 28, Share-based
compensation, which is deemed incorporated and
repeated herein by reference.
180
Annual Report 2014
Treasury shares
In connection with the Company’s share repurchase
programs, shares which have been repurchased and are
held in treasury for (i) delivery upon exercise of options,
performance and restricted share programs and
employee share purchase programs, and (ii) capital
reduction purposes, are accounted for as a reduction of
shareholders’ equity. Treasury shares are recorded at
cost, representing the market price on the acquisition
date. When issued, shares are removed from treasury
shares on a FIFO basis.
When treasury shares are reissued under the
Company’s option plans, the difference between the
cost and the cash received is recorded in retained
earnings. When treasury shares are reissued under the
Company’s share plans, the difference between the
market price of the shares issued and the cost is
recorded in retained earnings.
Dividend withholding tax in connection with the
Company’s purchase of treasury shares is recorded in
retained earnings.
The following transactions took place resulting from
employee option and share plans:
Koninklijke Philips N.V.
Employee option and share plan transactions
2013 - 2014
Shares acquired
2013
3,984
Average market price
EUR 22.51
2014
7,254,606
EUR 24.53
Amount paid
Shares delivered
Average market price
EUR 0 million
EUR 178 million
8,066,511
EUR 28.35
10,777,489
EUR 30.26
Cost of delivered shares
EUR 229 million
EUR 326 million
Total shares in treasury
at year-end
20,650,427
17,127,544
Total cost
EUR 618 million
EUR 470 million
In order to reduce share capital, the following
transactions took place:
Koninklijke Philips N.V.
Share capital transactions
2013 - 2014
Shares acquired
Average market price
2013
27,807,372
EUR 22.69
2014
21,283,315
EUR 23.95
Amount paid
EUR 631 million
EUR 510 million
Reduction of capital
stock (shares)
Reduction of capital
stock (EUR)
Total shares in treasury
at year-end
37,778,510
21,837,910
EUR 787 million
EUR 533 million
3,857,595
3,303,000
Total cost
EUR 100 million
EUR 77 million
Stock purchase transactions related to employee
option and share plans, as well as transactions related
to the reduction of share capital involved a cash outflow
Company financial statements 13.4
of EUR 712 million, which includes the impact of taxes.
Settlements of stock based compensation plans
involved a cash inflow of EUR 116 million.
Dividend distribution
A proposal will be submitted to the 2015 Annual
General Meeting of Shareholders to pay a dividend of
EUR 0.80 per common share, in cash or shares at the
option of the shareholder, from the 2014 net income
and retained earnings of the Company.
Legal reserves
As of December 31, 2014, legal reserves relate to the
revaluation of assets and liabilities of acquired
companies in the context of multi-stage acquisitions of
EUR 13 million (2013: EUR 23 million), unrealized gains
on available-for-sale financial assets of EUR 27 million
(2013: EUR 55 million), unrealized losses on cash flow
hedges of EUR 13 million (2013: EUR 24 million
unrealized gains), ‘affiliated companies’ of EUR 1,059
million (2013: EUR 1,319 million) and unrealized
currency translation gains of EUR 229 million (2013:
EUR 569 million unrealized losses).
The item ‘affiliated companies’ relates to the ‘wettelijke
reserve deelnemingen’, which is required by Dutch law.
This reserve relates to any legal or economic restrictions
on the ability of affiliated companies to transfer funds
to the parent company in the form of dividends.
Limitations in the distribution of shareholders’
equity
Pursuant to Dutch law, limitations exist relating to the
distribution of shareholders’ equity of EUR 1,515 million
as at December 31, 2014. Such limitations relate to
common shares of EUR 187 million, as well as to legal
reserves included under ‘revaluation’ of EUR 13 million,
available-for-sale financial assets of EUR 27 million,
unrealized currency translation gains of EUR 229
million and ‘affiliated companies’ of EUR 1,059 million.
The unrealized losses related to cash flow hedges of
EUR 13 million, although qualifying as a legal reserve,
reduce the distributable amount by their nature.
As at December 31, 2013 the limitations on distributable
amounts were EUR 1,609 million and related common
shares of EUR 188 million, as well as to legal reserves
included under ‘revaluation’ of EUR 23 million,
available-for-sale financial assets of EUR 55 million,
unrealized gains on cash flow hedges of EUR 24 million
and ‘affiliated companies’ of EUR 1,319 million. The
unrealized losses related to currency translation
differences of EUR 569 million, although qualifying as
a legal reserve, reduce the distributable amount by their
nature.
Annual Report 2014
181
Company financial statements 13.4
H
I
J
K
L
H Debt
Long-term debt
Koninklijke Philips N.V.
Long-term debt in millions of EUR, unless otherwise stated
2013 - 2014
USD bonds
Intercompany
financing
Bank borrowings
(range of)
interest
rates
3.8 - 7.8%
0.0 - 4.1%
1.3 - 1.6%
Other long-term debt
2.5 - 7.0%
Corresponding data
previous year
average
interest rate
amount
outstanding
in 2014
amount due
in 1 year
amount due
after 1 year
amount due
after 5 years
average
remaining
term (in
years)
amount
outstanding
2013
5.6%
3,355
–
3,355
2,333
12.7
2,958
0.8%
1.5%
4.5%
3,025
200
43
6,623
3,025
–
43
–
200
–
–
200
–
3,068
3,555
2,533
–
7.0
1.0
5,751
2,593
3,158
2,259
2,296
450
47
5,751
4,153
The following amounts of the long-term debt as of
December 31, 2014, are due in the next five years:
Koninklijke Philips N.V.
Long-term debt due in the next five years in millions of EUR
2014
2015
2016
2017
2018
2019
Long -term debt
Corresponding amount previous year
3,068
–
–
1,022
4,090
3,492
Short-term debt
Short-term debt includes the current portion of
outstanding external and intercompany long-term debt
of EUR 3,068 million (2013: EUR 2,593 million), other
debt to group companies totaling EUR 10,929 million
(2013: EUR 10,976 million) and short-term bank
borrowings of EUR 63 million (2013: EUR 76 million).
I Other current liabilities
Koninklijke Philips N.V.
Other current liabilities in millions of EUR
2013 - 2014
Income tax payable
Other short-term liabilities
Accrued expenses
Derivative instruments - liabilities
Other current liabilities
J Employees
2013
2014
4
53
174
471
702
–
63
138
1,009
1,210
The number of persons employed by the Company at
year-end 2014 was 10 (2013: 10) and included the
members of the Board of Management and certain
leaders from functions, businesses and markets,
together referred to as the Executive Committee. For the
remuneration of past and present members of both the
Board of Management and the Supervisory Board, please
refer to note 29, Information on remuneration, which is
deemed incorporated and repeated herein by reference.
K Contractual obligations and contingent
liabilities not appearing in the balance sheet
The Company has entered into a contract with a venture
capitalist where it committed itself to make, under certain
conditions, capital contributions to its investment funds
to an aggregated amount of EUR 35 million (2013: EUR 40
million) until June 30, 2021. As at December 31, 2014
capital contributions already made to this investment
fund are recorded as available-for-sale financial assets
within Other non-current financial assets. Furthermore,
the Company made commitments to third parties in 2014
of EUR 10 million (2013: EUR 16 million) with respect to
sponsoring activities. The amounts are due before 2016.
General guarantees as referred to in Section 403, Book 2,
of the Dutch Civil Code, have been given by the Company
on behalf of several group companies in the Netherlands.
The liabilities of these companies to third parties and
investments in associates totaled EUR 1,546 million as of
year-end 2014 (2013: EUR 1,255 million).
Guarantees totaling EUR 636 million (2013: EUR 613
million) have also been given on behalf of other group
companies and credit guarantees totaling EUR 4 million
(2013: EUR 15 million) on behalf of unconsolidated
companies and third-parties. The Company is the head
of a fiscal unity that contains the most significant Dutch
wholly-owned group companies. The Company is
therefore jointly and severally liable for the tax liabilities
of the tax entity as a whole. For additional information,
please refer to note 26, Contingent assets and
liabilities, which is deemed incorporated and repeated
herein by reference.
L Subsequent events
For subsequent events please refer to the Group Financial
Statements, note 32, Subsequent events, which is deemed
incorporated and repeated herein by reference.
182
Annual Report 2014
13.5 Independent auditor’s report
To: The Annual General Meeting of Shareholders of
Koninklijke Philips N.V.
Report on the audit of the financial statements
2014
Our opinion
We have audited the financial statements 2014 of
Koninklijke Philips N.V. (the Company), Eindhoven, the
Netherlands. The financial statements include the
consolidated and company financial statements.
In our opinion:
• the consolidated financial statements give a true and
fair view of the financial position of Koninklijke Philips
N.V. as at December 31, 2014 and of its result and its
cash flows for 2014 in accordance with International
Financial Reporting Standards as adopted by the
European Union (EU-IFRS) and with Part 9 of Book 2
of the Dutch Civil Code.
• The company financial statements give a true and fair view
of the financial position of Koninklijke Philips N.V. as at
December 31, 2014 and of its result for 2014 in accordance
with Part 9 of Book 2 of the Dutch Civil Code.
The consolidated financial statements comprise:
1.
2.
3.
the consolidated balance sheet as at December 31,
2014;
the following statements for 2014: consolidated
statements of income, comprehensive income,
cash flows and changes in equity for the year then
ended; and
the notes comprising a summary of the significant
accounting policies and other explanatory
information.
The company financial statements comprise:
1.
2.
3.
the company balance sheet as at December 31,
2014;
the company statement of income for 2014; and
the notes comprising a summary of the significant
accounting policies and other explanatory information.
Basis for our opinion
We conducted our audit in accordance with Dutch law,
including the Dutch Standards on Auditing. Our
responsibilities under those standards are further
described in the “Our responsibilities for the audit of the
financial statements” section of our report.
We are independent of Koninklijke Philips N.V. in
accordance with the “Verordening inzake de
onafhankelijkheid van accountants bij assurance-
opdrachten” (ViO) and other relevant independence
regulations in the Netherlands. Furthermore, we have
complied with the “Verordening gedrags- en
beroepsregels accountants” (VGBA).
Company financial statements 13.5
We believe that the audit evidence we have obtained is
sufficient and appropriate to provide a basis for our
opinion.
Materiality
Misstatements can arise from fraud or errors and are
considered material if, individually or in the aggregate,
they could reasonably be expected to influence the
economic decisions of users taken on the basis of these
financial statements. The materiality affects the nature,
timing and extent of our audit procedures and the
evaluation of the effect of identified misstatements on our
opinion.
Based on our professional judgment we determined the
materiality for the financial statements as a whole at
EUR 80 million. Materiality is based on sales, as we
consider this benchmark to be the most relevant given
the nature of the business and size of the Company and
approximates 0.4% of sales. We have also taken into
account misstatements and/or possible misstatements
that in our opinion are material for qualitative reasons
for the users of the financial statements.
We agreed with the Supervisory Board that
misstatements in excess of EUR 4 million, which are
identified during the audit, would be reported to them,
as well as smaller misstatements that in our view must
be reported on qualitative grounds.
Scope of our group audit
Koninklijke Philips N.V. is the parent company of the
Philips Group (the Group). The financial information of
the Group is included in the financial statements of
Koninklijke Philips N.V
Considering our ultimate responsibility for the opinion,
we are responsible for directing, supervising and
performing the group audit. In this context, we have
determined the nature and extent of the audit
procedures to be performed for group entities
(components). Decisive factors were the significance
and / or the risk profile of the components. On this basis,
we selected the components for which an audit of
account balance or specified procedures had to be
performed. Furthermore, we have determined the audit
procedures that we perform at group level, sector level
and in the Finance Operations centers.
We scope components to be involved with the audits of
account balances into the group audit where account
balances are of significant size, have significant risks of
material misstatement to the Group associated with
them or are considered significant for other reasons.
Where this does not give adequate coverage we use our
judgment to scope-in additional procedures on
account balances or request the component auditors to
perform specified procedures. As a result of our scoping
of account balances and the performance of audit
procedures at different levels in the organization, our
Annual Report 2014
183
Company financial statements 13.5
actual coverage varies per account balance and the
depth of our audit procedures per account balance
varies depending on our risk assessment.
Accordingly, our audit coverage per account balance
included in the key audit matters stated below, can be
summarized as follows:
• For goodwill, we have applied a centralized audit
approach with specified audit procedures on 90% of
the goodwill account balance and limited procedures
on the remaining of the goodwill account balance.
• For income taxes, we have identified 10 entities in the
group for which we performed an audit of account
balances and/or specified procedures at the
component level. These 10 entities represent 90% of
the income tax accounts deferred tax assets and
income tax provisions. The remaining population is
covered by limited procedures performed centrally
by the group auditor.
• For revenue recognition, we have identified 31 entities
in the group for which we performed an audit of
account balances and/or specified procedures at the
component level. These 31 entities represent 58% of
sales. This scope is extended by specified procedures
on sales performed centrally, representing an
additional 17% of sales resulting in a coverage of 75%
of sales. The remaining population is covered by
limited procedures performed.
• For contingent liabilities and provisions from legal
proceedings, we have applied a centralized audit
approach with specified audit procedures performed
by the component auditors. Our audit procedures
cover 96% of the recognized legal claim provision
and all significant legal proceedings without a legal
claim provision recognized.
Audits of account balances or specified procedures
were performed to materiality levels, the majority of
which were based on the relevant local statutory audit
materiality which is considerably lower than Group
materiality. In the other cases, component materiality
was determined by the judgment of the group auditor,
having regard to the materiality for the financial
statements as a whole and the reporting structure
within the Group. Component materiality did not
exceed EUR 40 million and the majority of our
component auditors applied a component materiality
that is significantly less than this threshold.
The group auditor sent detailed instructions to all
component auditors, covering the significant areas that
should be covered (which included the relevant risks of
material misstatement detailed above) and set out the
information required to be reported to the group
auditor. Based on our risk assessment, the group
auditor visited component locations in China, Germany,
Indonesia, the Netherlands, Panama, Singapore and
the USA. Most of our component auditors visited the
Netherlands in 2014 to attend our global audit
conference, which is held every three years, to discuss
the Group audit, risks, audit approach and instructions.
184
Annual Report 2014
Telephone calls were also held with the auditors of
components that were both physically and not
physically visited. During these visits and meetings, the
audit approach, findings and observations reported to
the group auditor were discussed in more detail.
We have used other auditors for the audit of
components outside The Netherlands. By performing
the procedures mentioned above at components,
combined with additional procedures at group level,
sector level and at Finance Operations centers, we have
been able to obtain sufficient and appropriate audit
evidence regarding the group’s financial information to
provide an opinion on the financial statements.
Our key audit matters
Key audit matters are those matters that, in our
professional judgment, were of most significance in our
audit of the financial statements. We have
communicated the key audit matters to the Supervisory
Board. The key audit matters are not a comprehensive
reflection of all matters discussed.
These matters were addressed in the context of our
audit of the financial statements as a whole and in
forming our opinion thereon, and we do not provide a
separate opinion on these matters.
Finance Transformation
The Company continued to implement its global
Accelerate! initiative, which includes a Finance
Transformation program. The Finance Transformation
has a significant impact on the Company’s business
processes, control activities and internal control
responsibilities. We focused on the Finance
Transformation as part of our audit because there is a
significant risk that a material misstatement could occur
if the program was not implemented with proper
oversight and a focus on maintaining effective internal
controls throughout the process.
Our audit procedures included, amongst others, meetings
with the Board of Management and the Audit Committee
of the Supervisory Board on a regular basis during the
year to understand and monitor the effects of changes to
the Company’s internal control environment, across the
organization. We performed site visits in three major
geographic regions to test the effectiveness of controls
impacted by the Finance Transformation and instructed
our component auditors globally to perform procedures
designed to provide reasonable assurance that a material
misstatement did not exist in the financial statements as
a result of the program. We also tested monitoring
activities executed at different levels of the organization
designed to ensure continued effectiveness of the internal
control framework during the Finance Transformation.
Valuation of goodwill
Under EU-IFRSs, the Company is required to test the
amount of goodwill for impairment, both annually and
if there is a trigger for testing. The impairment tests were
significant to our audit due to the complexity of the
assessment process and significant judgments and
assumptions involved which are affected by expected
future market or economic conditions. At December 31,
2014, the goodwill amounted to EUR 7.2 billion.
Our audit procedures included, amongst others, the
involvement of a valuation expert to assist us in
evaluating the assumptions and methodologies used
by the Company, in particular those relating to the
compound sales growth rate and pre-tax discount rate.
The cash flow projections, mainly for Healthcare cash-
generating units – Respiratory Care & Sleep
Management, Imaging Systems, and Patient Care &
Monitoring Solutions and Lighting cash-generating
units - Professional Lighting Solutions and Consumer
Luminaires have been assessed and challenged by us,
and includes an assessment of the historical accuracy
of management’s estimates and evaluation of business
plans. Based on the impairment test, it was noted that
with regard to the headroom for cash-generating unit
Consumer Luminaires, the estimated recoverable
amount approximates the carrying value of the cash-
generating unit. We also assessed the adequacy of the
disclosures in Section 12.9, Note 11 Goodwill relating to
those assumptions to which the outcome of the
impairment test is most sensitive, that is, those that
have the most significant effect on the determination of
the recoverable amount of goodwill.
Accounting for income tax positions
Income tax was significant to our audit because the
assessment process is complex and the amounts involved
are material to the financial statements as a whole. The
Company has extensive international operations and in the
normal course of business makes judgments and estimates
in relation to tax issues and exposures resulting in the
recognition of other tax liabilities. At December 31, 2014, the
net deferred tax assets are valued at EUR 2.4 billion and the
other tax liability related to tax uncertainties is valued at EUR
499 million.
We have tested the completeness and accuracy of the
amounts reported for current and deferred tax including
the assessment of disputes with tax authorities. In this
area our audit procedures included, amongst others,
assessment of correspondence with the relevant tax
authorities, testing the effectiveness of the Company’s
internal controls around the recording and continuous re-
assessment of the other tax liabilities, and the
involvement of our local component auditors including
tax specialists in those components determined to be the
regions with significant tax risk. In respect of deferred tax
assets, we tested management’s assumptions used to
determine the probability that deferred tax assets
recognized in the balance sheet will be recovered through
taxable income in the countries where the deferred tax
assets originated and during the periods when the
deferred tax assets become deductible. During our
procedures, we used amongst others budgets, forecasts
and tax laws and in addition we assessed the historical
accuracy of management’s assumptions. We also
Company financial statements 13.5
assessed the adequacy of the Company’s disclosure
included in Section 12.9, Note 8 Income taxes in respect
of income tax positions and uncertain tax positions.
Revenue recognition
Sales contracts for certain projects in the Healthcare
and Lighting sectors typically involve multi-element
contracts, for example a single sales transaction that
combines the delivery of goods and rendering of
services, and involve separately identifiable
components that are recognized based on relative fair
value. This gives rise to the risk that sales could be
misstated due to the complexity of the multi-element
contracts and the incorrect valuation of the relative fair
value elements. Sales in the remaining sectors are
generally recognized when the risks and rewards of the
underlying products have been transferred to the
customer and tend not to have multiple deliverable
elements. There is a risk that sales may be deliberately
overstated as a result of management override resulting
from the pressure management may feel to achieve
planned results. The management of the Group focuses
on sales as a key performance measure which could
create an incentive for sales to be recognized before
the risks and rewards have been transferred.
Our audit procedures included, amongst others,
assessing the appropriateness of the Company’s
revenue recognition accounting policies including
those relating to multi-element contracts and assess
compliance with the policies in terms of EU-IFRS. We
tested the effectiveness of the Company’s controls over
calculation of rebates, fair value determination of
multi-element sales contracts, and the correct timing of
revenue recognition. We also assessed sales
transactions taking place before and after year-end to
ensure that revenue was recognized in the correct
period and assessed the accuracy of the sales
recorded, based amongst others on inspection of sales
contracts, hand over certificates and hours reported
after recognition of revenue. We have assessed the
appropriateness of management’s response to
indications of improper revenue recognition and
performed additional work where considered
necessary. We also assessed the adequacy of the sales
disclosures contained in Section 12.9, Note 2
Information by sector and main country and Note 6
Income from operations.
Contingent liabilities and provisions from claims,
proceedings and investigations
The Company and certain of its group companies and
former group companies are involved as a party in legal
proceedings, including regulatory and other
governmental proceedings as well as investigations by
authorities. Since the ultimate disposition of asserted
claims and proceedings and investigations cannot be
predicted with certainty, an adverse outcome could
have a material adverse effect on the financial position,
results of operations and cashflows, resulting in the
identification of a significant financial statement risk.
Annual Report 2014
185
Company financial statements 13.5
The accounting for (contingent) liabilities from claims,
proceedings and investigations is complex and
judgemental, and the amounts involved are, or can be
material to the financial statements as a whole. At
December 31, 2014, the provisions from legal
proceedings amount to EUR 653 million, in case the
company has a present legal or constructive obligation
that cannot be estimated reliably, no provisions have
been recognized.
In response to these risks, our audit procedures
included, amongst others, testing the effectiveness of
the Company’s controls around the identification and
evaluation of claims, proceedings and investigations at
different levels in the organization, and the recording
and continuous re-assessment of the related
(contingent) liabilities and provisions and disclosures,
in accordance with EU-IFRS. We also inquired with both
legal and financial staff in respect of ongoing
investigations or claims, proceedings and
investigations, inspected relevant correspondence,
inspected the minutes of the meetings of the Audit
Committee, Supervisory Board and Executive
Committee, requested external legal confirmation
letters from a selection of external legal counsel and
obtained a legal representation letter from the
Company.
We evaluated and tested the Company’s policies,
procedures and controls surrounding the application of
the General Business Principles (GBP), the
identification and reporting of violations and assessed
management’s response to any GBP violations. We also
assessed the disclosure regarding (contingent)
liabilities from legal proceedings and investigations as
contained in Section 12.9, Note 19 Provisions, Note 22
Other Liabilities and Note 26 Contingent assets and
liabilities.
Responsibilities of the Board of Management and
the Supervisory Board for the financial statements
The Board of Management is responsible for the
preparation and fair presentation of the financial
statements in accordance with EU-IFRS and Part 9 of
Book 2 of the Dutch Civil Code, and for the preparation
of the Management report in accordance with Part 9 of
Book 2 of the Dutch Civil Code. Furthermore, the Board
of Management is responsible for such internal control
as the Board of Management determines is necessary
to enable the preparation of the financial statements
that are free from material misstatement, whether due
to fraud or error.
In preparing the financial statements, the Board of
Management is responsible for assessing the
Company’s ability to continue as a going concern.
Based on the financial reporting frameworks
mentioned, the Board of Management should prepare
the financial statements using the going concern basis
of accounting unless the Board of Management either
intends to liquidate the Company or to cease
operations, or has no realistic alternative but to do so.
186
Annual Report 2014
The Board of Management should disclose events and
circumstances that may cast significant doubt on the
Company’s ability to continue as a going concern in the
financial statements.
The Supervisory Board is responsible for overseeing the
Company’s financial reporting process.
Our responsibilities for the audit of the financial
statements
Our objective is to plan and perform the audit assignment in
a manner that allows us to obtain sufficient and appropriate
audit evidence for our opinion.
Our audit has been performed with a high, but not
absolute, level of assurance, which means we may have
not detected all errors and fraud.
For a further description of our responsibilities in
respect of an audit of financial statements in general,
we refer to the website of the professional body for
accountants in the Netherlands (NBA).
www.nba.nl/standardtexts-auditorsreport.
Report on other legal and regulatory requirements
Report on the Management report and the other
information
Pursuant to legal requirements under Part 9 of Book 2
of the Dutch Civil Code (concerning our obligation to
report about the Management report and other
information):
• We have no deficiencies to report as a result of our
examination whether the Management report, to the
extent we can assess, has been prepared in accordance
with Part 9 of Book 2 of the Dutch Civil Code, and whether
the information as required by Part 9 of Book 2 of the
Dutch Civil Code has been annexed.
• We report that the Management report, to the extent we
can assess, is consistent with the financial statements.
Appointment
We were appointed before 2008 for the first time as
auditor of Koninklijke Philips N.V. and operated as
auditor since then. We were re-appointed by the
Annual General Meeting of Shareholders as auditor of
Koninklijke Philips N.V. on March 31, 2011, for the three
year period 2012 – 2014. On May 1, 2014, we were
appointed by the Annual General Meeting of
Shareholders as auditor of Koninklijke Philips N.V. for
the year 2015, after which we will mandatorily rotate off
from the Philips audit pursuant to Dutch law.
Amsterdam, The Netherlands
February 24, 2015
KPMG Accountants N.V.
E.H.W. Weusten RA
14 Sustainability statements
Sustainability statements 14
Approach to sustainability reporting
In 1999 Philips published its first environmental Annual
Report. This was expanded in 2003, with the launch of our
first sustainability Annual Report, which provided details
of our social and economic performance in addition to our
environmental results.
In 2008, we decided to publish an integrated financial,
social and environmental report, reflecting the progress
we have made embedding sustainability in our way of
doing business. This is also supported by the inclusion of
sustainability in the Philips Mission, Vision and the
company strategy. For more information, please refer to
chapter 4, Our strategic focus, of this Annual Report.
This is our seventh annual integrated financial, social and
environmental report which has been prepared in line
with the International Integrated Reporting Council (IIRC)
Integrated Reporting
Continue reading text version or see original annual report in PDF format above